data_2kuq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kuq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 120.485 0.183 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.9 t80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.363 0.125 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.348 0.118 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.323 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.727 0.299 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.9 ptp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.363 0.125 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.738 -0.097 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HG ' ' A' ' 143' ' ' CYS . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.467 0.175 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . 0.4 ' HG ' ' HB2' ' A' ' 68' ' ' ASP . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.556 0.217 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 120.581 0.229 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.0 t80 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.492 0.187 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.679 0.275 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.719 0.295 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.4 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm . . . . . 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 120.859 0.361 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.174 0.035 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.683 0.278 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.843 0.354 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 120.522 0.201 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.436 0.16 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.665 0.269 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.82 0.343 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.435 0.159 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -148.17 150.11 33.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.96 1.304 . . . . 0.0 111.215 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 t -87.04 138.86 31.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.583 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.21 -175.44 50.51 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.617 1.103 . . . . 0.0 112.989 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 t -160.48 136.65 8.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.999 1.319 . . . . 0.0 110.638 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -79.87 117.87 21.12 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.244 -0.91 . . . . 0.0 111.268 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.59 -32.27 59.71 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.555 0.597 . . . . 0.0 113.801 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.71 159.34 13.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.969 2.107 . . . . 0.0 111.976 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -144.69 137.67 26.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.939 1.695 . . . . 0.0 109.497 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.41 41.8 0.32 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.154 1.382 . . . . 0.0 112.364 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -149.21 149.84 31.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.597 1.959 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -71.58 -18.93 62.2 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.08 120.89 69.22 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.252 1.021 . . . . 0.0 109.979 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.88 158.99 54.96 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.701 2.934 . . . . 0.0 113.83 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.39 -6.78 54.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.424 1.89 . . . . 0.0 114.113 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.36 24.79 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.331 1.853 . . . . 0.0 112.045 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -53.5 126.06 46.31 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.472 1.109 . . . . 0.0 112.623 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.3 -11.26 10.86 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.294 2.662 . . . . 0.0 115.36 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p -127.09 -41.74 1.76 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.04 1.291 . . . . 0.0 113.566 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.94 -146.76 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.81 -135.56 0.08 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.435 1.494 . . . . 0.0 111.575 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.76 -20.91 62.57 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.821 -1.174 . . . . 0.0 112.74 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.52 132.7 50.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.371 1.469 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.09 145.34 31.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 148.57 37.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.94 1.296 . . . . 0.0 112.258 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm -81.36 -22.99 38.01 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.06 -13.52 47.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.4 m -67.59 -20.29 65.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.69 147.62 39.26 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.607 0.763 . . . . 0.0 111.384 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.9 t -72.63 96.69 2.03 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.239 -0.913 . . . . 0.0 111.34 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.5 mm -139.48 136.42 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.835 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -78.79 136.1 37.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.929 0.892 . . . . 0.0 110.761 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.41 144.8 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.757 1.223 . . . . 0.0 110.933 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 169.36 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.539 1.936 . . . . 0.0 112.062 -170.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.95 140.03 30.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.109 0.964 . . . . 0.0 111.874 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -152.25 154.69 32.53 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.687 1.595 . . . . 0.0 110.781 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -75.51 149.51 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.275 2.65 . . . . 0.0 111.195 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.9 130.93 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.815 0.846 . . . . 0.0 109.23 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.8 mm -111.3 144.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.613 1.565 . . . . 0.0 109.828 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -62.55 120.57 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.13 0.972 . . . . 0.0 110.091 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.7 m -87.79 127.26 35.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.023 1.329 . . . . 0.0 109.45 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.7 p -82.08 153.84 25.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.639 1.176 . . . . 0.0 112.992 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.45 -151.52 15.99 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.761 1.172 . . . . 0.0 113.032 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -134.61 157.31 46.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.23 1.412 . . . . 0.0 111.394 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -73.78 -1.92 21.33 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.93 130.44 7.02 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.171 1.843 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -153.16 154.25 34.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.169 1.787 . . . . 0.0 110.459 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.3 p -160.79 167.31 27.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.636 1.175 . . . . 0.0 112.229 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -169.31 -142.31 3.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.613 1.101 . . . . 0.0 113.33 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.5 p -158.56 171.66 19.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 111.633 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.9 m -59.96 119.54 7.95 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.456 1.102 . . . . 0.0 113.405 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -110.88 -102.57 2.69 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.695 1.617 . . . . 0.0 111.425 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.5 p -70.63 156.85 38.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.018 1.327 . . . . 0.0 113.613 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.5 p -86.62 160.71 18.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.846 1.258 . . . . 0.0 113.358 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.2 -162.99 28.9 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.401 1.477 . . . . 0.0 112.965 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.78 166.3 22.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.301 1.041 . . . . 0.0 110.815 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -68.4 120.44 14.49 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.74 -0.6 . . . . 0.0 111.699 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -108.61 140.36 42.1 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.51 -133.45 5.45 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.808 1.194 . . . . 0.0 113.195 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -59.33 146.22 40.47 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.201 1.001 . . . . 0.0 111.586 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -146.39 136.56 23.65 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.745 1.218 . . . . 0.0 109.871 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -165.07 156.46 14.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.065 1.746 . . . . 0.0 109.675 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.959 1.704 . . . . 0.0 112.5 177.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -72.81 146.18 46.47 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.013 0.907 . . . . 0.0 112.043 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 m -76.09 -16.26 59.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.85 75.7 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.332 0.967 . . . . 0.0 114.625 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -64.62 140.12 58.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 113.863 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -164.08 166.86 20.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.606 1.562 . . . . 0.0 111.759 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.68 161.48 35.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.755 1.169 . . . . 0.0 113.403 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -144.98 161.74 38.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.215 1.806 . . . . 0.0 111.217 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -71.1 164.17 26.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.355 1.062 . . . . 0.0 112.384 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -75.64 76.55 2.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.904 1.282 . . . . 0.0 111.189 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -151.7 146.59 25.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.114 2.165 . . . . 0.0 110.192 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -68.94 -23.44 64.16 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -150.44 128.95 6.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 127.359 2.263 . . . . 0.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.97 145.5 31.65 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.769 2.313 . . . . 0.0 111.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.21 -2.13 14.92 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.873 1.669 . . . . 0.0 114.193 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.98 17.8 8.51 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.762 2.025 . . . . 0.0 112.335 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.05 133.0 40.29 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 120.621 -1.3 . . . . 0.0 113.189 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.7 -17.93 8.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.267 2.645 . . . . 0.0 116.358 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p -133.82 -28.47 1.39 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.274 1.397 . . . . 0.0 114.26 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.09 165.82 20.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -90.33 -37.52 13.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -84.43 -34.92 23.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.669 1.188 . . . . 0.0 112.515 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -105.22 162.27 13.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.769 2.028 . . . . 0.0 110.682 -172.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -65.08 163.42 14.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.967 0.907 . . . . 0.0 110.288 168.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.18 138.6 57.81 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.16 -0.963 . . . . 0.0 110.831 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp -93.59 -17.02 23.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -99.51 -24.75 14.66 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.762 1.165 . . . . 0.0 114.082 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.9 p -88.88 173.33 8.57 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.288 0.949 . . . . 0.0 113.45 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -155.94 20.48 0.38 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.366 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.9 t -159.15 161.8 36.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.301 1.44 . . . . 0.0 110.482 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.4 114.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.056 -1.028 . . . . 0.0 109.832 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -109.89 168.21 9.59 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.649 1.979 . . . . 0.0 111.378 169.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.55 143.05 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.435 1.494 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 174.15 11.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.964 1.705 . . . . 0.0 112.319 -170.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.9 133.51 44.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.275 1.83 . . . . 0.0 109.581 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -134.98 153.25 78.43 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.341 1.856 . . . . 0.0 110.374 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.53 165.66 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.862 3.041 . . . . 0.0 112.513 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.0 t -116.57 133.32 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.583 1.553 . . . . 0.0 108.73 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.99 124.27 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 109.278 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.87 122.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.11 0.964 . . . . 0.0 109.828 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 p -92.13 172.29 8.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.057 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.6 m -76.79 -1.28 27.38 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.79 161.33 30.1 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.443 1.497 . . . . 0.0 113.24 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.9 m -166.82 151.97 7.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.938 2.095 . . . . 0.0 110.111 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -163.41 157.81 20.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.601 1.16 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 136.24 170.39 12.0 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.354 1.454 . . . . 0.0 113.392 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -149.81 159.28 44.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.032 1.733 . . . . 0.0 110.545 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 77.5 p -154.34 157.91 39.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 112.854 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 156.62 -21.87 0.47 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.512 1.53 . . . . 0.0 114.063 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -56.56 128.36 35.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 111.73 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.24 -2.47 2.57 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.034 1.733 . . . . 0.0 114.229 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.79 52.4 3.91 Favored Glycine 0 N--CA 1.474 1.209 0 C-N-CA 126.26 1.886 . . . . 0.0 113.096 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.4 t -71.8 -20.3 61.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.749 1.219 . . . . 0.0 114.201 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.6 p -89.02 1.43 55.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.52 -124.16 7.1 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.708 1.146 . . . . 0.0 112.106 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.6 134.97 40.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.269 1.427 . . . . 0.0 109.585 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.41 137.34 36.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.117 0.567 . . . . 0.0 111.636 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -124.02 134.93 53.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -103.53 -97.49 2.43 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 124.657 1.123 . . . . 0.0 112.142 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -64.8 135.52 55.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.302 1.041 . . . . 0.0 111.548 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.99 -0.28 48.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -81.55 108.12 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.322 1.449 . . . . 0.0 109.083 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.888 2.075 . . . . 0.0 113.251 -173.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -147.14 169.52 19.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.185 1.394 . . . . 0.0 111.483 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -156.08 175.67 13.67 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.971 1.308 . . . . 0.0 111.114 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.9 146.91 42.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.402 1.001 . . . . 0.0 112.932 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -155.02 110.27 3.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.861 1.264 . . . . 0.0 110.625 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 m 63.46 6.13 2.38 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.316 1.846 . . . . 0.0 114.995 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.69 146.82 18.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.349 1.452 . . . . 0.0 112.879 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -165.3 150.03 8.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.37 1.868 . . . . 0.0 112.04 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -79.9 131.87 35.95 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.937 0.895 . . . . 0.0 111.443 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -102.9 9.3 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.488 1.515 . . . . 0.0 112.704 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -147.0 167.38 24.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.731 2.012 . . . . 0.0 110.113 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.8 m -90.4 -14.64 32.55 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -177.94 113.65 0.23 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.312 1.845 . . . . 0.0 112.106 -169.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.23 162.82 15.26 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.413 2.742 . . . . 0.0 111.505 169.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.47 3.66 5.79 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.358 1.463 . . . . 0.0 113.926 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 14.29 1.88 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.389 1.476 . . . . 0.0 114.479 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -50.86 137.83 24.98 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.444 1.098 . . . . 0.0 113.721 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.65 -23.03 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.643 2.895 . . . . 0.0 115.803 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -133.1 5.39 3.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.911 1.232 . . . . 0.0 114.166 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.87 158.05 38.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -110.74 -16.38 13.61 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -106.73 7.08 30.23 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.951 1.7 . . . . 0.0 112.675 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -160.04 156.64 27.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.897 2.879 . . . . 0.0 108.637 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.29 159.14 12.84 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.932 0.787 . . . . 0.0 111.472 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 134.14 54.45 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.126 -0.983 . . . . 0.0 111.099 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt -76.86 -31.1 56.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.4 -23.75 15.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.2 t -87.02 121.78 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.089 0.956 . . . . 0.0 111.485 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.99 -25.34 26.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -142.52 124.02 14.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.105 1.362 . . . . 0.0 110.873 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.66 124.46 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.767 1.627 . . . . 0.0 109.44 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.47 149.41 35.04 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.124 0.97 . . . . 0.0 111.472 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.95 123.26 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.653 1.181 . . . . 0.0 110.494 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.01 164.41 26.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.197 1.399 . . . . 0.0 112.803 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -63.3 150.73 42.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.014 0.925 . . . . 0.0 111.908 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.79 153.22 84.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.43 1.092 . . . . 0.0 112.381 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.94 164.08 36.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.479 2.786 . . . . 0.0 111.693 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.17 134.62 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 0.0 109.667 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.02 116.6 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.326 1.051 . . . . 0.0 109.407 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.9 mm -124.2 21.13 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.631 1.572 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p 61.1 29.99 19.19 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.754 2.022 . . . . 0.0 112.502 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -58.88 148.1 31.44 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.544 2.338 . . . . 0.0 114.462 -169.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.17 176.04 42.76 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.319 0.961 . . . . 0.0 113.703 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.0 m -151.04 156.95 42.17 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.57 1.548 . . . . 0.0 110.64 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -137.52 146.98 44.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.871 1.268 . . . . 0.0 111.779 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.88 165.42 45.65 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.519 1.056 . . . . 0.0 113.234 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 t -166.13 -41.75 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.937 1.295 . . . . 0.0 112.395 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.3 t -94.52 119.81 33.79 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.179 -0.951 . . . . 0.0 111.091 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.25 -141.27 11.14 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.348 1.452 . . . . 0.0 112.751 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.4 t -81.6 170.33 15.98 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.953 0.883 . . . . 0.0 112.635 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -168.26 -28.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.781 1.632 . . . . 0.0 113.842 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 131.96 85.74 0.32 Allowed Glycine 0 N--CA 1.471 0.985 0 C-N-CA 125.655 1.598 . . . . 0.0 111.7 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.4 p -166.43 162.73 17.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.945 1.698 . . . . 0.0 111.247 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.8 m -114.94 -0.4 13.43 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.81 -129.67 8.78 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.049 1.309 . . . . 0.0 112.758 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.1 mt -60.9 134.88 57.53 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.666 1.186 . . . . 0.0 112.141 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -98.3 131.23 44.79 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.418 . . . . 0.0 111.312 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.86 141.07 34.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -86.66 -136.22 4.47 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.369 0.985 . . . . 0.0 112.357 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -66.81 142.19 57.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.708 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -74.19 132.58 42.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.301 1.44 . . . . 0.0 109.293 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -152.4 135.57 15.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.339 1.856 . . . . 0.0 108.923 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.782 1.633 . . . . 0.0 112.558 -170.337 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -85.3 111.53 19.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.132 0.966 . . . . 0.0 111.166 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.5 m -148.44 152.5 37.05 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.987 1.315 . . . . 0.0 111.603 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.87 174.65 44.08 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.893 1.235 . . . . 0.0 113.549 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -165.43 168.73 16.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.362 1.465 . . . . 0.0 111.458 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -161.71 117.6 2.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.515 1.526 . . . . 0.0 110.425 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.02 -31.89 9.45 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.331 0.967 . . . . 0.0 113.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.07 171.35 8.53 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.771 1.628 . . . . 0.0 110.331 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -141.65 71.6 1.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 111.427 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 73.6 14.68 4.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.248 2.219 . . . . 0.0 114.069 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.79 -64.18 0.92 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.178 1.391 . . . . 0.0 113.055 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -92.38 -16.57 25.79 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.2 p -167.08 129.93 1.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.113 2.165 . . . . 0.0 109.416 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 144.94 26.69 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.221 2.614 . . . . 0.0 111.664 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.32 -6.23 38.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.134 1.374 . . . . 0.0 113.926 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -127.42 21.84 6.57 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.966 2.106 . . . . 0.0 112.911 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -41.23 125.17 2.16 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.984 1.714 . . . . 0.0 114.152 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.79 -12.05 11.15 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.156 2.571 . . . . 0.0 115.886 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p -141.48 -15.57 0.84 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt -137.64 153.05 49.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -96.89 -26.3 15.13 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -127.07 15.7 7.31 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.949 1.7 . . . . 0.0 113.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -142.25 157.35 44.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.184 2.594 . . . . 0.0 108.223 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.07 160.89 20.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.116 0.416 . . . . 0.0 112.086 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.79 130.39 43.01 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.818 -0.551 . . . . 0.0 109.956 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp -97.59 -24.15 15.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -93.65 -13.6 27.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.5 t -147.69 153.16 38.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.066 1.746 . . . . 0.0 110.767 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.0 -10.98 60.3 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.5 m -156.86 165.84 35.06 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.629 1.971 . . . . 0.0 109.725 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -69.28 110.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.688 0.795 . . . . 0.0 109.15 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.72 146.21 35.77 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.31 1.844 . . . . 0.0 110.308 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.24 125.57 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.299 0.64 . . . . 0.0 110.018 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.6 mmt -142.23 162.3 35.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.556 1.942 . . . . 0.0 110.852 -171.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.13 136.77 54.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.42 142.82 30.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.909 1.684 . . . . 0.0 109.505 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.07 159.27 53.79 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.992 3.795 . . . . 0.0 112.397 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.48 133.66 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 108.73 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.66 132.18 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.293 1.437 . . . . 0.0 109.149 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.99 127.38 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 109.8 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -86.27 154.08 21.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.95 1.7 . . . . 0.0 111.641 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.5 m -134.73 51.81 2.08 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.84 1.256 . . . . 0.0 111.159 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.38 -109.62 3.55 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 124.914 1.245 . . . . 0.0 110.641 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 61.7 p -157.17 149.6 23.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.952 1.301 . . . . 0.0 111.436 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -83.26 64.27 7.66 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.141 -0.975 . . . . 0.0 111.579 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.28 -147.05 26.83 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.112 1.339 . . . . 0.0 112.59 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 p -163.2 154.06 16.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.799 1.64 . . . . 0.0 110.9 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.0 m -161.54 113.58 1.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.576 1.15 . . . . 0.0 111.59 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.62 -4.84 30.03 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.965 1.269 . . . . 0.0 115.463 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.5 p -91.15 132.39 36.1 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.831 -173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.2 t -163.94 148.89 10.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.424 1.49 . . . . 0.0 110.906 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -92.43 2.64 74.45 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.912 1.244 . . . . 0.0 114.261 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.0 t -105.67 143.77 33.36 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.839 1.32 . . . . 0.0 113.279 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.0 p -81.98 179.78 7.69 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.039 1.335 . . . . 0.0 111.891 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.25 -136.51 8.56 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 120.934 -1.104 . . . . 0.0 113.455 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.55 166.47 21.89 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.672 1.189 . . . . 0.0 111.416 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -66.36 120.54 13.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.2 0.6 . . . . 0.0 110.857 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -113.52 135.63 53.68 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.0 -133.51 5.7 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.364 0.983 . . . . 0.0 113.063 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.54 159.17 10.93 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.509 1.124 . . . . 0.0 112.269 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.07 176.78 9.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 111.66 -173.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -85.96 99.33 11.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.408 1.083 . . . . 0.0 109.68 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.473 1.509 . . . . 0.0 114.106 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -164.2 152.62 12.98 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.425 1.89 . . . . 0.0 110.722 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 t -163.5 157.1 19.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.026 1.33 . . . . 0.0 111.364 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.77 141.54 6.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.758 1.171 . . . . 0.0 113.18 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -169.98 163.37 9.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.339 1.855 . . . . 0.0 110.298 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -81.81 -23.89 36.23 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.04 -1.037 . . . . 0.0 113.447 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.79 11.73 60.92 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.925 1.25 . . . . 0.0 114.825 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -68.54 130.92 44.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.789 1.236 . . . . 0.0 112.21 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -149.37 148.64 29.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.405 1.882 . . . . 0.0 110.702 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.28 111.94 21.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.144 0.978 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.82 -178.21 1.52 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.392 2.677 . . . . 0.0 109.991 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.9 t -80.32 -21.2 42.77 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -177.57 117.4 0.26 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.812 2.445 . . . . 0.0 110.504 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.93 137.66 29.82 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.446 2.097 . . . . 0.0 110.512 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -78.88 5.95 10.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 0.0 113.44 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -115.59 8.41 15.07 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.455 2.302 . . . . 0.0 113.091 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -49.01 137.33 13.69 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 125.29 1.436 . . . . 0.0 114.031 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -11.77 32.85 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.691 3.594 . . . . 0.0 116.656 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -150.57 -29.36 0.21 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.92 161.59 27.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -99.64 -12.52 19.98 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.298 1.039 . . . . 0.0 113.756 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -95.83 -16.99 21.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.783 1.633 . . . . 0.0 113.903 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -155.57 171.14 20.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.537 1.935 . . . . 0.0 112.269 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.75 149.06 49.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.659 0.784 . . . . 0.0 111.171 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.57 142.89 57.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.179 1.392 . . . . 0.0 112.795 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp -86.06 -33.61 20.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -81.86 -31.85 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.84 1.2 . . . . 0.0 113.207 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.8 t 47.87 61.28 3.05 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.347 1.859 . . . . 0.0 112.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -141.48 152.17 43.96 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.345 1.458 . . . . 0.0 111.774 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -72.69 103.7 3.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.735 1.214 . . . . 0.0 111.672 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.0 mm -134.7 138.22 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.931 2.092 . . . . 0.0 108.411 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -113.47 134.58 54.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 110.799 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.89 143.58 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.435 1.494 . . . . 0.0 110.174 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 155.55 18.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.48 1.512 . . . . 0.0 111.414 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.03 126.41 34.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 111.553 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.67 154.52 50.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 110.993 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.18 164.62 35.13 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.563 2.842 . . . . 0.0 111.617 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.81 134.29 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.348 1.459 . . . . 0.0 108.933 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.17 130.24 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.673 1.589 . . . . 0.0 108.566 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.2 mm -77.29 131.12 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.803 0.841 . . . . 0.0 110.408 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -113.15 157.5 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.182 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -108.17 121.7 45.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.398 1.079 . . . . 0.0 111.427 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.8 -174.94 38.23 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.004 1.288 . . . . 0.0 113.084 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -93.61 122.7 36.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.973 0.909 . . . . 0.0 110.426 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -79.9 123.31 27.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.044 -1.035 . . . . 0.0 112.094 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.83 168.29 33.16 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.735 1.16 . . . . 0.0 113.513 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.2 p -166.23 128.97 1.96 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.796 1.239 . . . . 0.0 111.403 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.8 t -80.21 3.89 19.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.63 173.41 19.01 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.414 1.959 . . . . 0.0 113.394 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -147.18 158.71 44.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.924 1.69 . . . . 0.0 109.964 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -107.0 175.45 5.5 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.131 -0.981 . . . . 0.0 112.498 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.72 124.31 7.03 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.459 1.028 . . . . 0.0 111.205 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.4 m -147.9 129.25 14.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.445 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 t -91.5 -6.4 52.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.19 -138.02 2.5 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.701 1.62 . . . . 0.0 112.567 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.75 151.48 47.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.287 1.035 . . . . 0.0 112.077 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -104.81 118.77 37.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.016 1.326 . . . . 0.0 110.511 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -109.67 150.54 28.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.29 -125.38 0.87 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.165 1.364 . . . . 0.0 112.506 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.12 142.83 55.65 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.911 -0.758 . . . . 0.0 112.318 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.61 166.63 32.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 111.227 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -96.74 114.37 26.01 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.21 1.404 . . . . 0.0 108.968 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.262 1.425 . . . . 0.0 113.991 176.625 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 67.44 26.1 8.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.241 1.416 . . . . 0.0 113.403 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -75.71 152.48 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.245 -1.534 . . . . 0.0 113.365 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.9 169.78 36.53 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.372 1.463 . . . . 0.0 113.104 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 p -87.65 -11.99 46.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -93.89 131.87 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.743 1.217 . . . . 0.0 111.175 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.94 -159.24 20.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.341 1.448 . . . . 0.0 113.055 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -142.4 159.96 41.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.239 1.816 . . . . 0.0 111.134 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.43 151.15 43.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.949 1.7 . . . . 0.0 110.654 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -137.75 115.48 11.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.369 1.467 . . . . 0.0 109.178 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -161.83 137.93 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.476 1.51 . . . . 0.0 110.115 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -84.06 -12.95 54.31 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -86.13 119.09 71.45 Favored Pre-proline 0 N--CA 1.477 0.879 0 O-C-N 120.959 -1.088 . . . . 0.0 110.372 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.82 149.74 78.39 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.682 2.922 . . . . 0.0 112.036 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.68 -8.43 42.44 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.46 30.72 3.81 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.581 1.953 . . . . 0.0 111.022 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -43.87 131.29 4.14 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 125.026 1.33 . . . . 0.0 113.352 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.52 -15.4 19.66 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.138 2.559 . . . . 0.0 115.71 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p -133.44 -20.73 2.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.567 1.53 . . . . 0.0 114.857 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt -131.27 156.64 45.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -108.98 -25.87 10.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -83.45 -54.08 5.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.025 1.33 . . . . 0.0 110.745 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -93.94 161.59 14.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.088 2.155 . . . . 0.0 110.405 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 163.58 9.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.626 0.77 . . . . 0.0 111.733 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.18 148.24 52.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.504 0.722 . . . . 0.0 111.745 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp -82.26 -25.75 33.78 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -91.58 -37.34 13.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.185 0.902 . . . . 0.0 113.12 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t 53.5 32.24 13.78 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.098 1.759 . . . . 0.0 114.432 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -160.14 161.82 33.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.5 1.52 . . . . 0.0 111.725 -170.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -76.89 90.32 3.51 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.182 -0.949 . . . . 0.0 111.442 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.4 mt -138.78 133.86 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.58 1.952 . . . . 0.0 108.003 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -139.53 29.32 2.17 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.804 1.241 . . . . 0.0 113.573 -169.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.2 m -60.53 146.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.858 1.663 . . . . 0.0 111.992 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 79.1 mtm -139.28 136.86 35.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.277 1.831 . . . . 0.0 110.787 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -143.38 150.37 39.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.878 2.071 . . . . 0.0 109.57 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.47 132.48 85.65 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.326 0.651 . . . . 0.0 110.91 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.86 152.72 47.23 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.308 2.672 . . . . 0.0 111.093 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.66 129.78 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.315 1.046 . . . . 0.0 108.782 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.8 mm -116.79 122.43 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.253 1.421 . . . . 0.0 108.963 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.45 153.89 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.148 1.779 . . . . 0.0 109.099 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -53.19 147.39 10.03 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.305 1.042 . . . . 0.0 111.116 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -52.49 -57.26 10.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.707 1.203 . . . . 0.0 113.866 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.15 1.02 24.64 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.305 0.955 . . . . 0.0 115.102 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.0 m -75.29 94.4 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.972 1.386 . . . . 0.0 112.249 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.9 t -74.89 -25.21 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.345 -0.847 . . . . 0.0 112.335 172.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.82 -165.98 54.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.184 1.373 . . . . 0.0 113.608 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 65.2 19.33 11.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.313 1.445 . . . . 0.0 114.837 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -41.83 95.65 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.724 -1.235 . . . . 0.0 113.026 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.99 30.89 76.72 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.028 0.823 . . . . 0.0 113.726 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 m -53.03 129.97 32.41 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.985 1.714 . . . . 0.0 113.997 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 90.4 p -163.74 172.02 14.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.289 1.436 . . . . 0.0 111.603 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.93 58.8 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.681 0.658 . . . . 0.0 113.984 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -136.42 137.16 40.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.333 1.453 . . . . 0.0 111.086 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 p -76.88 153.42 34.77 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.212 1.005 . . . . 0.0 111.641 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.84 -173.09 30.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.516 1.055 . . . . 0.0 113.251 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.92 164.27 15.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.611 1.964 . . . . 0.0 111.141 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -70.56 121.55 18.06 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.362 -0.836 . . . . 0.0 112.252 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -121.91 118.36 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.08 -95.54 1.46 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 124.322 0.963 . . . . 0.0 112.181 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -59.65 145.45 44.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.133 0.573 . . . . 0.0 111.384 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -151.9 164.69 36.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.185 1.394 . . . . 0.0 110.443 -172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -162.89 155.99 19.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.008 1.723 . . . . 0.0 109.78 -171.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.77 2.028 . . . . 0.0 113.525 -175.092 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.95 179.42 7.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.74 1.616 . . . . 0.0 110.931 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 t -160.99 143.76 12.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.598 1.559 . . . . 0.0 111.171 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.32 147.76 9.81 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.549 1.071 . . . . 0.0 113.417 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -156.42 168.91 25.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.532 1.933 . . . . 0.0 110.367 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 m -127.1 125.07 40.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.263 1.025 . . . . 0.0 110.564 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.07 92.24 1.31 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.208 1.385 . . . . 0.0 110.551 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.51 116.46 9.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.998 0.919 . . . . 0.0 109.593 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -112.32 159.46 18.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.435 1.494 . . . . 0.0 112.038 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -62.72 -27.23 69.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.087 0.955 . . . . 0.0 113.289 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.12 136.38 34.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.481 1.112 . . . . 0.0 110.874 169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -74.54 64.9 1.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.559 1.544 . . . . 0.0 112.717 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -150.83 136.19 10.35 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 125.636 1.575 . . . . 0.0 110.75 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.08 145.45 39.51 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.076 2.518 . . . . 0.0 111.153 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.42 -2.65 20.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 114.003 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.05 16.09 10.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.194 2.198 . . . . 0.0 113.506 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -47.97 134.47 11.56 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.626 1.171 . . . . 0.0 113.706 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.73 -17.65 42.35 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.221 3.281 . . . . 0.0 116.61 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t -151.38 -27.12 0.2 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt -126.05 135.51 51.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.99 137.45 56.51 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.891 . . . . 0.0 112.88 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 58.18 26.78 14.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.611 1.564 . . . . 0.0 113.525 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -147.03 173.27 12.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.139 2.176 . . . . 0.0 111.742 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.16 161.75 27.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.426 1.09 . . . . 0.0 111.493 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.7 136.34 39.09 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.737 -0.602 . . . . 0.0 109.684 169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 9.9 ptp -84.02 -26.36 29.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.2 -35.99 25.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.346 0.976 . . . . 0.0 112.813 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.256 16.0 p 45.77 17.64 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 128.868 2.867 . . . . 0.0 117.48 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -74.21 -37.63 63.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.818 1.247 . . . . 0.0 113.556 -171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 p -170.46 164.86 8.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.025 1.33 . . . . 0.0 111.763 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.6 mt -84.25 -15.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.749 1.22 . . . . 0.0 112.652 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -52.12 129.05 26.57 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.146 1.778 . . . . 0.0 113.015 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.5 144.66 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.03 1.732 . . . . 0.0 110.097 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 77.7 mtm -77.88 144.43 36.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.124 0.97 . . . . 0.0 112.379 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -80.15 71.68 6.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.509 1.123 . . . . 0.0 110.279 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.27 145.76 97.62 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.297 1.039 . . . . 0.0 111.405 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.82 135.98 34.3 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.392 2.728 . . . . 0.0 111.27 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.24 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.46 1.104 . . . . 0.0 109.653 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.82 116.69 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.392 1.477 . . . . 0.0 109.544 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.6 mt -137.2 136.27 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.139 1.776 . . . . 0.0 108.383 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.1 p -136.8 156.66 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.606 1.562 . . . . 0.0 111.089 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 t -85.31 48.02 1.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.537 1.135 . . . . 0.0 112.315 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -113.35 10.82 24.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.123 1.82 . . . . 0.0 115.26 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 t -74.46 147.52 41.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 118.706 1.253 . . . . 0.0 112.922 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.5 t -165.13 164.79 20.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.968 1.707 . . . . 0.0 111.198 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.78 155.27 7.21 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.419 1.485 . . . . 0.0 113.428 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.5 t -167.06 176.16 7.07 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.731 1.612 . . . . 0.0 111.173 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.7 m -88.01 100.62 13.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.271 1.029 . . . . 0.0 111.116 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.9 -160.84 36.91 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.0 1.286 . . . . 0.0 112.969 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.7 m -73.49 124.14 25.27 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.011 -0.699 . . . . 0.0 110.767 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.3 t -84.1 70.27 10.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.12 -0.987 . . . . 0.0 111.839 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.65 101.02 1.04 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.416 1.484 . . . . 0.0 112.59 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.9 t -162.84 136.87 6.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.836 1.654 . . . . 0.0 110.211 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.3 p -90.17 1.92 55.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.851 1.26 . . . . 0.0 113.358 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.43 -137.05 4.04 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.499 1.047 . . . . 0.0 113.331 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -116.41 138.23 51.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.668 1.587 . . . . 0.0 108.388 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 130.22 42.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.791 0.436 . . . . 0.0 111.296 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -112.17 140.84 46.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.91 -135.7 5.97 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.521 1.058 . . . . 0.0 113.249 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.24 148.33 11.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.769 1.228 . . . . 0.0 112.318 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 162.04 41.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.966 1.306 . . . . 0.0 111.177 -172.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -127.53 134.93 49.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.248 1.819 . . . . 0.0 108.41 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.75 2.02 . . . . 0.0 112.902 -172.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -157.03 150.31 24.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.36 1.464 . . . . 0.0 110.251 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m -73.86 -52.08 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.361 -0.837 . . . . 0.0 113.126 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.64 164.78 9.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.225 0.917 . . . . 0.0 113.13 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.5 m -134.38 96.59 3.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.087 0.955 . . . . 0.0 110.436 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.1 m -71.74 -16.43 62.21 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.59 143.97 5.65 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.526 1.536 . . . . 0.0 111.695 -170.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -72.41 134.17 45.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.425 0.69 . . . . 0.0 109.768 172.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -154.21 -56.49 0.11 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 68.97 0.67 2.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.696 1.999 . . . . 0.0 115.179 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -85.73 -1.89 57.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.652 -1.28 . . . . 0.0 113.938 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.6 p -157.15 165.98 34.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.682 1.593 . . . . 0.0 111.182 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.5 t -147.12 129.09 7.51 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 125.084 1.354 . . . . 0.0 109.318 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.0 151.25 61.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.469 2.78 . . . . 0.0 112.61 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -71.93 6.5 2.04 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.958 1.703 . . . . 0.0 113.746 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.0 20.0 2.12 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.364 2.266 . . . . 0.0 112.781 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -49.31 139.24 14.15 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.961 1.304 . . . . 0.0 113.115 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -21.51 23.17 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.36 2.706 . . . . 0.0 115.783 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p -132.16 -19.78 2.49 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.843 1.201 . . . . 0.0 113.989 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.67 145.33 49.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -66.45 120.79 13.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.861 0.864 . . . . 0.0 112.404 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 51.94 56.39 7.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.717 2.007 . . . . 0.0 112.385 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -158.3 163.35 37.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.545 2.338 . . . . 0.0 110.628 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.52 151.61 44.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.661 0.784 . . . . 0.0 111.04 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.1 136.43 35.18 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.507 0.723 . . . . 0.0 110.738 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' HB2' ' HG ' ' A' ' 143' ' ' CYS . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt -77.29 -47.76 19.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -82.42 -14.1 55.71 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.8 t -130.41 36.85 3.92 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.621 1.569 . . . . 0.0 111.549 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.23 142.99 45.94 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.461 1.104 . . . . 0.0 112.184 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 t -157.34 158.98 36.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.835 1.254 . . . . 0.0 111.227 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -134.86 104.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.299 1.439 . . . . 0.0 108.887 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -167.73 129.53 1.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 109.629 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.32 111.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.745 0.818 . . . . 0.0 109.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -146.63 140.55 26.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.126 1.771 . . . . 0.0 110.56 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.19 163.62 14.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.316 1.447 . . . . 0.0 112.634 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.13 154.71 31.25 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.667 1.587 . . . . 0.0 110.891 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.0 159.94 37.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.43 2.753 . . . . 0.0 111.484 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -133.87 130.79 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 108.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.74 122.74 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.271 1.428 . . . . 0.0 107.793 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.1 mt -106.82 74.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.2 1.0 . . . . 0.0 109.032 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -75.71 43.35 0.25 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.774 2.03 . . . . 0.0 112.115 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 t -71.56 -20.97 61.95 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -169.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.05 -140.74 47.91 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.595 1.093 . . . . 0.0 113.338 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 p -84.07 137.99 33.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.484 1.114 . . . . 0.0 111.092 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 t -160.54 153.61 21.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 111.556 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.27 -95.82 1.48 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.553 1.549 . . . . 0.0 111.552 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -162.67 -175.18 4.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.577 1.551 . . . . 0.0 111.042 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 m -161.29 143.15 11.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.76 2.024 . . . . 0.0 110.543 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.86 149.94 21.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.545 1.069 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.2 m -150.31 146.33 26.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.891 1.677 . . . . 0.0 110.24 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -157.77 133.74 9.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.259 1.024 . . . . 0.0 110.972 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.74 123.74 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.086 1.327 . . . . 0.0 111.586 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 p -87.61 111.29 21.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 111.524 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.1 m -83.79 -10.48 58.06 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.33 178.1 50.74 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.045 1.307 . . . . 0.0 113.21 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.18 119.07 37.79 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.001 1.32 . . . . 0.0 109.084 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 126.59 31.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.912 0.885 . . . . 0.0 111.016 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . 0.4 ' HG ' ' HB2' ' A' ' 68' ' ' ASP . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.14 145.26 48.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.91 -128.46 2.16 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.56 1.076 . . . . 0.0 112.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -55.54 139.82 42.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.574 1.15 . . . . 0.0 112.307 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -71.66 101.93 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.98 0.912 . . . . 0.0 110.072 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.36 67.23 1.07 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.028 1.731 . . . . 0.0 109.091 -170.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.433 1.093 . . . . 0.0 113.669 -179.426 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -80.46 172.42 13.78 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.243 1.017 . . . . 0.0 112.59 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.9 p -154.38 154.99 34.22 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.74 -1.225 . . . . 0.0 112.603 -174.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.52 -156.02 8.71 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.34 1.447 . . . . 0.0 112.72 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -160.44 165.1 31.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.696 1.199 . . . . 0.0 112.31 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -162.56 -179.12 6.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.721 1.609 . . . . 0.0 110.718 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.5 -124.07 7.33 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.77 1.176 . . . . 0.0 111.221 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.48 145.66 26.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.973 1.309 . . . . 0.0 111.728 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.01 158.69 43.42 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.624 1.97 . . . . 0.0 110.465 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -13.89 61.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -90.67 156.27 18.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.683 1.593 . . . . 0.0 112.907 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 t -85.07 -13.0 51.76 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.66 131.83 1.25 Allowed Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.785 2.034 . . . . 0.0 109.734 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.41 138.98 33.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.748 2.299 . . . . 0.0 110.262 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.45 -14.55 63.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -107.5 18.39 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.695 1.998 . . . . 0.0 113.454 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -45.37 132.43 5.97 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 124.784 1.234 . . . . 0.0 113.601 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.5 -19.41 42.77 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.933 3.088 . . . . 0.0 116.527 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -151.87 1.32 0.36 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.27 128.62 55.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -63.46 120.41 11.63 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 60.39 27.5 17.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.432 1.893 . . . . 0.0 112.805 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -135.25 171.8 13.92 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 109.82 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.44 150.6 46.05 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.718 . . . . 0.0 110.929 172.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.83 152.62 29.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 111.394 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp -81.06 -24.79 37.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -83.26 -35.94 24.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.76 1.164 . . . . 0.0 112.142 169.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.3 t 55.4 33.22 20.41 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.694 1.598 . . . . 0.0 113.484 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -126.48 144.39 50.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.967 2.107 . . . . 0.0 110.542 -177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 p -78.62 25.35 0.26 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.363 1.865 . . . . 0.0 114.387 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -82.07 108.24 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.008 1.323 . . . . 0.0 108.74 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -73.44 143.8 46.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 112.305 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.5 167.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.84 1.656 . . . . 0.0 110.937 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.6 mmm -60.22 120.17 9.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.579 1.151 . . . . 0.0 111.653 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -84.11 64.52 8.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.891 1.276 . . . . 0.0 111.045 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.17 152.02 90.34 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 112.034 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.23 146.82 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.519 2.813 . . . . 0.0 111.196 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.57 130.02 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.905 0.882 . . . . 0.0 109.309 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.2 128.68 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.73 1.612 . . . . 0.0 109.259 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.67 128.22 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.385 . . . . 0.0 108.456 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.0 p -137.08 101.81 4.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 109.53 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 p -169.35 165.5 10.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.326 1.45 . . . . 0.0 111.817 -172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.87 -147.98 20.22 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.939 1.257 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -142.07 137.19 30.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.866 1.266 . . . . 0.0 110.899 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.8 p -95.24 162.38 13.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.051 1.34 . . . . 0.0 112.805 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.91 -179.53 53.07 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.406 1.003 . . . . 0.0 113.127 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 t -66.12 125.07 24.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.997 -0.708 . . . . 0.0 111.097 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t -166.03 170.68 13.3 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.48 . . . . 0.0 111.193 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.14 -158.33 29.08 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.23 1.395 . . . . 0.0 113.438 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.8 t -161.86 -176.0 4.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 110.887 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.0 t -160.64 144.1 13.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.41 1.484 . . . . 0.0 111.164 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 155.18 -156.42 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.51 1.053 . . . . 0.0 114.052 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -143.91 26.77 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.984 1.314 . . . . 0.0 112.051 -170.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -65.24 -22.08 66.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.83 -167.47 54.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.965 1.269 . . . . 0.0 113.816 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.9 136.87 57.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.987 1.715 . . . . 0.0 111.75 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -116.57 125.25 51.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.171 1.388 . . . . 0.0 111.019 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.6 144.08 38.43 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.68 -135.5 5.29 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.573 1.083 . . . . 0.0 113.323 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.52 149.29 43.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.133 0.973 . . . . 0.0 112.127 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.83 163.61 30.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.688 1.595 . . . . 0.0 110.079 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -128.6 42.69 3.27 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.396 1.478 . . . . 0.0 110.84 -171.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.311 1.444 . . . . 0.0 114.008 178.436 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -115.75 1.53 13.48 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -81.08 -20.59 41.22 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.824 -1.173 . . . . 0.0 113.658 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.08 -162.21 53.63 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.779 1.181 . . . . 0.0 113.032 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.9 p -162.04 142.91 10.56 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.991 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -171.39 166.87 6.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.103 1.761 . . . . 0.0 111.24 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.92 84.98 0.12 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.182 0.896 . . . . 0.0 112.635 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.8 93.91 8.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.624 1.17 . . . . 0.0 109.161 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -165.76 157.54 14.37 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.954 1.701 . . . . 0.0 110.914 -171.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -63.67 -16.29 60.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.34 154.22 45.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.164 1.786 . . . . 0.0 110.358 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 t -64.05 -16.29 61.38 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -154.82 120.27 2.64 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.486 1.514 . . . . 0.0 111.065 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 137.49 42.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.793 2.328 . . . . 0.0 110.42 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.81 0.3 13.59 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -109.12 3.72 22.23 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.759 2.024 . . . . 0.0 113.908 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -47.68 132.74 10.94 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.74 -17.7 52.57 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.831 3.688 . . . . 0.0 116.786 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -146.57 -23.99 0.42 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.85 146.14 46.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -70.65 124.25 23.82 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.708 0.803 . . . . 0.0 112.609 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 51.27 53.3 13.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.561 1.944 . . . . 0.0 112.318 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -157.65 162.83 38.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 128.528 2.731 . . . . 0.0 109.57 -170.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -73.03 152.07 41.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.183 0.593 . . . . 0.0 110.476 169.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.57 147.31 37.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.021 0.528 . . . . 0.0 110.604 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt -68.86 -31.68 70.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -98.88 -8.6 25.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -77.56 64.03 2.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 112.251 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -77.61 68.44 3.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.286 1.434 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t 67.96 26.74 7.35 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.646 1.579 . . . . 0.0 112.714 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.2 mt -89.12 107.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.89 129.36 39.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.591 0.756 . . . . 0.0 111.236 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.95 144.48 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.504 1.522 . . . . 0.0 110.332 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.04 149.63 43.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.973 0.909 . . . . 0.0 112.319 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.59 145.96 54.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 112.366 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.59 148.65 73.63 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.913 0.885 . . . . 0.0 111.522 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.87 156.04 61.18 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.558 2.839 . . . . 0.0 111.765 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.11 128.75 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.12 142.5 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.81 1.644 . . . . 0.0 108.525 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.6 mt -71.49 106.41 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.552 -0.717 . . . . 0.0 109.47 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.9 m -144.1 141.75 30.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.075 2.15 . . . . 0.0 108.699 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -74.21 156.22 37.5 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.627 1.171 . . . . 0.0 114.145 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -100.62 172.34 23.8 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.225 1.393 . . . . 0.0 113.354 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m -76.86 139.85 40.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.146 0.978 . . . . 0.0 112.615 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 p -83.66 36.33 0.54 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.299 1.84 . . . . 0.0 113.359 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.2 140.63 45.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.331 1.443 . . . . 0.0 113.179 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -132.98 154.92 50.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.9 m -70.8 122.79 20.54 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.033 -1.042 . . . . 0.0 111.995 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.41 -63.64 0.67 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.306 0.955 . . . . 0.0 112.817 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -164.15 144.19 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.881 1.272 . . . . 0.0 112.341 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.0 m -168.05 160.61 12.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.74 2.016 . . . . 0.0 110.718 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.28 -111.33 0.48 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.345 0.974 . . . . 0.0 111.699 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -69.26 -5.7 24.59 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.417 1.087 . . . . 0.0 113.921 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.3 m -132.12 139.79 48.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.324 1.85 . . . . 0.0 110.551 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.0 -122.33 4.28 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.929 1.728 . . . . 0.0 112.139 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.92 132.45 53.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.625 1.17 . . . . 0.0 111.809 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.54 125.48 32.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.496 1.118 . . . . 0.0 110.498 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.78 148.52 45.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.28 -140.67 4.71 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.486 1.041 . . . . 0.0 111.794 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -69.07 117.1 10.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.306 0.642 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -150.12 157.11 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.169 1.787 . . . . 0.0 109.465 -173.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -94.81 109.73 21.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.49 1.116 . . . . 0.0 109.351 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.297 1.439 . . . . 0.0 114.034 178.226 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -163.93 167.06 21.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.199 1.4 . . . . 0.0 111.999 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -162.19 164.44 27.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.67 1.588 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.11 45.66 11.33 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 123.97 0.795 . . . . 0.0 113.114 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -153.78 176.87 11.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.019 1.328 . . . . 0.0 111.956 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 t -160.06 151.79 20.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.63 . . . . 0.0 111.334 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.83 -157.0 7.1 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.484 1.516 . . . . 0.0 113.888 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -154.13 140.01 18.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.445 1.498 . . . . 0.0 110.478 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -105.28 151.25 24.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.964 1.306 . . . . 0.0 112.058 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -72.79 -19.71 61.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.789 0.835 . . . . 0.0 113.155 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -120.44 124.65 45.97 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.602 1.961 . . . . 0.0 108.656 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 t -86.84 175.97 7.94 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.662 0.744 . . . . 0.0 112.801 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -159.86 119.88 1.69 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.069 1.747 . . . . 0.0 111.393 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 146.12 28.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.386 2.724 . . . . 0.0 109.444 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.25 -6.12 12.74 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.06 15.7 4.68 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.307 2.243 . . . . 0.0 113.447 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -42.15 121.04 2.45 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 125.477 1.511 . . . . 0.0 113.939 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -86.08 -13.6 5.42 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.14 2.56 . . . . 0.0 115.74 -169.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -131.32 -18.4 2.88 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.234 1.379 . . . . 0.0 114.623 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.77 -51.59 2.03 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 20.6 t-80 -162.52 -147.51 0.13 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.224 1.41 . . . . 0.0 111.207 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 64.2 ttt180 -60.9 -34.48 74.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.856 1.262 . . . . 0.0 111.943 169.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -47.25 131.68 13.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.847 1.659 . . . . 0.0 110.351 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.7 144.16 28.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.608 0.763 . . . . 0.0 112.491 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.54 142.73 57.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.675 0.79 . . . . 0.0 111.675 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp -80.31 -25.72 39.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.66 -18.21 19.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.58 95.77 4.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.068 1.347 . . . . 0.0 110.769 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.65 45.22 2.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.808 1.643 . . . . 0.0 110.804 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t 72.97 21.15 3.31 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.04 1.736 . . . . 0.0 113.692 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.6 mm -118.42 137.36 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.221 1.808 . . . . 0.0 108.465 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -77.56 -8.26 57.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.42 145.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.165 2.186 . . . . 0.0 110.139 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.81 12.37 21.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.69 122.65 12.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.127 1.371 . . . . 0.0 113.251 -170.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -162.86 157.43 18.12 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.799 2.04 . . . . 0.0 110.36 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.99 156.17 38.61 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.168 2.579 . . . . 0.0 110.823 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.3 t -125.82 128.64 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.772 1.229 . . . . 0.0 108.989 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.38 121.89 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 108.52 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.05 122.13 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.722 1.209 . . . . 0.0 108.7 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -163.62 162.1 24.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.004 1.721 . . . . 0.0 110.478 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 t -153.9 20.27 0.52 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.275 1.43 . . . . 0.0 112.591 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.2 -1.02 90.48 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.936 1.255 . . . . 0.0 115.199 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.0 m -64.45 135.6 56.24 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 112.882 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -163.64 161.86 23.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.181 1.392 . . . . 0.0 111.095 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.9 153.42 30.2 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.268 1.414 . . . . 0.0 113.624 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -168.06 148.91 5.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.579 1.951 . . . . 0.0 109.482 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m -157.68 137.21 12.04 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.104 . . . . 0.0 112.392 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.02 82.34 1.45 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.404 1.002 . . . . 0.0 111.337 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 p -69.99 -14.03 62.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.784 1.234 . . . . 0.0 113.859 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.2 p -165.9 167.44 16.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.386 2.274 . . . . 0.0 110.551 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.09 167.07 39.09 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.373 0.987 . . . . 0.0 113.606 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.1 p -167.33 167.09 14.26 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.544 1.538 . . . . 0.0 111.645 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p -79.37 152.72 30.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.343 1.057 . . . . 0.0 112.706 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.55 -130.86 7.16 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.842 1.21 . . . . 0.0 112.799 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.89 135.37 24.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.581 1.952 . . . . 0.0 112.883 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.94 119.78 22.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.546 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -98.96 132.96 43.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.93 -130.32 4.6 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.87 1.224 . . . . 0.0 111.984 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -65.47 143.96 57.35 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.255 0.622 . . . . 0.0 111.355 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.72 149.16 35.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.722 1.609 . . . . 0.0 109.161 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -154.94 147.19 23.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.681 1.592 . . . . 0.0 109.549 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.117 1.767 . . . . 0.0 112.835 -173.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -164.83 174.15 10.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.575 1.55 . . . . 0.0 111.548 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 t -156.61 156.22 33.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 111.035 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.68 124.98 6.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.148 0.88 . . . . 0.0 112.962 -174.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 t -167.69 154.62 8.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.554 1.942 . . . . 0.0 109.994 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -168.59 172.33 8.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.65 165.47 16.77 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.939 1.733 . . . . 0.0 113.756 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.64 150.47 7.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.998 2.119 . . . . 0.0 111.494 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -165.65 144.59 6.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.083 1.353 . . . . 0.0 111.629 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -96.9 123.4 40.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.751 1.22 . . . . 0.0 109.549 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -163.73 176.88 9.15 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.396 1.878 . . . . 0.0 110.366 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -70.64 -173.18 0.72 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.864 1.266 . . . . 0.0 112.937 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.13 115.45 65.73 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.87 149.82 43.08 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.351 2.701 . . . . 0.0 111.066 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.99 -4.53 21.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.625 1.17 . . . . 0.0 113.766 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -122.77 11.65 9.75 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.632 1.973 . . . . 0.0 112.867 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -45.33 133.31 5.83 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.546 1.538 . . . . 0.0 113.58 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.68 -17.85 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.185 2.59 . . . . 0.0 116.028 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p -130.22 -23.57 2.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.339 1.427 . . . . 0.0 114.042 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -128.11 162.77 26.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -86.69 -43.47 12.57 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.76 34.53 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.392 1.077 . . . . 0.0 113.042 -176.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -117.95 159.02 23.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.993 1.717 . . . . 0.0 110.678 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.74 157.45 30.16 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.137 0.575 . . . . 0.0 110.183 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 139.03 58.47 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.736 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp -79.75 -6.99 58.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.96 -17.58 6.7 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.2 m -127.56 39.18 3.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.032 1.733 . . . . 0.0 112.347 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -63.36 102.75 0.43 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.619 1.168 . . . . 0.0 111.686 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.1 t -95.02 61.38 2.48 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.699 1.599 . . . . 0.0 110.575 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.2 mt -57.74 -16.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.375 1.47 . . . . 0.0 113.487 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.14 -30.44 49.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.67 1.588 . . . . 0.0 113.73 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 p -166.56 133.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.419 1.087 . . . . 0.0 112.128 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.6 150.42 24.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 169.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -144.87 138.27 26.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.947 1.299 . . . . 0.0 110.523 -173.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.51 155.54 46.03 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.43 1.492 . . . . 0.0 112.116 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.11 161.94 20.46 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.701 2.934 . . . . 0.0 111.611 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.32 132.27 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.725 1.21 . . . . 0.0 109.583 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.9 mm -129.54 122.41 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.567 1.547 . . . . 0.0 108.595 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mm -122.96 107.49 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.237 1.015 . . . . 0.0 109.883 -173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p 40.0 50.92 2.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.139 2.576 . . . . 0.0 114.194 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -142.28 107.44 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.29 1.036 . . . . 0.0 112.489 -169.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.24 14.62 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.483 1.516 . . . . 0.0 113.277 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.6 t -163.66 141.86 7.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.312 1.445 . . . . 0.0 110.161 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -162.95 170.75 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.535 1.134 . . . . 0.0 112.605 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.29 118.45 2.42 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 125.851 1.691 . . . . 0.0 111.052 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.0 p -172.72 179.13 2.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.89 1.676 . . . . 0.0 111.093 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.6 m -139.23 146.16 40.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.796 1.239 . . . . 0.0 111.277 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.65 149.69 38.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.152 0.882 . . . . 0.0 112.817 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.6 p -168.23 171.37 9.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.882 1.673 . . . . 0.0 111.112 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.8 t -151.93 115.58 4.85 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.019 -1.05 . . . . 0.0 111.475 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.17 164.82 38.89 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.817 1.199 . . . . 0.0 112.673 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.9 m -112.23 12.41 20.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.644 1.178 . . . . 0.0 113.127 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.4 p -162.67 176.13 10.66 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.478 1.511 . . . . 0.0 111.976 -172.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.38 -172.88 32.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.396 0.998 . . . . 0.0 113.317 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.17 144.62 19.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.053 1.741 . . . . 0.0 110.949 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -75.89 123.28 25.43 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.723 -0.611 . . . . 0.0 112.379 -171.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -127.36 132.91 50.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.74 -119.75 3.01 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.124 1.345 . . . . 0.0 112.727 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -57.97 149.21 23.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.802 1.241 . . . . 0.0 112.224 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.88 158.4 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.483 1.513 . . . . 0.0 111.119 -169.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -79.42 105.07 10.47 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.632 1.173 . . . . 0.0 111.027 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.347 1.859 . . . . 0.0 111.693 176.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t 64.46 39.55 6.84 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.013 1.325 . . . . 0.0 112.82 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 t -152.53 144.58 23.78 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 111.476 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.92 -175.53 14.15 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.686 1.612 . . . . 0.0 113.903 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -164.08 -175.9 4.24 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.946 1.698 . . . . 0.0 110.817 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.6 p -158.09 158.0 33.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.365 1.466 . . . . 0.0 112.359 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.6 136.64 18.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.117 0.865 . . . . 0.0 112.53 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -145.88 153.57 41.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.701 2.0 . . . . 0.0 109.973 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.11 109.3 5.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.473 0.709 . . . . 0.0 110.908 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -164.67 131.76 3.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.975 1.31 . . . . 0.0 111.092 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -85.27 67.17 10.06 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 110.687 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -159.71 152.03 20.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.343 1.857 . . . . 0.0 111.147 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.3 t -95.92 124.47 52.08 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 109.759 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.91 148.85 41.27 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.548 2.832 . . . . 0.0 111.835 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.66 -2.67 18.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.358 1.463 . . . . 0.0 114.399 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -126.19 14.55 7.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.344 1.858 . . . . 0.0 113.618 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -46.12 129.82 7.41 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.627 1.171 . . . . 0.0 113.377 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.29 -18.27 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.411 2.741 . . . . 0.0 116.27 -169.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p -130.65 -0.39 4.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.113 1.324 . . . . 0.0 114.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt -136.85 163.04 31.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -102.76 -18.57 15.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -70.03 -46.56 64.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.704 1.602 . . . . 0.0 110.714 175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -138.81 165.54 26.74 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.65 2.38 . . . . 0.0 111.818 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.76 154.6 32.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.514 0.726 . . . . 0.0 111.363 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.66 127.86 31.96 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.694 -173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm -86.07 -23.96 26.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -89.04 -56.44 3.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.472 1.033 . . . . 0.0 112.173 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 36.9 m 47.83 25.04 0.66 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.015 1.726 . . . . 0.0 115.033 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -125.02 -60.53 1.35 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.513 1.525 . . . . 0.0 112.916 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m 70.19 10.25 7.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -100.06 101.56 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.652 -1.28 . . . . 0.0 109.171 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.0 m120 54.44 26.73 7.39 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.19 1.796 . . . . 0.0 114.886 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -58.7 130.96 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.592 . . . . 0.0 111.178 -172.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.65 144.76 50.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.307 1.843 . . . . 0.0 112.582 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -84.55 157.07 21.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.455 1.502 . . . . 0.0 112.732 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.27 155.67 30.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.797 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.79 153.31 42.82 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.369 2.713 . . . . 0.0 110.947 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -136.64 132.1 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 108.799 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.45 112.1 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.51 1.524 . . . . 0.0 108.454 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 84.3 mt -136.2 130.96 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.809 1.644 . . . . 0.0 108.571 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 m -65.74 137.8 57.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 110.444 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.7 p -76.45 3.95 10.12 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.4 -113.74 4.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.329 1.442 . . . . 0.0 111.309 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 t -158.38 168.22 27.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.203 1.401 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.0 t -86.54 125.7 33.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.126 -0.984 . . . . 0.0 111.751 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.56 156.78 22.66 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.075 1.322 . . . . 0.0 112.765 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 p -83.51 164.05 20.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 112.495 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.3 p -139.12 120.31 14.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 111.043 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.67 126.84 8.21 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.253 0.93 . . . . 0.0 111.597 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -153.49 152.8 31.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.587 1.555 . . . . 0.0 110.59 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.6 t -161.44 157.05 24.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.586 1.155 . . . . 0.0 111.383 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.59 143.7 8.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.253 1.406 . . . . 0.0 112.506 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 p -91.6 -10.3 40.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 0.0 113.983 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -169.5 -179.22 3.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.766 2.026 . . . . 0.0 110.374 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.78 -114.96 4.64 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.417 1.008 . . . . 0.0 112.885 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.21 134.93 54.1 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.775 1.63 . . . . 0.0 110.7 -171.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -83.25 128.42 34.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.304 0.641 . . . . 0.0 110.746 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -96.38 136.37 36.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.34 -140.71 5.38 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 123.981 0.801 . . . . 0.0 112.055 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -63.42 146.01 54.45 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.535 0.734 . . . . 0.0 111.481 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -154.16 -177.87 6.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.508 1.123 . . . . 0.0 111.61 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -104.38 109.7 21.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.532 1.133 . . . . 0.0 109.405 -173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 113.64 -177.393 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -148.79 152.99 37.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.473 1.509 . . . . 0.0 111.089 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 p -83.13 145.12 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.286 1.035 . . . . 0.0 113.277 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.89 67.41 3.59 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.97 1.271 . . . . 0.0 112.284 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -75.21 77.74 2.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.66 1.184 . . . . 0.0 111.505 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -135.27 122.74 21.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.43 1.492 . . . . 0.0 110.638 -176.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.07 160.94 27.81 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.647 1.117 . . . . 0.0 113.208 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.39 113.96 21.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.087 1.355 . . . . 0.0 109.667 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -168.8 172.4 7.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.936 2.094 . . . . 0.0 111.302 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.19 -4.38 57.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.976 1.311 . . . . 0.0 114.059 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -94.33 -41.75 9.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.71 1.204 . . . . 0.0 112.604 -171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m 64.15 8.09 3.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.569 1.948 . . . . 0.0 115.74 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.8 119.4 51.01 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.927 1.291 . . . . 0.0 111.237 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 162.52 37.85 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.332 2.688 . . . . 0.0 111.802 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.81 1.63 10.11 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.698 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.59 14.94 3.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.186 2.195 . . . . 0.0 113.312 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.41 141.52 16.36 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 124.51 1.124 . . . . 0.0 113.149 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.89 -19.32 18.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.368 2.712 . . . . 0.0 116.007 -169.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p -128.24 -17.27 4.31 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.051 1.296 . . . . 0.0 113.956 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.93 168.72 11.19 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -101.69 -41.47 6.55 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -71.78 -36.9 70.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.994 0.917 . . . . 0.0 112.981 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -119.08 166.46 12.88 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.161 2.184 . . . . 0.0 110.957 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.19 166.62 11.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.709 0.803 . . . . 0.0 110.189 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.3 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.369 -0.832 . . . . 0.0 111.822 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt -72.39 -46.98 52.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -80.83 -35.03 33.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.5 t 52.72 32.05 11.39 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.724 1.609 . . . . 0.0 113.389 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.54 -29.75 68.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 114.118 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -167.39 174.16 8.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.985 1.714 . . . . 0.0 110.424 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -92.37 92.14 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 108.448 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -90.73 109.15 20.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 110.728 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.7 22.48 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.249 1.42 . . . . 0.0 113.279 -171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -90.54 141.98 28.21 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.128 0.971 . . . . 0.0 110.567 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.8 155.81 20.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.032 0.933 . . . . 0.0 110.987 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.55 148.33 58.44 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.163 1.385 . . . . 0.0 110.058 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.29 150.72 53.4 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.265 2.643 . . . . 0.0 111.253 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.9 t -136.83 128.38 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.223 1.409 . . . . 0.0 108.307 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.33 107.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.56 1.544 . . . . 0.0 108.403 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 86.3 mt -133.69 107.83 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.017 1.327 . . . . 0.0 108.458 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 p -84.65 65.34 9.0 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.764 1.625 . . . . 0.0 110.838 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 t -135.97 123.39 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.265 1.426 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.95 -108.42 3.25 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.568 1.556 . . . . 0.0 111.886 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -159.66 178.31 9.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.791 1.637 . . . . 0.0 110.938 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 127.47 5.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 111.491 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.4 54.82 4.81 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.299 1.428 . . . . 0.0 112.558 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.3 t -67.04 150.84 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.204 1.002 . . . . 0.0 112.592 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -84.92 59.77 5.8 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.463 1.105 . . . . 0.0 112.173 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.11 166.73 12.51 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.148 1.833 . . . . 0.0 112.88 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 t -164.01 159.61 20.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.573 1.549 . . . . 0.0 110.854 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.5 t -163.44 130.92 3.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.258 1.423 . . . . 0.0 110.958 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.74 96.63 1.01 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.2 1.381 . . . . 0.0 111.209 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.1 t -166.53 175.64 7.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.421 1.488 . . . . 0.0 111.245 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.4 t -162.21 154.59 19.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.926 1.69 . . . . 0.0 111.004 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.66 -179.62 47.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.547 1.07 . . . . 0.0 112.04 -169.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.87 121.9 22.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.073 0.949 . . . . 0.0 111.824 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -80.05 131.15 35.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.191 0.997 . . . . 0.0 110.542 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -114.1 150.35 34.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.81 -134.71 2.21 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.717 1.151 . . . . 0.0 112.239 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.99 155.39 23.91 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -133.35 127.53 33.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.383 1.073 . . . . 0.0 109.887 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -163.42 146.13 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.889 1.676 . . . . 0.0 108.851 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.182 1.393 . . . . 0.0 113.84 -179.422 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -85.84 -20.21 29.47 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.721 -0.87 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -79.07 155.4 28.8 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.654 1.181 . . . . 0.0 113.476 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.92 148.34 20.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.491 1.519 . . . . 0.0 112.97 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 p -108.19 143.29 37.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.63 1.572 . . . . 0.0 112.166 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m 58.98 32.26 22.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.814 1.246 . . . . 0.0 113.725 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -52.35 53.15 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.608 1.099 . . . . 0.0 114.075 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.4 mt -149.93 118.0 6.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.948 1.699 . . . . 0.0 109.693 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.7 151.61 4.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.133 1.773 . . . . 0.0 111.759 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 171.47 13.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.958 0.903 . . . . 0.0 111.835 169.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.46 129.7 12.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.501 1.52 . . . . 0.0 110.441 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.4 m -96.38 -11.96 25.01 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.49 110.8 0.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.987 1.315 . . . . 0.0 112.139 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.04 149.63 90.07 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.203 2.602 . . . . 0.0 112.576 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.74 -4.23 22.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.55 1.54 . . . . 0.0 114.126 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.71 31.38 1.46 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.126 1.771 . . . . 0.0 111.534 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -43.53 127.81 3.84 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.617 1.567 . . . . 0.0 113.397 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.9 -20.01 6.75 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.057 2.504 . . . . 0.0 115.743 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p -127.73 -21.49 3.73 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.35 -51.61 2.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 13.0 t-80 -166.15 -148.1 0.1 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.21 1.804 . . . . 0.0 110.295 -176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 25.0 ptt180 -65.73 -14.97 62.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.509 1.124 . . . . 0.0 113.825 169.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -57.64 163.68 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 0.0 111.635 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -60.49 147.42 41.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.242 1.017 . . . . 0.0 111.263 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.91 146.68 29.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.176 0.99 . . . . 0.0 110.981 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp -81.93 -11.51 58.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -107.55 -18.99 13.7 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.47 132.59 48.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.366 1.066 . . . . 0.0 111.922 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.79 33.75 19.99 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.746 1.618 . . . . 0.0 112.899 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.2 t -144.56 164.42 30.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.29 1.436 . . . . 0.0 111.635 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -139.17 131.84 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.476 1.91 . . . . 0.0 108.611 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -152.39 150.2 29.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.752 1.621 . . . . 0.0 112.002 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.72 23.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.438 1.495 . . . . 0.0 113.144 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.7 mmm -83.45 55.22 3.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.816 1.646 . . . . 0.0 111.89 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.34 35.86 0.23 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.228 1.811 . . . . 0.0 114.082 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.15 151.35 29.28 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.241 1.817 . . . . 0.0 111.626 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.73 148.48 22.7 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.629 2.886 . . . . 0.0 110.962 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.2 t -141.7 130.41 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 108.566 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.63 119.31 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.525 1.53 . . . . 0.0 108.56 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.0 mm -124.87 124.27 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.353 1.461 . . . . 0.0 108.892 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.6 p -127.8 4.14 6.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.526 1.531 . . . . 0.0 113.695 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -74.08 -17.2 60.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.17 -138.42 32.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.171 1.367 . . . . 0.0 113.212 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -162.79 167.32 23.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.896 1.678 . . . . 0.0 110.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -144.19 131.54 20.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.059 1.344 . . . . 0.0 110.928 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.29 151.72 6.29 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.515 1.055 . . . . 0.0 113.313 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -152.07 135.14 15.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.622 1.569 . . . . 0.0 109.96 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.8 m -169.18 166.88 10.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.561 1.944 . . . . 0.0 111.075 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.39 -116.09 2.93 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.214 1.387 . . . . 0.0 111.817 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.5 t -159.16 -175.76 5.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.615 1.566 . . . . 0.0 110.826 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 m -69.18 119.51 13.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.271 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.71 -159.87 44.59 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.787 1.185 . . . . 0.0 114.036 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -147.02 147.04 30.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.607 1.563 . . . . 0.0 110.417 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -79.03 -0.73 32.46 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -169.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.89 -99.4 0.12 Allowed Glycine 0 N--CA 1.47 0.909 0 C-N-CA 124.632 1.111 . . . . 0.0 112.648 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.08 138.08 57.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.957 1.303 . . . . 0.0 111.19 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -79.89 115.83 19.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.903 0.481 . . . . 0.0 111.065 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -127.28 126.94 43.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.11 -101.28 2.71 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.429 1.49 . . . . 0.0 111.601 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.46 150.88 29.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.889 0.875 . . . . 0.0 112.615 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 -170.8 3.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.148 1.779 . . . . 0.0 109.975 -175.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -146.66 140.55 26.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.548 1.139 . . . . 0.0 109.483 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 126.584 1.954 . . . . 0.0 113.445 -174.506 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.86 178.13 8.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.824 1.649 . . . . 0.0 111.081 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -151.8 155.74 38.82 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.569 -1.332 . . . . 0.0 112.994 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.97 -174.03 13.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.107 1.813 . . . . 0.0 112.212 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.9 m -69.94 -41.73 74.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.9 p 54.74 -5.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.336 3.055 . . . . 0.0 118.833 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 80.41 1.58 Allowed Glycine 0 N--CA 1.468 0.825 0 C-N-CA 125.467 1.508 . . . . 0.0 113.468 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.9 tp -68.01 -33.2 74.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 111.962 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -79.33 134.17 36.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.479 1.112 . . . . 0.0 111.404 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -67.07 130.18 42.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.111 0.964 . . . . 0.0 110.69 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.97 153.23 42.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.006 1.722 . . . . 0.0 110.811 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -73.35 -12.73 60.93 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.25 118.63 41.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 109.351 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.68 142.58 48.66 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.322 2.681 . . . . 0.0 111.259 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.69 -4.91 25.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.718 1.207 . . . . 0.0 113.923 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.56 19.37 7.37 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.548 2.339 . . . . 0.0 112.469 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -42.24 126.17 2.79 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.524 1.529 . . . . 0.0 113.385 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.81 -22.1 12.04 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.812 2.341 . . . . 0.0 115.555 -169.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p -132.19 -11.06 3.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -129.68 127.57 40.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -64.45 135.82 56.47 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.64 0.776 . . . . 0.0 112.747 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? 61.59 22.99 13.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.183 1.793 . . . . 0.0 113.179 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -142.55 169.04 18.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.104 2.162 . . . . 0.0 110.762 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.37 156.12 31.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.725 . . . . 0.0 110.005 168.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.38 45.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.816 -0.553 . . . . 0.0 111.749 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -89.94 -22.62 21.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -89.35 -27.46 20.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.495 1.043 . . . . 0.0 112.636 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.7 m -123.17 89.59 3.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.445 1.498 . . . . 0.0 109.96 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.69 155.95 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.403 1.081 . . . . 0.0 112.306 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 t -153.92 157.27 38.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.951 1.3 . . . . 0.0 111.243 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -139.52 120.2 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.615 1.566 . . . . 0.0 108.322 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -130.82 4.23 4.52 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.777 1.231 . . . . 0.0 114.303 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.75 151.08 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.492 2.317 . . . . 0.0 110.009 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtt -89.26 100.26 13.08 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.279 1.031 . . . . 0.0 110.956 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -106.87 151.48 25.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.656 1.582 . . . . 0.0 110.721 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -61.72 141.69 94.95 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.516 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.37 138.52 30.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.27 2.647 . . . . 0.0 111.192 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.24 136.83 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.173 0.989 . . . . 0.0 110.423 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mm -116.0 121.46 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.03 1.332 . . . . 0.0 109.122 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.7 mm -126.03 139.41 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.788 1.635 . . . . 0.0 109.567 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.2 p -137.73 150.24 47.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.772 1.629 . . . . 0.0 110.324 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.2 p -92.43 -7.55 47.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.3 64.86 4.24 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.571 1.558 . . . . 0.0 112.159 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.3 p -159.46 176.3 12.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.886 1.275 . . . . 0.0 112.945 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -153.72 154.22 33.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 111.307 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.88 171.23 16.9 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.112 1.339 . . . . 0.0 114.45 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -151.56 155.63 38.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.335 1.854 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -65.66 130.96 45.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.239 1.016 . . . . 0.0 112.746 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.96 -166.96 27.07 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.92 1.248 . . . . 0.0 113.839 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.9 p -162.45 163.28 27.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.285 1.834 . . . . 0.0 110.751 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.7 m -161.45 136.61 7.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.057 1.343 . . . . 0.0 111.369 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.02 128.41 9.53 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.065 1.317 . . . . 0.0 111.693 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.9 m -154.9 163.08 40.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.99 1.716 . . . . 0.0 111.042 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -141.48 140.22 33.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.313 1.045 . . . . 0.0 111.809 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.92 0.24 Allowed Glycine 0 N--CA 1.471 1.027 0 C-N-CA 125.598 1.57 . . . . 0.0 112.167 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.04 130.88 35.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.856 0.862 . . . . 0.0 110.33 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -77.98 126.57 31.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.548 0.739 . . . . 0.0 111.342 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 58.21 8.14 0.76 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -8.43 -95.57 0.0 OUTLIER Glycine 0 N--CA 1.479 1.508 0 C-N-CA 130.431 3.872 . . . . 0.0 117.673 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -85.23 135.03 34.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.559 1.144 . . . . 0.0 109.853 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -156.67 153.33 28.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.648 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.95 101.39 3.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.56 1.144 . . . . 0.0 110.836 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.79 1.636 . . . . 0.0 114.022 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -157.69 -164.43 1.54 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.295 1.438 . . . . 0.0 110.805 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -147.6 144.41 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.268 1.427 . . . . 0.0 111.309 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 -169.29 51.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.602 1.096 . . . . 0.0 113.04 -171.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.4 p -164.7 173.27 12.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.6 1.56 . . . . 0.0 111.353 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -78.09 -14.22 59.57 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.978 -1.076 . . . . 0.0 113.868 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 174.5 28.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.185 1.374 . . . . 0.0 113.715 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.92 83.74 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.385 1.474 . . . . 0.0 109.183 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -152.98 155.95 37.92 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.212 1.805 . . . . 0.0 110.949 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -78.9 90.18 4.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.3 1.04 . . . . 0.0 110.696 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -160.33 140.41 11.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.819 2.048 . . . . 0.0 109.892 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t -99.53 -4.25 31.64 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -89.72 121.51 68.98 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 120.704 -1.248 . . . . 0.0 110.157 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.0 156.45 65.8 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.83 3.02 . . . . 0.0 112.611 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.26 -10.95 55.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.167 1.387 . . . . 0.0 114.329 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.82 32.21 2.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.756 1.623 . . . . 0.0 111.755 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -46.82 132.03 8.57 Favored Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 120.944 -1.097 . . . . 0.0 112.35 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.94 -15.27 46.54 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.742 2.961 . . . . 0.0 115.828 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -157.22 20.17 0.3 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -132.08 139.35 48.47 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.93 127.02 31.3 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.882 0.873 . . . . 0.0 112.876 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 50.18 46.25 24.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.558 1.943 . . . . 0.0 112.376 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -153.8 160.66 42.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.944 2.498 . . . . 0.0 109.946 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -69.42 151.59 45.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.031 0.533 . . . . 0.0 110.665 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.79 149.38 46.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.809 0.443 . . . . 0.0 110.604 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp -96.68 -20.32 18.36 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.12 -21.79 27.43 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.818 1.19 . . . . 0.0 113.312 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.91 114.88 2.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.534 1.134 . . . . 0.0 111.777 -174.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.88 19.78 10.06 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.007 1.723 . . . . 0.0 113.539 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.6 t -112.81 6.28 17.94 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.798 -1.189 . . . . 0.0 113.995 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.6 mt -94.9 100.77 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.776 -1.203 . . . . 0.0 109.742 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -117.47 -20.44 9.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.1 151.25 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.624 2.37 . . . . 0.0 107.964 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.42 151.94 5.19 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.588 1.155 . . . . 0.0 113.937 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.77 148.98 22.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.62 1.168 . . . . 0.0 113.105 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -74.76 151.1 86.71 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.26 1.024 . . . . 0.0 112.079 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.63 171.22 18.22 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.948 3.098 . . . . 0.0 111.062 173.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.43 135.96 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.204 1.002 . . . . 0.0 109.871 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.35 140.45 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.631 1.573 . . . . 0.0 110.006 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.48 136.01 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.53 1.532 . . . . 0.0 109.796 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.8 m -127.27 125.65 41.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.801 1.64 . . . . 0.0 109.532 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 m -81.67 -24.28 36.35 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.78 33.51 71.08 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.095 0.798 . . . . 0.0 115.095 171.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -58.83 147.97 31.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.504 1.122 . . . . 0.0 113.717 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.0 9.44 4.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.26 1.824 . . . . 0.0 113.828 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.88 66.52 2.78 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.627 1.585 . . . . 0.0 112.489 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 p -77.47 62.9 2.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.983 1.713 . . . . 0.0 113.029 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 p -71.25 119.94 16.1 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.61 -1.306 . . . . 0.0 112.392 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.13 -70.1 1.13 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.879 1.228 . . . . 0.0 111.177 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.3 t -166.25 153.88 10.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.833 1.653 . . . . 0.0 110.992 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.6 p -119.28 2.82 11.37 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.587 1.555 . . . . 0.0 113.049 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.18 -149.12 36.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.009 1.29 . . . . 0.0 112.901 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -119.22 125.85 50.14 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.919 1.287 . . . . 0.0 109.308 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 m -158.86 49.9 0.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.398 1.479 . . . . 0.0 110.876 -169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 -125.38 6.88 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.412 1.482 . . . . 0.0 111.172 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.94 129.3 37.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.547 1.139 . . . . 0.0 109.984 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -76.68 122.43 24.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.36 0.664 . . . . 0.0 111.278 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -100.67 147.41 26.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.91 -128.02 1.77 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.465 1.031 . . . . 0.0 112.424 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.44 175.73 2.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.084 0.954 . . . . 0.0 112.866 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -69.05 3.7 1.93 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 73.73 32.38 1.14 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.906 2.082 . . . . 0.0 111.913 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.171 2.188 . . . . 0.0 114.429 177.455 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -148.75 145.41 27.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.9 p -167.1 163.55 15.72 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.369 1.468 . . . . 0.0 111.683 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.5 150.55 25.79 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.343 0.973 . . . . 0.0 112.184 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -97.37 119.88 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.929 0.892 . . . . 0.0 110.613 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.1 p -166.41 153.99 9.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.121 1.368 . . . . 0.0 111.41 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.09 -39.79 1.86 Allowed Glycine 0 N--CA 1.475 1.268 0 C-N-CA 125.323 1.439 . . . . 0.0 114.529 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp 67.14 13.54 9.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.729 2.412 . . . . 0.0 112.979 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.39 152.12 44.45 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.02 1.328 . . . . 0.0 112.358 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 60.71 37.1 19.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.52 . . . . 0.0 113.098 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -52.12 -26.65 11.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -76.37 -19.17 58.44 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.2 t -152.81 100.03 2.74 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 126.276 1.83 . . . . 0.0 108.824 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -70.92 140.5 38.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.157 2.571 . . . . 0.0 111.169 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.64 -21.0 64.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -83.99 0.31 48.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.619 1.168 . . . . 0.0 113.863 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -59.3 126.16 81.12 Favored Pre-proline 0 CA--C 1.557 1.217 0 O-C-N 120.956 -1.09 . . . . 0.0 112.283 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.4 -17.72 12.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.89 2.393 . . . . 0.0 114.964 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -132.66 -10.74 3.12 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.08 137.5 41.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -65.98 132.64 49.06 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.554 -0.716 . . . . 0.0 112.346 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.76 26.98 16.47 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.642 1.577 . . . . 0.0 112.617 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -149.66 168.03 24.75 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.85 2.06 . . . . 0.0 111.068 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.02 159.88 33.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.885 0.874 . . . . 0.0 112.046 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 142.75 31.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.608 0.763 . . . . 0.0 111.002 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt -74.42 -38.45 63.05 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -76.85 -32.25 57.41 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 112.987 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.254 16.8 p 46.04 30.65 0.96 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.249 2.22 . . . . 0.0 115.393 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -139.88 144.77 37.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.006 2.122 . . . . 0.0 110.431 -172.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.0 p 48.58 49.14 18.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.857 1.663 . . . . 0.0 112.696 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mp -54.32 114.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.353 1.861 . . . . 0.0 110.722 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -99.17 112.88 24.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.34 27.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.53 1.932 . . . . 0.0 111.304 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.5 160.27 22.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.451 1.1 . . . . 0.0 111.61 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.22 110.6 5.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.48 0.712 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -105.43 151.47 39.72 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.866 1.666 . . . . 0.0 110.967 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.65 155.78 49.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.523 2.816 . . . . 0.0 111.608 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -139.67 131.93 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.624 1.57 . . . . 0.0 108.363 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.0 110.0 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.928 1.291 . . . . 0.0 108.298 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 mm -80.21 126.65 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.546 0.739 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 55.4 m -135.92 144.63 45.59 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.372 1.869 . . . . 0.0 108.913 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -137.46 123.27 20.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.32 1.048 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.3 -164.14 26.5 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.334 1.445 . . . . 0.0 113.316 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -79.13 161.21 26.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.479 0.712 . . . . 0.0 111.964 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -146.37 118.54 8.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.273 1.029 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -106.54 169.45 15.37 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.333 1.444 . . . . 0.0 113.154 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 m -67.52 136.4 54.51 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.9 0.88 . . . . 0.0 111.805 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.5 p -79.42 74.4 6.04 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.858 1.263 . . . . 0.0 111.853 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.71 -7.31 88.6 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.035 1.302 . . . . 0.0 115.214 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 t -82.43 136.29 34.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.669 1.235 . . . . 0.0 110.678 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -162.98 157.28 20.78 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.796 1.639 . . . . 0.0 111.518 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 166.57 -141.43 6.94 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.102 1.334 . . . . 0.0 111.907 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.0 t -69.38 142.68 53.88 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 117.322 0.561 . . . . 0.0 111.666 172.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.3 m -85.55 131.15 34.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.079 -1.013 . . . . 0.0 111.965 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.33 -150.11 11.26 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.439 1.019 . . . . 0.0 113.33 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.42 143.32 50.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.376 1.87 . . . . 0.0 109.461 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.76 127.81 33.45 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.148 0.431 . . . . 0.0 111.281 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -125.69 140.92 52.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.02 -112.91 1.92 Allowed Glycine 0 N--CA 1.468 0.815 0 C-N-CA 125.302 1.429 . . . . 0.0 112.671 -171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -66.33 127.97 34.31 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.318 1.047 . . . . 0.0 110.807 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -139.54 135.83 33.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.102 1.361 . . . . 0.0 110.02 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -96.63 52.52 1.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.209 1.404 . . . . 0.0 110.93 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 124.89 1.276 . . . . 0.0 114.064 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -161.56 158.38 26.25 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.564 1.545 . . . . 0.0 110.424 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -165.93 170.75 13.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.838 1.255 . . . . 0.0 112.721 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.52 156.65 30.35 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.372 1.463 . . . . 0.0 113.218 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -165.33 131.68 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.277 1.431 . . . . 0.0 111.134 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.9 m -83.16 155.53 23.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.041 0.936 . . . . 0.0 113.129 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.24 -163.35 13.7 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.266 1.412 . . . . 0.0 113.481 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.0 125.7 10.37 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.895 1.678 . . . . 0.0 108.374 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -127.17 124.01 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 111.332 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.25 60.01 5.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.363 1.465 . . . . 0.0 111.148 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.65 127.48 16.33 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.051 1.74 . . . . 0.0 110.658 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -97.02 -8.32 30.71 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -82.83 122.17 78.0 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.832 1.253 . . . . 0.0 109.025 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.78 158.95 46.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.41 2.74 . . . . 0.0 112.249 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.34 0.39 2.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.894 2.078 . . . . 0.0 115.287 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -146.68 17.68 1.29 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.169 1.787 . . . . 0.0 113.693 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -47.09 135.13 8.76 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.151 0.98 . . . . 0.0 113.26 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.31 -16.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.706 2.937 . . . . 0.0 115.467 -170.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t -162.05 49.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt -135.44 131.69 36.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -65.77 142.17 58.07 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.565 -0.709 . . . . 0.0 112.622 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 60.9 23.12 13.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 112.981 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -148.55 166.33 28.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.779 2.432 . . . . 0.0 110.623 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.3 158.4 32.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.333 0.653 . . . . 0.0 111.193 168.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.74 129.08 35.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.969 0.508 . . . . 0.0 110.306 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt -75.96 -39.21 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -80.08 -36.86 34.93 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.341 0.973 . . . . 0.0 112.791 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.2 t 51.89 31.7 8.8 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.581 1.552 . . . . 0.0 113.519 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.17 164.81 23.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.476 1.511 . . . . 0.0 112.695 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 p -66.68 100.34 0.68 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.231 1.013 . . . . 0.0 111.185 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -135.69 135.85 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 126.636 1.974 . . . . 0.0 108.462 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -80.0 -49.93 11.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.395 1.078 . . . . 0.0 112.85 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.87 150.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.734 2.413 . . . . 0.0 109.272 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.45 131.02 48.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.269 1.428 . . . . 0.0 109.908 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -130.86 145.89 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.693 1.597 . . . . 0.0 110.19 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.24 149.72 70.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.373 1.469 . . . . 0.0 110.519 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.77 155.09 44.04 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.597 2.864 . . . . 0.0 112.314 -173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.51 132.26 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.315 1.046 . . . . 0.0 109.268 174.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -123.39 146.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.335 1.854 . . . . 0.0 109.185 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.82 121.21 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.207 1.003 . . . . 0.0 109.986 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.2 t -71.08 143.89 50.52 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.561 1.144 . . . . 0.0 111.162 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -112.19 132.68 54.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.14 1.376 . . . . 0.0 111.533 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.72 -135.77 30.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.714 0.673 . . . . 0.0 112.278 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.9 t -164.41 -168.1 1.45 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.121 1.768 . . . . 0.0 110.226 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.3 p -153.32 164.61 37.82 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.667 -1.27 . . . . 0.0 112.196 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 100.7 1.44 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.09 1.328 . . . . 0.0 111.155 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m -150.53 149.67 30.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.598 1.559 . . . . 0.0 110.842 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -81.89 149.99 27.99 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.269 -0.894 . . . . 0.0 112.05 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.6 -131.94 2.65 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.027 1.298 . . . . 0.0 112.355 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -153.74 141.59 20.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.712 1.205 . . . . 0.0 111.022 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 m -99.81 127.89 45.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.112 . . . . 0.0 111.79 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.93 92.8 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.729 1.156 . . . . 0.0 111.305 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.6 t -75.85 77.22 2.77 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.876 1.27 . . . . 0.0 110.654 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t 68.24 9.69 7.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.295 1.838 . . . . 0.0 112.964 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.77 -148.94 20.0 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.672 2.082 . . . . 0.0 112.018 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.1 mt -114.59 139.44 49.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.715 1.606 . . . . 0.0 109.612 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -75.04 119.62 19.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.315 0.646 . . . . 0.0 111.33 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -128.5 135.05 48.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.55 -98.02 1.76 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.294 1.426 . . . . 0.0 111.52 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -75.09 161.69 29.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.045 1.338 . . . . 0.0 111.9 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -110.57 150.64 28.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.583 1.553 . . . . 0.0 109.059 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -154.49 139.29 17.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.025 1.73 . . . . 0.0 108.935 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.985 1.714 . . . . 0.0 113.781 -172.816 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -85.99 75.28 9.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.148 0.974 . . . . 0.0 111.374 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.5 p -84.57 6.1 25.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.15 1.38 . . . . 0.0 114.119 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.58 -161.84 13.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.313 1.911 . . . . 0.0 112.425 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 t -160.39 140.29 11.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.156 . . . . 0.0 111.47 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.8 t -102.53 -13.29 17.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.486 1.114 . . . . 0.0 112.858 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.96 147.74 6.36 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.39 1.471 . . . . 0.0 113.262 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.75 26.23 0.38 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.84 1.656 . . . . 0.0 112.804 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -120.75 148.83 43.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.919 1.688 . . . . 0.0 111.715 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.97 -20.68 48.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -99.55 162.12 13.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.949 1.699 . . . . 0.0 111.451 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 -0.23 15.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.278 1.031 . . . . 0.0 113.6 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -157.71 124.16 2.53 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -68.73 147.45 69.46 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.475 2.783 . . . . 0.0 111.999 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.15 -9.74 58.84 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.852 1.661 . . . . 0.0 114.151 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.25 17.42 10.68 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.29 1.836 . . . . 0.0 112.585 -173.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -55.45 130.87 70.39 Favored Pre-proline 0 CA--C 1.56 1.347 0 O-C-N 120.521 -1.362 . . . . 0.0 113.795 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.96 -14.75 7.25 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.286 2.658 . . . . 0.0 115.87 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p -133.14 -16.91 2.42 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.402 1.456 . . . . 0.0 114.791 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.62 163.25 25.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -98.27 -29.87 12.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.7 mmt-85 -86.14 -17.04 36.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.615 1.566 . . . . 0.0 114.413 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 164.46 30.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.115 2.166 . . . . 0.0 111.01 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.09 165.95 12.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.72 0.808 . . . . 0.0 110.895 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.38 129.12 39.66 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.48 -0.762 . . . . 0.0 111.903 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt -78.05 -38.39 44.6 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -88.74 -31.57 18.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.1 t 52.91 39.16 28.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.133 1.773 . . . . 0.0 113.688 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -154.94 153.95 31.85 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.373 1.869 . . . . 0.0 110.941 -173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m 72.33 8.52 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.155 1.782 . . . . 0.0 115.022 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp -73.7 114.91 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.924 -1.11 . . . . 0.0 109.455 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -134.76 143.16 46.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.719 2.008 . . . . 0.0 110.595 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.5 133.17 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.887 0.875 . . . . 0.0 110.828 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -155.93 135.47 12.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.891 1.676 . . . . 0.0 111.548 -171.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -83.9 136.38 34.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.095 1.358 . . . . 0.0 112.399 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -151.71 153.11 31.46 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.348 1.859 . . . . 0.0 109.995 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.7 164.05 36.84 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.46 2.773 . . . . 0.0 111.734 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.49 140.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.635 1.574 . . . . 0.0 110.342 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.82 127.86 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.181 1.393 . . . . 0.0 108.351 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.5 mm -99.87 121.54 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.158 0.983 . . . . 0.0 109.812 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -142.85 145.85 33.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.763 . . . . 0.0 109.355 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -136.03 147.89 48.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 111.087 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.32 -153.06 19.73 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.519 1.056 . . . . 0.0 112.84 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.3 t -156.66 166.2 34.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.839 1.256 . . . . 0.0 111.138 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 p -93.5 158.28 15.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.846 1.258 . . . . 0.0 113.125 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.95 -77.52 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.596 1.094 . . . . 0.0 112.238 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 67.24 15.68 10.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.615 1.566 . . . . 0.0 113.569 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.6 t -101.46 140.43 35.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.414 -1.429 . . . . 0.0 111.432 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.84 157.9 34.06 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.967 1.27 . . . . 0.0 113.699 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -172.12 156.61 4.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.074 1.749 . . . . 0.0 111.168 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 m -150.94 153.76 35.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.792 1.237 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.36 56.57 3.7 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 125.173 1.368 . . . . 0.0 112.582 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.0 m -114.2 165.17 12.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.995 1.718 . . . . 0.0 112.689 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 p -76.85 -2.3 32.67 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.72 -123.97 2.48 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.646 1.593 . . . . 0.0 111.879 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.3 mt -54.77 148.91 12.04 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.72 1.608 . . . . 0.0 111.755 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -77.3 114.42 16.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.217 0.607 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -130.18 136.74 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -97.59 -115.32 3.36 Favored Glycine 0 N--CA 1.467 0.728 0 C-N-CA 125.786 1.66 . . . . 0.0 112.531 -171.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -55.13 138.73 43.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.512 1.525 . . . . 0.0 112.055 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -90.96 126.85 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.419 1.088 . . . . 0.0 108.72 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -144.02 133.51 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.26 1.824 . . . . 0.0 108.393 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.117 1.767 . . . . 0.0 113.768 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 136' ' ' PHE . 50.0 t30 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 120.485 0.183 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.421 ' N ' HD22 ' A' ' 25' ' ' ASN . 26.9 t80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.363 0.125 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.348 0.118 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.323 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.727 0.299 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 136' ' ' PHE . 34.4 t30 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 102' ' ' GLN . 9.9 ptp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.524 ' N ' HD22 ' A' ' 25' ' ' ASN . 10.5 t80 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.363 0.125 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.738 -0.097 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.467 0.175 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.556 0.217 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 120.581 0.229 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 HD22 ' N ' ' A' ' 136' ' ' PHE . 48.6 t30 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.402 ' N ' HD22 ' A' ' 25' ' ' ASN . 40.0 t80 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.492 0.187 . . . . 0.0 110.498 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' HD23 ' A' ' 101' ' ' LEU . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 65' ' ' TYR . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.679 0.275 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 136' ' ' PHE . 45.9 t30 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.719 0.295 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.412 ' N ' HD22 ' A' ' 25' ' ' ASN . 31.4 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.42 HD22 ' N ' ' A' ' 136' ' ' PHE . 53.0 t30 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm . . . . . 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.42 ' N ' HD22 ' A' ' 25' ' ' ASN . 57.5 t80 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 120.859 0.361 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.174 0.035 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.683 0.278 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' CD1' HD23 ' A' ' 101' ' ' LEU . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 65' ' ' TYR . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 136' ' ' PHE . 24.9 t30 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.843 0.354 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.482 ' N ' HD22 ' A' ' 25' ' ' ASN . 24.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 120.522 0.201 . . . . 0.0 111.278 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.436 0.16 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 138' ' ' LEU . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.622 HD13 ' HD3' ' A' ' 142' ' ' PRO . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 146' ' ' VAL . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.622 ' HD3' HD13 ' A' ' 138' ' ' LEU . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 141' ' ' PHE . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.452 HD22 ' N ' ' A' ' 136' ' ' PHE . 50.7 t30 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.452 ' N ' HD22 ' A' ' 25' ' ' ASN . 21.2 t80 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.665 0.269 . . . . 0.0 111.33 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 33' ' ' LEU . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 26' ' ' VAL . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.82 0.343 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.435 0.159 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -148.17 150.11 33.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.96 1.304 . . . . 0.0 111.215 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 t -87.04 138.86 31.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.583 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.21 -175.44 50.51 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.617 1.103 . . . . 0.0 112.989 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 t -160.48 136.65 8.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.999 1.319 . . . . 0.0 110.638 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -79.87 117.87 21.12 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.244 -0.91 . . . . 0.0 111.268 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.59 -32.27 59.71 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.555 0.597 . . . . 0.0 113.801 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.71 159.34 13.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.969 2.107 . . . . 0.0 111.976 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -144.69 137.67 26.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.939 1.695 . . . . 0.0 109.497 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.41 41.8 0.32 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.154 1.382 . . . . 0.0 112.364 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -149.21 149.84 31.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.597 1.959 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -71.58 -18.93 62.2 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.08 120.89 69.22 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.252 1.021 . . . . 0.0 109.979 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.88 158.99 54.96 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.701 2.934 . . . . 0.0 113.83 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.39 -6.78 54.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.424 1.89 . . . . 0.0 114.113 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.36 24.79 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.331 1.853 . . . . 0.0 112.045 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -53.5 126.06 46.31 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.472 1.109 . . . . 0.0 112.623 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.3 -11.26 10.86 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.294 2.662 . . . . 0.0 115.36 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p -127.09 -41.74 1.76 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.04 1.291 . . . . 0.0 113.566 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.94 -146.76 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.81 -135.56 0.08 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.435 1.494 . . . . 0.0 111.575 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.76 -20.91 62.57 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.821 -1.174 . . . . 0.0 112.74 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.52 132.7 50.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.371 1.469 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.09 145.34 31.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 148.57 37.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.94 1.296 . . . . 0.0 112.258 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm -81.36 -22.99 38.01 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.06 -13.52 47.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.4 m -67.59 -20.29 65.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.69 147.62 39.26 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.607 0.763 . . . . 0.0 111.384 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.9 t -72.63 96.69 2.03 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.239 -0.913 . . . . 0.0 111.34 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.5 mm -139.48 136.42 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.835 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -78.79 136.1 37.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.929 0.892 . . . . 0.0 110.761 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.41 144.8 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.757 1.223 . . . . 0.0 110.933 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 169.36 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.539 1.936 . . . . 0.0 112.062 -170.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.95 140.03 30.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.109 0.964 . . . . 0.0 111.874 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -152.25 154.69 32.53 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.687 1.595 . . . . 0.0 110.781 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -75.51 149.51 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.275 2.65 . . . . 0.0 111.195 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.9 130.93 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.815 0.846 . . . . 0.0 109.23 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.8 mm -111.3 144.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.613 1.565 . . . . 0.0 109.828 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -62.55 120.57 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.13 0.972 . . . . 0.0 110.091 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.7 m -87.79 127.26 35.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.023 1.329 . . . . 0.0 109.45 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.7 p -82.08 153.84 25.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.639 1.176 . . . . 0.0 112.992 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.45 -151.52 15.99 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.761 1.172 . . . . 0.0 113.032 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -134.61 157.31 46.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.23 1.412 . . . . 0.0 111.394 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -73.78 -1.92 21.33 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.93 130.44 7.02 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.171 1.843 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -153.16 154.25 34.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.169 1.787 . . . . 0.0 110.459 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.3 p -160.79 167.31 27.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.636 1.175 . . . . 0.0 112.229 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -169.31 -142.31 3.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.613 1.101 . . . . 0.0 113.33 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.5 p -158.56 171.66 19.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 111.633 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.9 m -59.96 119.54 7.95 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.456 1.102 . . . . 0.0 113.405 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -110.88 -102.57 2.69 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.695 1.617 . . . . 0.0 111.425 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.5 p -70.63 156.85 38.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.018 1.327 . . . . 0.0 113.613 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.5 p -86.62 160.71 18.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.846 1.258 . . . . 0.0 113.358 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.2 -162.99 28.9 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.401 1.477 . . . . 0.0 112.965 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.78 166.3 22.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.301 1.041 . . . . 0.0 110.815 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -68.4 120.44 14.49 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.74 -0.6 . . . . 0.0 111.699 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -108.61 140.36 42.1 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.51 -133.45 5.45 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.808 1.194 . . . . 0.0 113.195 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -59.33 146.22 40.47 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.201 1.001 . . . . 0.0 111.586 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -146.39 136.56 23.65 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.745 1.218 . . . . 0.0 109.871 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -165.07 156.46 14.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.065 1.746 . . . . 0.0 109.675 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.959 1.704 . . . . 0.0 112.5 177.9 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -72.81 146.18 46.47 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.013 0.907 . . . . 0.0 112.043 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 m -76.09 -16.26 59.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.85 75.7 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.332 0.967 . . . . 0.0 114.625 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -64.62 140.12 58.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 113.863 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -164.08 166.86 20.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.606 1.562 . . . . 0.0 111.759 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.68 161.48 35.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.755 1.169 . . . . 0.0 113.403 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -144.98 161.74 38.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.215 1.806 . . . . 0.0 111.217 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -71.1 164.17 26.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.355 1.062 . . . . 0.0 112.384 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -75.64 76.55 2.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.904 1.282 . . . . 0.0 111.189 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -151.7 146.59 25.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.114 2.165 . . . . 0.0 110.192 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -68.94 -23.44 64.16 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -150.44 128.95 6.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 127.359 2.263 . . . . 0.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.97 145.5 31.65 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.769 2.313 . . . . 0.0 111.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.21 -2.13 14.92 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.873 1.669 . . . . 0.0 114.193 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.98 17.8 8.51 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.762 2.025 . . . . 0.0 112.335 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.05 133.0 40.29 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 120.621 -1.3 . . . . 0.0 113.189 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.7 -17.93 8.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.267 2.645 . . . . 0.0 116.358 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p -133.82 -28.47 1.39 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.274 1.397 . . . . 0.0 114.26 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.09 165.82 20.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -90.33 -37.52 13.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -84.43 -34.92 23.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.669 1.188 . . . . 0.0 112.515 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -105.22 162.27 13.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.769 2.028 . . . . 0.0 110.682 -172.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -65.08 163.42 14.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.967 0.907 . . . . 0.0 110.288 168.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.18 138.6 57.81 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.16 -0.963 . . . . 0.0 110.831 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp -93.59 -17.02 23.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -99.51 -24.75 14.66 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.762 1.165 . . . . 0.0 114.082 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.9 p -88.88 173.33 8.57 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.288 0.949 . . . . 0.0 113.45 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -155.94 20.48 0.38 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.366 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.9 t -159.15 161.8 36.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.301 1.44 . . . . 0.0 110.482 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.4 114.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.056 -1.028 . . . . 0.0 109.832 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -109.89 168.21 9.59 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.649 1.979 . . . . 0.0 111.378 169.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.55 143.05 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.435 1.494 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 174.15 11.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.964 1.705 . . . . 0.0 112.319 -170.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.9 133.51 44.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.275 1.83 . . . . 0.0 109.581 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -134.98 153.25 78.43 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.341 1.856 . . . . 0.0 110.374 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.53 165.66 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.862 3.041 . . . . 0.0 112.513 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.0 t -116.57 133.32 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.583 1.553 . . . . 0.0 108.73 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.99 124.27 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 109.278 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.87 122.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.11 0.964 . . . . 0.0 109.828 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 p -92.13 172.29 8.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.057 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.6 m -76.79 -1.28 27.38 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.79 161.33 30.1 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.443 1.497 . . . . 0.0 113.24 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.9 m -166.82 151.97 7.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.938 2.095 . . . . 0.0 110.111 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -163.41 157.81 20.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.601 1.16 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 136.24 170.39 12.0 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.354 1.454 . . . . 0.0 113.392 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -149.81 159.28 44.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.032 1.733 . . . . 0.0 110.545 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 77.5 p -154.34 157.91 39.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 112.854 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 156.62 -21.87 0.47 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.512 1.53 . . . . 0.0 114.063 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -56.56 128.36 35.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 111.73 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.24 -2.47 2.57 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.034 1.733 . . . . 0.0 114.229 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.79 52.4 3.91 Favored Glycine 0 N--CA 1.474 1.209 0 C-N-CA 126.26 1.886 . . . . 0.0 113.096 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.4 t -71.8 -20.3 61.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.749 1.219 . . . . 0.0 114.201 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.6 p -89.02 1.43 55.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.52 -124.16 7.1 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.708 1.146 . . . . 0.0 112.106 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.6 134.97 40.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.269 1.427 . . . . 0.0 109.585 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.41 137.34 36.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.117 0.567 . . . . 0.0 111.636 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -124.02 134.93 53.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -103.53 -97.49 2.43 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 124.657 1.123 . . . . 0.0 112.142 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -64.8 135.52 55.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.302 1.041 . . . . 0.0 111.548 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.99 -0.28 48.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -81.55 108.12 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.322 1.449 . . . . 0.0 109.083 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.888 2.075 . . . . 0.0 113.251 -173.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -147.14 169.52 19.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.185 1.394 . . . . 0.0 111.483 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -156.08 175.67 13.67 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.971 1.308 . . . . 0.0 111.114 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.9 146.91 42.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.402 1.001 . . . . 0.0 112.932 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -155.02 110.27 3.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.861 1.264 . . . . 0.0 110.625 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 m 63.46 6.13 2.38 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.316 1.846 . . . . 0.0 114.995 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.69 146.82 18.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.349 1.452 . . . . 0.0 112.879 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -165.3 150.03 8.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.37 1.868 . . . . 0.0 112.04 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -79.9 131.87 35.95 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.937 0.895 . . . . 0.0 111.443 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -102.9 9.3 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.488 1.515 . . . . 0.0 112.704 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -147.0 167.38 24.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.731 2.012 . . . . 0.0 110.113 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.8 m -90.4 -14.64 32.55 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -177.94 113.65 0.23 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.312 1.845 . . . . 0.0 112.106 -169.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.23 162.82 15.26 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.413 2.742 . . . . 0.0 111.505 169.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.47 3.66 5.79 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.358 1.463 . . . . 0.0 113.926 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 14.29 1.88 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.389 1.476 . . . . 0.0 114.479 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -50.86 137.83 24.98 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.444 1.098 . . . . 0.0 113.721 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.65 -23.03 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.643 2.895 . . . . 0.0 115.803 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -133.1 5.39 3.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.911 1.232 . . . . 0.0 114.166 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.87 158.05 38.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -110.74 -16.38 13.61 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -106.73 7.08 30.23 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.951 1.7 . . . . 0.0 112.675 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -160.04 156.64 27.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.897 2.879 . . . . 0.0 108.637 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.29 159.14 12.84 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.932 0.787 . . . . 0.0 111.472 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 134.14 54.45 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.126 -0.983 . . . . 0.0 111.099 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt -76.86 -31.1 56.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.4 -23.75 15.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.2 t -87.02 121.78 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.089 0.956 . . . . 0.0 111.485 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.99 -25.34 26.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -142.52 124.02 14.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.105 1.362 . . . . 0.0 110.873 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.66 124.46 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.767 1.627 . . . . 0.0 109.44 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.47 149.41 35.04 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.124 0.97 . . . . 0.0 111.472 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.95 123.26 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.653 1.181 . . . . 0.0 110.494 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.01 164.41 26.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.197 1.399 . . . . 0.0 112.803 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -63.3 150.73 42.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.014 0.925 . . . . 0.0 111.908 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.79 153.22 84.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.43 1.092 . . . . 0.0 112.381 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.94 164.08 36.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.479 2.786 . . . . 0.0 111.693 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.17 134.62 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 0.0 109.667 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.02 116.6 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.326 1.051 . . . . 0.0 109.407 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.9 mm -124.2 21.13 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.631 1.572 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p 61.1 29.99 19.19 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.754 2.022 . . . . 0.0 112.502 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -58.88 148.1 31.44 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.544 2.338 . . . . 0.0 114.462 -169.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.17 176.04 42.76 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.319 0.961 . . . . 0.0 113.703 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.0 m -151.04 156.95 42.17 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.57 1.548 . . . . 0.0 110.64 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -137.52 146.98 44.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.871 1.268 . . . . 0.0 111.779 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.88 165.42 45.65 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.519 1.056 . . . . 0.0 113.234 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 t -166.13 -41.75 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.937 1.295 . . . . 0.0 112.395 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.3 t -94.52 119.81 33.79 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.179 -0.951 . . . . 0.0 111.091 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.25 -141.27 11.14 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.348 1.452 . . . . 0.0 112.751 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.4 t -81.6 170.33 15.98 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.953 0.883 . . . . 0.0 112.635 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -168.26 -28.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.781 1.632 . . . . 0.0 113.842 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 131.96 85.74 0.32 Allowed Glycine 0 N--CA 1.471 0.985 0 C-N-CA 125.655 1.598 . . . . 0.0 111.7 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.4 p -166.43 162.73 17.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.945 1.698 . . . . 0.0 111.247 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.8 m -114.94 -0.4 13.43 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.81 -129.67 8.78 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.049 1.309 . . . . 0.0 112.758 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.1 mt -60.9 134.88 57.53 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.666 1.186 . . . . 0.0 112.141 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -98.3 131.23 44.79 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.418 . . . . 0.0 111.312 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.86 141.07 34.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -86.66 -136.22 4.47 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.369 0.985 . . . . 0.0 112.357 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -66.81 142.19 57.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.708 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -74.19 132.58 42.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.301 1.44 . . . . 0.0 109.293 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -152.4 135.57 15.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.339 1.856 . . . . 0.0 108.923 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.782 1.633 . . . . 0.0 112.558 -170.337 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -85.3 111.53 19.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.132 0.966 . . . . 0.0 111.166 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.5 m -148.44 152.5 37.05 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.987 1.315 . . . . 0.0 111.603 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.87 174.65 44.08 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.893 1.235 . . . . 0.0 113.549 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -165.43 168.73 16.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.362 1.465 . . . . 0.0 111.458 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -161.71 117.6 2.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.515 1.526 . . . . 0.0 110.425 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.02 -31.89 9.45 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.331 0.967 . . . . 0.0 113.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.07 171.35 8.53 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.771 1.628 . . . . 0.0 110.331 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -141.65 71.6 1.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 111.427 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 73.6 14.68 4.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.248 2.219 . . . . 0.0 114.069 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.79 -64.18 0.92 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.178 1.391 . . . . 0.0 113.055 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -92.38 -16.57 25.79 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.2 p -167.08 129.93 1.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.113 2.165 . . . . 0.0 109.416 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 144.94 26.69 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.221 2.614 . . . . 0.0 111.664 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.32 -6.23 38.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.134 1.374 . . . . 0.0 113.926 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -127.42 21.84 6.57 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.966 2.106 . . . . 0.0 112.911 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -41.23 125.17 2.16 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.984 1.714 . . . . 0.0 114.152 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.79 -12.05 11.15 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.156 2.571 . . . . 0.0 115.886 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p -141.48 -15.57 0.84 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt -137.64 153.05 49.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -96.89 -26.3 15.13 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -127.07 15.7 7.31 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.949 1.7 . . . . 0.0 113.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -142.25 157.35 44.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.184 2.594 . . . . 0.0 108.223 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.07 160.89 20.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.116 0.416 . . . . 0.0 112.086 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.79 130.39 43.01 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.818 -0.551 . . . . 0.0 109.956 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp -97.59 -24.15 15.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -93.65 -13.6 27.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.5 t -147.69 153.16 38.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.066 1.746 . . . . 0.0 110.767 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.0 -10.98 60.3 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.5 m -156.86 165.84 35.06 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.629 1.971 . . . . 0.0 109.725 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -69.28 110.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.688 0.795 . . . . 0.0 109.15 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.72 146.21 35.77 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.31 1.844 . . . . 0.0 110.308 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.24 125.57 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.299 0.64 . . . . 0.0 110.018 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.6 mmt -142.23 162.3 35.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.556 1.942 . . . . 0.0 110.852 -171.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.13 136.77 54.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.42 142.82 30.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.909 1.684 . . . . 0.0 109.505 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.07 159.27 53.79 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.992 3.795 . . . . 0.0 112.397 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.48 133.66 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 108.73 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.66 132.18 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.293 1.437 . . . . 0.0 109.149 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.99 127.38 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 109.8 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -86.27 154.08 21.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.95 1.7 . . . . 0.0 111.641 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.5 m -134.73 51.81 2.08 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.84 1.256 . . . . 0.0 111.159 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.38 -109.62 3.55 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 124.914 1.245 . . . . 0.0 110.641 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 61.7 p -157.17 149.6 23.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.952 1.301 . . . . 0.0 111.436 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -83.26 64.27 7.66 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.141 -0.975 . . . . 0.0 111.579 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.28 -147.05 26.83 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.112 1.339 . . . . 0.0 112.59 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 p -163.2 154.06 16.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.799 1.64 . . . . 0.0 110.9 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.0 m -161.54 113.58 1.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.576 1.15 . . . . 0.0 111.59 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.62 -4.84 30.03 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.965 1.269 . . . . 0.0 115.463 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.5 p -91.15 132.39 36.1 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.831 -173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.2 t -163.94 148.89 10.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.424 1.49 . . . . 0.0 110.906 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -92.43 2.64 74.45 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.912 1.244 . . . . 0.0 114.261 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.0 t -105.67 143.77 33.36 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.839 1.32 . . . . 0.0 113.279 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.0 p -81.98 179.78 7.69 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.039 1.335 . . . . 0.0 111.891 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.25 -136.51 8.56 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 120.934 -1.104 . . . . 0.0 113.455 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.55 166.47 21.89 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.672 1.189 . . . . 0.0 111.416 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -66.36 120.54 13.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.2 0.6 . . . . 0.0 110.857 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -113.52 135.63 53.68 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.0 -133.51 5.7 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.364 0.983 . . . . 0.0 113.063 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.54 159.17 10.93 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.509 1.124 . . . . 0.0 112.269 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.07 176.78 9.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 111.66 -173.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -85.96 99.33 11.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.408 1.083 . . . . 0.0 109.68 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.473 1.509 . . . . 0.0 114.106 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -164.2 152.62 12.98 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.425 1.89 . . . . 0.0 110.722 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 t -163.5 157.1 19.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.026 1.33 . . . . 0.0 111.364 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.77 141.54 6.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.758 1.171 . . . . 0.0 113.18 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -169.98 163.37 9.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.339 1.855 . . . . 0.0 110.298 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -81.81 -23.89 36.23 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.04 -1.037 . . . . 0.0 113.447 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.79 11.73 60.92 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.925 1.25 . . . . 0.0 114.825 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -68.54 130.92 44.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.789 1.236 . . . . 0.0 112.21 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -149.37 148.64 29.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.405 1.882 . . . . 0.0 110.702 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.28 111.94 21.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.144 0.978 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.82 -178.21 1.52 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.392 2.677 . . . . 0.0 109.991 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.9 t -80.32 -21.2 42.77 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -177.57 117.4 0.26 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.812 2.445 . . . . 0.0 110.504 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.93 137.66 29.82 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.446 2.097 . . . . 0.0 110.512 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -78.88 5.95 10.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 0.0 113.44 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -115.59 8.41 15.07 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.455 2.302 . . . . 0.0 113.091 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -49.01 137.33 13.69 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 125.29 1.436 . . . . 0.0 114.031 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -11.77 32.85 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.691 3.594 . . . . 0.0 116.656 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -150.57 -29.36 0.21 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.92 161.59 27.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -99.64 -12.52 19.98 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.298 1.039 . . . . 0.0 113.756 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -95.83 -16.99 21.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.783 1.633 . . . . 0.0 113.903 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -155.57 171.14 20.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.537 1.935 . . . . 0.0 112.269 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.75 149.06 49.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.659 0.784 . . . . 0.0 111.171 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.57 142.89 57.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.179 1.392 . . . . 0.0 112.795 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp -86.06 -33.61 20.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -81.86 -31.85 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.84 1.2 . . . . 0.0 113.207 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.8 t 47.87 61.28 3.05 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.347 1.859 . . . . 0.0 112.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -141.48 152.17 43.96 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.345 1.458 . . . . 0.0 111.774 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -72.69 103.7 3.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.735 1.214 . . . . 0.0 111.672 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.0 mm -134.7 138.22 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.931 2.092 . . . . 0.0 108.411 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -113.47 134.58 54.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 110.799 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.89 143.58 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.435 1.494 . . . . 0.0 110.174 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 155.55 18.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.48 1.512 . . . . 0.0 111.414 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.03 126.41 34.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 111.553 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.67 154.52 50.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 110.993 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.18 164.62 35.13 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.563 2.842 . . . . 0.0 111.617 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.81 134.29 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.348 1.459 . . . . 0.0 108.933 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.17 130.24 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.673 1.589 . . . . 0.0 108.566 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.2 mm -77.29 131.12 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.803 0.841 . . . . 0.0 110.408 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -113.15 157.5 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.182 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -108.17 121.7 45.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.398 1.079 . . . . 0.0 111.427 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.8 -174.94 38.23 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.004 1.288 . . . . 0.0 113.084 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -93.61 122.7 36.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.973 0.909 . . . . 0.0 110.426 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -79.9 123.31 27.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.044 -1.035 . . . . 0.0 112.094 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.83 168.29 33.16 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.735 1.16 . . . . 0.0 113.513 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.2 p -166.23 128.97 1.96 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.796 1.239 . . . . 0.0 111.403 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.8 t -80.21 3.89 19.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.63 173.41 19.01 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.414 1.959 . . . . 0.0 113.394 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -147.18 158.71 44.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.924 1.69 . . . . 0.0 109.964 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -107.0 175.45 5.5 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.131 -0.981 . . . . 0.0 112.498 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.72 124.31 7.03 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.459 1.028 . . . . 0.0 111.205 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.4 m -147.9 129.25 14.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.445 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 t -91.5 -6.4 52.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.19 -138.02 2.5 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.701 1.62 . . . . 0.0 112.567 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.75 151.48 47.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.287 1.035 . . . . 0.0 112.077 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -104.81 118.77 37.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.016 1.326 . . . . 0.0 110.511 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -109.67 150.54 28.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.29 -125.38 0.87 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.165 1.364 . . . . 0.0 112.506 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.12 142.83 55.65 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.911 -0.758 . . . . 0.0 112.318 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.61 166.63 32.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 111.227 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -96.74 114.37 26.01 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.21 1.404 . . . . 0.0 108.968 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.262 1.425 . . . . 0.0 113.991 176.625 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 67.44 26.1 8.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.241 1.416 . . . . 0.0 113.403 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -75.71 152.48 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.245 -1.534 . . . . 0.0 113.365 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.9 169.78 36.53 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.372 1.463 . . . . 0.0 113.104 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 p -87.65 -11.99 46.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -93.89 131.87 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.743 1.217 . . . . 0.0 111.175 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.94 -159.24 20.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.341 1.448 . . . . 0.0 113.055 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -142.4 159.96 41.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.239 1.816 . . . . 0.0 111.134 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.43 151.15 43.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.949 1.7 . . . . 0.0 110.654 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -137.75 115.48 11.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.369 1.467 . . . . 0.0 109.178 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -161.83 137.93 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.476 1.51 . . . . 0.0 110.115 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -84.06 -12.95 54.31 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -86.13 119.09 71.45 Favored Pre-proline 0 N--CA 1.477 0.879 0 O-C-N 120.959 -1.088 . . . . 0.0 110.372 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.82 149.74 78.39 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.682 2.922 . . . . 0.0 112.036 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.68 -8.43 42.44 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.46 30.72 3.81 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.581 1.953 . . . . 0.0 111.022 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -43.87 131.29 4.14 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 125.026 1.33 . . . . 0.0 113.352 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.52 -15.4 19.66 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.138 2.559 . . . . 0.0 115.71 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p -133.44 -20.73 2.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.567 1.53 . . . . 0.0 114.857 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt -131.27 156.64 45.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -108.98 -25.87 10.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -83.45 -54.08 5.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.025 1.33 . . . . 0.0 110.745 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -93.94 161.59 14.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.088 2.155 . . . . 0.0 110.405 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 163.58 9.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.626 0.77 . . . . 0.0 111.733 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.18 148.24 52.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.504 0.722 . . . . 0.0 111.745 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp -82.26 -25.75 33.78 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -91.58 -37.34 13.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.185 0.902 . . . . 0.0 113.12 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t 53.5 32.24 13.78 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.098 1.759 . . . . 0.0 114.432 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -160.14 161.82 33.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.5 1.52 . . . . 0.0 111.725 -170.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -76.89 90.32 3.51 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.182 -0.949 . . . . 0.0 111.442 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.4 mt -138.78 133.86 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.58 1.952 . . . . 0.0 108.003 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -139.53 29.32 2.17 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.804 1.241 . . . . 0.0 113.573 -169.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.2 m -60.53 146.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.858 1.663 . . . . 0.0 111.992 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 79.1 mtm -139.28 136.86 35.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.277 1.831 . . . . 0.0 110.787 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -143.38 150.37 39.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.878 2.071 . . . . 0.0 109.57 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.47 132.48 85.65 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.326 0.651 . . . . 0.0 110.91 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.86 152.72 47.23 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.308 2.672 . . . . 0.0 111.093 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.66 129.78 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.315 1.046 . . . . 0.0 108.782 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.8 mm -116.79 122.43 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.253 1.421 . . . . 0.0 108.963 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.45 153.89 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.148 1.779 . . . . 0.0 109.099 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -53.19 147.39 10.03 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.305 1.042 . . . . 0.0 111.116 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -52.49 -57.26 10.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.707 1.203 . . . . 0.0 113.866 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.15 1.02 24.64 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.305 0.955 . . . . 0.0 115.102 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.0 m -75.29 94.4 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.972 1.386 . . . . 0.0 112.249 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.9 t -74.89 -25.21 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.345 -0.847 . . . . 0.0 112.335 172.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.82 -165.98 54.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.184 1.373 . . . . 0.0 113.608 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 65.2 19.33 11.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.313 1.445 . . . . 0.0 114.837 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -41.83 95.65 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.724 -1.235 . . . . 0.0 113.026 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.99 30.89 76.72 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.028 0.823 . . . . 0.0 113.726 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 m -53.03 129.97 32.41 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.985 1.714 . . . . 0.0 113.997 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 90.4 p -163.74 172.02 14.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.289 1.436 . . . . 0.0 111.603 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.93 58.8 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.681 0.658 . . . . 0.0 113.984 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -136.42 137.16 40.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.333 1.453 . . . . 0.0 111.086 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 p -76.88 153.42 34.77 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.212 1.005 . . . . 0.0 111.641 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.84 -173.09 30.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.516 1.055 . . . . 0.0 113.251 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.92 164.27 15.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.611 1.964 . . . . 0.0 111.141 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -70.56 121.55 18.06 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.362 -0.836 . . . . 0.0 112.252 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -121.91 118.36 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.08 -95.54 1.46 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 124.322 0.963 . . . . 0.0 112.181 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -59.65 145.45 44.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.133 0.573 . . . . 0.0 111.384 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -151.9 164.69 36.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.185 1.394 . . . . 0.0 110.443 -172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -162.89 155.99 19.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.008 1.723 . . . . 0.0 109.78 -171.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.77 2.028 . . . . 0.0 113.525 -175.092 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.95 179.42 7.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.74 1.616 . . . . 0.0 110.931 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 t -160.99 143.76 12.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.598 1.559 . . . . 0.0 111.171 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.32 147.76 9.81 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.549 1.071 . . . . 0.0 113.417 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -156.42 168.91 25.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.532 1.933 . . . . 0.0 110.367 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 m -127.1 125.07 40.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.263 1.025 . . . . 0.0 110.564 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.07 92.24 1.31 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.208 1.385 . . . . 0.0 110.551 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.51 116.46 9.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.998 0.919 . . . . 0.0 109.593 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -112.32 159.46 18.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.435 1.494 . . . . 0.0 112.038 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -62.72 -27.23 69.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.087 0.955 . . . . 0.0 113.289 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.12 136.38 34.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.481 1.112 . . . . 0.0 110.874 169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -74.54 64.9 1.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.559 1.544 . . . . 0.0 112.717 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -150.83 136.19 10.35 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 125.636 1.575 . . . . 0.0 110.75 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.08 145.45 39.51 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.076 2.518 . . . . 0.0 111.153 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.42 -2.65 20.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 114.003 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.05 16.09 10.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.194 2.198 . . . . 0.0 113.506 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -47.97 134.47 11.56 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.626 1.171 . . . . 0.0 113.706 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.73 -17.65 42.35 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.221 3.281 . . . . 0.0 116.61 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t -151.38 -27.12 0.2 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt -126.05 135.51 51.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.99 137.45 56.51 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.891 . . . . 0.0 112.88 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 58.18 26.78 14.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.611 1.564 . . . . 0.0 113.525 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -147.03 173.27 12.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.139 2.176 . . . . 0.0 111.742 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.16 161.75 27.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.426 1.09 . . . . 0.0 111.493 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.7 136.34 39.09 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.737 -0.602 . . . . 0.0 109.684 169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 102' ' ' GLN . 9.9 ptp -84.02 -26.36 29.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.2 -35.99 25.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.346 0.976 . . . . 0.0 112.813 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.256 16.0 p 45.77 17.64 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 128.868 2.867 . . . . 0.0 117.48 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -74.21 -37.63 63.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.818 1.247 . . . . 0.0 113.556 -171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 p -170.46 164.86 8.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.025 1.33 . . . . 0.0 111.763 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.6 mt -84.25 -15.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.749 1.22 . . . . 0.0 112.652 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -52.12 129.05 26.57 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.146 1.778 . . . . 0.0 113.015 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.5 144.66 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.03 1.732 . . . . 0.0 110.097 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 77.7 mtm -77.88 144.43 36.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.124 0.97 . . . . 0.0 112.379 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -80.15 71.68 6.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.509 1.123 . . . . 0.0 110.279 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.27 145.76 97.62 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.297 1.039 . . . . 0.0 111.405 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.82 135.98 34.3 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.392 2.728 . . . . 0.0 111.27 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.24 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.46 1.104 . . . . 0.0 109.653 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.82 116.69 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.392 1.477 . . . . 0.0 109.544 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.6 mt -137.2 136.27 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.139 1.776 . . . . 0.0 108.383 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.1 p -136.8 156.66 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.606 1.562 . . . . 0.0 111.089 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 t -85.31 48.02 1.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.537 1.135 . . . . 0.0 112.315 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -113.35 10.82 24.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.123 1.82 . . . . 0.0 115.26 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 t -74.46 147.52 41.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 118.706 1.253 . . . . 0.0 112.922 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.5 t -165.13 164.79 20.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.968 1.707 . . . . 0.0 111.198 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.78 155.27 7.21 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.419 1.485 . . . . 0.0 113.428 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.5 t -167.06 176.16 7.07 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.731 1.612 . . . . 0.0 111.173 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.7 m -88.01 100.62 13.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.271 1.029 . . . . 0.0 111.116 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.9 -160.84 36.91 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.0 1.286 . . . . 0.0 112.969 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.7 m -73.49 124.14 25.27 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.011 -0.699 . . . . 0.0 110.767 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.3 t -84.1 70.27 10.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.12 -0.987 . . . . 0.0 111.839 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.65 101.02 1.04 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.416 1.484 . . . . 0.0 112.59 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.9 t -162.84 136.87 6.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.836 1.654 . . . . 0.0 110.211 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.3 p -90.17 1.92 55.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.851 1.26 . . . . 0.0 113.358 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.43 -137.05 4.04 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.499 1.047 . . . . 0.0 113.331 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -116.41 138.23 51.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.668 1.587 . . . . 0.0 108.388 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 130.22 42.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.791 0.436 . . . . 0.0 111.296 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -112.17 140.84 46.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.91 -135.7 5.97 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.521 1.058 . . . . 0.0 113.249 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.24 148.33 11.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.769 1.228 . . . . 0.0 112.318 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 162.04 41.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.966 1.306 . . . . 0.0 111.177 -172.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -127.53 134.93 49.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.248 1.819 . . . . 0.0 108.41 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.75 2.02 . . . . 0.0 112.902 -172.968 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -157.03 150.31 24.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.36 1.464 . . . . 0.0 110.251 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m -73.86 -52.08 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.361 -0.837 . . . . 0.0 113.126 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.64 164.78 9.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.225 0.917 . . . . 0.0 113.13 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.5 m -134.38 96.59 3.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.087 0.955 . . . . 0.0 110.436 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.1 m -71.74 -16.43 62.21 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.59 143.97 5.65 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.526 1.536 . . . . 0.0 111.695 -170.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -72.41 134.17 45.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.425 0.69 . . . . 0.0 109.768 172.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -154.21 -56.49 0.11 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 68.97 0.67 2.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.696 1.999 . . . . 0.0 115.179 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -85.73 -1.89 57.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.652 -1.28 . . . . 0.0 113.938 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.6 p -157.15 165.98 34.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.682 1.593 . . . . 0.0 111.182 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.5 t -147.12 129.09 7.51 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 125.084 1.354 . . . . 0.0 109.318 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.0 151.25 61.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.469 2.78 . . . . 0.0 112.61 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -71.93 6.5 2.04 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.958 1.703 . . . . 0.0 113.746 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.0 20.0 2.12 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.364 2.266 . . . . 0.0 112.781 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -49.31 139.24 14.15 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.961 1.304 . . . . 0.0 113.115 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -21.51 23.17 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.36 2.706 . . . . 0.0 115.783 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p -132.16 -19.78 2.49 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.843 1.201 . . . . 0.0 113.989 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.67 145.33 49.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -66.45 120.79 13.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.861 0.864 . . . . 0.0 112.404 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 51.94 56.39 7.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.717 2.007 . . . . 0.0 112.385 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -158.3 163.35 37.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.545 2.338 . . . . 0.0 110.628 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.52 151.61 44.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.661 0.784 . . . . 0.0 111.04 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.1 136.43 35.18 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.507 0.723 . . . . 0.0 110.738 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt -77.29 -47.76 19.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -82.42 -14.1 55.71 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.8 t -130.41 36.85 3.92 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.621 1.569 . . . . 0.0 111.549 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.23 142.99 45.94 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.461 1.104 . . . . 0.0 112.184 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 t -157.34 158.98 36.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.835 1.254 . . . . 0.0 111.227 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -134.86 104.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.299 1.439 . . . . 0.0 108.887 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -167.73 129.53 1.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 109.629 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.32 111.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.745 0.818 . . . . 0.0 109.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -146.63 140.55 26.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.126 1.771 . . . . 0.0 110.56 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.19 163.62 14.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.316 1.447 . . . . 0.0 112.634 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.13 154.71 31.25 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.667 1.587 . . . . 0.0 110.891 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.0 159.94 37.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.43 2.753 . . . . 0.0 111.484 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -133.87 130.79 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 108.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.74 122.74 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.271 1.428 . . . . 0.0 107.793 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.1 mt -106.82 74.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.2 1.0 . . . . 0.0 109.032 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -75.71 43.35 0.25 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.774 2.03 . . . . 0.0 112.115 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 t -71.56 -20.97 61.95 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -169.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.05 -140.74 47.91 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.595 1.093 . . . . 0.0 113.338 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 p -84.07 137.99 33.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.484 1.114 . . . . 0.0 111.092 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 t -160.54 153.61 21.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 111.556 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.27 -95.82 1.48 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.553 1.549 . . . . 0.0 111.552 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -162.67 -175.18 4.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.577 1.551 . . . . 0.0 111.042 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 m -161.29 143.15 11.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.76 2.024 . . . . 0.0 110.543 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.86 149.94 21.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.545 1.069 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.2 m -150.31 146.33 26.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.891 1.677 . . . . 0.0 110.24 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -157.77 133.74 9.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.259 1.024 . . . . 0.0 110.972 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.74 123.74 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.086 1.327 . . . . 0.0 111.586 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 p -87.61 111.29 21.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 111.524 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.1 m -83.79 -10.48 58.06 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.33 178.1 50.74 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.045 1.307 . . . . 0.0 113.21 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.18 119.07 37.79 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.001 1.32 . . . . 0.0 109.084 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 126.59 31.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.912 0.885 . . . . 0.0 111.016 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.14 145.26 48.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.91 -128.46 2.16 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.56 1.076 . . . . 0.0 112.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -55.54 139.82 42.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.574 1.15 . . . . 0.0 112.307 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -71.66 101.93 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.98 0.912 . . . . 0.0 110.072 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.36 67.23 1.07 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.028 1.731 . . . . 0.0 109.091 -170.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.433 1.093 . . . . 0.0 113.669 -179.426 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -80.46 172.42 13.78 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.243 1.017 . . . . 0.0 112.59 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.9 p -154.38 154.99 34.22 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.74 -1.225 . . . . 0.0 112.603 -174.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.52 -156.02 8.71 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.34 1.447 . . . . 0.0 112.72 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -160.44 165.1 31.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.696 1.199 . . . . 0.0 112.31 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -162.56 -179.12 6.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.721 1.609 . . . . 0.0 110.718 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.5 -124.07 7.33 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.77 1.176 . . . . 0.0 111.221 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.48 145.66 26.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.973 1.309 . . . . 0.0 111.728 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.01 158.69 43.42 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.624 1.97 . . . . 0.0 110.465 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -13.89 61.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -90.67 156.27 18.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.683 1.593 . . . . 0.0 112.907 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 t -85.07 -13.0 51.76 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.66 131.83 1.25 Allowed Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.785 2.034 . . . . 0.0 109.734 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.41 138.98 33.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.748 2.299 . . . . 0.0 110.262 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.45 -14.55 63.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -107.5 18.39 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.695 1.998 . . . . 0.0 113.454 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -45.37 132.43 5.97 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 124.784 1.234 . . . . 0.0 113.601 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.5 -19.41 42.77 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.933 3.088 . . . . 0.0 116.527 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -151.87 1.32 0.36 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.27 128.62 55.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -63.46 120.41 11.63 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 60.39 27.5 17.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.432 1.893 . . . . 0.0 112.805 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -135.25 171.8 13.92 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 109.82 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.44 150.6 46.05 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.718 . . . . 0.0 110.929 172.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.83 152.62 29.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 111.394 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp -81.06 -24.79 37.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 108' ' ' ASN . 12.7 pt20 -83.26 -35.94 24.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.76 1.164 . . . . 0.0 112.142 169.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.3 t 55.4 33.22 20.41 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.694 1.598 . . . . 0.0 113.484 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 106' ' ' GLN . 90.8 m-20 -126.48 144.39 50.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.967 2.107 . . . . 0.0 110.542 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 p -78.62 25.35 0.26 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.363 1.865 . . . . 0.0 114.387 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -82.07 108.24 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.008 1.323 . . . . 0.0 108.74 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -73.44 143.8 46.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 112.305 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.5 167.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.84 1.656 . . . . 0.0 110.937 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.6 mmm -60.22 120.17 9.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.579 1.151 . . . . 0.0 111.653 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -84.11 64.52 8.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.891 1.276 . . . . 0.0 111.045 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.17 152.02 90.34 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 112.034 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.23 146.82 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.519 2.813 . . . . 0.0 111.196 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.57 130.02 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.905 0.882 . . . . 0.0 109.309 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.2 128.68 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.73 1.612 . . . . 0.0 109.259 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.67 128.22 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.385 . . . . 0.0 108.456 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.0 p -137.08 101.81 4.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 109.53 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 p -169.35 165.5 10.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.326 1.45 . . . . 0.0 111.817 -172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.87 -147.98 20.22 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.939 1.257 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -142.07 137.19 30.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.866 1.266 . . . . 0.0 110.899 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.8 p -95.24 162.38 13.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.051 1.34 . . . . 0.0 112.805 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.91 -179.53 53.07 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.406 1.003 . . . . 0.0 113.127 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 t -66.12 125.07 24.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.997 -0.708 . . . . 0.0 111.097 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t -166.03 170.68 13.3 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.48 . . . . 0.0 111.193 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.14 -158.33 29.08 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.23 1.395 . . . . 0.0 113.438 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.8 t -161.86 -176.0 4.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 110.887 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.0 t -160.64 144.1 13.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.41 1.484 . . . . 0.0 111.164 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 155.18 -156.42 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.51 1.053 . . . . 0.0 114.052 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -143.91 26.77 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.984 1.314 . . . . 0.0 112.051 -170.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -65.24 -22.08 66.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.83 -167.47 54.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.965 1.269 . . . . 0.0 113.816 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.9 136.87 57.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.987 1.715 . . . . 0.0 111.75 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -116.57 125.25 51.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.171 1.388 . . . . 0.0 111.019 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.6 144.08 38.43 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.68 -135.5 5.29 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.573 1.083 . . . . 0.0 113.323 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.52 149.29 43.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.133 0.973 . . . . 0.0 112.127 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.83 163.61 30.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.688 1.595 . . . . 0.0 110.079 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -128.6 42.69 3.27 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.396 1.478 . . . . 0.0 110.84 -171.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.311 1.444 . . . . 0.0 114.008 178.436 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -115.75 1.53 13.48 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -81.08 -20.59 41.22 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.824 -1.173 . . . . 0.0 113.658 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.08 -162.21 53.63 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.779 1.181 . . . . 0.0 113.032 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.9 p -162.04 142.91 10.56 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.991 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -171.39 166.87 6.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.103 1.761 . . . . 0.0 111.24 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.92 84.98 0.12 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.182 0.896 . . . . 0.0 112.635 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.8 93.91 8.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.624 1.17 . . . . 0.0 109.161 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -165.76 157.54 14.37 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.954 1.701 . . . . 0.0 110.914 -171.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -63.67 -16.29 60.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.34 154.22 45.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.164 1.786 . . . . 0.0 110.358 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 t -64.05 -16.29 61.38 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -154.82 120.27 2.64 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.486 1.514 . . . . 0.0 111.065 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 137.49 42.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.793 2.328 . . . . 0.0 110.42 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.81 0.3 13.59 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -109.12 3.72 22.23 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.759 2.024 . . . . 0.0 113.908 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -47.68 132.74 10.94 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.74 -17.7 52.57 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.831 3.688 . . . . 0.0 116.786 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -146.57 -23.99 0.42 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.85 146.14 46.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -70.65 124.25 23.82 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.708 0.803 . . . . 0.0 112.609 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 51.27 53.3 13.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.561 1.944 . . . . 0.0 112.318 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -157.65 162.83 38.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 128.528 2.731 . . . . 0.0 109.57 -170.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -73.03 152.07 41.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.183 0.593 . . . . 0.0 110.476 169.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.57 147.31 37.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.021 0.528 . . . . 0.0 110.604 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt -68.86 -31.68 70.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -98.88 -8.6 25.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -77.56 64.03 2.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 112.251 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -77.61 68.44 3.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.286 1.434 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t 67.96 26.74 7.35 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.646 1.579 . . . . 0.0 112.714 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.2 mt -89.12 107.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.89 129.36 39.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.591 0.756 . . . . 0.0 111.236 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.95 144.48 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.504 1.522 . . . . 0.0 110.332 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.04 149.63 43.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.973 0.909 . . . . 0.0 112.319 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.59 145.96 54.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 112.366 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.59 148.65 73.63 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.913 0.885 . . . . 0.0 111.522 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.87 156.04 61.18 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.558 2.839 . . . . 0.0 111.765 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.11 128.75 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.12 142.5 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.81 1.644 . . . . 0.0 108.525 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.6 mt -71.49 106.41 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.552 -0.717 . . . . 0.0 109.47 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.9 m -144.1 141.75 30.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.075 2.15 . . . . 0.0 108.699 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -74.21 156.22 37.5 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.627 1.171 . . . . 0.0 114.145 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -100.62 172.34 23.8 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.225 1.393 . . . . 0.0 113.354 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m -76.86 139.85 40.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.146 0.978 . . . . 0.0 112.615 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 p -83.66 36.33 0.54 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.299 1.84 . . . . 0.0 113.359 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.2 140.63 45.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.331 1.443 . . . . 0.0 113.179 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -132.98 154.92 50.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.9 m -70.8 122.79 20.54 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.033 -1.042 . . . . 0.0 111.995 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.41 -63.64 0.67 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.306 0.955 . . . . 0.0 112.817 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -164.15 144.19 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.881 1.272 . . . . 0.0 112.341 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.0 m -168.05 160.61 12.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.74 2.016 . . . . 0.0 110.718 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.28 -111.33 0.48 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.345 0.974 . . . . 0.0 111.699 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -69.26 -5.7 24.59 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.417 1.087 . . . . 0.0 113.921 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.3 m -132.12 139.79 48.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.324 1.85 . . . . 0.0 110.551 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.0 -122.33 4.28 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.929 1.728 . . . . 0.0 112.139 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.92 132.45 53.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.625 1.17 . . . . 0.0 111.809 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.54 125.48 32.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.496 1.118 . . . . 0.0 110.498 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.78 148.52 45.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.28 -140.67 4.71 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.486 1.041 . . . . 0.0 111.794 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -69.07 117.1 10.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.306 0.642 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -150.12 157.11 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.169 1.787 . . . . 0.0 109.465 -173.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -94.81 109.73 21.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.49 1.116 . . . . 0.0 109.351 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.297 1.439 . . . . 0.0 114.034 178.226 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -163.93 167.06 21.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.199 1.4 . . . . 0.0 111.999 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -162.19 164.44 27.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.67 1.588 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.11 45.66 11.33 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 123.97 0.795 . . . . 0.0 113.114 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -153.78 176.87 11.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.019 1.328 . . . . 0.0 111.956 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 t -160.06 151.79 20.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.63 . . . . 0.0 111.334 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.83 -157.0 7.1 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.484 1.516 . . . . 0.0 113.888 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -154.13 140.01 18.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.445 1.498 . . . . 0.0 110.478 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -105.28 151.25 24.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.964 1.306 . . . . 0.0 112.058 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -72.79 -19.71 61.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.789 0.835 . . . . 0.0 113.155 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -120.44 124.65 45.97 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.602 1.961 . . . . 0.0 108.656 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 t -86.84 175.97 7.94 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.662 0.744 . . . . 0.0 112.801 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -159.86 119.88 1.69 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.069 1.747 . . . . 0.0 111.393 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 146.12 28.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.386 2.724 . . . . 0.0 109.444 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.25 -6.12 12.74 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.06 15.7 4.68 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.307 2.243 . . . . 0.0 113.447 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -42.15 121.04 2.45 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 125.477 1.511 . . . . 0.0 113.939 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -86.08 -13.6 5.42 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.14 2.56 . . . . 0.0 115.74 -169.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -131.32 -18.4 2.88 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.234 1.379 . . . . 0.0 114.623 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.77 -51.59 2.03 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 20.6 t-80 -162.52 -147.51 0.13 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.224 1.41 . . . . 0.0 111.207 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 64.2 ttt180 -60.9 -34.48 74.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.856 1.262 . . . . 0.0 111.943 169.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -47.25 131.68 13.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.847 1.659 . . . . 0.0 110.351 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.7 144.16 28.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.608 0.763 . . . . 0.0 112.491 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.54 142.73 57.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.675 0.79 . . . . 0.0 111.675 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' HD23 ' A' ' 101' ' ' LEU . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 65' ' ' TYR . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp -80.31 -25.72 39.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.66 -18.21 19.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.58 95.77 4.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.068 1.347 . . . . 0.0 110.769 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.65 45.22 2.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.808 1.643 . . . . 0.0 110.804 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t 72.97 21.15 3.31 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.04 1.736 . . . . 0.0 113.692 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.6 mm -118.42 137.36 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.221 1.808 . . . . 0.0 108.465 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -77.56 -8.26 57.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.42 145.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.165 2.186 . . . . 0.0 110.139 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.81 12.37 21.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.69 122.65 12.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.127 1.371 . . . . 0.0 113.251 -170.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -162.86 157.43 18.12 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.799 2.04 . . . . 0.0 110.36 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.99 156.17 38.61 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.168 2.579 . . . . 0.0 110.823 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.3 t -125.82 128.64 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.772 1.229 . . . . 0.0 108.989 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.38 121.89 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 108.52 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.05 122.13 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.722 1.209 . . . . 0.0 108.7 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -163.62 162.1 24.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.004 1.721 . . . . 0.0 110.478 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 t -153.9 20.27 0.52 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.275 1.43 . . . . 0.0 112.591 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.2 -1.02 90.48 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.936 1.255 . . . . 0.0 115.199 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.0 m -64.45 135.6 56.24 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 112.882 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -163.64 161.86 23.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.181 1.392 . . . . 0.0 111.095 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.9 153.42 30.2 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.268 1.414 . . . . 0.0 113.624 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -168.06 148.91 5.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.579 1.951 . . . . 0.0 109.482 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m -157.68 137.21 12.04 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.104 . . . . 0.0 112.392 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.02 82.34 1.45 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.404 1.002 . . . . 0.0 111.337 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 p -69.99 -14.03 62.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.784 1.234 . . . . 0.0 113.859 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.2 p -165.9 167.44 16.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.386 2.274 . . . . 0.0 110.551 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.09 167.07 39.09 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.373 0.987 . . . . 0.0 113.606 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.1 p -167.33 167.09 14.26 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.544 1.538 . . . . 0.0 111.645 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p -79.37 152.72 30.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.343 1.057 . . . . 0.0 112.706 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.55 -130.86 7.16 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.842 1.21 . . . . 0.0 112.799 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.89 135.37 24.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.581 1.952 . . . . 0.0 112.883 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.94 119.78 22.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.546 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -98.96 132.96 43.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.93 -130.32 4.6 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.87 1.224 . . . . 0.0 111.984 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -65.47 143.96 57.35 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.255 0.622 . . . . 0.0 111.355 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.72 149.16 35.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.722 1.609 . . . . 0.0 109.161 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -154.94 147.19 23.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.681 1.592 . . . . 0.0 109.549 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.117 1.767 . . . . 0.0 112.835 -173.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -164.83 174.15 10.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.575 1.55 . . . . 0.0 111.548 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 t -156.61 156.22 33.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 111.035 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.68 124.98 6.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.148 0.88 . . . . 0.0 112.962 -174.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 t -167.69 154.62 8.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.554 1.942 . . . . 0.0 109.994 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -168.59 172.33 8.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.65 165.47 16.77 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.939 1.733 . . . . 0.0 113.756 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.64 150.47 7.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.998 2.119 . . . . 0.0 111.494 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -165.65 144.59 6.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.083 1.353 . . . . 0.0 111.629 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -96.9 123.4 40.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.751 1.22 . . . . 0.0 109.549 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -163.73 176.88 9.15 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.396 1.878 . . . . 0.0 110.366 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -70.64 -173.18 0.72 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.864 1.266 . . . . 0.0 112.937 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.13 115.45 65.73 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.87 149.82 43.08 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.351 2.701 . . . . 0.0 111.066 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.99 -4.53 21.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.625 1.17 . . . . 0.0 113.766 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -122.77 11.65 9.75 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.632 1.973 . . . . 0.0 112.867 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -45.33 133.31 5.83 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.546 1.538 . . . . 0.0 113.58 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.68 -17.85 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.185 2.59 . . . . 0.0 116.028 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p -130.22 -23.57 2.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.339 1.427 . . . . 0.0 114.042 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -128.11 162.77 26.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -86.69 -43.47 12.57 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.76 34.53 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.392 1.077 . . . . 0.0 113.042 -176.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -117.95 159.02 23.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.993 1.717 . . . . 0.0 110.678 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.74 157.45 30.16 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.137 0.575 . . . . 0.0 110.183 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 139.03 58.47 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.736 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp -79.75 -6.99 58.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.96 -17.58 6.7 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.2 m -127.56 39.18 3.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.032 1.733 . . . . 0.0 112.347 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -63.36 102.75 0.43 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.619 1.168 . . . . 0.0 111.686 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.1 t -95.02 61.38 2.48 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.699 1.599 . . . . 0.0 110.575 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.2 mt -57.74 -16.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.375 1.47 . . . . 0.0 113.487 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.14 -30.44 49.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.67 1.588 . . . . 0.0 113.73 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 p -166.56 133.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.419 1.087 . . . . 0.0 112.128 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.6 150.42 24.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 169.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -144.87 138.27 26.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.947 1.299 . . . . 0.0 110.523 -173.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.51 155.54 46.03 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.43 1.492 . . . . 0.0 112.116 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.11 161.94 20.46 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.701 2.934 . . . . 0.0 111.611 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.32 132.27 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.725 1.21 . . . . 0.0 109.583 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.9 mm -129.54 122.41 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.567 1.547 . . . . 0.0 108.595 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mm -122.96 107.49 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.237 1.015 . . . . 0.0 109.883 -173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p 40.0 50.92 2.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.139 2.576 . . . . 0.0 114.194 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -142.28 107.44 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.29 1.036 . . . . 0.0 112.489 -169.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.24 14.62 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.483 1.516 . . . . 0.0 113.277 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.6 t -163.66 141.86 7.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.312 1.445 . . . . 0.0 110.161 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -162.95 170.75 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.535 1.134 . . . . 0.0 112.605 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.29 118.45 2.42 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 125.851 1.691 . . . . 0.0 111.052 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.0 p -172.72 179.13 2.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.89 1.676 . . . . 0.0 111.093 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.6 m -139.23 146.16 40.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.796 1.239 . . . . 0.0 111.277 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.65 149.69 38.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.152 0.882 . . . . 0.0 112.817 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.6 p -168.23 171.37 9.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.882 1.673 . . . . 0.0 111.112 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.8 t -151.93 115.58 4.85 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.019 -1.05 . . . . 0.0 111.475 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.17 164.82 38.89 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.817 1.199 . . . . 0.0 112.673 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.9 m -112.23 12.41 20.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.644 1.178 . . . . 0.0 113.127 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.4 p -162.67 176.13 10.66 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.478 1.511 . . . . 0.0 111.976 -172.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.38 -172.88 32.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.396 0.998 . . . . 0.0 113.317 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.17 144.62 19.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.053 1.741 . . . . 0.0 110.949 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -75.89 123.28 25.43 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.723 -0.611 . . . . 0.0 112.379 -171.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -127.36 132.91 50.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.74 -119.75 3.01 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.124 1.345 . . . . 0.0 112.727 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -57.97 149.21 23.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.802 1.241 . . . . 0.0 112.224 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.88 158.4 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.483 1.513 . . . . 0.0 111.119 -169.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -79.42 105.07 10.47 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.632 1.173 . . . . 0.0 111.027 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.347 1.859 . . . . 0.0 111.693 176.593 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t 64.46 39.55 6.84 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.013 1.325 . . . . 0.0 112.82 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 t -152.53 144.58 23.78 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 111.476 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.92 -175.53 14.15 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.686 1.612 . . . . 0.0 113.903 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -164.08 -175.9 4.24 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.946 1.698 . . . . 0.0 110.817 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.6 p -158.09 158.0 33.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.365 1.466 . . . . 0.0 112.359 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.6 136.64 18.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.117 0.865 . . . . 0.0 112.53 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -145.88 153.57 41.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.701 2.0 . . . . 0.0 109.973 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.11 109.3 5.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.473 0.709 . . . . 0.0 110.908 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -164.67 131.76 3.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.975 1.31 . . . . 0.0 111.092 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -85.27 67.17 10.06 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 110.687 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -159.71 152.03 20.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.343 1.857 . . . . 0.0 111.147 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.3 t -95.92 124.47 52.08 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 109.759 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.91 148.85 41.27 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.548 2.832 . . . . 0.0 111.835 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.66 -2.67 18.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.358 1.463 . . . . 0.0 114.399 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -126.19 14.55 7.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.344 1.858 . . . . 0.0 113.618 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -46.12 129.82 7.41 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.627 1.171 . . . . 0.0 113.377 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.29 -18.27 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.411 2.741 . . . . 0.0 116.27 -169.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p -130.65 -0.39 4.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.113 1.324 . . . . 0.0 114.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt -136.85 163.04 31.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -102.76 -18.57 15.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 51' ' ' ARG . 2.3 mmp_? -70.03 -46.56 64.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.704 1.602 . . . . 0.0 110.714 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -138.81 165.54 26.74 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.65 2.38 . . . . 0.0 111.818 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.76 154.6 32.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.514 0.726 . . . . 0.0 111.363 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.66 127.86 31.96 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.694 -173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm -86.07 -23.96 26.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -89.04 -56.44 3.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.472 1.033 . . . . 0.0 112.173 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 36.9 m 47.83 25.04 0.66 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.015 1.726 . . . . 0.0 115.033 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -125.02 -60.53 1.35 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.513 1.525 . . . . 0.0 112.916 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m 70.19 10.25 7.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -100.06 101.56 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.652 -1.28 . . . . 0.0 109.171 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.0 m120 54.44 26.73 7.39 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.19 1.796 . . . . 0.0 114.886 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -58.7 130.96 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.592 . . . . 0.0 111.178 -172.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.65 144.76 50.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.307 1.843 . . . . 0.0 112.582 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -84.55 157.07 21.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.455 1.502 . . . . 0.0 112.732 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.27 155.67 30.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.797 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.79 153.31 42.82 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.369 2.713 . . . . 0.0 110.947 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -136.64 132.1 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 108.799 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.45 112.1 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.51 1.524 . . . . 0.0 108.454 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 84.3 mt -136.2 130.96 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.809 1.644 . . . . 0.0 108.571 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 m -65.74 137.8 57.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 110.444 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.7 p -76.45 3.95 10.12 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.4 -113.74 4.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.329 1.442 . . . . 0.0 111.309 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 t -158.38 168.22 27.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.203 1.401 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.0 t -86.54 125.7 33.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.126 -0.984 . . . . 0.0 111.751 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.56 156.78 22.66 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.075 1.322 . . . . 0.0 112.765 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 p -83.51 164.05 20.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 112.495 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.3 p -139.12 120.31 14.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 111.043 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.67 126.84 8.21 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.253 0.93 . . . . 0.0 111.597 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -153.49 152.8 31.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.587 1.555 . . . . 0.0 110.59 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.6 t -161.44 157.05 24.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.586 1.155 . . . . 0.0 111.383 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.59 143.7 8.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.253 1.406 . . . . 0.0 112.506 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 p -91.6 -10.3 40.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 0.0 113.983 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -169.5 -179.22 3.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.766 2.026 . . . . 0.0 110.374 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.78 -114.96 4.64 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.417 1.008 . . . . 0.0 112.885 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.21 134.93 54.1 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.775 1.63 . . . . 0.0 110.7 -171.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -83.25 128.42 34.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.304 0.641 . . . . 0.0 110.746 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -96.38 136.37 36.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.34 -140.71 5.38 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 123.981 0.801 . . . . 0.0 112.055 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -63.42 146.01 54.45 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.535 0.734 . . . . 0.0 111.481 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -154.16 -177.87 6.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.508 1.123 . . . . 0.0 111.61 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -104.38 109.7 21.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.532 1.133 . . . . 0.0 109.405 -173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 113.64 -177.393 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -148.79 152.99 37.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.473 1.509 . . . . 0.0 111.089 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 p -83.13 145.12 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.286 1.035 . . . . 0.0 113.277 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.89 67.41 3.59 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.97 1.271 . . . . 0.0 112.284 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -75.21 77.74 2.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.66 1.184 . . . . 0.0 111.505 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -135.27 122.74 21.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.43 1.492 . . . . 0.0 110.638 -176.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.07 160.94 27.81 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.647 1.117 . . . . 0.0 113.208 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.39 113.96 21.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.087 1.355 . . . . 0.0 109.667 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -168.8 172.4 7.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.936 2.094 . . . . 0.0 111.302 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.19 -4.38 57.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.976 1.311 . . . . 0.0 114.059 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -94.33 -41.75 9.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.71 1.204 . . . . 0.0 112.604 -171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m 64.15 8.09 3.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.569 1.948 . . . . 0.0 115.74 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.8 119.4 51.01 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.927 1.291 . . . . 0.0 111.237 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 162.52 37.85 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.332 2.688 . . . . 0.0 111.802 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.81 1.63 10.11 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.698 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.59 14.94 3.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.186 2.195 . . . . 0.0 113.312 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.41 141.52 16.36 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 124.51 1.124 . . . . 0.0 113.149 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.89 -19.32 18.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.368 2.712 . . . . 0.0 116.007 -169.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p -128.24 -17.27 4.31 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.051 1.296 . . . . 0.0 113.956 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.93 168.72 11.19 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -101.69 -41.47 6.55 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -71.78 -36.9 70.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.994 0.917 . . . . 0.0 112.981 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -119.08 166.46 12.88 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.161 2.184 . . . . 0.0 110.957 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.19 166.62 11.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.709 0.803 . . . . 0.0 110.189 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.3 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.369 -0.832 . . . . 0.0 111.822 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt -72.39 -46.98 52.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -80.83 -35.03 33.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.5 t 52.72 32.05 11.39 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.724 1.609 . . . . 0.0 113.389 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.54 -29.75 68.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 114.118 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -167.39 174.16 8.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.985 1.714 . . . . 0.0 110.424 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -92.37 92.14 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 108.448 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -90.73 109.15 20.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 110.728 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.7 22.48 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.249 1.42 . . . . 0.0 113.279 -171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -90.54 141.98 28.21 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.128 0.971 . . . . 0.0 110.567 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.8 155.81 20.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.032 0.933 . . . . 0.0 110.987 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.55 148.33 58.44 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.163 1.385 . . . . 0.0 110.058 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.29 150.72 53.4 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.265 2.643 . . . . 0.0 111.253 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.9 t -136.83 128.38 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.223 1.409 . . . . 0.0 108.307 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.33 107.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.56 1.544 . . . . 0.0 108.403 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 86.3 mt -133.69 107.83 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.017 1.327 . . . . 0.0 108.458 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 p -84.65 65.34 9.0 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.764 1.625 . . . . 0.0 110.838 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 t -135.97 123.39 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.265 1.426 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.95 -108.42 3.25 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.568 1.556 . . . . 0.0 111.886 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -159.66 178.31 9.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.791 1.637 . . . . 0.0 110.938 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 127.47 5.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 111.491 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.4 54.82 4.81 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.299 1.428 . . . . 0.0 112.558 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.3 t -67.04 150.84 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.204 1.002 . . . . 0.0 112.592 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -84.92 59.77 5.8 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.463 1.105 . . . . 0.0 112.173 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.11 166.73 12.51 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.148 1.833 . . . . 0.0 112.88 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 t -164.01 159.61 20.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.573 1.549 . . . . 0.0 110.854 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.5 t -163.44 130.92 3.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.258 1.423 . . . . 0.0 110.958 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.74 96.63 1.01 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.2 1.381 . . . . 0.0 111.209 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.1 t -166.53 175.64 7.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.421 1.488 . . . . 0.0 111.245 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.4 t -162.21 154.59 19.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.926 1.69 . . . . 0.0 111.004 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.66 -179.62 47.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.547 1.07 . . . . 0.0 112.04 -169.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.87 121.9 22.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.073 0.949 . . . . 0.0 111.824 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -80.05 131.15 35.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.191 0.997 . . . . 0.0 110.542 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -114.1 150.35 34.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.81 -134.71 2.21 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.717 1.151 . . . . 0.0 112.239 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.99 155.39 23.91 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -133.35 127.53 33.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.383 1.073 . . . . 0.0 109.887 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -163.42 146.13 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.889 1.676 . . . . 0.0 108.851 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.182 1.393 . . . . 0.0 113.84 -179.422 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -85.84 -20.21 29.47 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.721 -0.87 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -79.07 155.4 28.8 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.654 1.181 . . . . 0.0 113.476 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.92 148.34 20.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.491 1.519 . . . . 0.0 112.97 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 p -108.19 143.29 37.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.63 1.572 . . . . 0.0 112.166 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m 58.98 32.26 22.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.814 1.246 . . . . 0.0 113.725 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -52.35 53.15 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.608 1.099 . . . . 0.0 114.075 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.4 mt -149.93 118.0 6.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.948 1.699 . . . . 0.0 109.693 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.7 151.61 4.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.133 1.773 . . . . 0.0 111.759 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 171.47 13.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.958 0.903 . . . . 0.0 111.835 169.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.46 129.7 12.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.501 1.52 . . . . 0.0 110.441 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.4 m -96.38 -11.96 25.01 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.49 110.8 0.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.987 1.315 . . . . 0.0 112.139 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.04 149.63 90.07 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.203 2.602 . . . . 0.0 112.576 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.74 -4.23 22.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.55 1.54 . . . . 0.0 114.126 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.71 31.38 1.46 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.126 1.771 . . . . 0.0 111.534 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -43.53 127.81 3.84 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.617 1.567 . . . . 0.0 113.397 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.9 -20.01 6.75 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.057 2.504 . . . . 0.0 115.743 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p -127.73 -21.49 3.73 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.35 -51.61 2.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 13.0 t-80 -166.15 -148.1 0.1 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.21 1.804 . . . . 0.0 110.295 -176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 25.0 ptt180 -65.73 -14.97 62.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.509 1.124 . . . . 0.0 113.825 169.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -57.64 163.68 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 0.0 111.635 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -60.49 147.42 41.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.242 1.017 . . . . 0.0 111.263 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.91 146.68 29.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.176 0.99 . . . . 0.0 110.981 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp -81.93 -11.51 58.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -107.55 -18.99 13.7 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.47 132.59 48.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.366 1.066 . . . . 0.0 111.922 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.79 33.75 19.99 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.746 1.618 . . . . 0.0 112.899 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.2 t -144.56 164.42 30.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.29 1.436 . . . . 0.0 111.635 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -139.17 131.84 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.476 1.91 . . . . 0.0 108.611 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -152.39 150.2 29.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.752 1.621 . . . . 0.0 112.002 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.72 23.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.438 1.495 . . . . 0.0 113.144 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.7 mmm -83.45 55.22 3.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.816 1.646 . . . . 0.0 111.89 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.34 35.86 0.23 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.228 1.811 . . . . 0.0 114.082 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.15 151.35 29.28 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.241 1.817 . . . . 0.0 111.626 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.73 148.48 22.7 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.629 2.886 . . . . 0.0 110.962 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.2 t -141.7 130.41 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 108.566 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.63 119.31 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.525 1.53 . . . . 0.0 108.56 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.0 mm -124.87 124.27 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.353 1.461 . . . . 0.0 108.892 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.6 p -127.8 4.14 6.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.526 1.531 . . . . 0.0 113.695 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -74.08 -17.2 60.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.17 -138.42 32.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.171 1.367 . . . . 0.0 113.212 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -162.79 167.32 23.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.896 1.678 . . . . 0.0 110.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -144.19 131.54 20.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.059 1.344 . . . . 0.0 110.928 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.29 151.72 6.29 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.515 1.055 . . . . 0.0 113.313 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -152.07 135.14 15.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.622 1.569 . . . . 0.0 109.96 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.8 m -169.18 166.88 10.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.561 1.944 . . . . 0.0 111.075 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.39 -116.09 2.93 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.214 1.387 . . . . 0.0 111.817 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.5 t -159.16 -175.76 5.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.615 1.566 . . . . 0.0 110.826 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 m -69.18 119.51 13.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.271 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.71 -159.87 44.59 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.787 1.185 . . . . 0.0 114.036 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -147.02 147.04 30.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.607 1.563 . . . . 0.0 110.417 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -79.03 -0.73 32.46 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -169.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.89 -99.4 0.12 Allowed Glycine 0 N--CA 1.47 0.909 0 C-N-CA 124.632 1.111 . . . . 0.0 112.648 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.08 138.08 57.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.957 1.303 . . . . 0.0 111.19 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -79.89 115.83 19.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.903 0.481 . . . . 0.0 111.065 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -127.28 126.94 43.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.11 -101.28 2.71 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.429 1.49 . . . . 0.0 111.601 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.46 150.88 29.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.889 0.875 . . . . 0.0 112.615 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 -170.8 3.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.148 1.779 . . . . 0.0 109.975 -175.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -146.66 140.55 26.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.548 1.139 . . . . 0.0 109.483 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 126.584 1.954 . . . . 0.0 113.445 -174.506 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.86 178.13 8.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.824 1.649 . . . . 0.0 111.081 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -151.8 155.74 38.82 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.569 -1.332 . . . . 0.0 112.994 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.97 -174.03 13.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.107 1.813 . . . . 0.0 112.212 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.9 m -69.94 -41.73 74.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.9 p 54.74 -5.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.336 3.055 . . . . 0.0 118.833 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 80.41 1.58 Allowed Glycine 0 N--CA 1.468 0.825 0 C-N-CA 125.467 1.508 . . . . 0.0 113.468 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.9 tp -68.01 -33.2 74.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 111.962 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -79.33 134.17 36.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.479 1.112 . . . . 0.0 111.404 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -67.07 130.18 42.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.111 0.964 . . . . 0.0 110.69 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.97 153.23 42.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.006 1.722 . . . . 0.0 110.811 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -73.35 -12.73 60.93 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.25 118.63 41.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 109.351 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.68 142.58 48.66 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.322 2.681 . . . . 0.0 111.259 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.69 -4.91 25.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.718 1.207 . . . . 0.0 113.923 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.56 19.37 7.37 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.548 2.339 . . . . 0.0 112.469 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -42.24 126.17 2.79 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.524 1.529 . . . . 0.0 113.385 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.81 -22.1 12.04 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.812 2.341 . . . . 0.0 115.555 -169.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p -132.19 -11.06 3.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -129.68 127.57 40.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -64.45 135.82 56.47 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.64 0.776 . . . . 0.0 112.747 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? 61.59 22.99 13.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.183 1.793 . . . . 0.0 113.179 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -142.55 169.04 18.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.104 2.162 . . . . 0.0 110.762 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.37 156.12 31.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.725 . . . . 0.0 110.005 168.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.38 45.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.816 -0.553 . . . . 0.0 111.749 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' CD1' HD23 ' A' ' 101' ' ' LEU . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 65' ' ' TYR . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -89.94 -22.62 21.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -89.35 -27.46 20.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.495 1.043 . . . . 0.0 112.636 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.7 m -123.17 89.59 3.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.445 1.498 . . . . 0.0 109.96 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.69 155.95 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.403 1.081 . . . . 0.0 112.306 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 t -153.92 157.27 38.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.951 1.3 . . . . 0.0 111.243 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -139.52 120.2 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.615 1.566 . . . . 0.0 108.322 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -130.82 4.23 4.52 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.777 1.231 . . . . 0.0 114.303 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.75 151.08 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.492 2.317 . . . . 0.0 110.009 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtt -89.26 100.26 13.08 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.279 1.031 . . . . 0.0 110.956 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -106.87 151.48 25.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.656 1.582 . . . . 0.0 110.721 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -61.72 141.69 94.95 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.516 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.37 138.52 30.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.27 2.647 . . . . 0.0 111.192 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.24 136.83 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.173 0.989 . . . . 0.0 110.423 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mm -116.0 121.46 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.03 1.332 . . . . 0.0 109.122 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.7 mm -126.03 139.41 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.788 1.635 . . . . 0.0 109.567 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.2 p -137.73 150.24 47.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.772 1.629 . . . . 0.0 110.324 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.2 p -92.43 -7.55 47.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.3 64.86 4.24 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.571 1.558 . . . . 0.0 112.159 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.3 p -159.46 176.3 12.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.886 1.275 . . . . 0.0 112.945 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -153.72 154.22 33.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 111.307 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.88 171.23 16.9 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.112 1.339 . . . . 0.0 114.45 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -151.56 155.63 38.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.335 1.854 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -65.66 130.96 45.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.239 1.016 . . . . 0.0 112.746 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.96 -166.96 27.07 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.92 1.248 . . . . 0.0 113.839 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.9 p -162.45 163.28 27.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.285 1.834 . . . . 0.0 110.751 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.7 m -161.45 136.61 7.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.057 1.343 . . . . 0.0 111.369 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.02 128.41 9.53 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.065 1.317 . . . . 0.0 111.693 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.9 m -154.9 163.08 40.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.99 1.716 . . . . 0.0 111.042 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -141.48 140.22 33.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.313 1.045 . . . . 0.0 111.809 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.92 0.24 Allowed Glycine 0 N--CA 1.471 1.027 0 C-N-CA 125.598 1.57 . . . . 0.0 112.167 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.04 130.88 35.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.856 0.862 . . . . 0.0 110.33 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -77.98 126.57 31.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.548 0.739 . . . . 0.0 111.342 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 58.21 8.14 0.76 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -8.43 -95.57 0.0 OUTLIER Glycine 0 N--CA 1.479 1.508 0 C-N-CA 130.431 3.872 . . . . 0.0 117.673 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -85.23 135.03 34.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.559 1.144 . . . . 0.0 109.853 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -156.67 153.33 28.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.648 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.95 101.39 3.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.56 1.144 . . . . 0.0 110.836 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.79 1.636 . . . . 0.0 114.022 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -157.69 -164.43 1.54 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.295 1.438 . . . . 0.0 110.805 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -147.6 144.41 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.268 1.427 . . . . 0.0 111.309 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 -169.29 51.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.602 1.096 . . . . 0.0 113.04 -171.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.4 p -164.7 173.27 12.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.6 1.56 . . . . 0.0 111.353 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -78.09 -14.22 59.57 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.978 -1.076 . . . . 0.0 113.868 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 174.5 28.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.185 1.374 . . . . 0.0 113.715 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.92 83.74 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.385 1.474 . . . . 0.0 109.183 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -152.98 155.95 37.92 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.212 1.805 . . . . 0.0 110.949 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -78.9 90.18 4.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.3 1.04 . . . . 0.0 110.696 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -160.33 140.41 11.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.819 2.048 . . . . 0.0 109.892 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t -99.53 -4.25 31.64 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -89.72 121.51 68.98 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 120.704 -1.248 . . . . 0.0 110.157 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.0 156.45 65.8 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.83 3.02 . . . . 0.0 112.611 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.26 -10.95 55.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.167 1.387 . . . . 0.0 114.329 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.82 32.21 2.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.756 1.623 . . . . 0.0 111.755 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -46.82 132.03 8.57 Favored Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 120.944 -1.097 . . . . 0.0 112.35 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.94 -15.27 46.54 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.742 2.961 . . . . 0.0 115.828 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -157.22 20.17 0.3 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -132.08 139.35 48.47 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.93 127.02 31.3 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.882 0.873 . . . . 0.0 112.876 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 50.18 46.25 24.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.558 1.943 . . . . 0.0 112.376 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -153.8 160.66 42.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.944 2.498 . . . . 0.0 109.946 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -69.42 151.59 45.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.031 0.533 . . . . 0.0 110.665 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.79 149.38 46.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.809 0.443 . . . . 0.0 110.604 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp -96.68 -20.32 18.36 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.12 -21.79 27.43 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.818 1.19 . . . . 0.0 113.312 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.91 114.88 2.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.534 1.134 . . . . 0.0 111.777 -174.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.88 19.78 10.06 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.007 1.723 . . . . 0.0 113.539 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.6 t -112.81 6.28 17.94 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.798 -1.189 . . . . 0.0 113.995 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.6 mt -94.9 100.77 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.776 -1.203 . . . . 0.0 109.742 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -117.47 -20.44 9.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.1 151.25 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.624 2.37 . . . . 0.0 107.964 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.42 151.94 5.19 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.588 1.155 . . . . 0.0 113.937 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.77 148.98 22.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.62 1.168 . . . . 0.0 113.105 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -74.76 151.1 86.71 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.26 1.024 . . . . 0.0 112.079 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.63 171.22 18.22 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.948 3.098 . . . . 0.0 111.062 173.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.43 135.96 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.204 1.002 . . . . 0.0 109.871 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.35 140.45 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.631 1.573 . . . . 0.0 110.006 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.48 136.01 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.53 1.532 . . . . 0.0 109.796 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.8 m -127.27 125.65 41.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.801 1.64 . . . . 0.0 109.532 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 m -81.67 -24.28 36.35 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.78 33.51 71.08 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.095 0.798 . . . . 0.0 115.095 171.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -58.83 147.97 31.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.504 1.122 . . . . 0.0 113.717 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.0 9.44 4.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.26 1.824 . . . . 0.0 113.828 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.88 66.52 2.78 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.627 1.585 . . . . 0.0 112.489 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 p -77.47 62.9 2.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.983 1.713 . . . . 0.0 113.029 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 p -71.25 119.94 16.1 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.61 -1.306 . . . . 0.0 112.392 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.13 -70.1 1.13 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.879 1.228 . . . . 0.0 111.177 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.3 t -166.25 153.88 10.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.833 1.653 . . . . 0.0 110.992 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.6 p -119.28 2.82 11.37 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.587 1.555 . . . . 0.0 113.049 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.18 -149.12 36.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.009 1.29 . . . . 0.0 112.901 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -119.22 125.85 50.14 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.919 1.287 . . . . 0.0 109.308 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 m -158.86 49.9 0.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.398 1.479 . . . . 0.0 110.876 -169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 -125.38 6.88 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.412 1.482 . . . . 0.0 111.172 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.94 129.3 37.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.547 1.139 . . . . 0.0 109.984 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -76.68 122.43 24.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.36 0.664 . . . . 0.0 111.278 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -100.67 147.41 26.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.91 -128.02 1.77 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.465 1.031 . . . . 0.0 112.424 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.44 175.73 2.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.084 0.954 . . . . 0.0 112.866 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -69.05 3.7 1.93 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 73.73 32.38 1.14 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.906 2.082 . . . . 0.0 111.913 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.171 2.188 . . . . 0.0 114.429 177.455 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -148.75 145.41 27.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.9 p -167.1 163.55 15.72 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.369 1.468 . . . . 0.0 111.683 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.5 150.55 25.79 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.343 0.973 . . . . 0.0 112.184 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -97.37 119.88 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.929 0.892 . . . . 0.0 110.613 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.1 p -166.41 153.99 9.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.121 1.368 . . . . 0.0 111.41 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.09 -39.79 1.86 Allowed Glycine 0 N--CA 1.475 1.268 0 C-N-CA 125.323 1.439 . . . . 0.0 114.529 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp 67.14 13.54 9.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.729 2.412 . . . . 0.0 112.979 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.39 152.12 44.45 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.02 1.328 . . . . 0.0 112.358 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 60.71 37.1 19.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.52 . . . . 0.0 113.098 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -52.12 -26.65 11.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -76.37 -19.17 58.44 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.2 t -152.81 100.03 2.74 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 126.276 1.83 . . . . 0.0 108.824 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -70.92 140.5 38.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.157 2.571 . . . . 0.0 111.169 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.64 -21.0 64.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -83.99 0.31 48.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.619 1.168 . . . . 0.0 113.863 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -59.3 126.16 81.12 Favored Pre-proline 0 CA--C 1.557 1.217 0 O-C-N 120.956 -1.09 . . . . 0.0 112.283 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.4 -17.72 12.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.89 2.393 . . . . 0.0 114.964 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -132.66 -10.74 3.12 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.08 137.5 41.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -65.98 132.64 49.06 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.554 -0.716 . . . . 0.0 112.346 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.76 26.98 16.47 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.642 1.577 . . . . 0.0 112.617 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -149.66 168.03 24.75 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.85 2.06 . . . . 0.0 111.068 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.02 159.88 33.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.885 0.874 . . . . 0.0 112.046 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 142.75 31.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.608 0.763 . . . . 0.0 111.002 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 138' ' ' LEU . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt -74.42 -38.45 63.05 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -76.85 -32.25 57.41 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 112.987 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.254 16.8 p 46.04 30.65 0.96 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.249 2.22 . . . . 0.0 115.393 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -139.88 144.77 37.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.006 2.122 . . . . 0.0 110.431 -172.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.0 p 48.58 49.14 18.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.857 1.663 . . . . 0.0 112.696 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mp -54.32 114.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.353 1.861 . . . . 0.0 110.722 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -99.17 112.88 24.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.34 27.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.53 1.932 . . . . 0.0 111.304 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.5 160.27 22.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.451 1.1 . . . . 0.0 111.61 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.22 110.6 5.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.48 0.712 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -105.43 151.47 39.72 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.866 1.666 . . . . 0.0 110.967 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.65 155.78 49.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.523 2.816 . . . . 0.0 111.608 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -139.67 131.93 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.624 1.57 . . . . 0.0 108.363 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.0 110.0 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.928 1.291 . . . . 0.0 108.298 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 mm -80.21 126.65 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.546 0.739 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 55.4 m -135.92 144.63 45.59 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.372 1.869 . . . . 0.0 108.913 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -137.46 123.27 20.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.32 1.048 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.3 -164.14 26.5 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.334 1.445 . . . . 0.0 113.316 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -79.13 161.21 26.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.479 0.712 . . . . 0.0 111.964 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -146.37 118.54 8.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.273 1.029 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -106.54 169.45 15.37 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.333 1.444 . . . . 0.0 113.154 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 m -67.52 136.4 54.51 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.9 0.88 . . . . 0.0 111.805 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.5 p -79.42 74.4 6.04 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.858 1.263 . . . . 0.0 111.853 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.71 -7.31 88.6 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.035 1.302 . . . . 0.0 115.214 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 t -82.43 136.29 34.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.669 1.235 . . . . 0.0 110.678 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -162.98 157.28 20.78 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.796 1.639 . . . . 0.0 111.518 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 166.57 -141.43 6.94 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.102 1.334 . . . . 0.0 111.907 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.0 t -69.38 142.68 53.88 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 117.322 0.561 . . . . 0.0 111.666 172.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.3 m -85.55 131.15 34.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.079 -1.013 . . . . 0.0 111.965 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.33 -150.11 11.26 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.439 1.019 . . . . 0.0 113.33 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.42 143.32 50.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.376 1.87 . . . . 0.0 109.461 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.76 127.81 33.45 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.148 0.431 . . . . 0.0 111.281 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.622 HD13 ' HD3' ' A' ' 142' ' ' PRO . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 146' ' ' VAL . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.622 ' HD3' HD13 ' A' ' 138' ' ' LEU . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 141' ' ' PHE . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -125.69 140.92 52.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.02 -112.91 1.92 Allowed Glycine 0 N--CA 1.468 0.815 0 C-N-CA 125.302 1.429 . . . . 0.0 112.671 -171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -66.33 127.97 34.31 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.318 1.047 . . . . 0.0 110.807 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -139.54 135.83 33.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.102 1.361 . . . . 0.0 110.02 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -96.63 52.52 1.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.209 1.404 . . . . 0.0 110.93 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 124.89 1.276 . . . . 0.0 114.064 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -161.56 158.38 26.25 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.564 1.545 . . . . 0.0 110.424 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -165.93 170.75 13.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.838 1.255 . . . . 0.0 112.721 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.52 156.65 30.35 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.372 1.463 . . . . 0.0 113.218 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -165.33 131.68 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.277 1.431 . . . . 0.0 111.134 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.9 m -83.16 155.53 23.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.041 0.936 . . . . 0.0 113.129 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.24 -163.35 13.7 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.266 1.412 . . . . 0.0 113.481 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.0 125.7 10.37 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.895 1.678 . . . . 0.0 108.374 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -127.17 124.01 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 111.332 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.25 60.01 5.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.363 1.465 . . . . 0.0 111.148 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.65 127.48 16.33 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.051 1.74 . . . . 0.0 110.658 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -97.02 -8.32 30.71 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -82.83 122.17 78.0 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.832 1.253 . . . . 0.0 109.025 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.78 158.95 46.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.41 2.74 . . . . 0.0 112.249 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.34 0.39 2.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.894 2.078 . . . . 0.0 115.287 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -146.68 17.68 1.29 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.169 1.787 . . . . 0.0 113.693 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -47.09 135.13 8.76 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.151 0.98 . . . . 0.0 113.26 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.31 -16.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.706 2.937 . . . . 0.0 115.467 -170.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t -162.05 49.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt -135.44 131.69 36.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -65.77 142.17 58.07 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.565 -0.709 . . . . 0.0 112.622 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 60.9 23.12 13.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 112.981 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -148.55 166.33 28.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.779 2.432 . . . . 0.0 110.623 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.3 158.4 32.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.333 0.653 . . . . 0.0 111.193 168.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.74 129.08 35.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.969 0.508 . . . . 0.0 110.306 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt -75.96 -39.21 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -80.08 -36.86 34.93 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.341 0.973 . . . . 0.0 112.791 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.2 t 51.89 31.7 8.8 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.581 1.552 . . . . 0.0 113.519 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.17 164.81 23.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.476 1.511 . . . . 0.0 112.695 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 p -66.68 100.34 0.68 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.231 1.013 . . . . 0.0 111.185 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -135.69 135.85 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 126.636 1.974 . . . . 0.0 108.462 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -80.0 -49.93 11.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.395 1.078 . . . . 0.0 112.85 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.87 150.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.734 2.413 . . . . 0.0 109.272 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.45 131.02 48.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.269 1.428 . . . . 0.0 109.908 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -130.86 145.89 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.693 1.597 . . . . 0.0 110.19 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.24 149.72 70.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.373 1.469 . . . . 0.0 110.519 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.77 155.09 44.04 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.597 2.864 . . . . 0.0 112.314 -173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.51 132.26 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.315 1.046 . . . . 0.0 109.268 174.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -123.39 146.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.335 1.854 . . . . 0.0 109.185 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.82 121.21 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.207 1.003 . . . . 0.0 109.986 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.2 t -71.08 143.89 50.52 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.561 1.144 . . . . 0.0 111.162 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -112.19 132.68 54.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.14 1.376 . . . . 0.0 111.533 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.72 -135.77 30.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.714 0.673 . . . . 0.0 112.278 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.9 t -164.41 -168.1 1.45 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.121 1.768 . . . . 0.0 110.226 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.3 p -153.32 164.61 37.82 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.667 -1.27 . . . . 0.0 112.196 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 100.7 1.44 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.09 1.328 . . . . 0.0 111.155 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m -150.53 149.67 30.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.598 1.559 . . . . 0.0 110.842 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -81.89 149.99 27.99 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.269 -0.894 . . . . 0.0 112.05 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.6 -131.94 2.65 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.027 1.298 . . . . 0.0 112.355 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -153.74 141.59 20.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.712 1.205 . . . . 0.0 111.022 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 m -99.81 127.89 45.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.112 . . . . 0.0 111.79 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.93 92.8 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.729 1.156 . . . . 0.0 111.305 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.6 t -75.85 77.22 2.77 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.876 1.27 . . . . 0.0 110.654 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t 68.24 9.69 7.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.295 1.838 . . . . 0.0 112.964 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.77 -148.94 20.0 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.672 2.082 . . . . 0.0 112.018 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.1 mt -114.59 139.44 49.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.715 1.606 . . . . 0.0 109.612 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -75.04 119.62 19.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.315 0.646 . . . . 0.0 111.33 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -128.5 135.05 48.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.55 -98.02 1.76 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.294 1.426 . . . . 0.0 111.52 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -75.09 161.69 29.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.045 1.338 . . . . 0.0 111.9 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -110.57 150.64 28.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.583 1.553 . . . . 0.0 109.059 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -154.49 139.29 17.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.025 1.73 . . . . 0.0 108.935 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.985 1.714 . . . . 0.0 113.781 -172.816 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -85.99 75.28 9.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.148 0.974 . . . . 0.0 111.374 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.5 p -84.57 6.1 25.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.15 1.38 . . . . 0.0 114.119 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.58 -161.84 13.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.313 1.911 . . . . 0.0 112.425 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 t -160.39 140.29 11.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.156 . . . . 0.0 111.47 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.8 t -102.53 -13.29 17.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.486 1.114 . . . . 0.0 112.858 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.96 147.74 6.36 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.39 1.471 . . . . 0.0 113.262 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.75 26.23 0.38 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.84 1.656 . . . . 0.0 112.804 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -120.75 148.83 43.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.919 1.688 . . . . 0.0 111.715 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.97 -20.68 48.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -99.55 162.12 13.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.949 1.699 . . . . 0.0 111.451 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 -0.23 15.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.278 1.031 . . . . 0.0 113.6 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -157.71 124.16 2.53 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -68.73 147.45 69.46 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.475 2.783 . . . . 0.0 111.999 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.15 -9.74 58.84 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.852 1.661 . . . . 0.0 114.151 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.25 17.42 10.68 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.29 1.836 . . . . 0.0 112.585 -173.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -55.45 130.87 70.39 Favored Pre-proline 0 CA--C 1.56 1.347 0 O-C-N 120.521 -1.362 . . . . 0.0 113.795 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.96 -14.75 7.25 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.286 2.658 . . . . 0.0 115.87 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p -133.14 -16.91 2.42 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.402 1.456 . . . . 0.0 114.791 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 33' ' ' LEU . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 26' ' ' VAL . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.62 163.25 25.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -98.27 -29.87 12.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.7 mmt-85 -86.14 -17.04 36.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.615 1.566 . . . . 0.0 114.413 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 164.46 30.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.115 2.166 . . . . 0.0 111.01 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.09 165.95 12.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.72 0.808 . . . . 0.0 110.895 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.38 129.12 39.66 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.48 -0.762 . . . . 0.0 111.903 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt -78.05 -38.39 44.6 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -88.74 -31.57 18.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.1 t 52.91 39.16 28.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.133 1.773 . . . . 0.0 113.688 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -154.94 153.95 31.85 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.373 1.869 . . . . 0.0 110.941 -173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m 72.33 8.52 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.155 1.782 . . . . 0.0 115.022 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp -73.7 114.91 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.924 -1.11 . . . . 0.0 109.455 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -134.76 143.16 46.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.719 2.008 . . . . 0.0 110.595 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.5 133.17 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.887 0.875 . . . . 0.0 110.828 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -155.93 135.47 12.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.891 1.676 . . . . 0.0 111.548 -171.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -83.9 136.38 34.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.095 1.358 . . . . 0.0 112.399 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -151.71 153.11 31.46 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.348 1.859 . . . . 0.0 109.995 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.7 164.05 36.84 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.46 2.773 . . . . 0.0 111.734 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.49 140.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.635 1.574 . . . . 0.0 110.342 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.82 127.86 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.181 1.393 . . . . 0.0 108.351 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.5 mm -99.87 121.54 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.158 0.983 . . . . 0.0 109.812 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -142.85 145.85 33.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.763 . . . . 0.0 109.355 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -136.03 147.89 48.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 111.087 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.32 -153.06 19.73 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.519 1.056 . . . . 0.0 112.84 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.3 t -156.66 166.2 34.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.839 1.256 . . . . 0.0 111.138 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 p -93.5 158.28 15.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.846 1.258 . . . . 0.0 113.125 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.95 -77.52 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.596 1.094 . . . . 0.0 112.238 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 67.24 15.68 10.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.615 1.566 . . . . 0.0 113.569 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.6 t -101.46 140.43 35.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.414 -1.429 . . . . 0.0 111.432 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.84 157.9 34.06 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.967 1.27 . . . . 0.0 113.699 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -172.12 156.61 4.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.074 1.749 . . . . 0.0 111.168 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 m -150.94 153.76 35.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.792 1.237 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.36 56.57 3.7 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 125.173 1.368 . . . . 0.0 112.582 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.0 m -114.2 165.17 12.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.995 1.718 . . . . 0.0 112.689 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 p -76.85 -2.3 32.67 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.72 -123.97 2.48 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.646 1.593 . . . . 0.0 111.879 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.3 mt -54.77 148.91 12.04 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.72 1.608 . . . . 0.0 111.755 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -77.3 114.42 16.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.217 0.607 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -130.18 136.74 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -97.59 -115.32 3.36 Favored Glycine 0 N--CA 1.467 0.728 0 C-N-CA 125.786 1.66 . . . . 0.0 112.531 -171.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -55.13 138.73 43.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.512 1.525 . . . . 0.0 112.055 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -90.96 126.85 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.419 1.088 . . . . 0.0 108.72 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -144.02 133.51 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.26 1.824 . . . . 0.0 108.393 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.117 1.767 . . . . 0.0 113.768 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.552 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 120.485 0.183 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.9 t80 . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 120.363 0.125 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 120.348 0.118 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p . . . . . 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.323 0.106 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 120.727 0.299 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 102' ' ' GLN . 9.9 ptp . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.5 t80 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.363 0.125 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 110.738 -0.097 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.467 0.175 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 120.556 0.217 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.467 0.41 0 CA-C-O 120.581 0.229 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 110.604 -0.147 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.0 t80 . . . . . 0 CA--C 1.537 0.443 0 CA-C-O 120.492 0.187 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' HD23 ' A' ' 101' ' ' LEU . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 65' ' ' TYR . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.679 0.275 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.719 0.295 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.4 t80 . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 N--CA 1.483 1.19 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm . . . . . 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.5 t80 . . . . . 0 CA--C 1.537 0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 120.859 0.361 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt . . . . . 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 110.542 -0.17 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.174 0.035 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 120.683 0.278 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.99 0.424 . . . . 0.0 111.749 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.402 ' CD1' HD23 ' A' ' 101' ' ' LEU . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 65' ' ' TYR . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.843 0.354 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 120.522 0.201 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.436 0.16 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 138' ' ' LEU . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.622 HD13 ' HD3' ' A' ' 142' ' ' PRO . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 146' ' ' VAL . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.622 ' HD3' HD13 ' A' ' 138' ' ' LEU . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 141' ' ' PHE . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 CA--C 1.538 0.494 0 CA-C-O 120.665 0.269 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 33' ' ' LEU . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 26' ' ' VAL . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.82 0.343 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.435 0.159 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -148.17 150.11 33.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.96 1.304 . . . . 0.0 111.215 -173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 t -87.04 138.86 31.13 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.396 -0.815 . . . . 0.0 111.583 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.21 -175.44 50.51 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.617 1.103 . . . . 0.0 112.989 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.1 t -160.48 136.65 8.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.999 1.319 . . . . 0.0 110.638 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -79.87 117.87 21.12 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.244 -0.91 . . . . 0.0 111.268 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.59 -32.27 59.71 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 123.555 0.597 . . . . 0.0 113.801 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.71 159.34 13.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.969 2.107 . . . . 0.0 111.976 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -144.69 137.67 26.74 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.939 1.695 . . . . 0.0 109.497 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -157.41 41.8 0.32 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.154 1.382 . . . . 0.0 112.364 -170.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -149.21 149.84 31.64 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.597 1.959 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -71.58 -18.93 62.2 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.3 t -90.08 120.89 69.22 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 124.252 1.021 . . . . 0.0 109.979 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.88 158.99 54.96 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.701 2.934 . . . . 0.0 113.83 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -77.39 -6.78 54.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.424 1.89 . . . . 0.0 114.113 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.36 24.79 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.331 1.853 . . . . 0.0 112.045 -175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -53.5 126.06 46.31 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.472 1.109 . . . . 0.0 112.623 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -82.3 -11.26 10.86 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.294 2.662 . . . . 0.0 115.36 -173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 29.5 p -127.09 -41.74 1.76 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.04 1.291 . . . . 0.0 113.566 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -82.67 140.1 33.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.675 0.67 . . . . 0.0 109.9 168.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.93 123.98 22.91 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.991 0.916 . . . . 0.0 110.497 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.48 129.35 39.55 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.094 0.558 . . . . 0.0 109.906 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.29 155.75 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.244 1.018 . . . . 0.0 112.243 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 m -136.7 114.49 11.24 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.515 1.126 . . . . 0.0 109.244 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -67.17 141.24 57.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.646 0.779 . . . . 0.0 111.103 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.96 155.61 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -84.74 -173.54 4.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.867 1.267 . . . . 0.0 113.265 171.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -73.4 -7.64 52.56 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.86 -2.2 32.71 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.799 2.04 . . . . 0.0 112.511 169.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.04 15.91 79.74 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.079 1.324 . . . . 0.0 114.373 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.4 t -78.52 130.01 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.986 1.315 . . . . 0.0 109.636 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.34 118.61 10.25 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.911 1.284 . . . . 0.0 111.61 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.0 mt -97.57 -53.08 3.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.522 1.129 . . . . 0.0 112.11 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.75 148.52 17.23 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 124.706 1.146 . . . . 0.0 113.768 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.7 p -92.49 153.86 18.83 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.221 1.409 . . . . 0.0 113.342 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.01 39.77 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.077 1.798 . . . . 0.0 112.675 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -121.96 114.86 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.63 0.772 . . . . 0.0 109.683 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.3 tpp -76.23 139.02 40.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.468 1.507 . . . . 0.0 109.882 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -134.25 138.43 45.04 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.869 2.067 . . . . 0.0 109.578 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mp -132.36 109.05 9.59 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.897 1.279 . . . . 0.0 108.622 -172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.9 p -105.93 171.15 7.5 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.328 1.051 . . . . 0.0 110.49 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -70.39 -1.6 11.17 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 170.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.0 m -106.3 -44.08 4.63 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.107 -0.996 . . . . 0.0 112.974 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -168.92 170.32 9.13 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.361 1.064 . . . . 0.0 113.076 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.76 138.05 36.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.822 0.849 . . . . 0.0 108.797 170.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.9 t -135.2 150.42 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.817 1.647 . . . . 0.0 109.268 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.88 114.5 8.04 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.767 1.227 . . . . 0.0 109.416 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -88.38 128.75 35.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.11 1.764 . . . . 0.0 111.12 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.4 mt -120.94 -146.76 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.237 1.815 . . . . 0.0 109.585 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.81 -135.56 0.08 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.435 1.494 . . . . 0.0 111.575 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.76 -20.91 62.57 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.821 -1.174 . . . . 0.0 112.74 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -64.52 132.7 50.63 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.371 1.469 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -57.09 145.34 31.22 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 113.618 0.969 . . . . 0.0 113.618 -175.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 148.57 37.33 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.94 1.296 . . . . 0.0 112.258 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.3 t -111.33 132.94 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.368 1.067 . . . . 0.0 109.813 -171.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.54 140.9 48.5 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.256 1.022 . . . . 0.0 112.071 -169.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -135.46 112.36 10.89 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.561 1.545 . . . . 0.0 110.745 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 140.3 47.36 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.72 2.28 . . . . 0.0 110.98 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.02 -25.21 68.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.98 -20.33 62.44 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.226 1.011 . . . . 0.0 113.625 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 78.9 m -95.51 4.65 53.0 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.5 mt -93.95 98.12 10.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.263 0.938 . . . . 0.0 109.415 170.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -73.09 -36.28 66.78 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.501 0.32 . . . . 0.0 111.52 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -153.25 151.73 30.38 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.343 1.057 . . . . 0.0 112.358 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -159.02 153.69 24.54 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.983 1.713 . . . . 0.0 110.591 -171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.96 179.04 39.81 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-O 122.366 0.981 . . . . 0.0 113.884 -168.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -160.41 158.77 30.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 122.221 1.01 . . . . 0.0 112.664 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -131.0 -178.06 4.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.474 1.91 . . . . 0.0 110.327 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.5 m -63.67 -19.31 64.8 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -142.95 15.23 1.91 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.605 1.562 . . . . 0.0 112.561 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.2 tp -142.86 140.78 31.38 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.801 1.24 . . . . 0.0 110.886 -169.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -128.11 127.77 43.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.909 1.683 . . . . 0.0 108.679 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.9 t -141.11 148.19 39.69 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.66 155.15 35.48 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 113.258 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -108.2 120.11 41.41 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.381 1.472 . . . . 0.0 108.874 177.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.2 m -107.74 134.38 50.79 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.472 1.109 . . . . 0.0 110.055 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.99 176.57 46.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.544 1.068 . . . . 0.0 114.606 -176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -72.84 21.63 0.07 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.387 1.875 . . . . 0.0 115.77 -174.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -124.21 16.65 9.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.599 1.96 . . . . 0.0 113.138 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 23.8 p -128.93 169.04 15.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.58 1.552 . . . . 0.0 112.71 -175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -61.87 -31.18 71.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.215 1.406 . . . . 0.0 114.032 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.0 p -87.98 -4.21 58.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.333 1.453 . . . . 0.0 114.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.09 -177.23 42.76 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.174 0.892 . . . . 0.0 112.022 -169.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -70.17 133.94 47.6 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.19 -0.594 . . . . 0.0 110.853 176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 179.67 168.31 38.31 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.954 0.742 . . . . 0.0 114.954 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.0 mt -100.67 123.26 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.069 1.348 . . . . 0.0 107.86 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.81 130.45 53.98 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.143 1.377 . . . . 0.0 109.625 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.46 141.61 45.41 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.925 0.869 . . . . 0.0 112.859 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -141.05 137.34 32.83 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.848 1.259 . . . . 0.0 111.325 -169.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -78.09 137.77 38.4 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.259 0.623 . . . . 0.0 110.14 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 39.3 t -166.08 128.02 1.9 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.538 1.535 . . . . 0.0 110.256 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -68.61 -15.68 63.61 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.31 -0.869 . . . . 0.0 112.864 175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.1 mtp85 -106.96 17.65 22.81 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.175 1.79 . . . . 0.0 112.738 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.93 -34.53 28.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.388 1.475 . . . . 0.0 114.791 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.31 -36.88 83.51 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.15 0.98 . . . . 0.0 112.507 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -74.3 -33.23 63.15 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.568 -0.708 . . . . 0.0 111.341 177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.57 -47.16 90.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-N 118.823 0.738 . . . . 0.0 109.986 172.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -60.08 -44.53 94.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.939 0.896 . . . . 0.0 112.608 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -68.38 -41.53 80.41 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 59.1 tp -65.49 -41.35 93.37 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 118.57 0.623 . . . . 0.0 111.172 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.1 -55.02 31.6 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.532 1.133 . . . . 0.0 111.916 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -66.44 -29.4 69.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -67.49 -44.19 79.11 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.75 -28.95 58.67 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.802 -0.561 . . . . 0.0 111.758 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.8 ptm -81.36 -22.99 38.01 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.65 0.981 . . . . 0.0 113.65 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -86.06 -13.52 47.11 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 170.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.4 m -67.59 -20.29 65.36 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -75.69 147.62 39.26 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.607 0.763 . . . . 0.0 111.384 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.9 t -72.63 96.69 2.03 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.239 -0.913 . . . . 0.0 111.34 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.5 mm -139.48 136.42 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.19 2.196 . . . . 0.0 108.835 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -78.79 136.1 37.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.929 0.892 . . . . 0.0 110.761 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.2 p -156.41 144.8 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.757 1.223 . . . . 0.0 110.933 -173.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.07 169.36 21.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.539 1.936 . . . . 0.0 112.062 -170.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.95 140.03 30.0 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.109 0.964 . . . . 0.0 111.874 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -152.25 154.69 32.53 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.687 1.595 . . . . 0.0 110.781 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -75.51 149.51 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.275 2.65 . . . . 0.0 111.195 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.7 t -78.9 130.93 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.815 0.846 . . . . 0.0 109.23 175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 43.8 mm -111.3 144.24 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.613 1.565 . . . . 0.0 109.828 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -62.55 120.57 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.13 0.972 . . . . 0.0 110.091 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.7 m -87.79 127.26 35.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.023 1.329 . . . . 0.0 109.45 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 29.7 p -82.08 153.84 25.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.639 1.176 . . . . 0.0 112.992 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.45 -151.52 15.99 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.761 1.172 . . . . 0.0 113.032 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 69.6 m -134.61 157.31 46.93 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.23 1.412 . . . . 0.0 111.394 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -73.78 -1.92 21.33 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.93 130.44 7.02 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.171 1.843 . . . . 0.0 112.362 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -153.16 154.25 34.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.169 1.787 . . . . 0.0 110.459 -176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 83.3 p -160.79 167.31 27.04 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.636 1.175 . . . . 0.0 112.229 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -169.31 -142.31 3.49 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.613 1.101 . . . . 0.0 113.33 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 70.5 p -158.56 171.66 19.72 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.564 1.546 . . . . 0.0 111.633 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.9 m -59.96 119.54 7.95 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.456 1.102 . . . . 0.0 113.405 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -110.88 -102.57 2.69 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.695 1.617 . . . . 0.0 111.425 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.5 p -70.63 156.85 38.92 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.018 1.327 . . . . 0.0 113.613 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 55.5 p -86.62 160.71 18.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.846 1.258 . . . . 0.0 113.358 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.2 -162.99 28.9 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.401 1.477 . . . . 0.0 112.965 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.9 mp -78.78 166.3 22.61 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.301 1.041 . . . . 0.0 110.815 174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -68.4 120.44 14.49 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.74 -0.6 . . . . 0.0 111.699 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.54 122.87 31.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.388 1.075 . . . . 0.0 110.03 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.46 146.13 31.56 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.735 0.814 . . . . 0.0 111.79 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.5 mtm180 -74.87 -26.02 59.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.987 1.315 . . . . 0.0 113.376 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -135.58 165.37 25.68 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.156 2.182 . . . . 0.0 112.131 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -90.76 120.97 68.71 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.636 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -87.86 -18.59 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.273 2.648 . . . . 0.0 114.697 -169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 98.0 m -89.95 139.45 30.59 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.95 0.9 . . . . 0.0 111.815 -176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.44 -21.24 73.16 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.742 0.687 . . . . 0.0 114.154 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -94.5 137.97 32.98 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.504 1.122 . . . . 0.0 110.192 171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.7 t -137.8 137.78 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.683 1.593 . . . . 0.0 109.091 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -140.31 144.69 36.49 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.424 2.289 . . . . 0.0 108.908 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -108.61 140.36 42.1 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.243 1.017 . . . . 0.0 112.63 -169.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.51 -133.45 5.45 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.808 1.194 . . . . 0.0 113.195 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -59.33 146.22 40.47 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.201 1.001 . . . . 0.0 111.586 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -146.39 136.56 23.65 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.745 1.218 . . . . 0.0 109.871 -170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -165.07 156.46 14.8 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.065 1.746 . . . . 0.0 109.675 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 . . . . . 0 C--O 1.255 1.362 0 C-N-CA 125.959 1.704 . . . . 0.0 112.5 177.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.479 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t -72.81 146.18 46.47 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 118.013 0.907 . . . . 0.0 112.043 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.5 m -76.09 -16.26 59.94 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.85 75.7 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.332 0.967 . . . . 0.0 114.625 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 m -64.62 140.12 58.83 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 113.863 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.6 p -164.08 166.86 20.95 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.606 1.562 . . . . 0.0 111.759 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.68 161.48 35.24 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.755 1.169 . . . . 0.0 113.403 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -144.98 161.74 38.64 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.215 1.806 . . . . 0.0 111.217 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -71.1 164.17 26.13 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.355 1.062 . . . . 0.0 112.384 174.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -75.64 76.55 2.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.904 1.282 . . . . 0.0 111.189 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -151.7 146.59 25.88 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.114 2.165 . . . . 0.0 110.192 -175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -68.94 -23.44 64.16 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -150.44 128.95 6.02 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 127.359 2.263 . . . . 0.0 107.588 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -74.97 145.5 31.65 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.769 2.313 . . . . 0.0 111.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -71.21 -2.13 14.92 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.873 1.669 . . . . 0.0 114.193 176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.98 17.8 8.51 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.762 2.025 . . . . 0.0 112.335 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -52.05 133.0 40.29 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 120.621 -1.3 . . . . 0.0 113.189 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.7 -17.93 8.26 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.267 2.645 . . . . 0.0 116.358 -169.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 43.1 p -133.82 -28.47 1.39 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 120.274 1.397 . . . . 0.0 114.26 -171.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.69 138.45 32.51 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.922 1.289 . . . . 0.0 108.761 168.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -140.57 123.03 16.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.887 0.875 . . . . 0.0 110.771 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -63.89 129.75 41.32 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.309 0.644 . . . . 0.0 110.367 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 m -139.19 155.66 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.812 1.245 . . . . 0.0 111.454 -177.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.5 m -135.56 116.65 14.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.301 1.04 . . . . 0.0 109.413 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -65.64 141.0 58.54 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.91 0.884 . . . . 0.0 111.278 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.25 156.55 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.21 -173.73 3.93 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.19 1.796 . . . . 0.0 113.627 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -63.42 -7.98 7.99 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.995 1.318 . . . . 0.0 114.268 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -113.95 2.46 15.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.939 1.696 . . . . 0.0 112.594 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.33 16.76 80.15 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.614 1.102 . . . . 0.0 114.452 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.0 132.12 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 118.927 1.364 . . . . 0.0 109.551 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.83 119.84 12.53 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.177 1.391 . . . . 0.0 111.56 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.83 -53.44 2.62 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.979 0.912 . . . . 0.0 113.247 -173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.3 134.55 4.97 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.582 1.087 . . . . 0.0 113.583 -176.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.5 p -95.81 145.49 25.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.312 1.045 . . . . 0.0 112.974 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.57 173.82 38.88 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.696 1.141 . . . . 0.0 114.447 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 69.6 t -109.38 114.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 125.637 1.575 . . . . 0.0 108.855 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.0 ttm -84.87 143.58 28.96 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.701 1.2 . . . . 0.0 110.318 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.27 129.91 20.25 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 109.442 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.38 131.39 56.94 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.814 0.846 . . . . 0.0 108.861 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.9 p -120.65 165.54 14.91 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.679 1.592 . . . . 0.0 109.589 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.59 -6.47 31.33 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 120.817 -1.177 . . . . 0.0 112.83 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m -98.9 -37.09 9.55 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.905 -1.122 . . . . 0.0 113.49 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -174.96 168.36 3.51 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.528 1.131 . . . . 0.0 113.482 -168.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.57 136.49 35.57 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.045 1.338 . . . . 0.0 109.509 170.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.19 149.86 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.981 1.712 . . . . 0.0 109.487 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.74 124.63 9.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.187 0.995 . . . . 0.0 110.359 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -110.72 122.95 49.07 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.23 2.212 . . . . 0.0 110.849 -175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.09 165.82 20.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.766 1.226 . . . . 0.0 111.344 -177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -90.33 -37.52 13.98 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.212 1.189 . . . . 0.0 114.212 -173.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.6 ttt-85 -84.43 -34.92 23.39 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.669 1.188 . . . . 0.0 112.515 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 45.6 mtt85 -105.22 162.27 13.55 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.769 2.028 . . . . 0.0 110.682 -172.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.8 mp0 -65.08 163.42 14.91 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.967 0.907 . . . . 0.0 110.288 168.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.18 138.6 57.81 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.16 -0.963 . . . . 0.0 110.831 170.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.64 133.29 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.494 1.118 . . . . 0.0 110.044 -174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.9 mtp85 -127.32 141.07 51.8 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.315 1.446 . . . . 0.0 110.688 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -133.74 113.86 12.97 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.989 1.316 . . . . 0.0 110.843 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.12 143.51 54.16 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.145 2.563 . . . . 0.0 111.309 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -67.12 -20.02 65.71 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -73.72 -17.58 61.1 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.737 1.215 . . . . 0.0 114.018 170.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.73 -9.09 45.0 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 120.091 1.314 . . . . 0.0 114.158 169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.1 91.36 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.881 0.764 . . . . 0.0 110.072 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -66.32 -27.54 67.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.905 0.882 . . . . 0.0 112.609 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -168.31 155.93 8.13 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.249 1.82 . . . . 0.0 111.474 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -152.82 156.77 39.67 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.834 1.654 . . . . 0.0 110.638 -175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.0 176.5 43.12 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 122.395 0.997 . . . . 0.0 114.099 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -150.57 155.22 39.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.885 0.85 . . . . 0.0 111.951 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -139.72 -173.12 3.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.729 1.612 . . . . 0.0 111.45 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.6 p -59.9 105.26 0.37 Allowed 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.12 0.962 . . . . 0.0 111.869 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 60.08 23.61 12.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.444 1.898 . . . . 0.0 114.136 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.6 tp -136.69 135.58 38.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.943 1.297 . . . . 0.0 111.151 -173.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -127.84 132.48 49.4 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.91 1.284 . . . . 0.0 109.765 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.8 t -142.92 151.29 40.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.73 153.84 37.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.274 1.03 . . . . 0.0 113.158 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -109.79 122.96 48.7 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.5 1.52 . . . . 0.0 109.976 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -111.98 138.08 49.1 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.388 1.475 . . . . 0.0 111.284 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.65 -177.82 45.12 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.622 1.106 . . . . 0.0 113.916 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.98 33.16 0.22 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.5 1.52 . . . . 0.0 114.826 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -130.4 37.38 3.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.579 1.952 . . . . 0.0 112.293 -172.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.2 m -131.4 168.59 17.34 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.575 1.55 . . . . 0.0 112.598 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -61.47 -28.43 69.28 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.643 0.777 . . . . 0.0 112.284 169.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.1 p -100.84 -10.72 20.45 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.125 1.77 . . . . 0.0 114.243 -175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.95 -165.04 53.34 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 123.924 0.773 . . . . 0.0 112.273 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -79.48 135.83 36.75 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.393 1.077 . . . . 0.0 111.314 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.62 -178.42 43.23 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 115.073 0.789 . . . . 0.0 115.073 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.9 mt -116.28 124.79 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.478 1.511 . . . . 0.0 108.435 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -119.64 129.3 54.52 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.032 1.333 . . . . 0.0 109.904 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.47 47.15 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 122.056 0.932 . . . . 0.0 112.385 -174.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -138.9 136.55 35.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.202 -170.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -84.08 134.49 34.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.753 0.821 . . . . 0.0 110.016 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 11.0 p -174.77 131.38 0.33 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.322 1.849 . . . . 0.0 110.763 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.1 t -60.96 -25.64 66.96 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.809 -1.182 . . . . 0.0 112.309 172.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -79.48 5.48 12.74 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.686 1.594 . . . . 0.0 113.567 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.35 -39.48 46.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.036 1.335 . . . . 0.0 114.326 -176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -63.37 -39.96 95.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.101 0.96 . . . . 0.0 111.997 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -75.52 -36.33 60.55 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.462 -0.774 . . . . 0.0 111.511 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.22 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 118.218 0.463 . . . . 0.0 109.884 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.85 -46.61 89.9 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.369 0.667 . . . . 0.0 112.536 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -61.96 -41.91 98.53 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.62 -42.98 85.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.357 0.663 . . . . 0.0 111.346 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -56.84 -54.56 44.99 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.369 1.068 . . . . 0.0 112.064 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -64.65 -29.49 70.49 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.41 -46.16 77.48 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.652 0.66 . . . . 0.0 112.156 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.44 -11.41 60.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.929 0.892 . . . . 0.0 112.775 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.4 mtp -93.59 -17.02 23.78 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.074 1.35 . . . . 0.0 113.367 170.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -99.51 -24.75 14.66 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 119.762 1.165 . . . . 0.0 114.082 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.9 p -88.88 173.33 8.57 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.288 0.949 . . . . 0.0 113.45 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.3 p30 -155.94 20.48 0.38 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.436 1.495 . . . . 0.0 113.366 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.9 t -159.15 161.8 36.31 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.301 1.44 . . . . 0.0 110.482 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.4 114.19 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 121.056 -1.028 . . . . 0.0 109.832 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -109.89 168.21 9.59 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.649 1.979 . . . . 0.0 111.378 169.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 p -145.55 143.05 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.435 1.494 . . . . 0.0 110.182 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.78 174.15 11.73 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.964 1.705 . . . . 0.0 112.319 -170.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -131.9 133.51 44.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.275 1.83 . . . . 0.0 109.581 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -134.98 153.25 78.43 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.341 1.856 . . . . 0.0 110.374 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.53 165.66 32.05 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.862 3.041 . . . . 0.0 112.513 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.0 t -116.57 133.32 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.583 1.553 . . . . 0.0 108.73 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -127.99 124.27 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.138 1.375 . . . . 0.0 109.278 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.87 122.43 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.11 0.964 . . . . 0.0 109.828 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 p -92.13 172.29 8.53 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.057 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.6 m -76.79 -1.28 27.38 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 173.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.79 161.33 30.1 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.443 1.497 . . . . 0.0 113.24 -176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 4.9 m -166.82 151.97 7.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.938 2.095 . . . . 0.0 110.111 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.1 p -163.41 157.81 20.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.601 1.16 . . . . 0.0 112.332 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 136.24 170.39 12.0 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.354 1.454 . . . . 0.0 113.392 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.8 m -149.81 159.28 44.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.032 1.733 . . . . 0.0 110.545 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 77.5 p -154.34 157.91 39.31 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.125 0.97 . . . . 0.0 112.854 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 156.62 -21.87 0.47 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.512 1.53 . . . . 0.0 114.063 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -56.56 128.36 35.84 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 111.73 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.24 -2.47 2.57 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.034 1.733 . . . . 0.0 114.229 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.79 52.4 3.91 Favored Glycine 0 N--CA 1.474 1.209 0 C-N-CA 126.26 1.886 . . . . 0.0 113.096 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.4 t -71.8 -20.3 61.87 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.749 1.219 . . . . 0.0 114.201 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 45.6 p -89.02 1.43 55.55 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.52 -124.16 7.1 Favored Glycine 0 C--N 1.344 0.973 0 C-N-CA 124.708 1.146 . . . . 0.0 112.106 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.4 mt -97.6 134.97 40.1 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.269 1.427 . . . . 0.0 109.585 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -80.41 137.34 36.5 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.117 0.567 . . . . 0.0 111.636 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.54 115.88 31.0 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.043 1.337 . . . . 0.0 109.394 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.9 mt -73.79 146.69 44.06 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.648 0.779 . . . . 0.0 111.169 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -73.57 -32.88 64.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.452 0.701 . . . . 0.0 112.622 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -133.49 150.53 51.71 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.232 1.813 . . . . 0.0 111.693 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -76.6 123.53 87.68 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.923 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -89.66 -22.12 0.96 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.06 2.507 . . . . 0.0 114.732 -169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.5 m -94.51 135.5 35.88 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.021 0.929 . . . . 0.0 112.143 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.45 -36.96 48.17 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.939 -0.476 . . . . 0.0 113.815 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -83.47 63.73 7.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.365 1.083 . . . . 0.0 112.669 -173.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -67.92 136.11 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.962 1.305 . . . . 0.0 110.369 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -142.8 162.15 36.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.294 1.838 . . . . 0.0 110.998 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -124.02 134.93 53.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.718 1.607 . . . . 0.0 111.252 -170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -103.53 -97.49 2.43 Favored Glycine 0 N--CA 1.47 0.906 0 C-N-CA 124.657 1.123 . . . . 0.0 112.142 -174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -64.8 135.52 55.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.302 1.041 . . . . 0.0 111.548 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -82.99 -0.28 48.04 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -81.55 108.12 14.86 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.322 1.449 . . . . 0.0 109.083 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 pp0? . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.888 2.075 . . . . 0.0 113.251 -173.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.524 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -147.14 169.52 19.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.185 1.394 . . . . 0.0 111.483 -175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.2 t -156.08 175.67 13.67 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.971 1.308 . . . . 0.0 111.114 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.9 146.91 42.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.402 1.001 . . . . 0.0 112.932 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 p -155.02 110.27 3.06 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.861 1.264 . . . . 0.0 110.625 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.0 m 63.46 6.13 2.38 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 126.316 1.846 . . . . 0.0 114.995 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.69 146.82 18.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.349 1.452 . . . . 0.0 112.879 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -165.3 150.03 8.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.37 1.868 . . . . 0.0 112.04 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -79.9 131.87 35.95 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.937 0.895 . . . . 0.0 111.443 172.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -102.9 9.3 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.488 1.515 . . . . 0.0 112.704 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -147.0 167.38 24.16 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.731 2.012 . . . . 0.0 110.113 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.8 m -90.4 -14.64 32.55 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -177.94 113.65 0.23 Allowed Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 126.312 1.845 . . . . 0.0 112.106 -169.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.23 162.82 15.26 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.413 2.742 . . . . 0.0 111.505 169.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.47 3.66 5.79 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.358 1.463 . . . . 0.0 113.926 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -142.98 14.29 1.88 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.389 1.476 . . . . 0.0 114.479 -173.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -50.86 137.83 24.98 Favored Pre-proline 0 CA--C 1.562 1.423 0 C-N-CA 124.444 1.098 . . . . 0.0 113.721 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.65 -23.03 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.643 2.895 . . . . 0.0 115.803 -174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.3 p -133.1 5.39 3.83 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 119.911 1.232 . . . . 0.0 114.166 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.15 132.97 54.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.546 1.938 . . . . 0.0 110.271 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -141.37 130.61 23.52 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.521 1.128 . . . . 0.0 111.375 -170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -68.37 133.12 48.22 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 121.439 -0.788 . . . . 0.0 110.116 169.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.6 m -139.39 159.36 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.54 1.536 . . . . 0.0 110.629 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.7 m -139.21 120.71 15.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 109.257 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -68.82 140.37 55.24 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.408 0.683 . . . . 0.0 110.87 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -139.11 157.14 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.96 -171.78 3.75 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.784 1.634 . . . . 0.0 112.491 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.69 -26.92 67.99 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -87.32 -3.35 59.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.383 1.073 . . . . 0.0 113.044 174.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.01 18.54 72.05 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 118.803 -0.999 . . . . 0.0 114.502 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.0 130.35 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 118.972 1.386 . . . . 0.0 109.483 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.2 112.74 4.65 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 110.726 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.9 mt -96.51 -53.54 3.55 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.663 0.785 . . . . 0.0 111.943 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.0 134.98 4.44 Favored Glycine 0 N--CA 1.467 0.71 0 C-N-CA 124.688 1.137 . . . . 0.0 112.683 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.4 p -86.19 154.31 21.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.605 1.162 . . . . 0.0 112.407 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.82 172.76 38.93 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 125.273 1.416 . . . . 0.0 113.704 -173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.4 t -116.51 108.6 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.389 1.076 . . . . 0.0 108.796 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.7 ttm -82.69 139.27 33.77 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.359 1.064 . . . . 0.0 110.217 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.27 123.0 19.91 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.95 1.7 . . . . 0.0 109.397 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.72 104.56 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -90.93 170.53 9.98 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.132 0.973 . . . . 0.0 110.541 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -72.05 -4.44 28.78 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.127 0.971 . . . . 0.0 112.858 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.7 m -115.28 -35.84 4.53 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.237 1.015 . . . . 0.0 113.502 -177.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.6 163.4 12.26 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.619 1.567 . . . . 0.0 112.55 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.87 135.37 37.0 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 171.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.04 146.99 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.1 1.36 . . . . 0.0 108.867 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.87 110.31 6.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.105 0.962 . . . . 0.0 109.427 177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -84.78 129.66 34.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.988 1.715 . . . . 0.0 110.798 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.87 158.05 38.84 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.141 1.776 . . . . 0.0 109.866 -175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -110.74 -16.38 13.61 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -106.73 7.08 30.23 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.951 1.7 . . . . 0.0 112.675 173.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.0 ttm-85 -160.04 156.64 27.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.897 2.879 . . . . 0.0 108.637 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.29 159.14 12.84 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.932 0.787 . . . . 0.0 111.472 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.01 134.14 54.45 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.126 -0.983 . . . . 0.0 111.099 174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.7 t -111.58 127.0 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.802 1.241 . . . . 0.0 109.826 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -111.4 147.43 35.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.02 1.328 . . . . 0.0 112.113 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -137.83 112.18 8.93 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.757 1.623 . . . . 0.0 110.57 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.61 139.1 43.56 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.701 2.267 . . . . 0.0 110.421 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -63.26 -27.27 69.23 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.501 0.72 . . . . 0.0 112.51 -175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.56 -15.04 61.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.049 1.34 . . . . 0.0 114.241 173.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.5 m -102.47 -0.87 31.67 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 169.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.99 105.41 13.96 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.4 tpp85 -71.41 -36.97 71.54 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 122.076 -0.39 . . . . 0.0 111.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -163.36 160.5 23.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.571 1.548 . . . . 0.0 111.946 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -159.09 155.63 27.68 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.865 1.666 . . . . 0.0 111.032 -169.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.95 174.34 40.89 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 122.588 1.104 . . . . 0.0 114.399 -173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -153.15 154.27 34.44 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.817 0.818 . . . . 0.0 112.528 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -125.32 -172.97 2.71 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.423 1.889 . . . . 0.0 110.691 169.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.7 m -65.58 -19.92 66.11 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -147.19 15.99 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.992 1.717 . . . . 0.0 112.688 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.7 tp -142.48 135.43 28.41 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.8 1.24 . . . . 0.0 110.515 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -119.89 130.61 54.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.334 1.453 . . . . 0.0 108.704 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -145.61 151.89 38.81 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -158.55 161.42 37.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.951 1.464 . . . . 0.0 114.951 -177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -102.58 143.58 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.762 1.625 . . . . 0.0 112.047 172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -122.76 154.31 38.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.928 1.291 . . . . 0.0 111.926 169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.73 159.64 48.52 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.494 1.521 . . . . 0.0 113.973 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -69.97 -3.59 16.85 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -126.62 76.89 1.67 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.869 1.667 . . . . 0.0 111.278 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.3 p -157.07 179.59 9.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.468 1.907 . . . . 0.0 110.981 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.59 -22.93 67.1 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -110.32 -6.19 15.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.019 1.328 . . . . 0.0 113.902 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.21 -171.92 48.05 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.004 1.288 . . . . 0.0 113.915 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -71.35 132.2 44.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.46 0.704 . . . . 0.0 109.333 172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.6 174.84 39.51 Favored Glycine 0 CA--C 1.526 0.733 0 O-C-N 122.006 -0.434 . . . . 0.0 113.947 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.28 119.13 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.67 1.588 . . . . 0.0 108.117 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -107.11 139.87 40.85 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.587 1.155 . . . . 0.0 109.469 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.65 132.7 26.14 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-O 121.54 0.686 . . . . 0.0 112.486 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -132.81 133.17 43.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.865 1.266 . . . . 0.0 111.252 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -75.51 134.2 40.84 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.531 0.732 . . . . 0.0 110.053 171.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 47.1 t -167.74 129.28 1.49 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.557 1.543 . . . . 0.0 110.326 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.5 t -67.33 -15.01 63.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 121.203 -0.936 . . . . 0.0 112.955 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -103.68 17.67 23.58 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.028 2.131 . . . . 0.0 112.658 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.36 -32.93 27.5 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.618 1.167 . . . . 0.0 114.016 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.32 -40.53 93.84 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.19 0.996 . . . . 0.0 112.534 174.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -73.27 -34.62 65.91 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.687 0.676 . . . . 0.0 111.677 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.19 -49.38 84.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.167 0.587 . . . . 0.0 109.596 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -61.66 -43.66 98.44 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.111 0.964 . . . . 0.0 112.188 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -61.61 -48.97 78.51 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.428 0.691 . . . . 0.0 111.519 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.11 -38.5 91.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.289 0.635 . . . . 0.0 111.879 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -58.71 -50.23 74.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.909 0.884 . . . . 0.0 112.28 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -68.55 -32.45 72.38 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 118.911 0.778 . . . . 0.0 112.567 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -65.4 -42.27 92.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.688 0.795 . . . . 0.0 111.712 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.77 -21.6 60.12 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.959 0.904 . . . . 0.0 112.947 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 55.7 mtt -76.86 -31.1 56.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 170.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.4 -23.75 15.46 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.2 t -87.02 121.78 29.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.089 0.956 . . . . 0.0 111.485 -177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -85.99 -25.34 26.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -174.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 65.7 m -142.52 124.02 14.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.105 1.362 . . . . 0.0 110.873 -177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.66 124.46 69.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.767 1.627 . . . . 0.0 109.44 -176.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.47 149.41 35.04 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.124 0.97 . . . . 0.0 111.472 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.95 123.26 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.653 1.181 . . . . 0.0 110.494 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.01 164.41 26.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.197 1.399 . . . . 0.0 112.803 -176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -63.3 150.73 42.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.014 0.925 . . . . 0.0 111.908 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -63.79 153.22 84.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.43 1.092 . . . . 0.0 112.381 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.94 164.08 36.95 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.479 2.786 . . . . 0.0 111.693 -178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -92.17 134.62 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.623 1.169 . . . . 0.0 109.667 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.02 116.6 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.326 1.051 . . . . 0.0 109.407 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.9 mm -124.2 21.13 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.631 1.572 . . . . 0.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 44.6 p 61.1 29.99 19.19 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 126.754 2.022 . . . . 0.0 112.502 -175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 2.6 m -58.88 148.1 31.44 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 127.544 2.338 . . . . 0.0 114.462 -169.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -168.17 176.04 42.76 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.319 0.961 . . . . 0.0 113.703 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 53.0 m -151.04 156.95 42.17 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.57 1.548 . . . . 0.0 110.64 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -137.52 146.98 44.81 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.871 1.268 . . . . 0.0 111.779 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.88 165.42 45.65 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.519 1.056 . . . . 0.0 113.234 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.4 t -166.13 -41.75 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.937 1.295 . . . . 0.0 112.395 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.3 t -94.52 119.81 33.79 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.179 -0.951 . . . . 0.0 111.091 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.25 -141.27 11.14 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.348 1.452 . . . . 0.0 112.751 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.4 t -81.6 170.33 15.98 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.953 0.883 . . . . 0.0 112.635 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 79.8 p -168.26 -28.31 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.781 1.632 . . . . 0.0 113.842 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 131.96 85.74 0.32 Allowed Glycine 0 N--CA 1.471 0.985 0 C-N-CA 125.655 1.598 . . . . 0.0 111.7 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.4 p -166.43 162.73 17.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.945 1.698 . . . . 0.0 111.247 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 48.8 m -114.94 -0.4 13.43 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -174.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.81 -129.67 8.78 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.049 1.309 . . . . 0.0 112.758 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 99.1 mt -60.9 134.88 57.53 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.666 1.186 . . . . 0.0 112.141 -174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -98.3 131.23 44.79 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.246 1.418 . . . . 0.0 111.312 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -99.55 118.48 36.22 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.236 1.414 . . . . 0.0 110.763 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.73 150.32 29.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.39 1.076 . . . . 0.0 111.046 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -78.48 -31.42 47.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.946 0.898 . . . . 0.0 113.241 174.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -136.16 154.49 50.95 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.261 1.825 . . . . 0.0 111.764 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.97 127.2 82.43 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.117 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -86.78 -17.33 3.3 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.114 2.542 . . . . 0.0 113.986 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.79 149.31 23.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.003 1.321 . . . . 0.0 111.694 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -86.7 -33.81 12.48 Favored Glycine 0 N--CA 1.474 1.212 0 O-C-N 121.617 -0.677 . . . . 0.0 113.899 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -85.44 68.53 10.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.579 -0.954 . . . . 0.0 112.983 -169.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.04 128.02 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.502 1.121 . . . . 0.0 111.491 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -123.25 149.51 44.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.189 2.195 . . . . 0.0 109.365 168.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -100.86 141.07 34.26 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.545 1.138 . . . . 0.0 111.293 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -86.66 -136.22 4.47 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.369 0.985 . . . . 0.0 112.357 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -66.81 142.19 57.44 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.708 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -74.19 132.58 42.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.301 1.44 . . . . 0.0 109.293 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -152.4 135.57 15.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.339 1.856 . . . . 0.0 108.923 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.782 1.633 . . . . 0.0 112.558 -170.337 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.486 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -85.3 111.53 19.97 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.132 0.966 . . . . 0.0 111.166 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.5 m -148.44 152.5 37.05 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.987 1.315 . . . . 0.0 111.603 -174.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.87 174.65 44.08 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.893 1.235 . . . . 0.0 113.549 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -165.43 168.73 16.38 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.362 1.465 . . . . 0.0 111.458 -178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.4 t -161.71 117.6 2.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.515 1.526 . . . . 0.0 110.425 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.02 -31.89 9.45 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.331 0.967 . . . . 0.0 113.752 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.07 171.35 8.53 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.771 1.628 . . . . 0.0 110.331 173.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -141.65 71.6 1.36 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.219 1.408 . . . . 0.0 111.427 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 73.6 14.68 4.22 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.248 2.219 . . . . 0.0 114.069 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -65.79 -64.18 0.92 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.178 1.391 . . . . 0.0 113.055 -169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -92.38 -16.57 25.79 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.2 p -167.08 129.93 1.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 127.113 2.165 . . . . 0.0 109.416 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.29 144.94 26.69 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.221 2.614 . . . . 0.0 111.664 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.32 -6.23 38.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.134 1.374 . . . . 0.0 113.926 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -127.42 21.84 6.57 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 126.966 2.106 . . . . 0.0 112.911 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -41.23 125.17 2.16 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 125.984 1.714 . . . . 0.0 114.152 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -81.79 -12.05 11.15 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.156 2.571 . . . . 0.0 115.886 -169.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 49.0 p -141.48 -15.57 0.84 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 -171.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 ttpp -131.94 128.82 39.29 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.093 1.357 . . . . 0.0 110.619 -177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -135.68 125.24 25.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.281 1.032 . . . . 0.0 111.291 -168.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -68.58 133.89 49.18 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.472 -0.767 . . . . 0.0 109.242 169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.28 155.92 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.883 1.273 . . . . 0.0 111.517 -174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -130.61 114.44 15.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.364 1.066 . . . . 0.0 109.299 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -64.73 137.85 58.04 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.28 0.632 . . . . 0.0 110.876 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.62 156.13 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.751 0.821 . . . . 0.0 113.016 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -88.4 -171.61 3.43 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.311 1.444 . . . . 0.0 113.687 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -6.11 15.2 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.565 1.546 . . . . 0.0 114.162 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.41 3.35 13.28 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.309 1.844 . . . . 0.0 112.318 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.12 81.06 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.745 1.164 . . . . 0.0 114.421 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.9 t -77.96 129.84 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.759 1.279 . . . . 0.0 109.856 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.75 115.17 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.371 1.469 . . . . 0.0 111.376 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 84.4 mt -94.21 -52.88 4.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.2 1.0 . . . . 0.0 111.768 -177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.16 153.8 21.26 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.039 1.304 . . . . 0.0 112.796 178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -108.53 144.54 36.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -171.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.36 -178.23 18.17 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 127.07 2.271 . . . . 0.0 112.437 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -118.49 114.55 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.389 0.676 . . . . 0.0 109.648 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.8 tpp -83.63 135.55 34.56 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.117 1.767 . . . . 0.0 109.807 177.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -141.88 129.51 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 125.023 1.329 . . . . 0.0 109.995 -175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -115.71 126.47 54.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.266 1.026 . . . . 0.0 108.955 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.4 p -115.63 169.18 9.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.118 1.367 . . . . 0.0 111.0 -173.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -68.33 2.11 2.5 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.377 -0.827 . . . . 0.0 113.08 173.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -120.35 -35.72 3.37 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -171.97 167.44 6.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.993 1.317 . . . . 0.0 113.747 -168.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.58 133.98 35.44 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.647 1.579 . . . . 0.0 109.14 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -129.38 141.44 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.486 1.514 . . . . 0.0 109.565 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.83 118.35 18.87 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.703 1.201 . . . . 0.0 109.938 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -95.85 131.43 42.19 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.203 1.801 . . . . 0.0 111.34 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.9 mt -137.64 153.05 49.92 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 110.361 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -96.89 -26.3 15.13 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -171.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -127.07 15.7 7.31 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.949 1.7 . . . . 0.0 113.352 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 -142.25 157.35 44.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 128.184 2.594 . . . . 0.0 108.223 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.07 160.89 20.02 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.116 0.416 . . . . 0.0 112.086 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.79 130.39 43.01 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.818 -0.551 . . . . 0.0 109.956 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.35 126.24 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 110.505 -172.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -118.72 135.25 54.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.152 1.381 . . . . 0.0 111.242 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -134.18 111.28 11.91 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.743 1.217 . . . . 0.0 110.286 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.5 144.59 73.69 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.156 1.904 . . . . 0.0 110.612 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -62.76 -19.34 63.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.34 -22.14 59.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.798 1.639 . . . . 0.0 114.272 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.4 p -90.9 -2.03 57.78 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 120.013 1.279 . . . . 0.0 113.996 170.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.7 mt -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.145 0.884 . . . . 0.0 110.251 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -68.97 -30.89 69.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.181 0.593 . . . . 0.0 112.572 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -155.44 152.26 28.77 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.884 0.874 . . . . 0.0 112.775 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -152.37 148.62 27.7 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.663 1.585 . . . . 0.0 110.792 -175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.1 177.91 33.74 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 124.618 1.104 . . . . 0.0 113.884 -169.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -161.74 158.29 25.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 122.092 0.948 . . . . 0.0 112.503 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -133.2 -176.21 4.06 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.807 1.643 . . . . 0.0 110.857 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.9 p -64.46 -17.56 63.94 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -153.13 30.64 0.49 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.93 1.692 . . . . 0.0 111.865 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.6 tp -151.23 133.81 15.56 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.962 1.305 . . . . 0.0 110.593 -173.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -116.44 131.55 56.92 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.545 1.538 . . . . 0.0 108.982 172.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 31.2 t -147.25 148.21 31.22 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.15 156.18 40.45 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.39 130.37 45.66 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.998 1.319 . . . . 0.0 109.305 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -111.71 143.68 42.22 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.652 0.781 . . . . 0.0 111.8 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.32 170.36 54.86 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.928 1.252 . . . . 0.0 114.889 -169.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 43.8 mtm180 -68.15 -10.36 53.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.85 1.66 . . . . 0.0 114.579 -172.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -127.03 67.83 1.27 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 127.167 2.187 . . . . 0.0 112.882 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.8 p -150.59 -178.23 6.43 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.704 2.002 . . . . 0.0 111.394 174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -57.68 -36.76 72.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.956 0.902 . . . . 0.0 112.824 -174.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.6 p -98.66 -7.35 28.06 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.327 1.451 . . . . 0.0 113.63 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 -159.65 38.77 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 123.911 0.767 . . . . 0.0 112.044 -169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -64.49 129.39 39.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.498 0.719 . . . . 0.0 110.845 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.87 163.41 32.29 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.832 0.729 . . . . 0.0 113.762 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.96 120.49 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.506 1.523 . . . . 0.0 107.476 173.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -118.1 145.04 45.16 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 110.041 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.96 141.45 31.42 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.91 0.862 . . . . 0.0 112.708 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -139.07 135.61 34.37 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 114.307 -1.315 . . . . 0.0 112.384 -172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -71.63 130.44 41.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.725 1.21 . . . . 0.0 108.943 169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.6 t -165.12 123.76 1.7 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.475 0.71 . . . . 0.0 111.601 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -72.62 -3.29 23.95 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -130.51 25.28 5.11 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.238 2.215 . . . . 0.0 111.882 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.96 -34.42 28.71 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.695 1.598 . . . . 0.0 114.255 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.1 -38.09 85.05 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.113 0.965 . . . . 0.0 112.324 175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.82 -28.29 55.48 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.706 -0.621 . . . . 0.0 112.199 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 32.5 mt -66.33 -46.4 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 119.053 0.842 . . . . 0.0 109.567 169.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.28 -46.97 87.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.068 0.947 . . . . 0.0 112.451 176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -59.95 -49.05 79.19 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.809 0.844 . . . . 0.0 111.687 175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.6 tp -63.24 -39.95 96.05 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.433 0.693 . . . . 0.0 111.88 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.15 -49.75 76.41 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.896 0.878 . . . . 0.0 112.143 177.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -65.38 -39.25 92.03 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.714 0.688 . . . . 0.0 111.641 176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -62.05 -39.26 91.76 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.012 0.925 . . . . 0.0 112.231 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -80.81 -14.99 57.56 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.257 1.023 . . . . 0.0 113.734 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.4 ptp -97.59 -24.15 15.67 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 171.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -93.65 -13.6 27.4 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 9.5 t -147.69 153.16 38.96 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.066 1.746 . . . . 0.0 110.767 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -69.0 -10.98 60.3 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.5 m -156.86 165.84 35.06 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.629 1.971 . . . . 0.0 109.725 -172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -69.28 110.06 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 123.688 0.795 . . . . 0.0 109.15 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.72 146.21 35.77 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.31 1.844 . . . . 0.0 110.308 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.24 125.57 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.299 0.64 . . . . 0.0 110.018 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.6 mmt -142.23 162.3 35.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.556 1.942 . . . . 0.0 110.852 -171.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -123.13 136.77 54.92 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 173.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.42 142.82 30.72 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.909 1.684 . . . . 0.0 109.505 -173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.07 159.27 53.79 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 124.992 3.795 . . . . 0.0 112.397 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.0 t -115.48 133.66 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.377 1.471 . . . . 0.0 108.73 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -122.66 132.18 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.293 1.437 . . . . 0.0 109.149 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mp -81.99 127.38 39.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 109.8 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -86.27 154.08 21.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.95 1.7 . . . . 0.0 111.641 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.5 m -134.73 51.81 2.08 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.84 1.256 . . . . 0.0 111.159 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 88.38 -109.62 3.55 Favored Glycine 0 C--N 1.343 0.917 0 C-N-CA 124.914 1.245 . . . . 0.0 110.641 -174.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 61.7 p -157.17 149.6 23.07 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.952 1.301 . . . . 0.0 111.436 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.1 t -83.26 64.27 7.66 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.141 -0.975 . . . . 0.0 111.579 -177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 81.28 -147.05 26.83 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.112 1.339 . . . . 0.0 112.59 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 35.0 p -163.2 154.06 16.64 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.799 1.64 . . . . 0.0 110.9 -175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 16.0 m -161.54 113.58 1.79 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.576 1.15 . . . . 0.0 111.59 -178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.62 -4.84 30.03 Favored Glycine 0 N--CA 1.475 1.262 0 C-N-CA 124.965 1.269 . . . . 0.0 115.463 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.5 p -91.15 132.39 36.1 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.73 1.212 . . . . 0.0 112.831 -173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.2 t -163.94 148.89 10.47 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.424 1.49 . . . . 0.0 110.906 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -92.43 2.64 74.45 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.912 1.244 . . . . 0.0 114.261 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.0 t -105.67 143.77 33.36 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.839 1.32 . . . . 0.0 113.279 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.0 p -81.98 179.78 7.69 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.039 1.335 . . . . 0.0 111.891 169.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 135.25 -136.51 8.56 Favored Glycine 0 N--CA 1.473 1.103 0 O-C-N 120.934 -1.104 . . . . 0.0 113.455 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.55 166.47 21.89 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.672 1.189 . . . . 0.0 111.416 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -66.36 120.54 13.49 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.2 0.6 . . . . 0.0 110.857 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -94.7 119.85 33.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.579 1.152 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 82.2 mt -76.54 142.11 40.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.014 0.926 . . . . 0.0 110.999 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -70.71 -25.61 63.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.967 0.907 . . . . 0.0 113.424 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -138.26 167.93 20.81 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.825 2.85 . . . . 0.0 111.252 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -88.66 125.94 61.43 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.331 -0.843 . . . . 0.0 111.105 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -86.27 -27.98 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.011 2.474 . . . . 0.0 114.437 -169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 91.6 m -87.76 140.24 29.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.952 0.901 . . . . 0.0 111.905 -173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.6 -31.37 56.59 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.589 0.614 . . . . 0.0 113.169 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -82.21 132.24 35.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.191 0.996 . . . . 0.0 110.319 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.5 t -142.79 131.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.192 1.397 . . . . 0.0 109.907 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 22.7 m-20 -119.76 155.46 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.598 1.959 . . . . 0.0 109.425 168.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -113.52 135.63 53.68 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.657 1.183 . . . . 0.0 111.152 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.0 -133.51 5.7 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.364 0.983 . . . . 0.0 113.063 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.54 159.17 10.93 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.509 1.124 . . . . 0.0 112.269 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -148.07 176.78 9.92 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.912 1.285 . . . . 0.0 111.66 -173.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -85.96 99.33 11.36 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.408 1.083 . . . . 0.0 109.68 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 C-N-CA 125.473 1.509 . . . . 0.0 114.106 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.581 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -164.2 152.62 12.98 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.425 1.89 . . . . 0.0 110.722 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 t -163.5 157.1 19.28 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.026 1.33 . . . . 0.0 111.364 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -171.77 141.54 6.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.758 1.171 . . . . 0.0 113.18 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.5 t -169.98 163.37 9.42 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.339 1.855 . . . . 0.0 110.298 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.4 p -81.81 -23.89 36.23 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.04 -1.037 . . . . 0.0 113.447 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.79 11.73 60.92 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.925 1.25 . . . . 0.0 114.825 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -68.54 130.92 44.27 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.789 1.236 . . . . 0.0 112.21 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -149.37 148.64 29.73 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.405 1.882 . . . . 0.0 110.702 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -87.28 111.94 21.54 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.144 0.978 . . . . 0.0 110.912 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.82 -178.21 1.52 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 128.392 2.677 . . . . 0.0 109.991 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.9 t -80.32 -21.2 42.77 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -177.57 117.4 0.26 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.812 2.445 . . . . 0.0 110.504 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.93 137.66 29.82 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.446 2.097 . . . . 0.0 110.512 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -78.88 5.95 10.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.219 1.008 . . . . 0.0 113.44 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -115.59 8.41 15.07 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 127.455 2.302 . . . . 0.0 113.091 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -49.01 137.33 13.69 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 125.29 1.436 . . . . 0.0 114.031 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.62 -11.77 32.85 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 124.691 3.594 . . . . 0.0 116.656 -172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -150.57 -29.36 0.21 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -82.59 131.87 35.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.986 0.914 . . . . 0.0 110.856 173.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -139.87 131.74 27.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.958 0.903 . . . . 0.0 111.815 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -71.26 129.76 39.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.341 0.657 . . . . 0.0 109.41 173.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.3 m -140.42 158.35 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.914 0.885 . . . . 0.0 112.67 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.2 m -140.25 119.38 12.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.232 1.413 . . . . 0.0 108.833 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -68.78 141.87 55.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 122.812 0.445 . . . . 0.0 111.102 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.56 151.19 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.5 p-10 -81.18 -173.89 4.57 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.519 1.128 . . . . 0.0 113.106 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -68.7 -13.6 62.48 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -96.76 -1.51 46.21 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.093 1.757 . . . . 0.0 112.403 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.46 16.24 80.56 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.99 1.281 . . . . 0.0 114.066 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.6 t -80.59 129.57 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 118.634 1.217 . . . . 0.0 109.562 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.6 117.24 5.98 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.111 1.364 . . . . 0.0 111.371 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -97.31 -54.05 3.27 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.994 0.918 . . . . 0.0 112.058 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.07 140.56 6.84 Favored Glycine 0 N--CA 1.467 0.732 0 C-N-CA 124.772 1.177 . . . . 0.0 112.906 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 60.4 p -85.6 155.76 21.0 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.595 1.158 . . . . 0.0 112.743 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.36 172.99 39.45 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.715 1.626 . . . . 0.0 112.773 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 90.9 t -114.53 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.097 0.959 . . . . 0.0 109.007 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.3 tpp -84.56 141.77 30.46 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.388 1.475 . . . . 0.0 109.985 177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -146.55 129.66 16.5 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.816 1.246 . . . . 0.0 110.874 -174.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.73 116.59 25.55 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.589 1.156 . . . . 0.0 109.798 -174.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.2 p -107.5 169.81 8.35 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 111.366 -172.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -70.06 5.51 1.6 Allowed 'General case' 0 CA--C 1.55 0.945 0 O-C-N 121.251 -0.906 . . . . 0.0 113.118 172.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -121.2 -37.96 2.87 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -171.25 168.31 6.73 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.588 1.155 . . . . 0.0 113.474 -169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.55 136.1 35.59 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.376 1.47 . . . . 0.0 109.186 172.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.93 143.23 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.961 1.704 . . . . 0.0 109.242 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.36 118.86 12.23 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.688 1.195 . . . . 0.0 109.451 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -100.88 127.57 47.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.307 1.843 . . . . 0.0 111.254 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -126.92 161.59 27.94 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.71 1.604 . . . . 0.0 111.346 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -99.64 -12.52 19.98 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.298 1.039 . . . . 0.0 113.756 174.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -95.83 -16.99 21.49 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.783 1.633 . . . . 0.0 113.903 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -155.57 171.14 20.45 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.537 1.935 . . . . 0.0 112.269 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.75 149.06 49.93 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.659 0.784 . . . . 0.0 111.171 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.57 142.89 57.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.179 1.392 . . . . 0.0 112.795 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.42 134.09 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.894 1.277 . . . . 0.0 110.075 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.65 144.21 50.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 111.847 -171.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.1 m-90 -138.91 116.54 8.94 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.132 1.373 . . . . 0.0 111.06 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -67.67 142.07 57.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.754 2.303 . . . . 0.0 110.886 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -65.71 -28.32 68.97 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -72.29 -15.24 61.9 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.548 1.139 . . . . 0.0 113.391 173.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.0 m -97.98 4.79 49.35 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 169.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.9 mt -89.25 104.15 16.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.552 1.069 . . . . 0.0 108.511 169.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -67.76 -35.47 78.77 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.455 0.302 . . . . 0.0 111.707 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -170.68 156.53 5.28 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.477 1.911 . . . . 0.0 110.697 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -160.13 152.14 20.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.652 1.581 . . . . 0.0 110.587 -170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.61 166.14 37.16 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-O 122.504 1.058 . . . . 0.0 113.911 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -144.2 156.85 44.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.218 1.008 . . . . 0.0 112.295 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.46 179.93 6.06 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.309 1.444 . . . . 0.0 110.823 174.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -49.99 -32.42 15.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -141.58 24.98 2.04 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.587 1.555 . . . . 0.0 112.129 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.94 136.41 42.25 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.935 1.294 . . . . 0.0 110.821 -169.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -126.58 118.21 24.39 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.36 1.464 . . . . 0.0 109.288 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.3 t -130.86 151.67 51.03 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -150.62 152.1 33.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.038 0.935 . . . . 0.0 113.193 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -108.83 109.27 20.35 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.318 1.447 . . . . 0.0 109.417 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.7 m -95.96 135.33 37.86 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.817 1.247 . . . . 0.0 110.615 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.17 -178.72 49.66 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.248 1.404 . . . . 0.0 114.248 -178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -72.6 -4.11 28.86 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 -170.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 52.9 mmm-85 -116.45 63.27 0.71 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.821 1.648 . . . . 0.0 111.637 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 24.8 p -156.12 169.33 24.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.98 1.712 . . . . 0.0 111.907 175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -36.98 74.17 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.833 1.253 . . . . 0.0 113.484 -172.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.5 p -87.18 -8.73 56.6 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.844 1.258 . . . . 0.0 113.873 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.86 -174.19 46.62 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.264 0.935 . . . . 0.0 112.045 -169.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -67.05 131.56 46.09 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.203 -0.586 . . . . 0.0 111.058 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.78 164.76 34.51 Favored Glycine 0 N--CA 1.47 0.921 0 N-CA-C 115.265 0.866 . . . . 0.0 115.265 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.87 121.42 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.307 1.443 . . . . 0.0 108.302 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -117.64 129.3 55.66 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.11 1.364 . . . . 0.0 110.2 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -133.77 134.43 42.9 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.215 1.006 . . . . 0.0 112.994 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -134.85 141.03 46.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.833 1.253 . . . . 0.0 111.756 -171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -95.15 125.93 40.13 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.982 1.313 . . . . 0.0 109.941 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.5 p -170.32 130.87 0.93 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.371 1.469 . . . . 0.0 111.652 -174.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -67.83 -13.52 62.2 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -109.11 18.28 20.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.324 2.25 . . . . 0.0 113.243 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.17 -36.09 18.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.365 1.466 . . . . 0.0 114.617 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -62.64 -36.35 82.55 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 112.399 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.42 -34.54 70.41 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.797 -0.564 . . . . 0.0 111.172 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 18.0 mt -67.27 -47.51 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.198 0.599 . . . . 0.0 110.281 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.25 -43.41 98.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.4 1.08 . . . . 0.0 112.8 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.72 -45.3 79.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.805 -0.559 . . . . 0.0 111.647 176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.16 -40.85 98.75 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.608 0.64 . . . . 0.0 111.386 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.4 tp -56.17 -53.14 60.64 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.287 0.635 . . . . 0.0 111.536 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.89 -31.87 71.1 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.75 -38.76 83.91 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.931 0.892 . . . . 0.0 113.0 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.8 mt -71.68 -23.7 61.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 112.303 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 94.8 mtp -86.06 -33.61 20.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.172 0.989 . . . . 0.0 112.708 177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -81.86 -31.85 31.36 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.84 1.2 . . . . 0.0 113.207 172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.8 t 47.87 61.28 3.05 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.347 1.859 . . . . 0.0 112.721 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -141.48 152.17 43.96 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.345 1.458 . . . . 0.0 111.774 -169.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.2 p -72.69 103.7 3.7 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.735 1.214 . . . . 0.0 111.672 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.0 mm -134.7 138.22 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.931 2.092 . . . . 0.0 108.411 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -113.47 134.58 54.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.326 1.451 . . . . 0.0 110.799 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.89 143.58 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.435 1.494 . . . . 0.0 110.174 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 155.55 18.12 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.48 1.512 . . . . 0.0 111.414 -173.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.03 126.41 34.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 111.553 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.67 154.52 50.64 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.709 1.204 . . . . 0.0 110.993 171.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -71.18 164.62 35.13 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.563 2.842 . . . . 0.0 111.617 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -125.81 134.29 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.348 1.459 . . . . 0.0 108.933 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.17 130.24 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.673 1.589 . . . . 0.0 108.566 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.2 mm -77.29 131.12 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.803 0.841 . . . . 0.0 110.408 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.7 p -113.15 157.5 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.182 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.7 m -108.17 121.7 45.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.398 1.079 . . . . 0.0 111.427 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -94.8 -174.94 38.23 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.004 1.288 . . . . 0.0 113.084 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -93.61 122.7 36.32 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.973 0.909 . . . . 0.0 110.426 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -79.9 123.31 27.66 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.044 -1.035 . . . . 0.0 112.094 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.83 168.29 33.16 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.735 1.16 . . . . 0.0 113.513 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 32.2 p -166.23 128.97 1.96 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.796 1.239 . . . . 0.0 111.403 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.8 t -80.21 3.89 19.3 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.033 1.333 . . . . 0.0 113.654 177.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 112.63 173.41 19.01 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.414 1.959 . . . . 0.0 113.394 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.5 m -147.18 158.71 44.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.924 1.69 . . . . 0.0 109.964 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -107.0 175.45 5.5 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 121.131 -0.981 . . . . 0.0 112.498 -178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -76.72 124.31 7.03 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.459 1.028 . . . . 0.0 111.205 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.4 m -147.9 129.25 14.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.851 1.26 . . . . 0.0 110.445 -175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 4.4 t -91.5 -6.4 52.64 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.19 -138.02 2.5 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.701 1.62 . . . . 0.0 112.567 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.75 151.48 47.37 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.287 1.035 . . . . 0.0 112.077 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -104.81 118.77 37.37 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.016 1.326 . . . . 0.0 110.511 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -83.12 122.66 28.66 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.756 1.222 . . . . 0.0 110.888 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 99.1 mt -83.18 148.14 27.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.943 0.897 . . . . 0.0 112.134 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -81.33 -25.32 36.5 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.884 1.274 . . . . 0.0 113.493 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -137.07 148.96 47.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.282 1.833 . . . . 0.0 111.841 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -78.41 128.68 77.1 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.852 0.861 . . . . 0.0 111.486 -172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -86.57 -21.0 2.41 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.492 2.795 . . . . 0.0 114.469 -169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 71.3 m -95.26 142.9 27.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.197 0.999 . . . . 0.0 112.053 -175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.79 -36.49 36.76 Favored Glycine 0 CA--C 1.533 1.177 0 O-C-N 122.069 -0.395 . . . . 0.0 113.065 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -86.79 67.35 9.8 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.597 -0.943 . . . . 0.0 112.658 -172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.71 136.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.588 1.155 . . . . 0.0 110.663 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -139.32 152.94 47.61 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.384 2.274 . . . . 0.0 109.941 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -109.67 150.54 28.11 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.183 1.393 . . . . 0.0 112.059 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.29 -125.38 0.87 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.165 1.364 . . . . 0.0 112.506 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.12 142.83 55.65 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.911 -0.758 . . . . 0.0 112.318 176.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -156.61 166.63 32.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.695 1.598 . . . . 0.0 111.227 178.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -96.74 114.37 26.01 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.21 1.404 . . . . 0.0 108.968 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.262 1.425 . . . . 0.0 113.991 176.625 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t 67.44 26.1 8.39 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.241 1.416 . . . . 0.0 113.403 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -75.71 152.48 37.47 Favored 'General case' 0 CA--C 1.545 0.788 0 O-C-N 120.245 -1.534 . . . . 0.0 113.365 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.9 169.78 36.53 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.372 1.463 . . . . 0.0 113.104 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.7 p -87.65 -11.99 46.81 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -93.89 131.87 38.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.743 1.217 . . . . 0.0 111.175 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.94 -159.24 20.34 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.341 1.448 . . . . 0.0 113.055 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.8 mt -142.4 159.96 41.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.239 1.816 . . . . 0.0 111.134 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -141.43 151.15 43.17 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.949 1.7 . . . . 0.0 110.654 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -137.75 115.48 11.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.369 1.467 . . . . 0.0 109.178 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -161.83 137.93 7.88 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.476 1.51 . . . . 0.0 110.115 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -84.06 -12.95 54.31 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.0 t -86.13 119.09 71.45 Favored Pre-proline 0 N--CA 1.477 0.879 0 O-C-N 120.959 -1.088 . . . . 0.0 110.372 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.82 149.74 78.39 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.682 2.922 . . . . 0.0 112.036 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -68.68 -8.43 42.44 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.46 30.72 3.81 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.581 1.953 . . . . 0.0 111.022 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -43.87 131.29 4.14 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 125.026 1.33 . . . . 0.0 113.352 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.52 -15.4 19.66 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.138 2.559 . . . . 0.0 115.71 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.6 p -133.44 -20.73 2.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 120.567 1.53 . . . . 0.0 114.857 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -97.93 140.46 32.25 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.047 1.339 . . . . 0.0 110.127 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -141.98 126.12 17.42 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.494 1.118 . . . . 0.0 110.9 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.94 130.05 41.91 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.416 0.687 . . . . 0.0 109.722 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -138.93 147.92 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.485 1.114 . . . . 0.0 111.449 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.4 m -121.69 114.86 21.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.366 1.067 . . . . 0.0 108.803 177.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.52 139.12 45.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.886 0.474 . . . . 0.0 110.512 175.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -135.52 154.09 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.772 0.829 . . . . 0.0 112.307 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -82.1 -174.95 5.39 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.132 0.973 . . . . 0.0 113.491 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.45 -13.41 40.04 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 114.169 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -108.91 1.98 21.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.22 1.808 . . . . 0.0 112.606 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.66 13.94 80.67 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.148 1.356 . . . . 0.0 114.8 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.3 t -74.14 131.68 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 118.845 1.322 . . . . 0.0 109.551 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.03 113.93 4.82 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.952 1.301 . . . . 0.0 110.985 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -93.46 -50.33 5.49 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.075 0.95 . . . . 0.0 111.644 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.26 159.92 33.28 Favored Glycine 0 N--CA 1.465 0.57 0 C-N-CA 125.56 1.552 . . . . 0.0 112.35 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -124.81 137.48 54.31 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.476 0.71 . . . . 0.0 111.391 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.39 -178.28 16.4 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.158 1.837 . . . . 0.0 112.958 -176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.0 112.81 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.859 0.863 . . . . 0.0 108.808 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.6 ttm -81.51 135.99 35.61 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.472 1.109 . . . . 0.0 109.497 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -131.63 123.62 28.22 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.746 1.619 . . . . 0.0 109.431 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.65 109.74 21.77 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.2 p -94.33 173.62 7.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.355 1.062 . . . . 0.0 110.583 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -76.11 -1.99 28.77 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.2 m -111.84 -41.93 3.91 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.296 1.038 . . . . 0.0 113.295 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -166.96 168.37 13.94 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.004 1.722 . . . . 0.0 112.211 -175.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.62 135.34 36.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.38 151.4 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.685 1.594 . . . . 0.0 109.074 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.52 116.4 8.28 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.467 1.107 . . . . 0.0 109.708 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.84 128.49 35.34 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.029 1.732 . . . . 0.0 110.941 177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.0 mt -131.27 156.64 45.08 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.728 2.011 . . . . 0.0 110.003 -177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -108.98 -25.87 10.5 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -83.45 -54.08 5.23 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.025 1.33 . . . . 0.0 110.745 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -93.94 161.59 14.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.088 2.155 . . . . 0.0 110.405 175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.01 163.58 9.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.626 0.77 . . . . 0.0 111.733 168.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.18 148.24 52.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.504 0.722 . . . . 0.0 111.745 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.8 t -128.03 132.64 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.839 0.856 . . . . 0.0 111.404 -171.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -122.45 144.73 48.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.226 1.41 . . . . 0.0 112.511 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -139.46 116.85 8.57 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.283 1.433 . . . . 0.0 111.455 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.96 137.98 42.86 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.805 2.337 . . . . 0.0 110.759 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -63.08 -33.51 75.6 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.454 0.702 . . . . 0.0 112.833 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -66.52 -17.12 64.63 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 174.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 72.5 m -99.01 5.87 46.93 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -87.98 105.76 17.68 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.235 0.925 . . . . 0.0 108.895 169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 35.3 mtp-105 -72.63 -27.4 62.12 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.513 0.561 . . . . 0.0 112.513 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.5 ptt-85 -166.3 164.0 17.62 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.105 1.762 . . . . 0.0 110.977 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -154.98 149.17 25.99 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.09 1.756 . . . . 0.0 109.846 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.45 165.49 34.45 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 124.21 0.91 . . . . 0.0 112.731 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -146.97 143.97 28.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.645 0.736 . . . . 0.0 112.047 -174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -111.83 -171.4 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.366 1.467 . . . . 0.0 110.814 169.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.3 t -67.0 -17.28 64.85 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.798 -1.189 . . . . 0.0 113.961 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -152.14 15.42 0.63 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.803 1.641 . . . . 0.0 113.608 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -139.77 136.7 34.37 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.487 1.515 . . . . 0.0 109.966 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -123.12 131.48 53.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.136 1.374 . . . . 0.0 109.155 174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.5 t -143.37 151.27 40.23 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -149.77 155.62 40.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.522 1.129 . . . . 0.0 113.321 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.0 120.94 44.04 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.013 1.325 . . . . 0.0 109.059 176.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.3 p -109.56 131.6 54.91 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.715 1.206 . . . . 0.0 111.101 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.9 170.02 44.49 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.245 0.926 . . . . 0.0 113.543 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.4 ptt-85 -61.49 -14.15 26.77 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -102.66 76.06 1.48 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.908 1.683 . . . . 0.0 111.049 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.81 177.83 10.03 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.525 1.53 . . . . 0.0 112.262 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -60.04 -34.25 73.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.289 1.035 . . . . 0.0 113.367 -174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.4 p -97.26 -14.66 21.23 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.889 1.276 . . . . 0.0 113.799 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.71 -169.76 54.24 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.855 0.752 . . . . 0.0 111.857 -168.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -62.74 131.36 48.64 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.077 0.951 . . . . 0.0 112.724 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -177.83 168.56 40.08 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.044 0.777 . . . . 0.0 115.044 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.8 mt -116.83 118.5 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.516 1.527 . . . . 0.0 106.983 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -112.61 143.27 44.07 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.466 1.107 . . . . 0.0 110.004 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.43 139.82 30.12 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.779 0.832 . . . . 0.0 112.032 -174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.81 131.73 31.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.113 -171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -80.49 132.48 35.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.069 0.548 . . . . 0.0 109.756 170.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 14.9 p -171.26 131.03 0.75 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.768 1.627 . . . . 0.0 110.774 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 m -68.74 -17.12 64.0 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.5 mtt-85 -102.36 23.34 11.92 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.704 1.601 . . . . 0.0 113.165 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.01 -35.5 46.98 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.618 1.167 . . . . 0.0 113.576 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -55.11 -51.03 67.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.543 1.537 . . . . 0.0 111.652 169.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.95 -37.66 78.97 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.234 -0.917 . . . . 0.0 111.59 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.35 -49.32 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.255 0.622 . . . . 0.0 110.142 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -60.6 -43.26 97.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.112 0.965 . . . . 0.0 112.485 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -64.9 -48.51 73.94 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.242 0.474 . . . . 0.0 112.075 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 63.9 tp -61.0 -40.32 93.09 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.288 0.635 . . . . 0.0 111.434 177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.14 -54.48 46.51 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.652 0.781 . . . . 0.0 111.687 175.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -66.52 -34.01 76.95 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.95 0.796 . . . . 0.0 112.398 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -62.74 -42.61 99.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.082 0.953 . . . . 0.0 112.068 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.3 mt -69.81 -31.54 69.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.984 0.914 . . . . 0.0 112.356 175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 85.3 mtp -82.26 -25.75 33.78 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.894 0.878 . . . . 0.0 113.295 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -91.58 -37.34 13.15 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.185 0.902 . . . . 0.0 113.12 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t 53.5 32.24 13.78 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 126.098 1.759 . . . . 0.0 114.432 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -160.14 161.82 33.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.5 1.52 . . . . 0.0 111.725 -170.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.5 m -76.89 90.32 3.51 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.182 -0.949 . . . . 0.0 111.442 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.4 mt -138.78 133.86 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.58 1.952 . . . . 0.0 108.003 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -139.53 29.32 2.17 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.804 1.241 . . . . 0.0 113.573 -169.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.2 m -60.53 146.7 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.858 1.663 . . . . 0.0 111.992 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 79.1 mtm -139.28 136.86 35.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.277 1.831 . . . . 0.0 110.787 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -143.38 150.37 39.01 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.878 2.071 . . . . 0.0 109.57 -176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.47 132.48 85.65 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.326 0.651 . . . . 0.0 110.91 176.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -73.86 152.72 47.23 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.308 2.672 . . . . 0.0 111.093 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.66 129.78 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.315 1.046 . . . . 0.0 108.782 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.8 mm -116.79 122.43 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.253 1.421 . . . . 0.0 108.963 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.45 153.89 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.148 1.779 . . . . 0.0 109.099 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -53.19 147.39 10.03 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.305 1.042 . . . . 0.0 111.116 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.6 t -52.49 -57.26 10.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.707 1.203 . . . . 0.0 113.866 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.15 1.02 24.64 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.305 0.955 . . . . 0.0 115.102 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 72.0 m -75.29 94.4 3.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.972 1.386 . . . . 0.0 112.249 -174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.9 t -74.89 -25.21 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.345 -0.847 . . . . 0.0 112.335 172.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 74.82 -165.98 54.81 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.184 1.373 . . . . 0.0 113.608 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 65.2 19.33 11.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.313 1.445 . . . . 0.0 114.837 169.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 34.1 t -64.73 -41.83 95.65 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 120.724 -1.235 . . . . 0.0 113.026 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 61.99 30.89 76.72 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.028 0.823 . . . . 0.0 113.726 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 m -53.03 129.97 32.41 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.985 1.714 . . . . 0.0 113.997 -169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 90.4 p -163.74 172.02 14.77 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.289 1.436 . . . . 0.0 111.603 -171.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.9 23.93 58.8 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.681 0.658 . . . . 0.0 113.984 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.7 m -136.42 137.16 40.18 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.333 1.453 . . . . 0.0 111.086 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.6 p -76.88 153.42 34.77 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.212 1.005 . . . . 0.0 111.641 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.84 -173.09 30.36 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.516 1.055 . . . . 0.0 113.251 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -65.92 164.27 15.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.611 1.964 . . . . 0.0 111.141 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -70.56 121.55 18.06 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.362 -0.836 . . . . 0.0 112.252 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -89.0 115.67 26.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.367 1.467 . . . . 0.0 110.332 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 74.8 mt -77.72 151.84 33.96 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.805 0.842 . . . . 0.0 112.201 176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -71.03 -28.63 64.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.817 1.247 . . . . 0.0 113.528 175.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.83 175.9 10.29 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.274 1.83 . . . . 0.0 112.348 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.58 120.5 69.56 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.934 0.894 . . . . 0.0 111.126 -176.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -85.43 -26.08 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.869 2.38 . . . . 0.0 114.641 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 97.0 m -89.73 134.62 34.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.135 0.879 . . . . 0.0 112.081 -174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.17 -34.04 47.67 Favored Glycine 0 N--CA 1.475 1.285 0 O-C-N 121.752 -0.593 . . . . 0.0 113.588 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -81.12 58.76 3.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.449 1.099 . . . . 0.0 112.766 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.36 135.58 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.051 1.34 . . . . 0.0 110.503 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -139.69 149.54 43.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.166 1.786 . . . . 0.0 110.462 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -121.91 118.36 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.131 1.372 . . . . 0.0 110.439 -171.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.08 -95.54 1.46 Allowed Glycine 0 N--CA 1.47 0.961 0 C-N-CA 124.322 0.963 . . . . 0.0 112.181 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -59.65 145.45 44.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.133 0.573 . . . . 0.0 111.384 171.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -151.9 164.69 36.58 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.185 1.394 . . . . 0.0 110.443 -172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -162.89 155.99 19.51 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.008 1.723 . . . . 0.0 109.78 -171.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.77 2.028 . . . . 0.0 113.525 -175.092 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.95 179.42 7.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.74 1.616 . . . . 0.0 110.931 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.1 t -160.99 143.76 12.73 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.598 1.559 . . . . 0.0 111.171 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -173.32 147.76 9.81 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.549 1.071 . . . . 0.0 113.417 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -156.42 168.91 25.88 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.532 1.933 . . . . 0.0 110.367 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 m -127.1 125.07 40.62 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.263 1.025 . . . . 0.0 110.564 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.07 92.24 1.31 Allowed Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.208 1.385 . . . . 0.0 110.551 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -69.51 116.46 9.95 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.998 0.919 . . . . 0.0 109.593 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -112.32 159.46 18.64 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.435 1.494 . . . . 0.0 112.038 -171.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -62.72 -27.23 69.12 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.087 0.955 . . . . 0.0 113.289 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.12 136.38 34.02 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.481 1.112 . . . . 0.0 110.874 169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.0 m -74.54 64.9 1.22 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.559 1.544 . . . . 0.0 112.717 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.3 p -150.83 136.19 10.35 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 125.636 1.575 . . . . 0.0 110.75 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.08 145.45 39.51 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.076 2.518 . . . . 0.0 111.153 174.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -72.42 -2.65 20.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.832 1.253 . . . . 0.0 114.003 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.05 16.09 10.79 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.194 2.198 . . . . 0.0 113.506 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -47.97 134.47 11.56 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 124.626 1.171 . . . . 0.0 113.706 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.73 -17.65 42.35 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 124.221 3.281 . . . . 0.0 116.61 -172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 t -151.38 -27.12 0.2 Allowed 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.28 128.55 33.93 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.517 1.053 . . . . 0.0 110.344 169.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -134.17 123.09 23.77 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.818 1.247 . . . . 0.0 109.899 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -67.62 124.31 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 169.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.06 155.05 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.266 1.426 . . . . 0.0 110.172 -176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -136.09 119.45 16.81 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.036 0.934 . . . . 0.0 109.305 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.23 143.91 53.83 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.144 0.977 . . . . 0.0 111.313 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -136.6 149.68 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.16 176.08 2.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.21 1.404 . . . . 0.0 112.425 170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.02 -22.61 62.84 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.246 1.019 . . . . 0.0 113.082 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -89.88 -0.57 57.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.668 1.587 . . . . 0.0 113.242 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.11 8.86 87.25 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.662 1.125 . . . . 0.0 115.257 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.9 t -73.77 133.99 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.88 1.272 . . . . 0.0 110.268 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.64 117.43 11.23 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.688 1.195 . . . . 0.0 111.475 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.49 -57.7 2.51 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.4 1.08 . . . . 0.0 112.254 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.78 142.74 8.48 Favored Glycine 0 N--CA 1.466 0.668 0 C-N-CA 124.714 1.149 . . . . 0.0 112.825 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.0 p -93.2 156.9 16.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.743 1.217 . . . . 0.0 112.993 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.94 172.79 39.88 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.558 1.552 . . . . 0.0 113.437 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.6 108.18 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.048 0.939 . . . . 0.0 109.12 176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.9 ttm -80.57 141.03 35.47 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.817 1.247 . . . . 0.0 109.934 174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.57 132.49 20.19 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.894 1.678 . . . . 0.0 109.991 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -118.66 116.84 27.43 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.588 1.155 . . . . 0.0 109.371 -175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.5 p -104.02 174.21 5.97 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.407 1.083 . . . . 0.0 110.891 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -71.28 8.63 0.96 Allowed 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.01 -1.056 . . . . 0.0 112.75 170.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -128.17 -40.3 1.66 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.915 1.286 . . . . 0.0 113.785 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.19 172.53 14.66 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 120.547 1.521 . . . . 0.0 114.203 -175.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.15 130.72 34.83 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.796 1.238 . . . . 0.0 107.883 169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 t -126.05 148.27 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.947 1.699 . . . . 0.0 108.994 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.44 115.4 7.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.134 0.974 . . . . 0.0 109.653 178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -91.77 126.58 36.91 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.898 1.679 . . . . 0.0 110.523 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.5 mt -126.05 135.51 51.84 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.92 1.688 . . . . 0.0 110.677 -172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -66.99 137.45 56.51 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.891 . . . . 0.0 112.88 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 58.18 26.78 14.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.611 1.564 . . . . 0.0 113.525 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -147.03 173.27 12.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 127.139 2.176 . . . . 0.0 111.742 -171.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.16 161.75 27.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.426 1.09 . . . . 0.0 111.493 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.7 136.34 39.09 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.737 -0.602 . . . . 0.0 109.684 169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.15 132.06 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.814 1.246 . . . . 0.0 109.441 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -128.03 138.41 52.57 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.366 1.067 . . . . 0.0 112.481 -169.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.8 m-90 -134.45 113.44 12.12 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.513 1.525 . . . . 0.0 110.775 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.51 137.89 34.23 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.863 2.375 . . . . 0.0 110.855 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -60.27 -27.94 67.66 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.2 -17.28 60.92 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.198 . . . . 0.0 114.035 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.8 m -99.49 0.78 43.15 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 171.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -82.07 107.96 15.18 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.969 0.804 . . . . 0.0 109.519 171.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -74.0 -36.55 64.5 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.72 0.808 . . . . 0.0 111.932 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -159.67 158.72 31.98 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.738 1.615 . . . . 0.0 111.626 176.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -154.93 152.64 29.97 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.556 1.542 . . . . 0.0 110.465 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.22 168.55 40.5 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-O 122.527 1.071 . . . . 0.0 113.543 -169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -147.63 149.85 33.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.684 0.754 . . . . 0.0 111.662 -175.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.79 -174.07 3.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.45 1.5 . . . . 0.0 111.442 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 m -58.83 107.34 0.51 Allowed 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.303 -0.873 . . . . 0.0 112.084 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 55.94 26.05 9.39 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.707 2.003 . . . . 0.0 113.954 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.1 tp -135.55 134.53 39.51 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 111.189 -171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -125.94 131.74 52.23 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.14 1.376 . . . . 0.0 109.482 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 17.6 t -142.83 150.17 39.56 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -151.5 157.05 41.79 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.166 0.986 . . . . 0.0 112.669 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -116.62 121.61 42.21 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.171 1.789 . . . . 0.0 109.493 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 t -115.45 141.92 47.4 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.098 0.959 . . . . 0.0 110.927 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.59 175.73 43.39 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.215 0.912 . . . . 0.0 112.589 172.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -66.79 -7.5 21.81 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -86.88 41.06 0.94 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.086 2.154 . . . . 0.0 112.738 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.8 p -149.47 173.54 13.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.244 1.417 . . . . 0.0 112.512 -176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -61.36 -36.08 79.23 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.177 0.991 . . . . 0.0 113.039 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.1 p -89.47 -8.59 52.58 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.856 1.263 . . . . 0.0 113.654 -177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.55 -171.58 43.82 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 121.763 0.646 . . . . 0.0 111.724 -168.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -65.67 133.11 50.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.454 0.702 . . . . 0.0 111.363 -177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.67 168.63 36.95 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.94 120.81 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.726 1.61 . . . . 0.0 107.709 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -118.62 127.33 53.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.838 1.255 . . . . 0.0 109.908 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -129.88 138.96 51.23 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.279 1.032 . . . . 0.0 112.537 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -138.49 140.33 39.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.208 1.403 . . . . 0.0 111.559 -170.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -83.36 132.6 34.99 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.036 0.934 . . . . 0.0 110.078 169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.9 p -172.16 133.03 0.67 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.127 1.771 . . . . 0.0 111.048 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.5 t -70.21 -29.96 66.94 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.957 -1.089 . . . . 0.0 113.161 -176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.7 mtp85 -86.76 19.42 2.95 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.464 1.106 . . . . 0.0 113.617 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.87 -34.34 19.8 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -176.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -65.29 -35.4 80.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.31 1.044 . . . . 0.0 112.831 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.32 -38.99 75.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.779 0.832 . . . . 0.0 110.517 175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.2 mt -64.43 -46.41 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 122.758 0.423 . . . . 0.0 110.131 175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.18 -49.25 77.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.096 0.958 . . . . 0.0 112.539 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -62.52 -47.62 83.12 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.211 0.604 . . . . 0.0 111.86 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.6 tp -62.98 -41.94 99.7 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.36 0.664 . . . . 0.0 111.544 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.9 tp -56.42 -52.13 65.79 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 123.467 0.707 . . . . 0.0 111.963 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 13.8 pt20 -69.27 -35.12 75.73 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.257 0.48 . . . . 0.0 112.28 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -62.35 -42.55 99.48 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.306 1.042 . . . . 0.0 112.142 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -73.15 -30.97 63.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 102' ' ' GLN . 9.9 ptp -84.02 -26.36 29.19 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.2 -35.99 25.02 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.346 0.976 . . . . 0.0 112.813 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.256 16.0 p 45.77 17.64 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 128.868 2.867 . . . . 0.0 117.48 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -74.21 -37.63 63.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.818 1.247 . . . . 0.0 113.556 -171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.7 p -170.46 164.86 8.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.025 1.33 . . . . 0.0 111.763 -169.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.6 mt -84.25 -15.7 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 124.749 1.22 . . . . 0.0 112.652 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -52.12 129.05 26.57 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.146 1.778 . . . . 0.0 113.015 -178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.8 p -159.5 144.66 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.03 1.732 . . . . 0.0 110.097 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 77.7 mtm -77.88 144.43 36.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.124 0.97 . . . . 0.0 112.379 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -80.15 71.68 6.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.509 1.123 . . . . 0.0 110.279 174.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -68.27 145.76 97.62 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.297 1.039 . . . . 0.0 111.405 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.82 135.98 34.3 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.392 2.728 . . . . 0.0 111.27 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.24 131.02 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.46 1.104 . . . . 0.0 109.653 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.9 mm -122.82 116.69 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.392 1.477 . . . . 0.0 109.544 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 79.6 mt -137.2 136.27 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.139 1.776 . . . . 0.0 108.383 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.1 p -136.8 156.66 48.21 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.606 1.562 . . . . 0.0 111.089 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 4.8 t -85.31 48.02 1.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.537 1.135 . . . . 0.0 112.315 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -113.35 10.82 24.15 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 126.123 1.82 . . . . 0.0 115.26 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.0 t -74.46 147.52 41.87 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 118.706 1.253 . . . . 0.0 112.922 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.5 t -165.13 164.79 20.22 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.968 1.707 . . . . 0.0 111.198 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 154.78 155.27 7.21 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.419 1.485 . . . . 0.0 113.428 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.5 t -167.06 176.16 7.07 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.731 1.612 . . . . 0.0 111.173 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 71.7 m -88.01 100.62 13.06 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.271 1.029 . . . . 0.0 111.116 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -89.9 -160.84 36.91 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.0 1.286 . . . . 0.0 112.969 175.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.7 m -73.49 124.14 25.27 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 122.011 -0.699 . . . . 0.0 110.767 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.3 t -84.1 70.27 10.49 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 121.12 -0.987 . . . . 0.0 111.839 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.65 101.02 1.04 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.416 1.484 . . . . 0.0 112.59 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.9 t -162.84 136.87 6.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.836 1.654 . . . . 0.0 110.211 168.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.3 p -90.17 1.92 55.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.851 1.26 . . . . 0.0 113.358 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 172.43 -137.05 4.04 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.499 1.047 . . . . 0.0 113.331 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.6 mt -116.41 138.23 51.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.668 1.587 . . . . 0.0 108.388 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 130.22 42.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 122.791 0.436 . . . . 0.0 111.296 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -102.53 108.3 19.56 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.211 1.404 . . . . 0.0 109.659 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.97 145.25 42.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.839 0.855 . . . . 0.0 110.655 176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.0 mtt85 -80.47 -28.87 37.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.044 0.938 . . . . 0.0 113.025 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.85 148.96 50.93 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.501 1.92 . . . . 0.0 111.696 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -78.45 126.35 83.18 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.288 -174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -88.1 -28.05 0.45 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.952 2.435 . . . . 0.0 114.735 -168.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 85.5 m -88.99 138.21 31.62 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 111.923 -173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.72 -36.61 53.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.857 -0.527 . . . . 0.0 113.651 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -83.17 61.72 6.23 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.405 -1.056 . . . . 0.0 112.819 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.77 135.82 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.86 1.264 . . . . 0.0 110.921 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -140.23 156.2 46.59 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.533 1.933 . . . . 0.0 109.918 169.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -112.17 140.84 46.53 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.247 1.419 . . . . 0.0 112.504 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -89.91 -135.7 5.97 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.521 1.058 . . . . 0.0 113.249 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.24 148.33 11.6 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.769 1.228 . . . . 0.0 112.318 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.76 162.04 41.57 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.966 1.306 . . . . 0.0 111.177 -172.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -127.53 134.93 49.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.248 1.819 . . . . 0.0 108.41 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.75 2.02 . . . . 0.0 112.902 -172.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -157.03 150.31 24.05 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.36 1.464 . . . . 0.0 110.251 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.5 m -73.86 -52.08 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.361 -0.837 . . . . 0.0 113.126 -172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.64 164.78 9.9 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.225 0.917 . . . . 0.0 113.13 -170.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.5 m -134.38 96.59 3.63 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.087 0.955 . . . . 0.0 110.436 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.1 m -71.74 -16.43 62.21 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.59 143.97 5.65 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.526 1.536 . . . . 0.0 111.695 -170.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.562 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -72.41 134.17 45.26 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.425 0.69 . . . . 0.0 109.768 172.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -154.21 -56.49 0.11 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -169.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 68.97 0.67 2.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.696 1.999 . . . . 0.0 115.179 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -85.73 -1.89 57.66 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.652 -1.28 . . . . 0.0 113.938 -176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.6 p -157.15 165.98 34.5 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.682 1.593 . . . . 0.0 111.182 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 43.5 t -147.12 129.09 7.51 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 125.084 1.354 . . . . 0.0 109.318 -172.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.0 151.25 61.82 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.469 2.78 . . . . 0.0 112.61 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -71.93 6.5 2.04 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.958 1.703 . . . . 0.0 113.746 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -142.0 20.0 2.12 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.364 2.266 . . . . 0.0 112.781 -174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -49.31 139.24 14.15 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.961 1.304 . . . . 0.0 113.115 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.28 -21.51 23.17 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.36 2.706 . . . . 0.0 115.783 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.3 p -132.16 -19.78 2.49 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.843 1.201 . . . . 0.0 113.989 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -98.81 150.55 21.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.548 1.539 . . . . 0.0 111.481 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -143.53 115.95 8.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.231 1.412 . . . . 0.0 110.368 -170.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -64.0 125.68 25.21 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.091 0.956 . . . . 0.0 110.622 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.37 160.93 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.419 1.488 . . . . 0.0 111.525 -173.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -139.84 120.18 13.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.592 1.157 . . . . 0.0 109.208 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -67.56 139.61 56.93 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.512 0.725 . . . . 0.0 111.077 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.95 155.48 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.54 -172.5 4.21 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.44 1.496 . . . . 0.0 112.761 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.6 -27.82 69.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.908 1.283 . . . . 0.0 114.101 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -91.72 -0.37 57.55 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.815 1.246 . . . . 0.0 113.208 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.36 19.52 71.5 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 121.207 -0.933 . . . . 0.0 114.624 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.2 t -77.04 130.6 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.368 1.467 . . . . 0.0 109.474 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -65.17 114.81 4.93 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.778 1.231 . . . . 0.0 111.231 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.7 mt -96.03 -55.97 2.8 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.939 0.896 . . . . 0.0 111.537 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.73 134.2 4.26 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.525 1.06 . . . . 0.0 113.147 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.6 p -82.16 150.75 27.26 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 112.256 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.71 -178.46 37.36 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.647 1.594 . . . . 0.0 112.801 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -127.31 111.85 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.499 0.72 . . . . 0.0 109.883 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 tpp -77.86 138.51 38.97 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.04 1.336 . . . . 0.0 109.252 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.23 129.51 29.58 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.886 1.274 . . . . 0.0 110.117 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.56 118.67 33.78 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.106 0.962 . . . . 0.0 109.206 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -107.94 175.48 5.47 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.97 1.308 . . . . 0.0 110.37 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -75.57 0.12 18.48 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 73.2 m -112.29 -43.71 3.49 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.312 0.96 . . . . 0.0 113.128 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.45 170.0 21.88 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 0.0 113.006 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.21 134.67 35.65 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 168.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.3 t -126.32 147.28 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.985 1.714 . . . . 0.0 109.02 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.38 117.05 14.96 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.212 1.005 . . . . 0.0 109.393 175.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -91.98 131.68 37.09 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.242 1.817 . . . . 0.0 111.268 173.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.67 145.33 49.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.588 1.555 . . . . 0.0 109.643 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -66.45 120.79 13.97 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.861 0.864 . . . . 0.0 112.404 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 51.94 56.39 7.86 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.717 2.007 . . . . 0.0 112.385 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -158.3 163.35 37.46 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.545 2.338 . . . . 0.0 110.628 -169.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -70.52 151.61 44.89 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.661 0.784 . . . . 0.0 111.04 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.1 136.43 35.18 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.507 0.723 . . . . 0.0 110.738 171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.85 123.41 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.887 0.875 . . . . 0.0 110.393 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -103.56 138.74 39.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.778 1.631 . . . . 0.0 112.043 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -130.32 114.01 17.1 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 125.799 1.639 . . . . 0.0 110.127 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.53 134.85 36.99 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.354 2.036 . . . . 0.0 110.219 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -57.78 -33.15 68.22 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.78 -17.64 62.16 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.177 0.991 . . . . 0.0 113.509 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.7 m -93.01 -2.87 55.32 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 170.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.75 119.57 22.16 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.767 1.167 . . . . 0.0 108.924 169.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -73.89 -38.01 64.52 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -171.81 158.36 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.304 1.842 . . . . 0.0 111.111 -175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -155.66 154.66 31.92 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.707 1.203 . . . . 0.0 111.988 -171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.11 171.16 34.46 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 124.924 1.25 . . . . 0.0 113.535 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -152.07 132.58 13.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.172 0.989 . . . . 0.0 111.117 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.7 -173.91 2.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 111.018 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 m -56.43 111.32 0.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.385 -0.822 . . . . 0.0 111.028 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 46.73 35.53 3.17 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.952 2.101 . . . . 0.0 115.489 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -143.13 136.74 28.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.07 1.348 . . . . 0.0 111.355 -174.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -126.38 131.88 51.66 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.985 1.714 . . . . 0.0 109.473 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.5 t -147.83 149.9 33.18 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.64 155.9 38.2 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.76 1.224 . . . . 0.0 113.733 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -107.04 119.4 39.28 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.603 1.961 . . . . 0.0 110.291 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 89.0 p -92.91 150.66 20.43 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.317 1.047 . . . . 0.0 112.899 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.84 158.22 36.58 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.46 1.029 . . . . 0.0 113.702 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -61.24 -10.27 6.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 -174.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -104.89 5.64 33.11 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.54 1.536 . . . . 0.0 114.736 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 60.7 m -66.72 169.36 8.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.241 0.928 . . . . 0.0 111.783 171.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.42 -30.43 70.56 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.666 -0.646 . . . . 0.0 112.249 172.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.2 p -91.17 -19.45 23.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.655 1.582 . . . . 0.0 113.283 176.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.65 -157.16 35.74 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.457 1.027 . . . . 0.0 111.667 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -82.91 131.57 35.19 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.079 0.952 . . . . 0.0 110.959 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 175.77 152.47 9.51 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.781 0.705 . . . . 0.0 114.092 175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.24 122.29 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 169.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -106.76 145.73 31.71 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.483 1.113 . . . . 0.0 110.052 172.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -145.11 135.9 24.55 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.852 0.835 . . . . 0.0 112.436 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -133.85 138.9 45.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.179 1.392 . . . . 0.0 111.67 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -97.88 122.71 41.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.557 1.543 . . . . 0.0 109.743 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.3 p -172.21 129.48 0.59 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.584 1.553 . . . . 0.0 111.144 -172.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.4 t -63.74 -30.79 71.85 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 120.854 -1.154 . . . . 0.0 112.732 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -77.99 10.07 3.16 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.644 1.978 . . . . 0.0 114.91 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.64 -36.62 25.15 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.116 1.366 . . . . 0.0 114.356 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.5 -41.91 90.95 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.56 1.144 . . . . 0.0 112.226 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.92 -34.5 69.13 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.62 -0.675 . . . . 0.0 111.418 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.72 -47.7 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.23 0.612 . . . . 0.0 109.876 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -63.73 -40.98 98.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.181 0.992 . . . . 0.0 113.18 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -64.25 -46.85 81.93 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.816 -0.552 . . . . 0.0 111.631 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.9 tp -62.23 -40.04 94.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 122.999 0.52 . . . . 0.0 111.602 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.07 -48.85 78.9 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.288 1.035 . . . . 0.0 112.923 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.98 -31.18 66.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -65.76 -38.84 90.17 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.597 0.759 . . . . 0.0 112.56 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.0 mt -73.36 -22.89 60.18 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.702 0.801 . . . . 0.0 112.579 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 30.5 mtt -77.29 -47.76 19.22 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.791 0.836 . . . . 0.0 112.158 169.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -82.42 -14.1 55.71 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.8 t -130.41 36.85 3.92 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.621 1.569 . . . . 0.0 111.549 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -58.23 142.99 45.94 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.461 1.104 . . . . 0.0 112.184 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.8 t -157.34 158.98 36.99 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.835 1.254 . . . . 0.0 111.227 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.4 mt -134.86 104.22 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.299 1.439 . . . . 0.0 108.887 -176.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -167.73 129.53 1.52 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 109.629 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.32 111.01 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.745 0.818 . . . . 0.0 109.351 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -146.63 140.55 26.12 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.126 1.771 . . . . 0.0 110.56 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.19 163.62 14.2 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.316 1.447 . . . . 0.0 112.634 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.13 154.71 31.25 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.667 1.587 . . . . 0.0 110.891 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.0 159.94 37.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.43 2.753 . . . . 0.0 111.484 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.3 t -133.87 130.79 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.188 1.395 . . . . 0.0 108.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.74 122.74 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 125.271 1.428 . . . . 0.0 107.793 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.1 mt -106.82 74.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.2 1.0 . . . . 0.0 109.032 -171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.6 m -75.71 43.35 0.25 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.774 2.03 . . . . 0.0 112.115 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.9 t -71.56 -20.97 61.95 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -169.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 60.05 -140.74 47.91 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.595 1.093 . . . . 0.0 113.338 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.2 p -84.07 137.99 33.29 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.484 1.114 . . . . 0.0 111.092 169.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.4 t -160.54 153.61 21.57 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.931 -1.106 . . . . 0.0 111.556 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.27 -95.82 1.48 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.553 1.549 . . . . 0.0 111.552 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 7.8 t -162.67 -175.18 4.31 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.577 1.551 . . . . 0.0 111.042 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 26.2 m -161.29 143.15 11.88 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.76 2.024 . . . . 0.0 110.543 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.86 149.94 21.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.545 1.069 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 75.2 m -150.31 146.33 26.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.891 1.677 . . . . 0.0 110.24 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.3 t -157.77 133.74 9.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.259 1.024 . . . . 0.0 110.972 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.74 123.74 0.99 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.086 1.327 . . . . 0.0 111.586 -171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.6 p -87.61 111.29 21.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.025 0.93 . . . . 0.0 111.524 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.1 m -83.79 -10.48 58.06 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.33 178.1 50.74 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.045 1.307 . . . . 0.0 113.21 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.18 119.07 37.79 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.001 1.32 . . . . 0.0 109.084 172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -80.86 126.59 31.53 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.912 0.885 . . . . 0.0 111.016 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.36 117.09 29.56 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.227 1.011 . . . . 0.0 109.488 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -78.04 145.76 35.71 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.203 1.001 . . . . 0.0 110.456 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -73.06 -23.33 60.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.603 1.161 . . . . 0.0 113.796 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -138.62 171.14 14.79 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.033 2.133 . . . . 0.0 111.864 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -88.3 118.98 70.12 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.182 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -81.73 -16.7 8.89 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.5 2.8 . . . . 0.0 114.131 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 46.8 t -93.7 140.93 29.07 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.466 1.106 . . . . 0.0 112.154 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.66 -8.51 87.43 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.606 1.098 . . . . 0.0 114.464 176.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -109.44 134.47 51.82 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.794 1.638 . . . . 0.0 110.303 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.48 134.59 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.785 1.234 . . . . 0.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -131.87 159.14 39.46 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.924 1.69 . . . . 0.0 110.563 172.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.14 145.26 48.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.44 1.496 . . . . 0.0 111.326 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.91 -128.46 2.16 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.56 1.076 . . . . 0.0 112.316 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -55.54 139.82 42.76 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.574 1.15 . . . . 0.0 112.307 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -71.66 101.93 2.66 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.98 0.912 . . . . 0.0 110.072 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.36 67.23 1.07 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.028 1.731 . . . . 0.0 109.091 -170.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.433 1.093 . . . . 0.0 113.669 -179.426 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.884 -0.487 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -80.46 172.42 13.78 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.243 1.017 . . . . 0.0 112.59 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.9 p -154.38 154.99 34.22 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.74 -1.225 . . . . 0.0 112.603 -174.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.52 -156.02 8.71 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.34 1.447 . . . . 0.0 112.72 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.6 p -160.44 165.1 31.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.696 1.199 . . . . 0.0 112.31 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.3 t -162.56 -179.12 6.68 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.721 1.609 . . . . 0.0 110.718 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.5 -124.07 7.33 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.77 1.176 . . . . 0.0 111.221 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 pp -150.48 145.66 26.14 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.973 1.309 . . . . 0.0 111.728 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -152.01 158.69 43.42 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.624 1.97 . . . . 0.0 110.465 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -13.89 61.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -90.67 156.27 18.23 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.683 1.593 . . . . 0.0 112.907 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 t -85.07 -13.0 51.76 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 p -168.66 131.83 1.25 Allowed Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.785 2.034 . . . . 0.0 109.734 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.41 138.98 33.8 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.748 2.299 . . . . 0.0 110.262 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.45 -14.55 63.03 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -107.5 18.39 21.56 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.695 1.998 . . . . 0.0 113.454 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -45.37 132.43 5.97 Favored Pre-proline 0 CA--C 1.561 1.376 0 C-N-CA 124.784 1.234 . . . . 0.0 113.601 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.5 -19.41 42.77 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.933 3.088 . . . . 0.0 116.527 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -151.87 1.32 0.36 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -168.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -124.66 137.93 54.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.173 1.389 . . . . 0.0 110.256 169.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -139.25 122.24 16.72 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.1 0.96 . . . . 0.0 110.637 -171.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -65.65 128.7 37.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.205 0.602 . . . . 0.0 109.542 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -138.53 152.59 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.692 1.197 . . . . 0.0 111.514 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.0 m -130.47 115.67 17.14 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.152 1.381 . . . . 0.0 108.603 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -70.0 141.14 52.97 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.263 0.625 . . . . 0.0 110.829 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.38 153.69 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -83.31 -173.27 4.61 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.84 1.256 . . . . 0.0 112.749 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.16 -19.5 64.8 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -93.35 -0.71 56.52 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.781 1.232 . . . . 0.0 113.369 170.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.77 16.99 73.95 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.69 1.138 . . . . 0.0 115.114 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.89 136.01 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.737 1.615 . . . . 0.0 109.954 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.17 115.62 5.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.178 1.391 . . . . 0.0 111.352 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.1 mt -97.41 -51.57 4.11 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.879 0.871 . . . . 0.0 112.215 -177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.0 156.3 28.13 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.199 1.381 . . . . 0.0 112.44 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -125.45 153.5 43.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.867 0.867 . . . . 0.0 112.945 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.8 -173.85 32.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.4 1.476 . . . . 0.0 113.641 -176.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.67 112.99 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.057 1.343 . . . . 0.0 108.852 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.4 ttm -84.08 138.75 32.89 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.114 1.366 . . . . 0.0 110.039 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.42 133.93 26.56 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.647 1.579 . . . . 0.0 109.723 -173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.7 mp -118.77 122.59 42.78 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.716 1.206 . . . . 0.0 108.714 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 p -109.49 177.88 4.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.539 1.136 . . . . 0.0 110.863 -173.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -71.31 2.31 4.97 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 120.819 -1.176 . . . . 0.0 112.46 170.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.6 m -126.53 -37.92 2.14 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.89 171.02 18.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 120.431 1.469 . . . . 0.0 113.851 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.46 129.23 34.86 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 168.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -123.13 147.58 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.872 1.669 . . . . 0.0 108.914 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.65 115.87 9.92 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.231 1.012 . . . . 0.0 109.664 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -92.98 121.77 34.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.261 1.824 . . . . 0.0 109.795 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.5 mt -117.27 128.62 55.25 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 109.53 -174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -63.46 120.41 11.63 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -169.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 60.39 27.5 17.09 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.432 1.893 . . . . 0.0 112.805 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -135.25 171.8 13.92 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 109.82 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.44 150.6 46.05 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.55 -0.718 . . . . 0.0 110.929 172.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.83 152.62 29.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 111.394 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 37.3 t -126.87 130.39 71.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.851 0.86 . . . . 0.0 110.186 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -125.44 145.36 50.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.888 1.275 . . . . 0.0 112.306 -175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -134.57 113.89 12.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 110.403 173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.36 139.93 46.95 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.496 2.131 . . . . 0.0 110.01 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -62.4 -28.15 69.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.48 -17.11 62.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.707 1.203 . . . . 0.0 113.908 173.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 75.5 m -100.67 5.62 43.83 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.5 104.33 16.7 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.516 1.053 . . . . 0.0 108.532 169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -75.1 -35.9 61.72 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.487 0.315 . . . . 0.0 111.406 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -159.72 159.7 33.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.668 1.587 . . . . 0.0 111.833 175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -157.83 151.69 24.07 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.856 1.662 . . . . 0.0 110.615 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 170.12 41.44 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-O 122.083 0.824 . . . . 0.0 113.622 -170.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -151.83 142.67 22.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.52 0.676 . . . . 0.0 112.615 -171.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -115.18 176.4 5.08 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.928 1.691 . . . . 0.0 109.598 168.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.6 m -60.49 -11.73 7.76 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -169.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -152.04 16.63 0.66 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.663 1.585 . . . . 0.0 113.777 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.9 tp -142.77 127.59 18.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.842 1.257 . . . . 0.0 110.396 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -109.87 133.25 53.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.013 1.325 . . . . 0.0 109.347 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.1 t -142.26 149.73 39.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -150.14 158.82 44.56 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.009 0.924 . . . . 0.0 113.313 177.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.59 126.75 53.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.957 1.703 . . . . 0.0 110.574 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 76.0 p -102.96 146.91 27.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.933 1.293 . . . . 0.0 113.026 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.38 167.42 54.06 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.256 0.931 . . . . 0.0 111.635 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.78 1.94 7.59 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -117.31 63.11 0.73 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.199 1.8 . . . . 0.0 111.722 -176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.0 p -155.06 173.97 15.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.965 1.706 . . . . 0.0 111.44 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -58.53 -35.3 72.09 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.96 0.904 . . . . 0.0 113.264 -170.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.5 p -96.16 -5.54 40.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.927 1.291 . . . . 0.0 113.786 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.22 -170.76 49.68 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.139 0.876 . . . . 0.0 112.568 -169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -71.18 129.0 37.8 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.848 0.859 . . . . 0.0 110.587 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -178.14 -176.92 46.49 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.948 0.785 . . . . 0.0 113.507 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.17 130.45 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.054 1.342 . . . . 0.0 107.676 170.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -124.41 127.27 47.29 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.42 1.088 . . . . 0.0 109.999 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.32 138.79 52.55 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.157 0.983 . . . . 0.0 112.376 -175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -134.02 132.79 40.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.011 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -78.22 131.31 37.08 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.398 0.679 . . . . 0.0 109.679 171.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 p -170.28 132.78 1.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.736 1.614 . . . . 0.0 110.702 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.1 p -71.52 -6.65 42.19 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -122.22 25.39 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.906 1.683 . . . . 0.0 112.443 -177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.91 -33.64 17.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.557 1.543 . . . . 0.0 114.153 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.5 -38.47 87.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.529 1.131 . . . . 0.0 112.754 174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -76.12 -31.27 58.57 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.556 -0.715 . . . . 0.0 111.686 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.11 -48.17 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 118.703 0.683 . . . . 0.0 109.651 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -59.54 -46.79 87.86 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.948 0.899 . . . . 0.0 112.417 175.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.76 -48.54 80.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.349 0.66 . . . . 0.0 111.56 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.45 -40.22 93.68 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.585 0.754 . . . . 0.0 111.49 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.1 tp -59.1 -52.57 65.15 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.427 0.691 . . . . 0.0 111.861 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.18 -31.99 71.93 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.015 0.825 . . . . 0.0 112.63 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -64.13 -41.38 97.23 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.279 1.032 . . . . 0.0 111.911 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.2 mt -73.35 -31.07 63.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.277 1.031 . . . . 0.0 112.122 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.9 mtp -81.06 -24.79 37.57 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 108' ' ' ASN . 12.7 pt20 -83.26 -35.94 24.93 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.76 1.164 . . . . 0.0 112.142 169.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.3 t 55.4 33.22 20.41 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.694 1.598 . . . . 0.0 113.484 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 106' ' ' GLN . 90.8 m-20 -126.48 144.39 50.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.967 2.107 . . . . 0.0 110.542 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 p -78.62 25.35 0.26 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.363 1.865 . . . . 0.0 114.387 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -82.07 108.24 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.008 1.323 . . . . 0.0 108.74 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -73.44 143.8 46.55 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.274 1.03 . . . . 0.0 112.305 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.5 167.36 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.84 1.656 . . . . 0.0 110.937 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 91.6 mmm -60.22 120.17 9.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.579 1.151 . . . . 0.0 111.653 178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -84.11 64.52 8.26 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.891 1.276 . . . . 0.0 111.045 -173.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -73.17 152.02 90.34 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.661 1.184 . . . . 0.0 112.034 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -76.23 146.82 28.82 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 123.519 2.813 . . . . 0.0 111.196 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.57 130.02 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.905 0.882 . . . . 0.0 109.309 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.2 mm -121.2 128.68 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.73 1.612 . . . . 0.0 109.259 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 67.2 mt -132.67 128.22 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.164 1.385 . . . . 0.0 108.456 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.0 p -137.08 101.81 4.66 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.525 1.53 . . . . 0.0 109.53 -176.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.5 p -169.35 165.5 10.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.326 1.45 . . . . 0.0 111.817 -172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -90.87 -147.98 20.22 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.939 1.257 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.7 m -142.07 137.19 30.84 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.866 1.266 . . . . 0.0 110.899 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.8 p -95.24 162.38 13.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.051 1.34 . . . . 0.0 112.805 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -80.91 -179.53 53.07 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.406 1.003 . . . . 0.0 113.127 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.3 t -66.12 125.07 24.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.997 -0.708 . . . . 0.0 111.097 177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.4 t -166.03 170.68 13.3 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.401 1.48 . . . . 0.0 111.193 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.14 -158.33 29.08 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.23 1.395 . . . . 0.0 113.438 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.8 t -161.86 -176.0 4.99 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 110.887 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.0 t -160.64 144.1 13.47 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.41 1.484 . . . . 0.0 111.164 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 155.18 -156.42 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.51 1.053 . . . . 0.0 114.052 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -143.91 26.77 1.51 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.984 1.314 . . . . 0.0 112.051 -170.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.5 m -65.24 -22.08 66.82 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 73.83 -167.47 54.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.965 1.269 . . . . 0.0 113.816 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.9 136.87 57.72 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.987 1.715 . . . . 0.0 111.75 176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -116.57 125.25 51.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.171 1.388 . . . . 0.0 111.019 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -80.75 113.71 19.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 110.058 176.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.24 143.38 45.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.289 0.635 . . . . 0.0 110.019 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -71.58 -30.23 65.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.072 0.949 . . . . 0.0 113.295 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -139.95 157.25 45.99 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.504 1.922 . . . . 0.0 111.684 -178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -76.92 124.42 87.49 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.926 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.27 -37.28 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.847 2.365 . . . . 0.0 114.342 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.4 m -78.91 147.96 32.87 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.073 0.852 . . . . 0.0 112.919 -171.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -81.43 -42.01 9.59 Favored Glycine 0 N--CA 1.471 0.969 0 C-N-CA 123.921 0.772 . . . . 0.0 113.458 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -82.11 64.4 6.77 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.659 -0.906 . . . . 0.0 112.674 -173.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 63.9 t -68.43 134.34 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.97 1.308 . . . . 0.0 110.931 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -135.7 155.05 51.01 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.289 2.236 . . . . 0.0 109.394 169.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -109.6 144.08 38.43 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.888 1.275 . . . . 0.0 112.754 -168.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -88.68 -135.5 5.29 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.573 1.083 . . . . 0.0 113.323 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -62.52 149.29 43.38 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.133 0.973 . . . . 0.0 112.127 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -137.83 163.61 30.99 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.688 1.595 . . . . 0.0 110.079 -175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -128.6 42.69 3.27 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.396 1.478 . . . . 0.0 110.84 -171.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.311 1.444 . . . . 0.0 114.008 178.436 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.7 p -115.75 1.53 13.48 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t -81.08 -20.59 41.22 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.824 -1.173 . . . . 0.0 113.658 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.08 -162.21 53.63 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.779 1.181 . . . . 0.0 113.032 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 65.9 p -162.04 142.91 10.56 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.829 1.252 . . . . 0.0 111.991 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.1 p -171.39 166.87 6.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.103 1.761 . . . . 0.0 111.24 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.92 84.98 0.12 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 124.182 0.896 . . . . 0.0 112.635 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.8 93.91 8.68 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.624 1.17 . . . . 0.0 109.161 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -165.76 157.54 14.37 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.954 1.701 . . . . 0.0 110.914 -171.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -63.67 -16.29 60.62 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -127.34 154.22 45.22 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.164 1.786 . . . . 0.0 110.358 172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 t -64.05 -16.29 61.38 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.8 p -154.82 120.27 2.64 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.486 1.514 . . . . 0.0 111.065 172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.68 137.49 42.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.793 2.328 . . . . 0.0 110.42 173.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.81 0.3 13.59 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -109.12 3.72 22.23 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.759 2.024 . . . . 0.0 113.908 176.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -47.68 132.74 10.94 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -171.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.74 -17.7 52.57 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.831 3.688 . . . . 0.0 116.786 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.4 t -146.57 -23.99 0.42 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.79 89.17 7.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -85.88 117.37 24.69 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.994 0.918 . . . . 0.0 110.583 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -62.53 122.28 15.38 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.39 155.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.081 0.953 . . . . 0.0 111.69 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.6 m -137.88 120.32 15.98 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.502 1.121 . . . . 0.0 108.68 173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -68.49 142.05 55.4 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.563 0.745 . . . . 0.0 110.583 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.7 m -130.47 153.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.46 0.704 . . . . 0.0 112.61 -175.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -78.89 -175.08 4.31 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.305 1.042 . . . . 0.0 112.918 171.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.45 -11.51 60.88 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -102.36 -0.46 32.64 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.37 1.868 . . . . 0.0 112.676 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.25 15.37 74.48 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.892 1.234 . . . . 0.0 114.804 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -78.91 129.29 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.043 1.337 . . . . 0.0 109.94 -177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -59.41 124.47 20.14 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.746 1.218 . . . . 0.0 111.789 177.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -106.37 -68.35 0.88 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.348 1.059 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -139.0 140.4 10.93 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 124.683 1.135 . . . . 0.0 112.678 -176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -90.28 153.36 20.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.076 1.35 . . . . 0.0 112.967 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.21 176.13 40.2 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.307 1.432 . . . . 0.0 113.644 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 77.2 t -120.75 114.52 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.937 1.295 . . . . 0.0 109.001 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.2 ttm -87.99 146.54 25.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.652 1.181 . . . . 0.0 110.22 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -147.25 132.76 18.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.789 1.635 . . . . 0.0 110.118 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -118.41 118.41 31.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.483 1.113 . . . . 0.0 108.51 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -103.46 173.92 6.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.182 . . . . 0.0 110.387 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.48 -8.94 21.81 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 120.877 -1.139 . . . . 0.0 112.359 170.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.7 m -109.83 -40.62 4.74 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -164.18 172.89 13.06 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 120.534 1.515 . . . . 0.0 114.826 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.99 132.66 35.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.643 1.177 . . . . 0.0 107.977 168.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.75 147.27 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.053 1.741 . . . . 0.0 109.056 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.22 123.73 17.08 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.389 1.076 . . . . 0.0 109.444 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -105.29 124.74 50.06 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.841 2.057 . . . . 0.0 110.006 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.85 146.14 46.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.764 1.225 . . . . 0.0 110.535 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -70.65 124.25 23.82 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.708 0.803 . . . . 0.0 112.609 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 51.27 53.3 13.15 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.561 1.944 . . . . 0.0 112.318 -176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -157.65 162.83 38.67 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 128.528 2.731 . . . . 0.0 109.57 -170.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -73.03 152.07 41.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.183 0.593 . . . . 0.0 110.476 169.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.57 147.31 37.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.021 0.528 . . . . 0.0 110.604 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 t -119.09 136.26 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.701 1.201 . . . . 0.0 109.62 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -127.91 139.17 52.76 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.082 1.353 . . . . 0.0 111.796 -171.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -135.89 113.18 10.68 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.26 1.424 . . . . 0.0 110.924 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.37 139.82 46.55 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.02 -31.65 72.06 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.554 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -67.61 -14.7 63.16 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.8 m -103.66 11.53 35.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.358 1.063 . . . . 0.0 113.659 169.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 89.6 mt -97.55 103.56 15.51 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.75 1.159 . . . . 0.0 109.629 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -78.52 -34.22 47.46 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 118.546 -0.74 . . . . 0.0 112.264 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -154.55 153.62 31.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.138 0.975 . . . . 0.0 113.314 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -161.65 146.93 13.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.505 1.922 . . . . 0.0 110.803 -170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.92 169.74 33.08 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.102 1.334 . . . . 0.0 113.163 -173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -155.57 138.34 15.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 113.415 -174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -106.56 -178.12 3.56 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.034 1.734 . . . . 0.0 109.893 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.4 m -67.91 -14.72 63.19 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.71 -1.244 . . . . 0.0 114.272 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -144.92 13.23 1.47 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.014 1.725 . . . . 0.0 113.188 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.28 128.77 14.99 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.963 -1.086 . . . . 0.0 110.706 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -112.16 134.28 53.8 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.572 1.149 . . . . 0.0 109.567 172.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.4 t -140.37 147.98 40.59 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.56 161.93 41.91 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -114.65 125.21 53.49 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.714 1.606 . . . . 0.0 108.981 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.0 p -96.31 132.44 41.8 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.271 1.028 . . . . 0.0 111.489 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.28 172.72 49.78 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.387 0.994 . . . . 0.0 112.921 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -63.03 -29.04 70.51 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -171.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -99.04 67.26 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.143 1.777 . . . . 0.0 111.902 -172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 22.5 p -153.79 170.46 20.9 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.072 1.349 . . . . 0.0 111.977 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -61.68 -37.08 82.77 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.076 0.951 . . . . 0.0 112.688 -173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 62.2 p -81.79 -15.56 53.82 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.505 1.122 . . . . 0.0 113.574 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.38 -165.14 53.64 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.59 1.091 . . . . 0.0 112.385 -170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -63.2 136.0 57.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.719 0.407 . . . . 0.0 111.566 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.16 178.37 44.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.637 0.637 . . . . 0.0 114.648 177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.5 mt -126.3 131.12 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.286 1.434 . . . . 0.0 108.11 174.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -128.11 138.94 52.73 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.892 1.277 . . . . 0.0 110.419 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.18 40.63 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.214 1.006 . . . . 0.0 111.863 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -139.27 137.51 35.95 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.882 1.273 . . . . 0.0 111.57 -172.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -87.8 125.09 34.25 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.335 1.054 . . . . 0.0 109.688 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 28.0 t -169.85 126.64 0.86 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.66 1.584 . . . . 0.0 110.799 -169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -63.4 -37.84 88.83 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.843 0.857 . . . . 0.0 112.473 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.7 mtm-85 -81.34 21.74 0.74 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.89 1.276 . . . . 0.0 114.099 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.97 -33.05 49.48 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.902 -1.124 . . . . 0.0 113.507 172.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -62.0 -41.86 98.52 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.215 1.006 . . . . 0.0 112.609 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -73.12 -37.38 66.69 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.708 0.685 . . . . 0.0 111.431 178.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.4 mt -58.94 -50.18 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 118.914 0.779 . . . . 0.0 110.101 173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -61.4 -46.94 88.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.909 0.884 . . . . 0.0 112.615 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -70.76 -30.5 67.01 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.6 tp -72.06 -44.21 63.68 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 111.671 170.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.0 tp -56.69 -47.11 80.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.347 1.059 . . . . 0.0 112.482 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -72.91 -27.88 62.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -41.05 64.35 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.238 0.472 . . . . 0.0 112.073 175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.3 mt -67.93 -23.7 65.1 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.212 0.605 . . . . 0.0 112.349 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 29.0 mtt -68.86 -31.68 70.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 169.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -98.88 -8.6 25.43 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -77.56 64.03 2.8 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 112.251 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -77.61 68.44 3.69 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.286 1.434 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 t 67.96 26.74 7.35 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.646 1.579 . . . . 0.0 112.714 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.2 mt -89.12 107.33 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.019 1.328 . . . . 0.0 109.275 -175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.89 129.36 39.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.591 0.756 . . . . 0.0 111.236 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.5 p -161.95 144.48 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.504 1.522 . . . . 0.0 110.332 -176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.04 149.63 43.04 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.973 0.909 . . . . 0.0 112.319 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.59 145.96 54.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 112.366 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -78.59 148.65 73.63 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.913 0.885 . . . . 0.0 111.522 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.87 156.04 61.18 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.558 2.839 . . . . 0.0 111.765 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 57.6 t -107.11 128.75 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.86 1.264 . . . . 0.0 109.249 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.12 142.5 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.81 1.644 . . . . 0.0 108.525 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.6 mt -71.49 106.41 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.552 -0.717 . . . . 0.0 109.47 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.9 m -144.1 141.75 30.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.075 2.15 . . . . 0.0 108.699 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 p -74.21 156.22 37.5 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.627 1.171 . . . . 0.0 114.145 -177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -100.62 172.34 23.8 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.225 1.393 . . . . 0.0 113.354 175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 70.6 m -76.86 139.85 40.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.146 0.978 . . . . 0.0 112.615 177.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.8 p -83.66 36.33 0.54 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 126.299 1.84 . . . . 0.0 113.359 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -63.2 140.63 45.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.331 1.443 . . . . 0.0 113.179 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.5 m -132.98 154.92 50.03 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -170.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.9 m -70.8 122.79 20.54 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.033 -1.042 . . . . 0.0 111.995 178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -104.41 -63.64 0.67 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.306 0.955 . . . . 0.0 112.817 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -164.15 144.19 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.881 1.272 . . . . 0.0 112.341 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 21.0 m -168.05 160.61 12.1 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.74 2.016 . . . . 0.0 110.718 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 154.28 -111.33 0.48 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 124.345 0.974 . . . . 0.0 111.699 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 19.7 m -69.26 -5.7 24.59 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.417 1.087 . . . . 0.0 113.921 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 73.3 m -132.12 139.79 48.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.324 1.85 . . . . 0.0 110.551 172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -111.0 -122.33 4.28 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.929 1.728 . . . . 0.0 112.139 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.3 mt -60.92 132.45 53.91 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.625 1.17 . . . . 0.0 111.809 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.54 125.48 32.45 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.496 1.118 . . . . 0.0 110.498 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -89.27 124.06 34.05 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.263 1.025 . . . . 0.0 109.661 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.5 mt -81.77 143.79 31.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.628 0.771 . . . . 0.0 111.357 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.3 mtm180 -76.58 -27.5 55.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.337 1.055 . . . . 0.0 113.319 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -134.35 162.46 32.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.911 2.084 . . . . 0.0 112.007 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -87.51 124.2 68.24 Favored Pre-proline 0 CA--C 1.552 1.056 0 CA-C-O 118.683 -0.675 . . . . 0.0 110.551 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -86.16 1.17 7.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.077 3.184 . . . . 0.0 115.493 -168.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.8 t -127.91 142.45 51.26 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.356 1.062 . . . . 0.0 112.135 -173.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -80.6 -26.19 54.76 Favored Glycine 0 N--CA 1.474 1.205 0 C-N-CA 123.666 0.651 . . . . 0.0 113.585 176.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -83.58 51.82 2.1 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.867 1.267 . . . . 0.0 112.895 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 53.4 t -69.59 134.56 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.699 1.6 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -131.54 162.06 31.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.319 2.248 . . . . 0.0 109.554 170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -122.78 148.52 45.27 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.974 1.31 . . . . 0.0 112.182 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.28 -140.67 4.71 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.486 1.041 . . . . 0.0 111.794 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -69.07 117.1 10.29 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.306 0.642 . . . . 0.0 110.741 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -150.12 157.11 42.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.169 1.787 . . . . 0.0 109.465 -173.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -94.81 109.73 21.67 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.49 1.116 . . . . 0.0 109.351 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.297 1.439 . . . . 0.0 114.034 178.226 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.7 p -163.93 167.06 21.06 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.199 1.4 . . . . 0.0 111.999 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.4 t -162.19 164.44 27.82 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.67 1.588 . . . . 0.0 110.567 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 77.11 45.66 11.33 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 123.97 0.795 . . . . 0.0 113.114 178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -153.78 176.87 11.62 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.019 1.328 . . . . 0.0 111.956 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 t -160.06 151.79 20.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.63 . . . . 0.0 111.334 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -139.83 -157.0 7.1 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.484 1.516 . . . . 0.0 113.888 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -154.13 140.01 18.18 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.445 1.498 . . . . 0.0 110.478 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -105.28 151.25 24.36 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.964 1.306 . . . . 0.0 112.058 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -72.79 -19.71 61.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.789 0.835 . . . . 0.0 113.155 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -120.44 124.65 45.97 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.602 1.961 . . . . 0.0 108.656 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 t -86.84 175.97 7.94 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.662 0.744 . . . . 0.0 112.801 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -159.86 119.88 1.69 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.069 1.747 . . . . 0.0 111.393 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.01 146.12 28.84 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.386 2.724 . . . . 0.0 109.444 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -66.25 -6.12 12.74 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -132.06 15.7 4.68 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.307 2.243 . . . . 0.0 113.447 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -42.15 121.04 2.45 Favored Pre-proline 0 CA--C 1.56 1.364 0 C-N-CA 125.477 1.511 . . . . 0.0 113.939 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -86.08 -13.6 5.42 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.14 2.56 . . . . 0.0 115.74 -169.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.0 p -131.32 -18.4 2.88 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.234 1.379 . . . . 0.0 114.623 -172.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -117.93 140.67 49.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.241 1.417 . . . . 0.0 110.139 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -137.8 119.86 15.53 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.532 1.133 . . . . 0.0 110.398 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.63 127.42 32.69 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -136.51 154.31 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.679 1.591 . . . . 0.0 111.015 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 95.5 m -132.11 117.73 18.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.193 0.997 . . . . 0.0 109.149 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -63.88 138.13 58.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.706 0.802 . . . . 0.0 110.658 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.49 153.31 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.533 0.733 . . . . 0.0 112.42 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.88 -174.13 4.86 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.626 1.17 . . . . 0.0 112.62 174.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.58 -25.63 68.32 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.399 1.08 . . . . 0.0 113.711 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.9 0.54 57.43 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.864 1.266 . . . . 0.0 113.377 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 16.38 71.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.551 1.072 . . . . 0.0 115.121 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.36 131.61 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.088 1.355 . . . . 0.0 109.747 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -64.45 120.18 11.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.181 1.392 . . . . 0.0 111.622 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.5 mt -101.93 -54.34 2.74 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.279 1.032 . . . . 0.0 112.2 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.93 146.37 11.69 Favored Glycine 0 N--CA 1.47 0.916 0 C-N-CA 124.631 1.11 . . . . 0.0 113.559 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.3 p -99.31 153.1 19.22 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.877 1.271 . . . . 0.0 113.531 -175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.56 179.17 38.79 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.094 1.807 . . . . 0.0 112.963 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.5 t -117.49 112.42 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.899 1.28 . . . . 0.0 109.176 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.9 ttm -82.85 142.07 31.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.252 1.421 . . . . 0.0 110.26 176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -140.79 129.96 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.611 1.565 . . . . 0.0 109.634 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.88 130.86 55.95 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.043 0.937 . . . . 0.0 109.321 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.1 p -125.27 157.46 36.55 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.469 1.507 . . . . 0.0 109.234 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -63.43 -8.95 10.4 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 121.31 -0.869 . . . . 0.0 113.072 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.7 m -96.93 -34.12 11.34 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -175.11 164.88 3.38 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.381 1.072 . . . . 0.0 113.672 -168.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.97 134.8 34.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.532 1.533 . . . . 0.0 109.134 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.6 t -129.32 150.72 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.808 1.643 . . . . 0.0 109.482 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.07 120.65 11.08 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.011 0.924 . . . . 0.0 110.527 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -100.72 128.82 46.62 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.042 2.137 . . . . 0.0 110.671 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.77 -51.59 2.03 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 20.6 t-80 -162.52 -147.51 0.13 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.224 1.41 . . . . 0.0 111.207 -175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 64.2 ttt180 -60.9 -34.48 74.72 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.856 1.262 . . . . 0.0 111.943 169.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -47.25 131.68 13.01 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.847 1.659 . . . . 0.0 110.351 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -55.7 144.16 28.07 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.608 0.763 . . . . 0.0 112.491 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.54 142.73 57.83 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.675 0.79 . . . . 0.0 111.675 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -95.44 121.04 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.489 1.116 . . . . 0.0 109.68 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -115.99 138.6 51.06 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.369 1.068 . . . . 0.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.9 m-90 -131.39 110.81 15.12 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.205 1.402 . . . . 0.0 110.178 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.33 143.21 63.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.583 2.188 . . . . 0.0 109.877 176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.2 m-30 -64.53 -24.51 67.63 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.04 -18.44 63.29 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 172.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -88.07 -11.48 46.99 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 120.108 1.322 . . . . 0.0 113.709 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -81.57 97.99 8.11 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.003 0.82 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -70.73 -35.95 72.94 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.402 0.681 . . . . 0.0 111.479 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -160.71 152.24 19.45 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.272 1.429 . . . . 0.0 111.928 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' CD1' HD23 ' A' ' 101' ' ' LEU . 54.3 p90 -154.86 152.19 29.49 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.534 1.534 . . . . 0.0 110.714 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.95 177.81 38.04 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-O 122.291 0.94 . . . . 0.0 114.646 -168.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -158.38 161.06 37.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 122.366 1.079 . . . . 0.0 112.927 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -133.58 -177.65 4.64 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.426 1.891 . . . . 0.0 110.929 170.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 45.8 m -64.61 -10.48 26.77 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -169.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -155.43 19.45 0.41 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.202 1.801 . . . . 0.0 113.078 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 tp -145.04 139.72 27.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.346 1.458 . . . . 0.0 110.347 -169.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -129.43 129.13 44.27 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.276 1.43 . . . . 0.0 109.116 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.4 t -140.57 151.5 44.76 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -176.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -155.04 154.6 32.73 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -107.86 130.48 55.0 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.017 1.727 . . . . 0.0 110.178 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -118.16 135.12 54.42 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.805 1.242 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.11 -177.05 45.12 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.577 1.085 . . . . 0.0 113.315 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.33 4.35 2.33 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -176.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -99.55 11.15 39.94 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 126.436 1.894 . . . . 0.0 114.128 -172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.7 p -120.38 177.61 4.97 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.033 1.333 . . . . 0.0 114.083 -170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -70.08 -21.35 63.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.308 1.443 . . . . 0.0 113.897 -172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 p -104.51 -9.36 18.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.24 1.416 . . . . 0.0 114.22 -176.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.86 177.86 49.92 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.115 0.864 . . . . 0.0 112.352 -169.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -66.63 129.55 40.24 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.324 0.65 . . . . 0.0 111.577 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 171.75 -171.57 44.17 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 115.303 0.881 . . . . 0.0 115.303 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.2 mt -127.63 142.65 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.329 1.851 . . . . 0.0 108.732 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -133.56 152.74 51.95 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.917 1.287 . . . . 0.0 110.882 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.53 143.46 31.55 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.84 0.829 . . . . 0.0 112.348 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -134.96 134.47 40.58 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.027 1.331 . . . . 0.0 111.512 -174.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -90.44 127.28 36.17 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.939 1.296 . . . . 0.0 109.708 178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 16.8 p -170.28 136.77 1.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.434 1.494 . . . . 0.0 111.184 -173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.1 p -72.62 -16.34 61.72 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.7 mtp85 -106.02 20.51 18.84 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.239 1.416 . . . . 0.0 112.817 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.74 -36.47 16.46 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.759 1.624 . . . . 0.0 114.581 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.42 -34.63 78.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.068 0.947 . . . . 0.0 112.665 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -75.38 -33.22 61.01 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.579 -0.701 . . . . 0.0 111.536 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.82 -48.67 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.553 0.615 . . . . 0.0 109.604 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.72 -46.14 91.57 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.979 0.912 . . . . 0.0 112.554 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -62.76 -46.65 87.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.283 0.633 . . . . 0.0 111.826 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 65.2 tp -63.86 -39.31 93.91 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.464 0.706 . . . . 0.0 111.493 177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.43 HD23 ' CD1' ' A' ' 65' ' ' TYR . 42.4 tp -59.15 -53.21 60.86 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.377 0.671 . . . . 0.0 111.77 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -65.12 -33.23 75.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.039 0.836 . . . . 0.0 112.227 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -67.45 -42.08 83.68 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.064 0.946 . . . . 0.0 112.123 177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.5 -25.64 59.49 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.551 -0.718 . . . . 0.0 112.358 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.1 mtp -80.31 -25.72 39.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.763 0.825 . . . . 0.0 113.103 174.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.66 -18.21 19.85 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.7 t -120.58 95.77 4.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.068 1.347 . . . . 0.0 110.769 177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.65 45.22 2.1 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.808 1.643 . . . . 0.0 110.804 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.6 t 72.97 21.15 3.31 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.04 1.736 . . . . 0.0 113.692 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.6 mm -118.42 137.36 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.221 1.808 . . . . 0.0 108.465 177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -77.56 -8.26 57.57 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.42 145.02 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.165 2.186 . . . . 0.0 110.139 -174.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.81 12.37 21.66 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -56.69 122.65 12.59 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.127 1.371 . . . . 0.0 113.251 -170.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -162.86 157.43 18.12 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.799 2.04 . . . . 0.0 110.36 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.99 156.17 38.61 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.168 2.579 . . . . 0.0 110.823 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 62.3 t -125.82 128.64 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.772 1.229 . . . . 0.0 108.989 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.38 121.89 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 108.52 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.1 mp -96.05 122.13 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.722 1.209 . . . . 0.0 108.7 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t -163.62 162.1 24.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.004 1.721 . . . . 0.0 110.478 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.0 t -153.9 20.27 0.52 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.275 1.43 . . . . 0.0 112.591 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.2 -1.02 90.48 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.936 1.255 . . . . 0.0 115.199 -174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.0 m -64.45 135.6 56.24 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.048 1.339 . . . . 0.0 112.882 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.6 t -163.64 161.86 23.91 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.181 1.392 . . . . 0.0 111.095 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.9 153.42 30.2 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.268 1.414 . . . . 0.0 113.624 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 33.4 t -168.06 148.91 5.06 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.579 1.951 . . . . 0.0 109.482 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m -157.68 137.21 12.04 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.934 -1.104 . . . . 0.0 112.392 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -80.02 82.34 1.45 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.404 1.002 . . . . 0.0 111.337 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.5 p -69.99 -14.03 62.51 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.784 1.234 . . . . 0.0 113.859 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 80.2 p -165.9 167.44 16.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.386 2.274 . . . . 0.0 110.551 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -166.09 167.07 39.09 Favored Glycine 0 N--CA 1.47 0.949 0 C-N-CA 124.373 0.987 . . . . 0.0 113.606 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.1 p -167.33 167.09 14.26 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.544 1.538 . . . . 0.0 111.645 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.6 p -79.37 152.72 30.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.343 1.057 . . . . 0.0 112.706 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 126.55 -130.86 7.16 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.842 1.21 . . . . 0.0 112.799 -177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.4 mt -50.89 135.37 24.39 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.581 1.952 . . . . 0.0 112.883 -173.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -78.94 119.78 22.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.546 -176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 122.59 24.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.37 1.068 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.97 147.67 24.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.41 1.484 . . . . 0.0 111.8 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -88.65 -28.3 20.71 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.709 1.204 . . . . 0.0 113.42 175.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -126.88 160.59 30.51 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.556 1.942 . . . . 0.0 112.395 -177.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -96.39 118.27 65.51 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.185 0.994 . . . . 0.0 110.998 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -89.08 -21.72 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.092 2.528 . . . . 0.0 114.735 -169.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 75.4 m -82.93 140.25 32.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.258 0.935 . . . . 0.0 112.55 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.78 -23.41 64.4 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.944 0.783 . . . . 0.0 114.841 -176.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -97.61 139.74 33.07 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.637 1.175 . . . . 0.0 110.108 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.1 t -141.24 130.59 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.932 1.293 . . . . 0.0 110.657 178.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -110.25 149.82 29.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.622 2.369 . . . . 0.0 109.04 167.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -98.96 132.96 43.88 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.987 0.915 . . . . 0.0 110.281 171.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -90.93 -130.32 4.6 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 124.87 1.224 . . . . 0.0 111.984 -175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -65.47 143.96 57.35 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.255 0.622 . . . . 0.0 111.355 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -144.72 149.16 35.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.722 1.609 . . . . 0.0 109.161 -169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -154.94 147.19 23.85 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.681 1.592 . . . . 0.0 109.549 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 126.117 1.767 . . . . 0.0 112.835 -173.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -164.83 174.15 10.94 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.575 1.55 . . . . 0.0 111.548 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 t -156.61 156.22 33.17 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.894 1.277 . . . . 0.0 111.035 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.68 124.98 6.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.148 0.88 . . . . 0.0 112.962 -174.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 t -167.69 154.62 8.2 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.554 1.942 . . . . 0.0 109.994 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.4 t -168.59 172.33 8.18 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.456 1.502 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.65 165.47 16.77 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.939 1.733 . . . . 0.0 113.756 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -166.64 150.47 7.17 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.998 2.119 . . . . 0.0 111.494 -176.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -165.65 144.59 6.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.083 1.353 . . . . 0.0 111.629 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -96.9 123.4 40.6 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.751 1.22 . . . . 0.0 109.549 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -163.73 176.88 9.15 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.396 1.878 . . . . 0.0 110.366 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -70.64 -173.18 0.72 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.864 1.266 . . . . 0.0 112.937 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.13 115.45 65.73 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -173.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.87 149.82 43.08 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.351 2.701 . . . . 0.0 111.066 170.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.99 -4.53 21.22 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.625 1.17 . . . . 0.0 113.766 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -122.77 11.65 9.75 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.632 1.973 . . . . 0.0 112.867 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -45.33 133.31 5.83 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.546 1.538 . . . . 0.0 113.58 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.68 -17.85 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.185 2.59 . . . . 0.0 116.028 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.8 p -130.22 -23.57 2.68 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.339 1.427 . . . . 0.0 114.042 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -93.19 147.32 22.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.17 0.988 . . . . 0.0 111.919 171.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -142.53 127.5 18.39 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 111.104 -176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -62.81 128.34 35.46 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.55 0.74 . . . . 0.0 109.777 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 m -139.39 149.94 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 124.421 1.089 . . . . 0.0 111.847 -175.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -128.34 117.38 21.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.416 1.487 . . . . 0.0 108.002 175.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -69.91 136.79 50.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.115 0.566 . . . . 0.0 110.692 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.65 151.36 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -83.77 -170.79 3.25 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 113.283 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.46 -17.89 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -96.47 -15.32 21.79 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.874 2.07 . . . . 0.0 111.05 176.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.2 18.91 44.32 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.42 1.486 . . . . 0.0 113.859 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 50.3 t -69.1 130.08 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 109.56 178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.64 111.01 5.81 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.448 1.099 . . . . 0.0 110.376 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.3 mt -93.16 -52.07 4.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.537 0.735 . . . . 0.0 112.097 -172.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.61 34.31 Favored Glycine 0 N--CA 1.465 0.613 0 C-N-CA 125.752 1.644 . . . . 0.0 112.123 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -127.04 153.67 45.65 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.934 0.873 . . . . 0.0 113.073 -170.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.11 -176.25 33.03 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 125.582 1.563 . . . . 0.0 112.995 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.06 110.46 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.825 1.25 . . . . 0.0 108.958 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.6 tpp -71.12 141.12 50.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.929 1.292 . . . . 0.0 109.451 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -138.62 140.27 38.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.109 1.764 . . . . 0.0 109.965 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.98 116.54 17.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.432 1.093 . . . . 0.0 108.677 -174.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -119.65 156.39 30.53 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.562 1.145 . . . . 0.0 109.448 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.63 -1.41 1.27 Allowed 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -95.7 -36.86 11.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 118.223 -0.894 . . . . 0.0 113.39 169.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -175.85 167.12 3.1 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 120.04 1.291 . . . . 0.0 113.587 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.42 137.25 34.76 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.03 1.332 . . . . 0.0 109.048 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -135.06 152.2 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.393 1.477 . . . . 0.0 109.294 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.37 122.86 11.05 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.427 1.091 . . . . 0.0 109.6 178.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -103.62 127.23 51.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.441 1.896 . . . . 0.0 111.188 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mp -128.11 162.77 26.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.331 1.453 . . . . 0.0 111.378 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -86.69 -43.47 12.57 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.29 -28.76 34.53 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.392 1.077 . . . . 0.0 113.042 -176.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.4 mtt85 -117.95 159.02 23.86 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.993 1.717 . . . . 0.0 110.678 -175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.74 157.45 30.16 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.137 0.575 . . . . 0.0 110.183 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 139.03 58.47 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.474 -0.766 . . . . 0.0 111.736 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.8 t -116.73 124.96 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 110.754 -171.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtm-85 -117.82 139.45 51.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.063 1.345 . . . . 0.0 111.811 -173.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -131.44 109.68 14.88 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.227 1.411 . . . . 0.0 110.584 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.69 140.81 63.52 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.552 2.168 . . . . 0.0 110.061 174.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.09 -26.73 68.34 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.98 -24.36 63.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.422 1.089 . . . . 0.0 113.174 172.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.0 m -85.96 -5.97 59.14 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.93 118.7 15.11 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.755 1.616 . . . . 0.0 109.77 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -35.18 56.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.684 0.793 . . . . 0.0 111.664 176.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -171.52 156.49 4.47 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 127.646 2.378 . . . . 0.0 109.889 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -152.04 151.27 30.92 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.742 1.217 . . . . 0.0 110.732 -174.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -165.56 178.42 40.42 Favored Glycine 0 CA--C 1.517 0.204 0 CA-C-O 122.387 0.993 . . . . 0.0 114.054 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -158.14 156.28 30.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.319 1.057 . . . . 0.0 112.606 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -130.91 -174.81 3.48 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.036 1.734 . . . . 0.0 110.837 171.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.6 t -60.93 -27.47 68.24 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -170.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -144.49 22.01 1.67 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.904 1.682 . . . . 0.0 112.518 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.5 tp -145.61 136.64 24.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.71 1.204 . . . . 0.0 110.468 -170.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -124.02 130.2 52.18 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.361 1.464 . . . . 0.0 109.151 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -144.33 151.85 39.91 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -155.61 155.47 33.34 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.608 1.163 . . . . 0.0 113.661 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -104.92 121.82 44.53 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.839 2.055 . . . . 0.0 109.484 177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.0 p -95.13 151.32 19.3 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.72 1.208 . . . . 0.0 113.758 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.63 157.76 42.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.556 1.074 . . . . 0.0 113.016 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.88 -1.35 5.42 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -170.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -116.97 3.46 12.8 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.761 1.624 . . . . 0.0 115.224 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.3 p -80.08 -178.63 6.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.718 0.807 . . . . 0.0 111.803 172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -60.61 -36.06 77.66 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.458 -0.776 . . . . 0.0 112.807 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.3 p -93.54 -10.11 35.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.989 1.315 . . . . 0.0 113.756 -176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.33 -163.36 54.83 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.936 0.779 . . . . 0.0 111.297 -168.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -76.73 125.91 30.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.496 0.718 . . . . 0.0 111.092 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.71 159.53 27.29 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.264 0.935 . . . . 0.0 113.935 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.8 mt -99.12 121.7 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 170.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.45 144.04 41.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.618 1.167 . . . . 0.0 109.687 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.69 134.61 33.84 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.802 0.81 . . . . 0.0 111.487 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -127.68 132.05 49.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.857 -174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -89.75 123.61 33.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.581 1.153 . . . . 0.0 109.686 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.6 p -169.64 129.33 1.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.197 1.399 . . . . 0.0 111.284 -171.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.7 m -68.89 -12.3 61.45 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 -101.2 13.5 34.92 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.354 1.861 . . . . 0.0 113.243 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.11 -34.76 32.01 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -63.57 -37.23 86.54 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 112.507 175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -70.53 -37.07 74.04 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.655 -0.653 . . . . 0.0 111.289 176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.3 mt -62.67 -49.34 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.076 0.55 . . . . 0.0 109.74 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.85 -45.59 93.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.945 0.898 . . . . 0.0 112.586 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.19 -47.06 84.18 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.952 0.501 . . . . 0.0 111.568 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.4 tp -63.41 -38.4 90.98 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.49 0.716 . . . . 0.0 111.456 178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 52.8 tp -58.19 -54.83 42.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.953 0.901 . . . . 0.0 111.679 175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.73 -27.75 67.07 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -70.32 -47.36 61.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.231 1.012 . . . . 0.0 111.87 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.7 mt -66.36 -27.41 67.86 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.091 -1.006 . . . . 0.0 112.097 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.5 mtp -79.75 -6.99 58.35 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.465 1.106 . . . . 0.0 113.781 175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.96 -17.58 6.7 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 93.2 m -127.56 39.18 3.93 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.032 1.733 . . . . 0.0 112.347 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -63.36 102.75 0.43 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.619 1.168 . . . . 0.0 111.686 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.1 t -95.02 61.38 2.48 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.699 1.599 . . . . 0.0 110.575 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 88.2 mt -57.74 -16.94 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.375 1.47 . . . . 0.0 113.487 -172.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -54.14 -30.44 49.0 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.67 1.588 . . . . 0.0 113.73 169.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.4 p -166.56 133.99 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.419 1.087 . . . . 0.0 112.128 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.6 150.42 24.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.93 1.292 . . . . 0.0 111.129 169.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -144.87 138.27 26.86 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.947 1.299 . . . . 0.0 110.523 -173.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.51 155.54 46.03 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.43 1.492 . . . . 0.0 112.116 176.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.11 161.94 20.46 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.701 2.934 . . . . 0.0 111.611 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.32 132.27 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.725 1.21 . . . . 0.0 109.583 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.9 mm -129.54 122.41 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.567 1.547 . . . . 0.0 108.595 -177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.8 mm -122.96 107.49 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.237 1.015 . . . . 0.0 109.883 -173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 40.6 p 40.0 50.92 2.52 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 128.139 2.576 . . . . 0.0 114.194 170.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 75.5 m -142.28 107.44 4.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.29 1.036 . . . . 0.0 112.489 -169.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.94 173.24 14.62 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.483 1.516 . . . . 0.0 113.277 172.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.6 t -163.66 141.86 7.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.312 1.445 . . . . 0.0 110.161 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -162.95 170.75 17.61 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.535 1.134 . . . . 0.0 112.605 -169.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 123.29 118.45 2.42 Favored Glycine 0 N--CA 1.47 0.927 0 C-N-CA 125.851 1.691 . . . . 0.0 111.052 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.0 p -172.72 179.13 2.46 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.89 1.676 . . . . 0.0 111.093 -169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.6 m -139.23 146.16 40.12 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.796 1.239 . . . . 0.0 111.277 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.65 149.69 38.71 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.152 0.882 . . . . 0.0 112.817 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.6 p -168.23 171.37 9.41 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.882 1.673 . . . . 0.0 111.112 -176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.8 t -151.93 115.58 4.85 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.019 -1.05 . . . . 0.0 111.475 176.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.17 164.82 38.89 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.817 1.199 . . . . 0.0 112.673 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.9 m -112.23 12.41 20.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.644 1.178 . . . . 0.0 113.127 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 88.4 p -162.67 176.13 10.66 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.478 1.511 . . . . 0.0 111.976 -172.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.38 -172.88 32.26 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.396 0.998 . . . . 0.0 113.317 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.0 mt -54.17 144.62 19.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.053 1.741 . . . . 0.0 110.949 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -75.89 123.28 25.43 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.723 -0.611 . . . . 0.0 112.379 -171.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 110.49 18.76 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.536 1.135 . . . . 0.0 110.587 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.33 144.57 40.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.207 1.003 . . . . 0.0 110.588 170.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -79.71 -30.01 40.86 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.133 0.973 . . . . 0.0 112.481 172.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -111.56 170.89 7.82 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.85 2.06 . . . . 0.0 112.547 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -102.01 119.55 56.42 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.042 0.937 . . . . 0.0 110.314 173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -86.61 -26.06 1.08 Allowed 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.93 2.42 . . . . 0.0 114.432 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.2 m -80.69 137.36 36.3 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.978 0.911 . . . . 0.0 112.319 -175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.55 -20.38 76.78 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 119.073 -0.849 . . . . 0.0 114.814 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -99.41 139.32 35.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.371 1.086 . . . . 0.0 110.222 171.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.78 140.11 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 126.187 1.795 . . . . 0.0 109.414 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -141.96 160.17 40.74 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.427 1.891 . . . . 0.0 110.323 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -127.36 132.91 50.11 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.612 1.565 . . . . 0.0 111.126 -170.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -93.74 -119.75 3.01 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.124 1.345 . . . . 0.0 112.727 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -57.97 149.21 23.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.802 1.241 . . . . 0.0 112.224 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.88 158.4 39.27 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.483 1.513 . . . . 0.0 111.119 -169.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -79.42 105.07 10.47 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.632 1.173 . . . . 0.0 111.027 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.347 1.859 . . . . 0.0 111.693 176.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 t 64.46 39.55 6.84 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.013 1.325 . . . . 0.0 112.82 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.8 t -152.53 144.58 23.78 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.529 -1.357 . . . . 0.0 111.476 -176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.92 -175.53 14.15 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.686 1.612 . . . . 0.0 113.903 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.7 t -164.08 -175.9 4.24 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.946 1.698 . . . . 0.0 110.817 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.6 p -158.09 158.0 33.9 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.365 1.466 . . . . 0.0 112.359 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.6 136.64 18.2 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.117 0.865 . . . . 0.0 112.53 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -145.88 153.57 41.0 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.701 2.0 . . . . 0.0 109.973 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -71.11 109.3 5.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.473 0.709 . . . . 0.0 110.908 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -164.67 131.76 3.1 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.975 1.31 . . . . 0.0 111.092 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -85.27 67.17 10.06 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 110.687 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.9 m -159.71 152.03 20.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.343 1.857 . . . . 0.0 111.147 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 77.3 t -95.92 124.47 52.08 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 124.544 1.138 . . . . 0.0 109.759 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.91 148.85 41.27 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.548 2.832 . . . . 0.0 111.835 178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -71.66 -2.67 18.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.358 1.463 . . . . 0.0 114.399 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -126.19 14.55 7.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.344 1.858 . . . . 0.0 113.618 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -46.12 129.82 7.41 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.627 1.171 . . . . 0.0 113.377 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.29 -18.27 23.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.411 2.741 . . . . 0.0 116.27 -169.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 81.5 p -130.65 -0.39 4.36 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 120.113 1.324 . . . . 0.0 114.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -133.72 134.71 43.35 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.37 1.868 . . . . 0.0 110.212 -171.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -140.78 129.02 22.31 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.212 1.005 . . . . 0.0 111.642 -169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -65.37 132.21 48.41 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.82 -0.55 . . . . 0.0 110.213 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -141.21 159.86 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.9 1.28 . . . . 0.0 110.95 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.5 m -141.46 122.98 15.04 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.41 1.084 . . . . 0.0 108.905 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -70.7 139.89 51.3 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 122.982 0.513 . . . . 0.0 110.594 178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.79 152.13 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -173.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -75.58 -179.86 4.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.451 1.1 . . . . 0.0 112.215 169.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.22 -19.03 65.78 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.271 1.029 . . . . 0.0 113.297 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -86.39 -2.94 58.86 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.421 1.488 . . . . 0.0 112.979 171.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.65 11.95 84.85 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.022 1.296 . . . . 0.0 114.716 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.2 t -69.93 127.63 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.455 1.502 . . . . 0.0 110.11 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.82 110.75 4.51 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.829 1.252 . . . . 0.0 110.994 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.24 -53.52 5.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.155 0.982 . . . . 0.0 111.584 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.91 144.89 9.23 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.017 1.294 . . . . 0.0 112.565 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.6 p -82.23 160.6 22.95 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.178 0.989 . . . . 0.0 112.761 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.5 175.1 39.78 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 112.231 -175.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 95.4 t -126.48 111.18 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.782 0.833 . . . . 0.0 109.862 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.5 ttm -87.39 141.65 28.47 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.094 1.357 . . . . 0.0 110.505 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -145.44 128.66 16.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.692 1.197 . . . . 0.0 110.612 -171.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -117.81 126.74 52.98 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.607 1.163 . . . . 0.0 108.992 -175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.6 p -118.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.48 1.512 . . . . 0.0 111.122 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -78.46 4.98 11.75 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.648 -1.283 . . . . 0.0 112.256 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.9 m -120.99 -47.49 2.28 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.922 -1.111 . . . . 0.0 113.249 -173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -162.47 169.75 19.85 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.842 1.257 . . . . 0.0 112.62 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.79 128.03 33.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.27 146.59 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.082 1.353 . . . . 0.0 109.199 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -144.52 111.7 5.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.802 0.811 . . . . 0.0 110.259 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -84.9 132.42 34.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.568 1.947 . . . . 0.0 111.058 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.1 mt -136.85 163.04 31.59 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.199 1.8 . . . . 0.0 110.92 -171.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -102.76 -18.57 15.09 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 51' ' ' ARG . 2.3 mmp_? -70.03 -46.56 64.79 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.704 1.602 . . . . 0.0 110.714 175.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -138.81 165.54 26.74 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 127.65 2.38 . . . . 0.0 111.818 -170.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.76 154.6 32.82 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.514 0.726 . . . . 0.0 111.363 172.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.66 127.86 31.96 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.097 0.959 . . . . 0.0 112.694 -173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -95.61 140.49 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.092 1.357 . . . . 0.0 109.699 -173.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -121.29 139.34 53.53 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.406 1.082 . . . . 0.0 111.704 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.4 m-90 -130.54 112.46 16.54 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.297 1.439 . . . . 0.0 110.01 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.63 140.23 46.62 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.838 2.358 . . . . 0.0 110.561 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -64.6 -28.67 69.78 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -65.15 -19.75 66.13 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 172.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.5 2.29 52.32 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 171.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.09 105.31 17.09 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.856 1.207 . . . . 0.0 109.796 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -68.3 -40.2 81.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 0.0 111.598 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -164.91 154.26 12.99 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.854 1.661 . . . . 0.0 111.408 -176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -153.79 146.59 24.34 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.843 1.657 . . . . 0.0 110.302 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.22 174.34 32.66 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 124.397 0.999 . . . . 0.0 113.765 -169.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -157.65 155.1 29.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 122.105 0.955 . . . . 0.0 112.181 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -129.54 -172.09 2.67 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.768 1.627 . . . . 0.0 111.255 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 8.2 t -62.28 -19.41 63.23 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -156.01 21.74 0.38 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 113.192 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.5 tp -143.86 139.15 29.11 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.358 1.463 . . . . 0.0 110.195 -169.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -124.73 130.71 52.93 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.126 1.37 . . . . 0.0 109.044 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.9 t -141.81 150.36 41.57 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.89 164.44 38.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -115.84 128.84 56.13 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.386 1.075 . . . . 0.0 111.131 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -109.47 140.01 43.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.88 0.872 . . . . 0.0 109.651 168.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.99 165.87 50.5 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.337 0.97 . . . . 0.0 114.641 -169.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -56.75 -11.76 1.55 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -98.0 -0.82 43.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.191 1.797 . . . . 0.0 115.376 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.9 p -85.6 174.01 9.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.131 0.972 . . . . 0.0 113.059 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -63.16 -30.54 71.67 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.766 1.227 . . . . 0.0 113.772 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.4 p -95.07 -4.66 45.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.838 1.255 . . . . 0.0 113.699 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.59 -176.96 44.69 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.973 0.797 . . . . 0.0 112.212 -169.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -69.31 131.05 44.24 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.18 -0.6 . . . . 0.0 110.711 178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -176.75 158.56 24.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 123.562 0.601 . . . . 0.0 113.895 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 82.3 mt -93.49 118.53 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -111.11 126.01 54.38 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.157 0.983 . . . . 0.0 109.469 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -134.32 138.71 45.15 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.348 1.059 . . . . 0.0 111.912 -172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -139.07 131.98 29.34 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.758 -169.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -81.29 128.93 34.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.154 0.982 . . . . 0.0 109.666 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.0 t -165.14 125.67 1.93 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.91 1.284 . . . . 0.0 110.794 -169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 m -65.6 -24.47 67.07 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.333 -0.854 . . . . 0.0 112.774 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.8 mtm-85 -99.21 23.95 8.53 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.605 1.962 . . . . 0.0 113.277 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.59 -30.78 63.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.772 -1.205 . . . . 0.0 114.035 178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -70.25 -40.72 74.25 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.708 0.803 . . . . 0.0 111.134 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -67.24 -37.6 83.81 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.745 1.218 . . . . 0.0 111.681 177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.8 mt -64.07 -48.0 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.866 0.757 . . . . 0.0 110.405 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.65 -44.51 96.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.44 0.696 . . . . 0.0 112.24 177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -66.13 -33.74 76.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.945 0.898 . . . . 0.0 112.761 177.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.5 tp -72.92 -44.39 61.27 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.933 0.788 . . . . 0.0 111.228 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.3 tp -57.82 -46.7 84.32 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.826 0.739 . . . . 0.0 112.355 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -68.43 -28.11 66.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.18 -38.1 87.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.623 0.725 . . . . 0.0 111.63 175.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 39.2 mt -79.66 -13.7 59.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.868 1.667 . . . . 0.0 111.989 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.6 mmm -86.07 -23.96 26.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.616 1.167 . . . . 0.0 113.059 168.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -89.04 -56.44 3.28 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.472 1.033 . . . . 0.0 112.173 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 36.9 m 47.83 25.04 0.66 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 126.015 1.726 . . . . 0.0 115.033 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -125.02 -60.53 1.35 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.513 1.525 . . . . 0.0 112.916 -169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.9 m 70.19 10.25 7.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -100.06 101.56 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.652 -1.28 . . . . 0.0 109.171 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.0 m120 54.44 26.73 7.39 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.19 1.796 . . . . 0.0 114.886 171.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.9 t -58.7 130.96 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.592 . . . . 0.0 111.178 -172.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.65 144.76 50.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.307 1.843 . . . . 0.0 112.582 -173.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -84.55 157.07 21.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.455 1.502 . . . . 0.0 112.732 176.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -155.27 155.67 30.2 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 125.693 1.597 . . . . 0.0 110.797 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -74.79 153.31 42.82 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 123.369 2.713 . . . . 0.0 110.947 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -136.64 132.1 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.238 1.415 . . . . 0.0 108.799 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -132.45 112.1 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.51 1.524 . . . . 0.0 108.454 -176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 84.3 mt -136.2 130.96 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.809 1.644 . . . . 0.0 108.571 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.4 m -65.74 137.8 57.52 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.055 1.342 . . . . 0.0 110.444 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 51.7 p -76.45 3.95 10.12 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 92.4 -113.74 4.47 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.329 1.442 . . . . 0.0 111.309 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.0 t -158.38 168.22 27.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.203 1.401 . . . . 0.0 111.107 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.0 t -86.54 125.7 33.95 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.126 -0.984 . . . . 0.0 111.751 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -175.56 156.78 22.66 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.075 1.322 . . . . 0.0 112.765 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 p -83.51 164.05 20.07 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.394 1.078 . . . . 0.0 112.495 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.3 p -139.12 120.31 14.72 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.693 1.197 . . . . 0.0 111.043 -177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -87.67 126.84 8.21 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.253 0.93 . . . . 0.0 111.597 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -153.49 152.8 31.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.587 1.555 . . . . 0.0 110.59 -178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.6 t -161.44 157.05 24.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.586 1.155 . . . . 0.0 111.383 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -168.59 143.7 8.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.253 1.406 . . . . 0.0 112.506 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.4 p -91.6 -10.3 40.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 0.0 113.983 -177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.7 t -169.5 -179.22 3.34 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.766 2.026 . . . . 0.0 110.374 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 91.78 -114.96 4.64 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.417 1.008 . . . . 0.0 112.885 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.21 134.93 54.1 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.775 1.63 . . . . 0.0 110.7 -171.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -83.25 128.42 34.48 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.304 0.641 . . . . 0.0 110.746 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -91.78 121.74 33.69 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.03 1.332 . . . . 0.0 109.397 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.6 146.05 38.52 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.025 -0.422 . . . . 0.0 111.138 177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -80.1 -25.36 40.01 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.103 0.961 . . . . 0.0 113.442 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -141.95 157.85 44.47 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.313 1.845 . . . . 0.0 112.277 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -82.82 124.6 76.9 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.86 0.864 . . . . 0.0 112.338 -168.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -87.4 -29.15 0.4 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.913 2.409 . . . . 0.0 114.529 -170.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 89.8 m -80.64 134.13 35.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.229 0.922 . . . . 0.0 111.727 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -78.72 -12.95 83.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 119.182 -0.788 . . . . 0.0 115.04 -176.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -106.65 135.6 47.9 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.778 1.231 . . . . 0.0 109.806 171.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 43.8 t -137.49 137.24 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.558 1.543 . . . . 0.0 109.347 177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -127.72 140.73 51.89 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.653 1.981 . . . . 0.0 109.628 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -96.38 136.37 36.97 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.939 1.296 . . . . 0.0 110.969 -172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -85.34 -140.71 5.38 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 123.981 0.801 . . . . 0.0 112.055 -177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 17.4 m-30 -63.42 146.01 54.45 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.535 0.734 . . . . 0.0 111.481 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -154.16 -177.87 6.72 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.508 1.123 . . . . 0.0 111.61 -169.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -104.38 109.7 21.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.532 1.133 . . . . 0.0 109.405 -173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.254 1.296 0 C-N-CA 126.106 1.762 . . . . 0.0 113.64 -177.393 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 112.018 -0.433 . . . . 0.0 112.018 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -148.79 152.99 37.51 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.473 1.509 . . . . 0.0 111.089 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.3 p -83.13 145.12 29.4 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.286 1.035 . . . . 0.0 113.277 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.89 67.41 3.59 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 124.97 1.271 . . . . 0.0 112.284 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 t -75.21 77.74 2.34 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.66 1.184 . . . . 0.0 111.505 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -135.27 122.74 21.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.43 1.492 . . . . 0.0 110.638 -176.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.07 160.94 27.81 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.647 1.117 . . . . 0.0 113.208 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -120.39 113.96 21.11 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.087 1.355 . . . . 0.0 109.667 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -168.8 172.4 7.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.936 2.094 . . . . 0.0 111.302 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -90.19 -4.38 57.27 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.976 1.311 . . . . 0.0 114.059 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -94.33 -41.75 9.26 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.71 1.204 . . . . 0.0 112.604 -171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m 64.15 8.09 3.85 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.569 1.948 . . . . 0.0 115.74 169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.8 119.4 51.01 Favored Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 124.927 1.291 . . . . 0.0 111.237 -170.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.55 162.52 37.85 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.332 2.688 . . . . 0.0 111.802 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.81 1.63 10.11 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.558 1.143 . . . . 0.0 113.698 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -134.59 14.94 3.7 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.186 2.195 . . . . 0.0 113.312 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -50.41 141.52 16.36 Favored Pre-proline 0 CA--C 1.563 1.455 0 C-N-CA 124.51 1.124 . . . . 0.0 113.149 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.89 -19.32 18.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.368 2.712 . . . . 0.0 116.007 -169.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 79.1 p -128.24 -17.27 4.31 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.051 1.296 . . . . 0.0 113.956 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.85 139.94 41.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.805 1.642 . . . . 0.0 110.59 169.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -138.7 127.19 23.16 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.674 1.189 . . . . 0.0 109.982 -173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -66.83 133.68 50.58 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.998 -0.439 . . . . 0.0 109.87 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.93 157.7 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.48 1.112 . . . . 0.0 111.764 -174.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.9 m -137.13 118.79 14.98 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.602 1.161 . . . . 0.0 108.047 174.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -67.95 140.07 56.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.728 0.411 . . . . 0.0 110.519 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -130.83 154.1 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.67 -172.88 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.759 1.224 . . . . 0.0 112.818 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -69.58 -11.98 61.27 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.14 -1.03 32.31 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.224 1.81 . . . . 0.0 112.754 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.47 16.45 77.9 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.41 1.005 . . . . 0.0 114.111 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.34 126.97 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.765 1.226 . . . . 0.0 109.208 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -71.3 115.33 10.33 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.664 1.585 . . . . 0.0 111.259 -176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 74.8 mt -96.04 -54.2 3.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.49 1.116 . . . . 0.0 112.284 -171.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.43 144.97 10.74 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.601 1.096 . . . . 0.0 113.382 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.2 p -88.04 152.34 22.1 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.967 1.307 . . . . 0.0 113.295 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.33 -180.0 38.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.025 1.774 . . . . 0.0 112.74 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.3 t -125.29 114.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.771 0.828 . . . . 0.0 109.786 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.6 tpp -78.84 136.21 37.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.146 1.378 . . . . 0.0 109.028 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -136.23 121.55 19.24 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.76 1.224 . . . . 0.0 110.521 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 mp -106.49 114.39 28.47 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.834 0.854 . . . . 0.0 109.053 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -101.65 179.55 4.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.127 1.371 . . . . 0.0 110.456 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -84.97 5.27 29.88 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.3 m -118.03 -47.23 2.59 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.967 -1.083 . . . . 0.0 112.983 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.98 168.56 26.84 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.819 1.247 . . . . 0.0 112.505 176.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.98 132.06 35.94 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 170.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.8 t -123.99 147.67 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.46 1.504 . . . . 0.0 109.346 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.02 116.58 9.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.039 0.936 . . . . 0.0 109.873 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -83.88 121.12 26.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.503 1.521 . . . . 0.0 110.876 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.93 168.72 11.19 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.56 1.944 . . . . 0.0 111.477 -176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -101.69 -41.47 6.55 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.0 tpt85 -71.78 -36.9 70.47 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.994 0.917 . . . . 0.0 112.981 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -119.08 166.46 12.88 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 127.161 2.184 . . . . 0.0 110.957 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -66.19 166.62 11.57 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.709 0.803 . . . . 0.0 110.189 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.66 132.3 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.369 -0.832 . . . . 0.0 111.822 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -103.31 135.23 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.182 1.393 . . . . 0.0 110.201 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -116.44 139.17 50.73 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.131 1.372 . . . . 0.0 111.309 -177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -133.6 113.81 13.11 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.762 1.225 . . . . 0.0 110.122 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.71 134.82 42.36 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.255 1.97 . . . . 0.0 109.863 174.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -57.44 -37.64 73.14 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.92 -17.29 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 74.1 m -94.82 0.75 55.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.86 114.66 21.81 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.244 0.929 . . . . 0.0 108.986 169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -73.35 -38.46 65.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.169 -0.332 . . . . 0.0 111.398 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -167.61 156.83 9.97 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.573 1.149 . . . . 0.0 113.227 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -160.03 148.96 17.4 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.879 1.672 . . . . 0.0 112.323 -168.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.24 172.14 35.24 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.518 1.532 . . . . 0.0 113.584 -170.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -156.68 115.67 3.4 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.553 1.168 . . . . 0.0 113.873 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -86.32 -172.03 3.85 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 120.123 -1.611 . . . . 0.0 110.892 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -69.24 -10.63 58.71 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -170.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -160.61 25.28 0.15 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.499 1.92 . . . . 0.0 112.76 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -147.19 130.42 16.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.606 1.562 . . . . 0.0 110.023 -170.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -115.84 134.37 55.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.459 1.504 . . . . 0.0 109.373 177.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.6 t -147.48 148.99 31.81 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 155.42 34.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.219 1.008 . . . . 0.0 112.9 -175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -106.33 128.96 54.39 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.311 1.444 . . . . 0.0 109.224 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -112.57 133.42 54.62 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.368 0.667 . . . . 0.0 109.915 169.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.12 174.06 47.54 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.037 0.827 . . . . 0.0 113.237 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.0 ptt-85 -60.47 -17.09 42.73 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -86.37 72.56 10.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.455 1.502 . . . . 0.0 111.897 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.0 170.36 22.25 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.2 -25.41 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.588 1.555 . . . . 0.0 113.226 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.0 p -101.68 -9.17 21.13 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.35 1.46 . . . . 0.0 114.148 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.01 167.89 28.35 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.581 1.086 . . . . 0.0 112.819 -169.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -61.66 132.05 51.99 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.196 0.998 . . . . 0.0 112.133 -176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.62 35.08 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 114.951 0.74 . . . . 0.0 114.951 176.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.0 mt -100.0 127.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.202 1.401 . . . . 0.0 108.456 170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -111.46 149.1 31.77 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.623 1.569 . . . . 0.0 109.837 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.37 135.49 22.66 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.905 0.86 . . . . 0.0 113.111 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -136.44 136.87 39.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 125.024 1.33 . . . . 0.0 111.28 -173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -95.86 123.94 39.66 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.459 1.504 . . . . 0.0 109.777 -176.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 18.7 p -171.59 135.25 0.88 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.348 1.459 . . . . 0.0 110.95 -170.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.6 t -62.94 -40.5 97.83 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.363 -0.836 . . . . 0.0 112.007 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 41.5 mtp85 -82.08 18.63 1.31 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.421 1.088 . . . . 0.0 113.787 -175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.4 -36.0 13.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.771 1.629 . . . . 0.0 113.66 177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.36 -46.17 90.88 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.092 1.357 . . . . 0.0 112.708 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.52 -33.38 72.73 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.672 -0.642 . . . . 0.0 112.111 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 60.7 mt -63.28 -48.02 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 118.666 0.667 . . . . 0.0 109.98 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.78 -40.78 96.39 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.569 1.148 . . . . 0.0 112.882 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -67.97 -46.16 72.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 118.442 0.565 . . . . 0.0 112.313 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.32 -41.22 98.37 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.566 0.621 . . . . 0.0 111.33 177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.96 -45.17 87.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.742 0.817 . . . . 0.0 113.031 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -76.46 -29.01 56.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -65.04 -35.7 82.01 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.475 -0.766 . . . . 0.0 111.997 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.9 mt -74.64 -23.28 58.66 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.593 1.157 . . . . 0.0 112.643 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 12.0 mmt -72.39 -46.98 52.83 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 111.678 169.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -80.83 -35.03 33.4 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 3.5 t 52.72 32.05 11.39 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.724 1.609 . . . . 0.0 113.389 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -68.54 -29.75 68.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.698 1.199 . . . . 0.0 114.118 -169.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -167.39 174.16 8.22 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.985 1.714 . . . . 0.0 110.424 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -92.37 92.14 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 108.448 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -90.73 109.15 20.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 110.728 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.9 m -132.7 22.48 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.249 1.42 . . . . 0.0 113.279 -171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -90.54 141.98 28.21 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.128 0.971 . . . . 0.0 110.567 170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.8 155.81 20.84 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.032 0.933 . . . . 0.0 110.987 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -138.55 148.33 58.44 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.163 1.385 . . . . 0.0 110.058 -178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.29 150.72 53.4 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 123.265 2.643 . . . . 0.0 111.253 -179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 88.9 t -136.83 128.38 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.223 1.409 . . . . 0.0 108.307 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.33 107.48 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.56 1.544 . . . . 0.0 108.403 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 86.3 mt -133.69 107.83 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.017 1.327 . . . . 0.0 108.458 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.7 p -84.65 65.34 9.0 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.764 1.625 . . . . 0.0 110.838 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.1 t -135.97 123.39 22.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.265 1.426 . . . . 0.0 110.726 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.95 -108.42 3.25 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.568 1.556 . . . . 0.0 111.886 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -159.66 178.31 9.97 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.791 1.637 . . . . 0.0 110.938 -179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -157.97 127.47 5.89 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.785 1.234 . . . . 0.0 111.491 -177.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.4 54.82 4.81 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.299 1.428 . . . . 0.0 112.558 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.3 t -67.04 150.84 48.67 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.204 1.002 . . . . 0.0 112.592 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 6.2 t -84.92 59.77 5.8 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.463 1.105 . . . . 0.0 112.173 -174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -110.11 166.73 12.51 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.148 1.833 . . . . 0.0 112.88 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.2 t -164.01 159.61 20.87 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.573 1.549 . . . . 0.0 110.854 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.5 t -163.44 130.92 3.5 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.258 1.423 . . . . 0.0 110.958 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -108.74 96.63 1.01 Allowed Glycine 0 N--CA 1.471 0.974 0 C-N-CA 125.2 1.381 . . . . 0.0 111.209 175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.1 t -166.53 175.64 7.9 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.421 1.488 . . . . 0.0 111.245 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.4 t -162.21 154.59 19.4 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.926 1.69 . . . . 0.0 111.004 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.66 -179.62 47.58 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.547 1.07 . . . . 0.0 112.04 -169.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.87 121.9 22.56 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.073 0.949 . . . . 0.0 111.824 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -80.05 131.15 35.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.191 0.997 . . . . 0.0 110.542 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -98.84 124.29 43.65 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.54 1.136 . . . . 0.0 109.713 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.0 mt -86.46 146.67 26.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.915 1.286 . . . . 0.0 111.119 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.4 mtm180 -82.29 -25.01 34.37 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.928 1.291 . . . . 0.0 113.519 175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 30.8 p80 -128.75 166.02 19.79 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.905 2.082 . . . . 0.0 112.399 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.13 119.34 72.36 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.383 -0.818 . . . . 0.0 109.674 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.95 -27.83 6.62 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 122.925 2.417 . . . . 0.0 113.129 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 48.7 m -81.21 138.36 35.81 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.12 1.368 . . . . 0.0 111.144 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.64 70.07 Favored Glycine 0 N--CA 1.477 1.392 0 C-N-CA 123.707 0.67 . . . . 0.0 113.722 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -91.28 143.3 26.79 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.733 1.613 . . . . 0.0 110.635 169.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 95.9 t -149.03 134.87 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.576 1.55 . . . . 0.0 108.884 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -120.79 154.94 35.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.019 2.128 . . . . 0.0 109.922 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -114.1 150.35 34.2 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.381 1.472 . . . . 0.0 111.641 -174.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.81 -134.71 2.21 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.717 1.151 . . . . 0.0 112.239 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -61.99 155.39 23.91 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.791 0.836 . . . . 0.0 112.467 174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -133.35 127.53 33.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.383 1.073 . . . . 0.0 109.887 -176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -163.42 146.13 10.07 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.889 1.676 . . . . 0.0 108.851 -176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 125.182 1.393 . . . . 0.0 113.84 -179.422 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.0 t -85.84 -20.21 29.47 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 121.721 -0.87 . . . . 0.0 113.338 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -79.07 155.4 28.8 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.654 1.181 . . . . 0.0 113.476 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.92 148.34 20.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.491 1.519 . . . . 0.0 112.97 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.0 p -108.19 143.29 37.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.63 1.572 . . . . 0.0 112.166 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.6 m 58.98 32.26 22.11 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.814 1.246 . . . . 0.0 113.725 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.46 -52.35 53.15 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.608 1.099 . . . . 0.0 114.075 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 64.4 mt -149.93 118.0 6.34 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.948 1.699 . . . . 0.0 109.693 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.7 151.61 4.33 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.133 1.773 . . . . 0.0 111.759 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 171.47 13.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.958 0.903 . . . . 0.0 111.835 169.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.46 129.7 12.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.501 1.52 . . . . 0.0 110.441 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.4 m -96.38 -11.96 25.01 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -167.49 110.8 0.62 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.987 1.315 . . . . 0.0 112.139 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.04 149.63 90.07 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.203 2.602 . . . . 0.0 112.576 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -70.74 -4.23 22.75 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.55 1.54 . . . . 0.0 114.126 -177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.71 31.38 1.46 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.126 1.771 . . . . 0.0 111.534 -178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -43.53 127.81 3.84 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 125.617 1.567 . . . . 0.0 113.397 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -81.9 -20.01 6.75 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.057 2.504 . . . . 0.0 115.743 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.9 p -127.73 -21.49 3.73 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -172.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -109.96 149.01 30.55 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.338 1.455 . . . . 0.0 110.804 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.9 130.6 21.42 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.218 1.007 . . . . 0.0 111.216 -175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.98 130.74 48.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.483 0.713 . . . . 0.0 110.444 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.4 m -142.3 155.48 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.391 1.076 . . . . 0.0 111.457 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.0 m -140.76 116.7 10.43 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.126 0.97 . . . . 0.0 109.29 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -65.66 140.57 58.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 111.128 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.7 m -127.91 153.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -85.29 -172.96 4.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.846 1.259 . . . . 0.0 113.258 173.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -69.02 -13.88 62.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -97.59 -1.48 43.76 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.88 1.672 . . . . 0.0 112.325 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.87 16.44 79.97 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.095 1.331 . . . . 0.0 114.103 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -78.47 129.65 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 118.729 1.265 . . . . 0.0 109.66 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.54 115.29 4.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.03 1.332 . . . . 0.0 111.15 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.16 -54.16 3.68 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.164 0.986 . . . . 0.0 111.951 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 140.2 6.56 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.699 1.142 . . . . 0.0 113.245 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 p -87.0 150.77 23.82 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.015 1.326 . . . . 0.0 112.749 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.02 -173.12 31.35 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 126.882 2.182 . . . . 0.0 112.335 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.4 t -128.84 118.64 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.549 1.139 . . . . 0.0 109.763 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 43.5 tpp -85.58 141.32 29.92 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.028 1.331 . . . . 0.0 109.951 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -142.44 134.87 27.85 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.772 1.229 . . . . 0.0 111.092 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.8 mp -119.19 123.99 45.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.815 1.246 . . . . 0.0 108.751 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.7 p -115.5 170.56 8.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.274 1.029 . . . . 0.0 111.649 -175.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -65.32 -1.96 2.76 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.774 0.83 . . . . 0.0 112.772 170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 m -107.76 -48.1 3.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.641 1.176 . . . . 0.0 113.289 173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -171.03 176.03 4.16 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 119.694 1.134 . . . . 0.0 113.992 -169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.59 131.28 35.27 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.038 1.335 . . . . 0.0 109.141 172.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.2 t -130.31 136.6 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.619 1.568 . . . . 0.0 109.675 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 115.4 21.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.836 1.254 . . . . 0.0 109.745 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -95.74 127.23 41.58 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.191 1.797 . . . . 0.0 110.814 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.35 -51.61 2.86 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.8 0.84 . . . . 0.0 112.077 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.458 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 13.0 t-80 -166.15 -148.1 0.1 Allowed 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 126.21 1.804 . . . . 0.0 110.295 -176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 25.0 ptt180 -65.73 -14.97 62.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.509 1.124 . . . . 0.0 113.825 169.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -57.64 163.68 2.39 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.931 2.492 . . . . 0.0 111.635 170.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -60.49 147.42 41.3 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.242 1.017 . . . . 0.0 111.263 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.91 146.68 29.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.176 0.99 . . . . 0.0 110.981 174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.1 t -101.28 126.37 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.53 0.732 . . . . 0.0 109.27 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 55.8 mtp85 -121.51 138.92 54.09 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.394 1.077 . . . . 0.0 111.692 -170.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.71 116.02 12.55 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.773 1.229 . . . . 0.0 111.401 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.89 140.95 56.92 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.958 2.438 . . . . 0.0 110.915 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -64.29 -28.06 69.46 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -175.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -71.11 -16.55 62.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 113.718 173.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.3 m -100.15 6.95 44.88 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.5 mt -83.33 118.05 23.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.169 0.895 . . . . 0.0 109.04 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -76.34 -32.79 58.87 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.765 0.826 . . . . 0.0 111.861 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -171.2 163.29 7.15 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 127.787 2.435 . . . . 0.0 110.178 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -155.93 151.35 26.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.486 1.514 . . . . 0.0 110.353 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -167.38 172.01 42.2 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-O 122.564 1.091 . . . . 0.0 113.946 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -147.07 156.14 42.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.134 0.969 . . . . 0.0 112.307 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -130.39 -177.7 4.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.716 1.606 . . . . 0.0 111.15 171.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.8 t -63.32 -22.42 66.86 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -169.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -142.18 17.53 2.08 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.604 1.561 . . . . 0.0 112.71 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.4 tp -144.73 139.32 27.81 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.562 1.145 . . . . 0.0 111.462 -168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -123.64 132.67 53.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.599 1.56 . . . . 0.0 109.215 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -145.46 152.95 40.61 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -153.69 159.65 42.1 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.792 1.237 . . . . 0.0 113.117 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -122.76 131.33 53.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.73 1.612 . . . . 0.0 110.645 -174.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.5 p -105.91 147.68 28.49 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.715 1.206 . . . . 0.0 113.715 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.66 157.33 47.38 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 ptp85 -62.43 -20.58 64.64 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 -171.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 ptp180 -89.62 56.07 3.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.914 1.686 . . . . 0.0 113.669 -174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.2 p -151.26 171.66 17.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.242 1.417 . . . . 0.0 112.279 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.86 -39.48 77.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.803 1.241 . . . . 0.0 113.399 -169.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.4 p -86.09 -6.43 59.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.787 1.235 . . . . 0.0 113.692 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 -165.76 53.57 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.653 1.12 . . . . 0.0 112.286 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -71.26 129.71 39.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.666 0.787 . . . . 0.0 109.956 174.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.64 175.14 45.77 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.715 0.674 . . . . 0.0 114.104 175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.34 126.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.638 1.575 . . . . 0.0 106.923 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -118.0 139.07 51.72 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.633 1.173 . . . . 0.0 109.517 -177.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.32 136.77 31.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.893 0.854 . . . . 0.0 112.079 -174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -137.92 129.33 27.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.271 -171.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -72.36 135.65 45.93 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.738 -0.601 . . . . 0.0 109.727 171.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 46.5 t -162.61 131.22 4.05 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.005 1.322 . . . . 0.0 110.783 -173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.6 p -75.09 -13.7 60.51 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.8 mtp85 -119.16 26.77 9.26 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.038 1.735 . . . . 0.0 112.492 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -52.34 -33.3 42.16 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -65.59 -34.22 77.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.333 1.053 . . . . 0.0 112.707 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.0 -37.32 64.44 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.187 -0.945 . . . . 0.0 110.65 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.36 -48.8 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.179 0.592 . . . . 0.0 109.945 172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -58.74 -45.53 89.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.897 0.879 . . . . 0.0 112.747 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -63.19 -49.28 74.85 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.778 0.431 . . . . 0.0 112.017 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.0 tp -60.88 -38.93 87.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.618 0.767 . . . . 0.0 111.275 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.29 -55.82 29.96 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.119 0.967 . . . . 0.0 111.733 174.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -67.43 -29.02 68.4 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.073 0.851 . . . . 0.0 113.135 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -64.95 -52.82 54.23 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.964 0.905 . . . . 0.0 111.198 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.75 -24.42 67.7 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.492 0.717 . . . . 0.0 112.678 178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 82.7 mtp -81.93 -11.51 58.85 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.72 1.208 . . . . 0.0 113.802 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -107.55 -18.99 13.7 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.47 132.59 48.81 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.366 1.066 . . . . 0.0 111.922 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.79 33.75 19.99 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.746 1.618 . . . . 0.0 112.899 177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.2 t -144.56 164.42 30.95 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.29 1.436 . . . . 0.0 111.635 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -139.17 131.84 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 126.476 1.91 . . . . 0.0 108.611 -175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -152.39 150.2 29.43 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.752 1.621 . . . . 0.0 112.002 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.72 23.6 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 125.438 1.495 . . . . 0.0 113.144 -174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.7 mmm -83.45 55.22 3.1 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.816 1.646 . . . . 0.0 111.89 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.34 35.86 0.23 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.228 1.811 . . . . 0.0 114.082 -174.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.15 151.35 29.28 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.241 1.817 . . . . 0.0 111.626 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -78.73 148.48 22.7 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.629 2.886 . . . . 0.0 110.962 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.2 t -141.7 130.41 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 108.566 177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.2 mp -135.63 119.31 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.525 1.53 . . . . 0.0 108.56 -176.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.0 mm -124.87 124.27 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.353 1.461 . . . . 0.0 108.892 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 38.6 p -127.8 4.14 6.04 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.526 1.531 . . . . 0.0 113.695 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -74.08 -17.2 60.98 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.17 -138.42 32.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 125.171 1.367 . . . . 0.0 113.212 173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -162.79 167.32 23.06 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.896 1.678 . . . . 0.0 110.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -144.19 131.54 20.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.059 1.344 . . . . 0.0 110.928 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 160.29 151.72 6.29 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.515 1.055 . . . . 0.0 113.313 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.7 m -152.07 135.14 15.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.622 1.569 . . . . 0.0 109.96 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.8 m -169.18 166.88 10.63 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.561 1.944 . . . . 0.0 111.075 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 122.39 -116.09 2.93 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.214 1.387 . . . . 0.0 111.817 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.5 t -159.16 -175.76 5.44 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.615 1.566 . . . . 0.0 110.826 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.9 m -69.18 119.51 13.58 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.664 1.186 . . . . 0.0 112.271 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.71 -159.87 44.59 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.787 1.185 . . . . 0.0 114.036 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -147.02 147.04 30.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.607 1.563 . . . . 0.0 110.417 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 15.1 m -79.03 -0.73 32.46 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.302 1.593 . . . . 0.0 115.302 -169.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -174.89 -99.4 0.12 Allowed Glycine 0 N--CA 1.47 0.909 0 C-N-CA 124.632 1.111 . . . . 0.0 112.648 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.08 138.08 57.69 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.957 1.303 . . . . 0.0 111.19 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -79.89 115.83 19.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.903 0.481 . . . . 0.0 111.065 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -82.0 122.01 27.25 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.643 1.177 . . . . 0.0 110.978 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.2 mt -82.42 149.51 27.6 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.179 0.992 . . . . 0.0 111.403 174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -78.47 -28.55 46.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.111 0.964 . . . . 0.0 113.313 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -135.26 156.21 49.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.003 1.721 . . . . 0.0 112.375 -176.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -86.05 121.63 72.79 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 124.259 1.024 . . . . 0.0 111.269 -171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -89.0 -26.15 0.52 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.793 2.329 . . . . 0.0 114.609 -169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 94.9 m -83.19 138.15 33.75 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.044 0.838 . . . . 0.0 112.035 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.7 -40.26 38.1 Favored Glycine 0 CA--C 1.531 1.057 0 O-C-N 121.9 -0.5 . . . . 0.0 113.653 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -84.38 66.09 9.23 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.303 1.051 . . . . 0.0 112.468 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.08 139.36 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 110.854 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -144.08 152.92 41.62 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.964 2.106 . . . . 0.0 110.67 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -127.28 126.94 43.53 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.986 1.714 . . . . 0.0 110.774 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -107.11 -101.28 2.71 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 125.429 1.49 . . . . 0.0 111.601 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.46 150.88 29.77 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.889 0.875 . . . . 0.0 112.615 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 -170.8 3.35 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.148 1.779 . . . . 0.0 109.975 -175.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -146.66 140.55 26.06 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.548 1.139 . . . . 0.0 109.483 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 . . . . . 0 C--O 1.253 1.285 0 C-N-CA 126.584 1.954 . . . . 0.0 113.445 -174.506 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 112.104 -0.399 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.86 178.13 8.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.824 1.649 . . . . 0.0 111.081 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -151.8 155.74 38.82 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.569 -1.332 . . . . 0.0 112.994 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.97 -174.03 13.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 126.107 1.813 . . . . 0.0 112.212 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.9 m -69.94 -41.73 74.18 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.9 p 54.74 -5.62 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 129.336 3.055 . . . . 0.0 118.833 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 80.41 1.58 Allowed Glycine 0 N--CA 1.468 0.825 0 C-N-CA 125.467 1.508 . . . . 0.0 113.468 -173.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.9 tp -68.01 -33.2 74.16 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.636 1.174 . . . . 0.0 111.962 172.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -79.33 134.17 36.61 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.479 1.112 . . . . 0.0 111.404 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -67.07 130.18 42.28 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.111 0.964 . . . . 0.0 110.69 174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -142.97 153.23 42.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.006 1.722 . . . . 0.0 110.811 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.0 t -73.35 -12.73 60.93 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.25 118.63 41.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.371 1.468 . . . . 0.0 109.351 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.68 142.58 48.66 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.322 2.681 . . . . 0.0 111.259 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -70.69 -4.91 25.98 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.718 1.207 . . . . 0.0 113.923 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -126.56 19.37 7.37 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.548 2.339 . . . . 0.0 112.469 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -42.24 126.17 2.79 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 125.524 1.529 . . . . 0.0 113.385 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.81 -22.1 12.04 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.812 2.341 . . . . 0.0 115.555 -169.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 72.5 p -132.19 -11.06 3.3 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.34 131.97 53.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.909 1.684 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -142.21 127.01 18.14 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.972 0.909 . . . . 0.0 111.955 -168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.26 130.73 43.45 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.416 -0.803 . . . . 0.0 109.192 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.31 152.12 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.124 1.37 . . . . 0.0 111.434 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.2 m -126.64 118.89 25.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.728 1.211 . . . . 0.0 108.61 178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -72.24 142.86 48.95 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.56 0.618 . . . . 0.0 110.884 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 151.79 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.59 0.756 . . . . 0.0 112.927 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.83 -179.42 1.82 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.519 1.127 . . . . 0.0 112.015 170.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.19 -16.57 54.02 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 172.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -92.85 -2.34 55.97 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.823 1.649 . . . . 0.0 113.406 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.92 19.28 77.79 Favored Glycine 0 N--CA 1.474 1.233 0 O-C-N 121.049 -1.032 . . . . 0.0 114.975 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.22 132.5 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.866 1.666 . . . . 0.0 110.188 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.84 115.21 5.71 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.901 1.281 . . . . 0.0 111.682 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.4 mt -94.91 -56.1 2.87 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.24 1.016 . . . . 0.0 111.964 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -167.37 162.95 36.74 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 125.806 1.669 . . . . 0.0 111.89 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 m -125.51 150.83 47.05 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.34 -179.43 24.29 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.482 1.991 . . . . 0.0 112.768 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -115.18 111.27 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.0 ttm -84.99 141.84 30.04 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.393 1.477 . . . . 0.0 110.392 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -143.7 129.67 19.53 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.669 1.588 . . . . 0.0 109.765 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -112.37 130.06 56.09 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.31 1.044 . . . . 0.0 108.73 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -121.22 174.48 6.67 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.953 1.301 . . . . 0.0 111.224 -173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -70.77 -0.06 8.14 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.316 -0.865 . . . . 0.0 112.841 172.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 72.2 m -120.29 -40.38 2.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -166.58 168.88 14.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.402 1.081 . . . . 0.0 113.331 -173.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.06 129.46 34.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 168.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.4 t -122.99 144.92 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.183 1.393 . . . . 0.0 109.254 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 117.33 12.3 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.083 0.953 . . . . 0.0 109.876 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -92.76 129.77 38.58 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.269 1.828 . . . . 0.0 110.765 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -129.68 127.57 40.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.683 1.593 . . . . 0.0 109.997 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -64.45 135.82 56.47 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.64 0.776 . . . . 0.0 112.747 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? 61.59 22.99 13.37 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.183 1.793 . . . . 0.0 113.179 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -142.55 169.04 18.32 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.104 2.162 . . . . 0.0 110.762 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.37 156.12 31.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.514 0.725 . . . . 0.0 110.005 168.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.38 45.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.816 -0.553 . . . . 0.0 111.749 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.9 t -119.61 124.83 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.609 1.164 . . . . 0.0 109.602 -178.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.51 140.82 48.95 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.856 1.262 . . . . 0.0 111.966 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -132.89 107.41 12.69 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.262 1.425 . . . . 0.0 110.283 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -66.04 141.49 64.25 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.675 2.25 . . . . 0.0 110.611 177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -62.29 -26.01 68.17 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -70.52 -20.69 62.8 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.322 1.449 . . . . 0.0 114.622 172.227 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.3 p -89.29 -9.63 49.86 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.086 1.312 . . . . 0.0 113.779 169.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.15 89.9 4.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.874 0.761 . . . . 0.0 109.974 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -61.95 -25.6 67.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.524 1.13 . . . . 0.0 112.69 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -170.35 146.51 2.88 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.916 2.086 . . . . 0.0 111.118 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.402 ' CD1' HD23 ' A' ' 101' ' ' LEU . 45.3 p90 -146.85 148.14 31.55 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.655 1.582 . . . . 0.0 111.325 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.41 178.21 35.62 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 124.856 1.217 . . . . 0.0 115.098 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -161.2 138.23 8.78 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -106.08 -171.86 1.98 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.796 1.638 . . . . 0.0 110.827 171.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.8 t -68.45 -15.32 63.51 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.779 -1.201 . . . . 0.0 114.2 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.03 18.75 0.58 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 112.778 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.6 tp -146.74 131.61 18.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.729 1.212 . . . . 0.0 110.157 -169.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -112.91 131.21 55.83 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.39 1.476 . . . . 0.0 108.573 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.9 t -147.36 148.87 31.8 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 -174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -156.08 156.8 34.96 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -106.89 131.13 54.32 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.012 1.725 . . . . 0.0 110.343 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -112.38 139.14 48.19 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.663 1.185 . . . . 0.0 110.868 175.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.88 176.14 51.38 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.548 1.071 . . . . 0.0 113.589 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -65.0 -17.55 64.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -101.02 75.71 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.026 1.33 . . . . 0.0 111.255 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 20.5 p -160.39 172.07 17.95 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.914 1.686 . . . . 0.0 111.643 171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -63.56 -27.13 69.04 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.593 1.157 . . . . 0.0 113.728 -172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 p -99.8 -9.41 23.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.977 1.311 . . . . 0.0 114.007 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.58 -178.11 48.38 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.321 0.963 . . . . 0.0 113.162 -171.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.21 130.21 42.45 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.062 0.945 . . . . 0.0 111.87 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.4 179.46 40.77 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 123.82 0.724 . . . . 0.0 114.794 178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 91.1 mt -117.75 139.85 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.629 1.572 . . . . 0.0 108.929 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -129.86 155.62 45.71 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.522 1.529 . . . . 0.0 110.697 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.34 141.86 25.39 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.57 0.748 . . . . 0.0 112.982 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -133.05 130.86 39.94 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.028 1.331 . . . . 0.0 111.043 -177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -88.65 123.47 33.14 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.733 1.613 . . . . 0.0 109.635 -175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.2 t -168.31 130.77 1.44 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.702 1.201 . . . . 0.0 111.637 -169.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.0 m -65.03 -26.21 68.17 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.491 0.717 . . . . 0.0 112.922 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -92.31 14.89 15.07 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.4 1.88 . . . . 0.0 113.233 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.12 -34.27 21.58 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 113.466 173.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.15 -41.98 98.81 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.571 1.148 . . . . 0.0 112.744 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -78.25 -32.55 49.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.878 0.763 . . . . 0.0 112.406 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.5 -49.06 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 169.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -62.43 -43.52 98.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.446 0.698 . . . . 0.0 112.234 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -57.49 -50.13 74.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.714 0.805 . . . . 0.0 111.484 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.03 -40.9 99.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.297 0.639 . . . . 0.0 111.978 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 65' ' ' TYR . 32.3 tp -60.67 -50.07 74.99 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.46 0.704 . . . . 0.0 111.948 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -67.28 -33.19 74.78 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.993 0.815 . . . . 0.0 112.48 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.45 -43.58 98.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.144 0.884 . . . . 0.0 111.617 174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -72.1 -28.01 63.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.402 1.081 . . . . 0.0 112.732 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -89.94 -22.62 21.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -89.35 -27.46 20.47 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.495 1.043 . . . . 0.0 112.636 172.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 90.7 m -123.17 89.59 3.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.445 1.498 . . . . 0.0 109.96 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -62.69 155.95 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.403 1.081 . . . . 0.0 112.306 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 t -153.92 157.27 38.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.951 1.3 . . . . 0.0 111.243 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.0 mt -139.52 120.2 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.615 1.566 . . . . 0.0 108.322 -176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -130.82 4.23 4.52 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.777 1.231 . . . . 0.0 114.303 -177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.75 151.08 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 127.492 2.317 . . . . 0.0 110.009 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtt -89.26 100.26 13.08 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.279 1.031 . . . . 0.0 110.956 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -106.87 151.48 25.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.656 1.582 . . . . 0.0 110.721 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 mp0 -61.72 141.69 94.95 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.252 1.021 . . . . 0.0 111.516 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.37 138.52 30.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.27 2.647 . . . . 0.0 111.192 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.1 p -86.24 136.83 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.173 0.989 . . . . 0.0 110.423 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mm -116.0 121.46 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.03 1.332 . . . . 0.0 109.122 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.7 mm -126.03 139.41 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.788 1.635 . . . . 0.0 109.567 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 62.2 p -137.73 150.24 47.12 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.772 1.629 . . . . 0.0 110.324 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.2 p -92.43 -7.55 47.26 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -83.3 64.86 4.24 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 125.571 1.558 . . . . 0.0 112.159 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 98.3 p -159.46 176.3 12.26 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.886 1.275 . . . . 0.0 112.945 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 77.9 p -153.72 154.22 33.67 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 111.307 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.88 171.23 16.9 Favored Glycine 0 N--CA 1.472 1.039 0 C-N-CA 125.112 1.339 . . . . 0.0 114.45 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 49.2 m -151.56 155.63 38.85 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.335 1.854 . . . . 0.0 110.629 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 29.7 m -65.66 130.96 45.12 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.239 1.016 . . . . 0.0 112.746 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.96 -166.96 27.07 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.92 1.248 . . . . 0.0 113.839 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 79.9 p -162.45 163.28 27.7 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.285 1.834 . . . . 0.0 110.751 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 37.7 m -161.45 136.61 7.51 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.057 1.343 . . . . 0.0 111.369 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -103.02 128.41 9.53 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.065 1.317 . . . . 0.0 111.693 176.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.9 m -154.9 163.08 40.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.99 1.716 . . . . 0.0 111.042 -175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.2 m -141.48 140.22 33.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.313 1.045 . . . . 0.0 111.809 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 113.79 -68.92 0.24 Allowed Glycine 0 N--CA 1.471 1.027 0 C-N-CA 125.598 1.57 . . . . 0.0 112.167 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.04 130.88 35.99 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.856 0.862 . . . . 0.0 110.33 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -77.98 126.57 31.02 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.548 0.739 . . . . 0.0 111.342 178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.85 119.93 32.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 109.871 175.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 36.2 mt -86.47 141.28 29.21 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.589 1.556 . . . . 0.0 110.201 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -75.63 -34.62 60.57 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.582 0.753 . . . . 0.0 112.559 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 21.1 m80 -136.4 156.29 48.83 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.666 1.987 . . . . 0.0 111.29 -172.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.82 120.79 83.03 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 118.572 -0.728 . . . . 0.0 110.498 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -82.57 26.69 0.63 Allowed 'Trans proline' 0 CA--C 1.548 1.18 0 C-N-CA 124.609 3.539 . . . . 0.0 113.571 -176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 29.4 t -152.49 143.72 23.21 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.968 -1.083 . . . . 0.0 112.494 -170.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -93.78 -12.73 56.43 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.428 1.489 . . . . 0.0 114.654 176.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -102.89 103.78 13.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.743 1.272 . . . . 0.0 109.202 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 99.5 t -142.77 138.26 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.584 1.154 . . . . 0.0 109.844 -171.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -103.67 -15.22 15.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 58.21 8.14 0.76 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 127.155 2.182 . . . . 0.0 116.814 174.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -8.43 -95.57 0.0 OUTLIER Glycine 0 N--CA 1.479 1.508 0 C-N-CA 130.431 3.872 . . . . 0.0 117.673 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -85.23 135.03 34.11 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.559 1.144 . . . . 0.0 109.853 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -156.67 153.33 28.32 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.81 0.844 . . . . 0.0 110.648 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -72.95 101.39 3.19 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.56 1.144 . . . . 0.0 110.836 177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.79 1.636 . . . . 0.0 114.022 177.639 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.47 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -157.69 -164.43 1.54 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.295 1.438 . . . . 0.0 110.805 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -147.6 144.41 28.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.268 1.427 . . . . 0.0 111.309 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.1 -169.29 51.6 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.602 1.096 . . . . 0.0 113.04 -171.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.4 p -164.7 173.27 12.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.6 1.56 . . . . 0.0 111.353 -178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 m -78.09 -14.22 59.57 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.978 -1.076 . . . . 0.0 113.868 178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.3 174.5 28.1 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.185 1.374 . . . . 0.0 113.715 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.92 83.74 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.385 1.474 . . . . 0.0 109.183 175.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -152.98 155.95 37.92 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.212 1.805 . . . . 0.0 110.949 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -78.9 90.18 4.72 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.3 1.04 . . . . 0.0 110.696 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -160.33 140.41 11.41 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.819 2.048 . . . . 0.0 109.892 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 t -99.53 -4.25 31.64 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -89.72 121.51 68.98 Favored Pre-proline 0 N--CA 1.478 0.965 0 O-C-N 120.704 -1.248 . . . . 0.0 110.157 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.0 156.45 65.8 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.83 3.02 . . . . 0.0 112.611 177.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.26 -10.95 55.86 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.167 1.387 . . . . 0.0 114.329 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.82 32.21 2.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.756 1.623 . . . . 0.0 111.755 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -46.82 132.03 8.57 Favored Pre-proline 0 CA--C 1.558 1.272 0 O-C-N 120.944 -1.097 . . . . 0.0 112.35 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.94 -15.27 46.54 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.742 2.961 . . . . 0.0 115.828 -174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.1 t -157.22 20.17 0.3 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -144.16 126.3 15.56 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.809 1.244 . . . . 0.0 110.234 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -141.72 122.23 14.14 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.445 0.698 . . . . 0.0 112.468 -169.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -64.14 130.94 45.95 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 168.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.5 m -137.86 157.08 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.057 1.343 . . . . 0.0 110.597 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.5 m -133.94 117.17 16.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.187 0.995 . . . . 0.0 108.551 175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.62 140.63 57.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.101 -0.476 . . . . 0.0 110.513 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.2 m -138.26 151.31 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.42 -174.89 4.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.12 1.368 . . . . 0.0 113.438 175.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -65.75 -14.77 61.98 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.757 1.223 . . . . 0.0 114.017 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -100.77 -1.89 33.75 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.828 1.651 . . . . 0.0 112.702 175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.96 18.43 74.96 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.772 1.177 . . . . 0.0 114.347 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.41 136.25 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.525 1.53 . . . . 0.0 109.506 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.68 115.06 9.4 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.79 1.236 . . . . 0.0 111.674 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.43 -51.68 9.68 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.592 0.757 . . . . 0.0 110.785 173.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.41 154.7 12.99 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.394 1.473 . . . . 0.0 113.009 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 p -95.58 147.02 24.01 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.613 1.165 . . . . 0.0 112.981 -177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -149.73 172.97 29.61 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 126.526 2.013 . . . . 0.0 112.974 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.19 113.02 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.973 0.909 . . . . 0.0 109.113 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.5 ttm -90.63 138.14 31.8 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.974 1.309 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -138.39 129.15 26.61 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.25 1.82 . . . . 0.0 109.751 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mp -114.51 105.84 13.57 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.663 1.185 . . . . 0.0 108.756 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.18 179.27 6.41 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.934 0.494 . . . . 0.0 110.267 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -76.98 0.55 20.74 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.479 -0.763 . . . . 0.0 112.63 170.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -119.67 -35.62 3.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.482 1.113 . . . . 0.0 113.557 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -166.11 162.46 17.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.084 0.954 . . . . 0.0 112.984 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 134.25 35.47 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.0 t -128.35 142.82 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.385 1.474 . . . . 0.0 109.115 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 119.71 15.97 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.474 1.11 . . . . 0.0 109.822 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -96.63 132.37 42.34 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.499 1.92 . . . . 0.0 110.575 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.3 mt -132.08 139.35 48.47 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.413 1.485 . . . . 0.0 110.865 -172.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -67.93 127.02 31.3 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.882 0.873 . . . . 0.0 112.876 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 50.18 46.25 24.96 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.558 1.943 . . . . 0.0 112.376 -177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -153.8 160.66 42.31 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.944 2.498 . . . . 0.0 109.946 -173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -69.42 151.59 45.93 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.031 0.533 . . . . 0.0 110.665 170.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.79 149.38 46.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.809 0.443 . . . . 0.0 110.604 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 t -118.97 128.27 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.355 1.062 . . . . 0.0 109.549 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -121.12 136.69 54.93 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.935 1.294 . . . . 0.0 111.689 -174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.1 m-90 -130.93 109.74 15.54 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.034 1.334 . . . . 0.0 109.976 173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -66.62 142.24 63.65 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.244 1.962 . . . . 0.0 110.208 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -64.11 -17.68 63.68 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 pp -77.3 -21.98 52.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.795 1.238 . . . . 0.0 113.974 174.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.9 p -89.78 -8.82 51.3 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 119.714 1.143 . . . . 0.0 113.74 170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.26 111.39 8.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.308 0.958 . . . . 0.0 109.821 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.7 mmm-85 -73.13 -31.36 64.24 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.968 0.907 . . . . 0.0 111.813 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -174.99 163.83 3.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.942 2.497 . . . . 0.0 110.527 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -152.97 158.26 41.8 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.048 1.339 . . . . 0.0 111.246 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.27 176.13 42.8 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-O 122.459 1.033 . . . . 0.0 113.982 -170.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -153.12 155.53 36.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.871 0.843 . . . . 0.0 111.906 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -173.27 3.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.492 1.517 . . . . 0.0 111.432 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.5 p -59.74 105.72 0.4 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.12 0.962 . . . . 0.0 112.054 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 59.88 24.72 13.79 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.446 1.898 . . . . 0.0 114.061 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -137.57 134.56 35.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.537 1.135 . . . . 0.0 111.528 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -123.74 131.88 53.69 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.041 1.337 . . . . 0.0 109.471 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 t -143.97 150.85 38.93 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -150.21 155.83 40.47 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.401 1.081 . . . . 0.0 112.918 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -114.7 121.32 42.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.365 1.466 . . . . 0.0 110.142 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.5 p -108.41 143.05 37.86 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.715 1.206 . . . . 0.0 112.881 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.89 160.6 47.94 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.614 1.578 . . . . 0.0 113.266 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.19 -18.53 64.58 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -175.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -98.97 80.26 2.46 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 111.278 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 27.8 p -164.4 171.89 14.14 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.108 1.763 . . . . 0.0 111.45 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -61.17 -26.5 67.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.958 1.303 . . . . 0.0 113.725 -173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 45.5 p -100.72 -7.36 23.86 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.243 1.417 . . . . 0.0 113.862 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.8 -172.28 51.22 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.612 1.101 . . . . 0.0 113.166 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -63.97 133.37 53.07 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.777 0.831 . . . . 0.0 110.127 176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.06 178.54 48.82 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.9 mt -127.04 122.42 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.971 1.708 . . . . 0.0 107.125 172.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.15 125.78 50.91 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.351 1.06 . . . . 0.0 110.218 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.15 136.77 54.44 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.209 1.004 . . . . 0.0 112.035 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -128.92 138.37 51.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.026 1.33 . . . . 0.0 111.323 -173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -97.08 117.69 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.761 1.625 . . . . 0.0 109.737 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.9 p -169.73 132.03 1.14 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.336 1.454 . . . . 0.0 111.059 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 p -67.74 -21.71 65.27 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -94.61 22.78 5.89 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.148 1.779 . . . . 0.0 113.675 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.75 -31.56 58.65 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.741 1.216 . . . . 0.0 114.106 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -68.41 -40.43 81.26 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.727 0.811 . . . . 0.0 110.805 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -69.47 -36.29 76.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.282 1.033 . . . . 0.0 111.683 178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.8 mt -64.18 -45.85 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 118.816 0.735 . . . . 0.0 110.221 172.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -61.18 -45.27 95.3 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.369 0.531 . . . . 0.0 112.148 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -60.6 -43.18 97.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.526 0.73 . . . . 0.0 112.15 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.7 tp -62.79 -44.72 95.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.416 0.686 . . . . 0.0 111.305 175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 tp -59.45 -48.99 79.54 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.36 0.664 . . . . 0.0 112.283 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -69.1 -29.93 68.12 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.41 -43.99 97.91 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.456 1.026 . . . . 0.0 111.698 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.7 mt -75.74 -25.27 56.4 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 112.136 -177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.6 mtp -96.68 -20.32 18.36 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -86.12 -21.79 27.43 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.818 1.19 . . . . 0.0 113.312 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.91 114.88 2.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.534 1.134 . . . . 0.0 111.777 -174.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 60.88 19.78 10.06 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 126.007 1.723 . . . . 0.0 113.539 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.6 t -112.81 6.28 17.94 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 120.798 -1.189 . . . . 0.0 113.995 -169.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.6 mt -94.9 100.77 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 120.776 -1.203 . . . . 0.0 109.742 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -117.47 -20.44 9.06 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.1 151.25 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 127.624 2.37 . . . . 0.0 107.964 -173.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.42 151.94 5.19 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.588 1.155 . . . . 0.0 113.937 174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.77 148.98 22.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.62 1.168 . . . . 0.0 113.105 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -74.76 151.1 86.71 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.26 1.024 . . . . 0.0 112.079 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.63 171.22 18.22 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.948 3.098 . . . . 0.0 111.062 173.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.43 135.96 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.204 1.002 . . . . 0.0 109.871 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.35 140.45 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 125.631 1.573 . . . . 0.0 110.006 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 82.9 mt -100.48 136.01 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.53 1.532 . . . . 0.0 109.796 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.8 m -127.27 125.65 41.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.801 1.64 . . . . 0.0 109.532 -177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.3 m -81.67 -24.28 36.35 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -169.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.78 33.51 71.08 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 115.095 0.798 . . . . 0.0 115.095 171.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.9 m -58.83 147.97 31.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.504 1.122 . . . . 0.0 113.717 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 74.0 9.44 4.67 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.26 1.824 . . . . 0.0 113.828 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.88 66.52 2.78 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.627 1.585 . . . . 0.0 112.489 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 p -77.47 62.9 2.53 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.983 1.713 . . . . 0.0 113.029 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.1 p -71.25 119.94 16.1 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 120.61 -1.306 . . . . 0.0 112.392 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.13 -70.1 1.13 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 124.879 1.228 . . . . 0.0 111.177 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.3 t -166.25 153.88 10.07 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.833 1.653 . . . . 0.0 110.992 176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.6 p -119.28 2.82 11.37 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.587 1.555 . . . . 0.0 113.049 173.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.18 -149.12 36.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.009 1.29 . . . . 0.0 112.901 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -119.22 125.85 50.14 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.919 1.287 . . . . 0.0 109.308 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 m -158.86 49.9 0.36 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.398 1.479 . . . . 0.0 110.876 -169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 -125.38 6.88 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 125.412 1.482 . . . . 0.0 111.172 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.94 129.3 37.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.547 1.139 . . . . 0.0 109.984 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -76.68 122.43 24.67 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.36 0.664 . . . . 0.0 111.278 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 33.5 mtm-85 -89.43 106.55 18.52 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.31 1.444 . . . . 0.0 110.788 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.9 mt -71.06 143.4 50.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.42 0.688 . . . . 0.0 111.109 176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -77.92 -30.17 50.41 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.364 1.066 . . . . 0.0 112.981 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -132.9 156.45 47.2 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.386 1.874 . . . . 0.0 111.587 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -76.23 124.51 88.22 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.401 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -88.52 -20.51 1.63 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.092 2.528 . . . . 0.0 114.914 -169.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 92.9 m -96.23 132.07 42.06 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.753 0.821 . . . . 0.0 111.479 -173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.31 61.6 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.859 -0.526 . . . . 0.0 113.441 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -82.68 63.88 7.03 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.589 -0.947 . . . . 0.0 112.334 -175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.5 t -66.51 134.21 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.194 0.997 . . . . 0.0 110.133 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -136.13 147.45 47.77 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.163 1.785 . . . . 0.0 109.728 170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -100.67 147.41 26.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.763 1.225 . . . . 0.0 111.421 -172.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -84.91 -128.02 1.77 Allowed Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.465 1.031 . . . . 0.0 112.424 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -67.44 175.73 2.66 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.084 0.954 . . . . 0.0 112.866 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -69.05 3.7 1.93 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 73.73 32.38 1.14 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.906 2.082 . . . . 0.0 111.913 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 127.171 2.188 . . . . 0.0 114.429 177.455 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.838 -0.505 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -148.75 145.41 27.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 77.9 p -167.1 163.55 15.72 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.369 1.468 . . . . 0.0 111.683 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.5 150.55 25.79 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.343 0.973 . . . . 0.0 112.184 173.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -97.37 119.88 36.72 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.929 0.892 . . . . 0.0 110.613 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.1 p -166.41 153.99 9.87 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.121 1.368 . . . . 0.0 111.41 -174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.09 -39.79 1.86 Allowed Glycine 0 N--CA 1.475 1.268 0 C-N-CA 125.323 1.439 . . . . 0.0 114.529 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp 67.14 13.54 9.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.729 2.412 . . . . 0.0 112.979 175.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -70.39 152.12 44.45 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.02 1.328 . . . . 0.0 112.358 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 60.71 37.1 19.24 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.52 . . . . 0.0 113.098 172.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -52.12 -26.65 11.76 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.3 t -76.37 -19.17 58.44 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.2 t -152.81 100.03 2.74 Favored Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 126.276 1.83 . . . . 0.0 108.824 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -70.92 140.5 38.46 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.157 2.571 . . . . 0.0 111.169 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -68.64 -21.0 64.49 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -83.99 0.31 48.56 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.619 1.168 . . . . 0.0 113.863 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -59.3 126.16 81.12 Favored Pre-proline 0 CA--C 1.557 1.217 0 O-C-N 120.956 -1.09 . . . . 0.0 112.283 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -78.4 -17.72 12.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.89 2.393 . . . . 0.0 114.964 -171.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.7 p -132.66 -10.74 3.12 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -170.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -108.05 133.77 51.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.06 1.744 . . . . 0.0 111.182 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.22 137.69 27.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 0.0 112.036 -171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -69.11 137.3 53.32 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.378 -0.826 . . . . 0.0 111.136 170.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.28 161.03 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 125.168 1.387 . . . . 0.0 111.699 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.1 m -137.59 121.41 17.56 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.214 1.405 . . . . 0.0 108.346 172.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.47 138.08 54.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.312 0.506 . . . . 0.0 110.907 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.97 152.07 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.12 174.23 2.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.089 1.356 . . . . 0.0 111.425 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -61.84 -18.07 58.68 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.984 -1.073 . . . . 0.0 113.669 173.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -95.53 1.2 53.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.909 1.684 . . . . 0.0 113.331 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.64 79.09 Favored Glycine 0 CA--C 1.535 1.337 0 O-C-N 120.968 -1.083 . . . . 0.0 115.026 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.6 t -73.31 121.2 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.222 1.409 . . . . 0.0 110.52 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.8 119.17 12.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.721 1.608 . . . . 0.0 112.218 -177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.8 mt -95.59 -58.15 2.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.077 0.951 . . . . 0.0 112.027 177.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.91 146.51 12.48 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 124.504 1.05 . . . . 0.0 113.464 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.4 p -87.19 155.28 20.16 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.627 1.171 . . . . 0.0 112.96 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.47 178.98 38.84 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.024 1.773 . . . . 0.0 112.494 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.58 112.57 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.873 0.869 . . . . 0.0 109.856 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.4 tpp -80.87 141.03 35.01 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.82 1.648 . . . . 0.0 109.461 176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.59 125.28 11.13 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.862 0.865 . . . . 0.0 110.704 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 mp -113.16 105.24 13.21 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.974 0.909 . . . . 0.0 109.273 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.3 p -91.54 171.21 9.34 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.86 0.864 . . . . 0.0 109.258 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -72.96 -8.81 57.39 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.63 -0.668 . . . . 0.0 112.097 172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.7 m -95.98 -46.02 6.69 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.915 -1.116 . . . . 0.0 112.513 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -161.85 172.82 15.46 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.404 1.082 . . . . 0.0 113.148 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.82 132.58 36.16 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 168.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -125.45 142.38 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.304 1.442 . . . . 0.0 109.145 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.09 121.7 26.89 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.486 1.115 . . . . 0.0 108.749 173.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -95.66 116.91 29.55 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.55 1.54 . . . . 0.0 109.734 174.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.08 137.5 41.94 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.371 1.468 . . . . 0.0 110.027 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -65.98 132.64 49.06 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.554 -0.716 . . . . 0.0 112.346 176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.76 26.98 16.47 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.642 1.577 . . . . 0.0 112.617 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -149.66 168.03 24.75 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.85 2.06 . . . . 0.0 111.068 -169.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.02 159.88 33.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.885 0.874 . . . . 0.0 112.046 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 142.75 31.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.608 0.763 . . . . 0.0 111.002 171.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.2 t -116.5 130.74 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.387 1.075 . . . . 0.0 110.569 -175.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -115.91 135.44 53.99 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.359 1.464 . . . . 0.0 111.958 -173.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -129.48 109.98 17.63 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.24 1.416 . . . . 0.0 110.85 174.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.63 138.61 54.87 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.751 2.301 . . . . 0.0 110.667 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -62.53 -29.62 70.7 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.74 -17.47 63.45 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.525 1.13 . . . . 0.0 113.65 173.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 95.6 m -95.68 6.51 48.76 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.7 mt -96.78 105.58 17.73 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.604 1.093 . . . . 0.0 109.789 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -78.27 -26.1 47.03 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.702 0.631 . . . . 0.0 112.702 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -162.76 152.39 15.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.339 1.456 . . . . 0.0 112.218 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -151.93 150.29 29.87 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.288 1.835 . . . . 0.0 110.162 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.8 172.37 37.1 Favored Glycine 0 CA--C 1.517 0.183 0 CA-C-O 122.152 0.862 . . . . 0.0 113.481 -170.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -155.74 148.29 23.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.473 1.13 . . . . 0.0 112.49 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.71 -177.81 3.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.944 1.698 . . . . 0.0 111.006 172.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -60.49 -21.75 62.76 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -145.39 20.02 1.54 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.113 1.765 . . . . 0.0 111.894 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.4 tp -144.01 140.98 29.88 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.458 1.103 . . . . 0.0 111.554 -167.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -130.28 128.19 41.06 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.57 1.548 . . . . 0.0 109.37 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 t -138.46 152.31 48.2 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.39 152.63 26.09 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.8 141.7 32.26 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.593 1.557 . . . . 0.0 110.194 172.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.5 p -125.77 145.45 50.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.737 1.215 . . . . 0.0 111.542 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.88 171.18 50.64 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.758 1.17 . . . . 0.0 114.849 -172.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 -57.94 -19.78 32.68 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.377 2.671 . . . . 0.0 114.93 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 51.2 mmm-85 -106.02 3.2 28.01 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -170.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 -178.06 6.47 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.297 1.039 . . . . 0.0 112.942 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -61.55 -31.55 71.58 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.411 1.084 . . . . 0.0 113.857 -172.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -100.73 -4.96 27.15 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.056 1.342 . . . . 0.0 113.793 -176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.8 -173.78 51.81 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -166.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.7 pm0 -66.02 153.48 42.09 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.447 -1.031 . . . . 0.0 113.141 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.96 169.32 26.2 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.205 0.907 . . . . 0.0 113.46 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.597 HG22 HD12 ' A' ' 138' ' ' LEU . 26.6 mt -139.36 125.59 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 124.886 1.274 . . . . 0.0 107.864 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -127.92 139.1 52.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.629 1.172 . . . . 0.0 110.826 -169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.05 143.74 51.08 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.291 1.043 . . . . 0.0 112.586 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -136.09 139.08 42.72 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.584 1.553 . . . . 0.0 110.675 -174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -101.28 127.63 47.79 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.388 1.075 . . . . 0.0 110.627 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.2 p -172.52 137.05 0.8 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.536 . . . . 0.0 110.769 -171.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.6 p -67.26 -20.28 65.63 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.035 -1.041 . . . . 0.0 113.357 174.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -92.64 13.49 19.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.678 1.591 . . . . 0.0 113.152 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.41 -36.52 44.0 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.234 1.414 . . . . 0.0 113.886 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.25 -41.42 94.33 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.511 1.124 . . . . 0.0 112.44 177.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -66.49 -39.18 88.58 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.335 0.654 . . . . 0.0 111.369 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.42 -46.11 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.111 0.564 . . . . 0.0 110.461 176.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -58.29 -43.93 88.28 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.819 0.848 . . . . 0.0 112.261 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -64.58 -49.24 71.94 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.908 -0.495 . . . . 0.0 112.2 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.13 -38.52 83.32 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.298 0.639 . . . . 0.0 111.646 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.54 -50.6 73.28 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.647 0.779 . . . . 0.0 111.989 176.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -69.33 -32.05 70.9 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.801 0.728 . . . . 0.0 112.655 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -64.1 -41.95 97.07 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.192 0.997 . . . . 0.0 112.025 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.89 -26.89 60.78 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.089 0.956 . . . . 0.0 112.343 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 41.2 mtt -74.42 -38.45 63.05 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.793 0.837 . . . . 0.0 113.117 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -76.85 -32.25 57.41 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 112.987 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . 0.254 16.8 p 46.04 30.65 0.96 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.249 2.22 . . . . 0.0 115.393 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -139.88 144.77 37.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.006 2.122 . . . . 0.0 110.431 -172.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.0 p 48.58 49.14 18.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.857 1.663 . . . . 0.0 112.696 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.4 mp -54.32 114.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.353 1.861 . . . . 0.0 110.722 -170.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 t-20 -99.17 112.88 24.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.34 27.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.53 1.932 . . . . 0.0 111.304 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 65.0 mtt -65.5 160.27 22.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.451 1.1 . . . . 0.0 111.61 173.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -70.22 110.6 5.3 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.48 0.712 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -105.43 151.47 39.72 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.866 1.666 . . . . 0.0 110.967 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -73.65 155.78 49.43 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.523 2.816 . . . . 0.0 111.608 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.4 t -139.67 131.93 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.624 1.57 . . . . 0.0 108.363 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -111.0 110.0 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.928 1.291 . . . . 0.0 108.298 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 mm -80.21 126.65 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.546 0.739 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 55.4 m -135.92 144.63 45.59 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.372 1.869 . . . . 0.0 108.913 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 20.8 t -137.46 123.27 20.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.32 1.048 . . . . 0.0 110.626 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -102.3 -164.14 26.5 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.334 1.445 . . . . 0.0 113.316 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 68.6 m -79.13 161.21 26.62 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.479 0.712 . . . . 0.0 111.964 171.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.6 t -146.37 118.54 8.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.273 1.029 . . . . 0.0 110.188 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -106.54 169.45 15.37 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.333 1.444 . . . . 0.0 113.154 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 45.6 m -67.52 136.4 54.51 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.9 0.88 . . . . 0.0 111.805 175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.5 p -79.42 74.4 6.04 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.858 1.263 . . . . 0.0 111.853 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -79.71 -7.31 88.6 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.035 1.302 . . . . 0.0 115.214 -176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.0 t -82.43 136.29 34.96 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.669 1.235 . . . . 0.0 110.678 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -162.98 157.28 20.78 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.796 1.639 . . . . 0.0 111.518 -175.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 166.57 -141.43 6.94 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.102 1.334 . . . . 0.0 111.907 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 11.0 t -69.38 142.68 53.88 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 117.322 0.561 . . . . 0.0 111.666 172.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 74.3 m -85.55 131.15 34.41 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.079 -1.013 . . . . 0.0 111.965 -177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 174.33 -150.11 11.26 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.439 1.019 . . . . 0.0 113.33 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.42 143.32 50.98 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.376 1.87 . . . . 0.0 109.461 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -76.76 127.81 33.45 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.148 0.431 . . . . 0.0 111.281 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -94.63 115.74 27.92 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.459 1.103 . . . . 0.0 109.844 173.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.622 HD13 ' HD3' ' A' ' 142' ' ' PRO . 18.9 mt -73.61 143.81 46.2 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.58 1.152 . . . . 0.0 111.716 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.1 mmt-85 -68.78 -37.95 79.66 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.012 0.925 . . . . 0.0 112.778 175.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -138.61 -102.89 0.17 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.77 1.628 . . . . 0.0 110.394 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.412 ' CE2' HG22 ' A' ' 146' ' ' VAL . 2.8 t80 -160.17 126.99 2.54 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 119.991 1.269 . . . . 0.0 111.675 -176.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.622 ' HD3' HD13 ' A' ' 138' ' ' LEU . 93.6 Cg_endo -87.48 -29.06 0.4 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.387 2.725 . . . . 0.0 114.076 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 72.4 m -78.16 138.24 38.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.77 0.828 . . . . 0.0 111.857 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.84 3.04 85.12 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 115.555 0.982 . . . . 0.0 115.555 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.06 131.83 41.07 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.657 1.583 . . . . 0.0 109.15 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 141' ' ' PHE . 50.9 t -141.55 145.75 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.401 1.48 . . . . 0.0 110.502 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -144.16 164.52 30.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.711 2.404 . . . . 0.0 110.413 -174.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -125.69 140.92 52.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.812 1.245 . . . . 0.0 112.983 -168.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -92.02 -112.91 1.92 Allowed Glycine 0 N--CA 1.468 0.815 0 C-N-CA 125.302 1.429 . . . . 0.0 112.671 -171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -66.33 127.97 34.31 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.318 1.047 . . . . 0.0 110.807 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -139.54 135.83 33.84 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.102 1.361 . . . . 0.0 110.02 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -96.63 52.52 1.21 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.209 1.404 . . . . 0.0 110.93 -170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 . . . . . 0 C--O 1.254 1.334 0 C-N-CA 124.89 1.276 . . . . 0.0 114.064 179.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 112.002 -0.439 . . . . 0.0 112.002 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -161.56 158.38 26.25 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.564 1.545 . . . . 0.0 110.424 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -165.93 170.75 13.38 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.838 1.255 . . . . 0.0 112.721 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.52 156.65 30.35 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.372 1.463 . . . . 0.0 113.218 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -165.33 131.68 2.76 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.277 1.431 . . . . 0.0 111.134 -176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.9 m -83.16 155.53 23.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.041 0.936 . . . . 0.0 113.129 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.24 -163.35 13.7 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.266 1.412 . . . . 0.0 113.481 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.0 125.7 10.37 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.895 1.678 . . . . 0.0 108.374 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -127.17 124.01 38.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.52 1.128 . . . . 0.0 111.332 -171.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.25 60.01 5.98 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.363 1.465 . . . . 0.0 111.148 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -144.65 127.48 16.33 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.051 1.74 . . . . 0.0 110.658 -171.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 t -97.02 -8.32 30.71 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -82.83 122.17 78.0 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.832 1.253 . . . . 0.0 109.025 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.78 158.95 46.2 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.41 2.74 . . . . 0.0 112.249 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -66.34 0.39 2.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.894 2.078 . . . . 0.0 115.287 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -146.68 17.68 1.29 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.169 1.787 . . . . 0.0 113.693 -173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -47.09 135.13 8.76 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 124.151 0.98 . . . . 0.0 113.26 174.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.31 -16.55 35.26 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.706 2.937 . . . . 0.0 115.467 -170.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.257 13.2 t -162.05 49.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 123.701 1.715 . . . . 0.0 112.535 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 117.93 3.22 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.88 -1.137 . . . . 0.0 111.425 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -140.95 118.84 11.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.958 0.903 . . . . 0.0 110.588 -169.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 130.51 46.1 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.681 -0.637 . . . . 0.0 109.661 169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 m -136.5 151.73 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.016 1.326 . . . . 0.0 110.7 -176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.9 m -132.16 113.68 13.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.222 1.009 . . . . 0.0 108.862 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -65.53 139.85 58.51 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.356 0.663 . . . . 0.0 111.212 -178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.2 m -126.92 155.51 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.47 -175.06 5.51 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.803 1.641 . . . . 0.0 113.307 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -64.11 -14.27 53.58 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -99.27 -20.13 16.73 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.78 2.032 . . . . 0.0 111.578 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.6 17.21 31.64 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.091 1.329 . . . . 0.0 114.416 -175.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.51 128.6 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 118.922 1.361 . . . . 0.0 109.586 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -68.01 116.42 8.63 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.025 1.33 . . . . 0.0 110.976 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -97.94 -54.97 2.93 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 112.624 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.39 154.14 24.93 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.209 1.385 . . . . 0.0 112.854 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 62.4 p -104.07 154.47 19.66 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.62 176.71 35.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 127.101 2.286 . . . . 0.0 112.129 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 89.8 t -124.12 117.62 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.532 0.733 . . . . 0.0 110.035 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 50.8 ttm -92.14 138.03 31.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.931 1.293 . . . . 0.0 111.148 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -138.38 133.16 32.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.918 2.087 . . . . 0.0 110.07 -176.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mp -120.14 108.89 14.79 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.806 1.242 . . . . 0.0 109.193 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 p -96.59 173.63 7.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.607 0.763 . . . . 0.0 110.595 -177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -73.23 0.17 12.63 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 170.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.2 m -107.27 -45.1 4.18 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.463 1.105 . . . . 0.0 112.719 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -169.5 169.79 8.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.565 1.146 . . . . 0.0 113.122 -171.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.92 134.56 35.75 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 173.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.8 t -128.22 143.17 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.71 1.604 . . . . 0.0 109.419 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.26 110.1 8.16 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.006 0.923 . . . . 0.0 110.005 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -80.25 131.68 35.72 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.087 1.755 . . . . 0.0 111.14 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.9 mt -135.44 131.69 36.52 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.122 1.769 . . . . 0.0 109.447 -176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -65.77 142.17 58.07 Favored 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.565 -0.709 . . . . 0.0 112.622 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 60.9 23.12 13.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 112.981 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -148.55 166.33 28.56 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 127.779 2.432 . . . . 0.0 110.623 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -75.3 158.4 32.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.333 0.653 . . . . 0.0 111.193 168.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.74 129.08 35.81 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.969 0.508 . . . . 0.0 110.306 172.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.46 130.21 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.569 0.747 . . . . 0.0 109.341 -177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -116.24 140.14 49.62 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.986 1.314 . . . . 0.0 112.316 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -134.33 113.39 12.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.116 1.366 . . . . 0.0 110.88 173.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.43 137.76 44.08 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.58 2.186 . . . . 0.0 110.401 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -63.89 -28.74 70.05 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -69.76 -17.14 63.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.764 1.226 . . . . 0.0 113.634 173.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.8 m -98.19 6.68 47.23 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.6 mt -93.88 110.67 22.32 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.592 1.087 . . . . 0.0 109.377 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -71.82 -35.46 69.92 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.156 -0.34 . . . . 0.0 111.8 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -163.32 161.9 24.82 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.099 1.359 . . . . 0.0 112.598 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 50.4 p90 -157.93 154.04 27.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.074 1.75 . . . . 0.0 110.442 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.13 174.18 37.68 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 124.31 0.957 . . . . 0.0 112.817 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -150.7 155.29 39.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.998 0.904 . . . . 0.0 111.619 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.04 -175.66 4.5 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.891 1.676 . . . . 0.0 111.255 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 p -56.21 111.03 0.85 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.15 -0.969 . . . . 0.0 111.708 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.267 15.2 p30 52.58 24.99 3.37 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.98 2.112 . . . . 0.0 115.904 -174.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.8 tp -137.34 135.93 37.49 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.15 1.38 . . . . 0.0 111.365 -174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -129.08 132.49 47.43 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 109.684 177.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.4 t -139.39 150.61 45.49 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -151.0 160.23 44.07 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.495 1.118 . . . . 0.0 112.939 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -119.58 122.22 41.1 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.331 1.452 . . . . 0.0 110.425 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.6 m -104.69 141.8 35.81 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.76 1.224 . . . . 0.0 112.239 -174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.29 169.13 36.92 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.462 1.506 . . . . 0.0 114.161 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -67.07 -25.94 66.49 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -171.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -100.82 0.33 38.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -168.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 p -79.19 171.54 15.05 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.374 0.988 . . . . 0.0 112.031 174.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -59.92 -30.8 69.29 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 p -86.6 -9.17 56.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.214 1.406 . . . . 0.0 113.914 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.82 -173.72 49.65 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.49 1.043 . . . . 0.0 112.036 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -62.99 131.43 48.62 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.38 -0.482 . . . . 0.0 109.752 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.72 161.59 30.43 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-O 121.661 0.589 . . . . 0.0 113.974 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 95.5 mt -111.45 130.14 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -129.11 124.2 34.14 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.55 1.14 . . . . 0.0 109.295 -174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.18 146.83 48.43 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 122.162 0.982 . . . . 0.0 111.935 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -137.74 133.97 34.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.314 -171.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -90.0 125.87 35.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.518 1.127 . . . . 0.0 109.303 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.3 p -169.77 133.27 1.23 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.693 1.597 . . . . 0.0 110.55 -172.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.8 p -63.76 -27.87 69.49 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.021 0.928 . . . . 0.0 113.309 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.4 mtm-85 -94.51 21.29 7.37 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.551 1.94 . . . . 0.0 113.605 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.44 -35.8 20.45 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.757 1.223 . . . . 0.0 114.056 175.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.94 -39.05 90.14 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.534 1.134 . . . . 0.0 112.753 176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -67.64 -41.0 84.56 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.262 0.625 . . . . 0.0 110.874 176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.73 -47.56 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.706 0.402 . . . . 0.0 110.39 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -60.58 -43.41 97.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.678 0.791 . . . . 0.0 112.63 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -65.8 -47.13 76.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.025 0.53 . . . . 0.0 111.851 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -62.02 -40.68 96.51 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.085 0.954 . . . . 0.0 111.681 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.96 -52.43 65.81 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.951 0.9 . . . . 0.0 112.029 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -67.34 -31.67 72.1 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.506 0.594 . . . . 0.0 112.531 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -66.17 -41.49 90.22 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.794 0.838 . . . . 0.0 112.667 176.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.14 -28.29 63.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.059 0.943 . . . . 0.0 112.22 175.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 13.6 mtt -75.96 -39.21 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.037 0.935 . . . . 0.0 113.106 173.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -80.08 -36.86 34.93 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.341 0.973 . . . . 0.0 112.791 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.2 t 51.89 31.7 8.8 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.581 1.552 . . . . 0.0 113.519 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.17 164.81 23.41 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.476 1.511 . . . . 0.0 112.695 -173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.6 p -66.68 100.34 0.68 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.231 1.013 . . . . 0.0 111.185 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -135.69 135.85 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 126.636 1.974 . . . . 0.0 108.462 -175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -80.0 -49.93 11.12 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.395 1.078 . . . . 0.0 112.85 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.1 p -173.87 150.36 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 127.734 2.413 . . . . 0.0 109.272 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.45 131.02 48.39 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.269 1.428 . . . . 0.0 109.908 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -130.86 145.89 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.693 1.597 . . . . 0.0 110.19 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -135.24 149.72 70.71 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.373 1.469 . . . . 0.0 110.519 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.77 155.09 44.04 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.597 2.864 . . . . 0.0 112.314 -173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.51 132.26 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.315 1.046 . . . . 0.0 109.268 174.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.9 mm -123.39 146.73 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 126.335 1.854 . . . . 0.0 109.185 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.82 121.21 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.207 1.003 . . . . 0.0 109.986 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.2 t -71.08 143.89 50.52 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.561 1.144 . . . . 0.0 111.162 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.7 p -112.19 132.68 54.76 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.14 1.376 . . . . 0.0 111.533 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 67.72 -135.77 30.96 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 123.714 0.673 . . . . 0.0 112.278 -176.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.9 t -164.41 -168.1 1.45 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.121 1.768 . . . . 0.0 110.226 176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 90.3 p -153.32 164.61 37.82 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.667 -1.27 . . . . 0.0 112.196 176.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 92.69 100.7 1.44 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.09 1.328 . . . . 0.0 111.155 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 68.5 m -150.53 149.67 30.25 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.598 1.559 . . . . 0.0 110.842 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 9.5 t -81.89 149.99 27.99 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.269 -0.894 . . . . 0.0 112.05 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 162.6 -131.94 2.65 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.027 1.298 . . . . 0.0 112.355 -174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -153.74 141.59 20.13 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.712 1.205 . . . . 0.0 111.022 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.6 m -99.81 127.89 45.94 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.112 . . . . 0.0 111.79 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.93 92.8 0.23 Allowed Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.729 1.156 . . . . 0.0 111.305 -178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.6 t -75.85 77.22 2.77 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.876 1.27 . . . . 0.0 110.654 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 t 68.24 9.69 7.37 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.295 1.838 . . . . 0.0 112.964 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 136.77 -148.94 20.0 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.672 2.082 . . . . 0.0 112.018 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.1 mt -114.59 139.44 49.61 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.715 1.606 . . . . 0.0 109.612 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -75.04 119.62 19.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.315 0.646 . . . . 0.0 111.33 -175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -85.92 107.09 17.56 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.073 1.349 . . . . 0.0 109.283 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 64.5 mt -73.22 146.97 45.11 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.86 1.264 . . . . 0.0 112.036 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -79.42 -24.66 42.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.352 1.061 . . . . 0.0 113.432 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -136.51 166.78 22.71 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.428 1.891 . . . . 0.0 112.368 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -92.94 113.34 59.52 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.007 0.923 . . . . 0.0 110.084 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.69 -22.88 3.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.056 2.504 . . . . 0.0 114.791 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 86.8 m -89.71 132.71 35.05 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.311 0.959 . . . . 0.0 111.572 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.01 -33.27 46.12 Favored Glycine 0 N--CA 1.473 1.136 0 O-C-N 121.659 -0.65 . . . . 0.0 113.757 -178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -82.72 61.3 5.74 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.086 0.954 . . . . 0.0 112.641 -173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.9 136.16 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.016 1.326 . . . . 0.0 110.651 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -141.42 161.58 37.57 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 127.464 2.306 . . . . 0.0 109.926 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -128.5 135.05 48.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.838 1.255 . . . . 0.0 112.287 -168.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -95.55 -98.02 1.76 Allowed Glycine 0 C--N 1.339 0.738 0 C-N-CA 125.294 1.426 . . . . 0.0 111.52 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -75.09 161.69 29.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.045 1.338 . . . . 0.0 111.9 173.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -110.57 150.64 28.65 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.583 1.553 . . . . 0.0 109.059 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -154.49 139.29 17.12 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.025 1.73 . . . . 0.0 108.935 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.985 1.714 . . . . 0.0 113.781 -172.816 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 t -85.99 75.28 9.98 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.148 0.974 . . . . 0.0 111.374 -178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.5 p -84.57 6.1 25.14 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.15 1.38 . . . . 0.0 114.119 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.58 -161.84 13.49 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.313 1.911 . . . . 0.0 112.425 -173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.1 t -160.39 140.29 11.24 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.591 1.156 . . . . 0.0 111.47 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.8 t -102.53 -13.29 17.25 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.486 1.114 . . . . 0.0 112.858 175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.96 147.74 6.36 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.39 1.471 . . . . 0.0 113.262 -174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.75 26.23 0.38 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.84 1.656 . . . . 0.0 112.804 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -120.75 148.83 43.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.919 1.688 . . . . 0.0 111.715 -171.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -78.97 -20.68 48.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -99.55 162.12 13.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.949 1.699 . . . . 0.0 111.451 176.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.4 t -74.07 -0.23 15.82 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.278 1.031 . . . . 0.0 113.6 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -157.71 124.16 2.53 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.501 1.92 . . . . 0.0 110.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -68.73 147.45 69.46 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.475 2.783 . . . . 0.0 111.999 172.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.15 -9.74 58.84 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.852 1.661 . . . . 0.0 114.151 177.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.25 17.42 10.68 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.29 1.836 . . . . 0.0 112.585 -173.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -55.45 130.87 70.39 Favored Pre-proline 0 CA--C 1.56 1.347 0 O-C-N 120.521 -1.362 . . . . 0.0 113.795 -174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -83.96 -14.75 7.25 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.286 2.658 . . . . 0.0 115.87 -175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 47.5 p -133.14 -16.91 2.42 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.402 1.456 . . . . 0.0 114.791 -175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -98.79 138.42 35.97 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.819 1.648 . . . . 0.0 109.409 169.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.82 129.2 30.0 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.439 1.095 . . . . 0.0 110.978 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.29 131.5 44.97 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.953 -0.467 . . . . 0.0 109.833 169.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.32 160.61 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.624 1.17 . . . . 0.0 110.558 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.0 m -139.57 115.6 10.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.657 0.783 . . . . 0.0 109.475 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -61.7 142.23 57.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.867 0.867 . . . . 0.0 111.841 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' HD12 ' A' ' 33' ' ' LEU . 27.0 m -134.47 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.889 0.876 . . . . 0.0 113.167 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 45.8 p-10 -83.32 -171.34 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.838 1.655 . . . . 0.0 113.23 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -69.87 -11.7 61.07 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.002 1.321 . . . . 0.0 114.379 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -102.46 -0.04 33.01 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.206 1.802 . . . . 0.0 112.537 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.04 17.02 79.03 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.906 1.241 . . . . 0.0 114.396 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.3 t -82.6 130.88 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.695 1.247 . . . . 0.0 109.628 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.13 121.09 13.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.08 1.352 . . . . 0.0 111.964 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 26' ' ' VAL . 4.7 mp -89.65 -56.54 3.21 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.038 0.935 . . . . 0.0 111.247 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.56 153.95 22.04 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.058 1.314 . . . . 0.0 112.84 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.4 p -82.98 145.69 29.2 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.068 0.947 . . . . 0.0 112.846 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -142.35 172.7 24.15 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.948 2.214 . . . . 0.0 112.318 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 72.1 t -120.4 112.89 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.368 1.067 . . . . 0.0 108.983 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 ttm -95.06 142.19 27.81 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.764 1.226 . . . . 0.0 110.754 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -146.96 129.84 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.476 1.511 . . . . 0.0 110.223 -171.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.69 127.44 54.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.648 1.179 . . . . 0.0 109.155 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.1 p -119.85 174.49 6.41 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.972 1.309 . . . . 0.0 110.868 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -69.71 -2.08 10.88 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 120.896 -1.128 . . . . 0.0 113.141 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.6 m -109.07 -41.47 4.69 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -170.29 168.82 7.95 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.285 0.948 . . . . 0.0 113.367 -169.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.08 129.19 34.44 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.7 t -121.11 141.67 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.697 1.599 . . . . 0.0 108.779 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.66 113.6 7.21 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.088 0.946 . . . . 0.0 110.249 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -90.92 130.24 36.87 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.526 1.93 . . . . 0.0 110.454 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -128.62 163.25 25.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.012 1.725 . . . . 0.0 110.808 -173.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -98.27 -29.87 12.93 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.7 mmt-85 -86.14 -17.04 36.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.615 1.566 . . . . 0.0 114.413 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.76 164.46 30.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.115 2.166 . . . . 0.0 111.01 -176.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -66.09 165.95 12.58 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.72 0.808 . . . . 0.0 110.895 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.38 129.12 39.66 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.48 -0.762 . . . . 0.0 111.903 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -108.61 130.13 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.227 1.411 . . . . 0.0 109.11 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -126.12 142.85 51.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.755 1.222 . . . . 0.0 111.825 -174.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -134.6 112.5 11.73 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.506 1.522 . . . . 0.0 110.345 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.58 140.71 57.93 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.589 2.193 . . . . 0.0 110.696 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -62.8 -21.96 66.27 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.8 -22.47 59.8 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.559 1.144 . . . . 0.0 113.529 174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -92.12 -13.08 31.3 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 171.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.2 mt -73.1 103.49 3.87 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.885 0.766 . . . . 0.0 109.771 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.4 tpp85 -68.91 -39.96 79.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.189 0.596 . . . . 0.0 111.511 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -163.23 156.45 19.21 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.348 1.459 . . . . 0.0 111.901 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -156.0 144.07 19.8 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.558 1.543 . . . . 0.0 111.164 -173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.3 173.22 29.21 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.746 1.165 . . . . 0.0 113.882 -175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -155.38 107.66 2.67 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.655 1.217 . . . . 0.0 113.421 -168.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.29 -176.68 3.47 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.772 -1.205 . . . . 0.0 111.78 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.2 p -59.7 112.96 2.01 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.122 -0.986 . . . . 0.0 110.873 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.44 22.4 13.22 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.938 1.695 . . . . 0.0 114.007 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.9 tp -143.59 139.66 29.8 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.622 -1.299 . . . . 0.0 112.42 -170.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -128.34 136.29 50.74 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.171 1.788 . . . . 0.0 109.555 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 t -146.52 150.99 36.62 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -158.38 159.73 36.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -110.68 128.8 55.85 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.104 1.762 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.4 p -100.2 152.34 20.38 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.183 1.793 . . . . 0.0 112.782 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.87 163.99 35.29 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.329 0.966 . . . . 0.0 113.687 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -68.6 13.61 0.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 -175.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.7 26.04 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.726 1.611 . . . . 0.0 114.426 -171.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 21.5 p -112.17 -175.68 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.058 1.743 . . . . 0.0 111.656 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -59.47 -29.89 68.14 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.3 p -104.81 -9.85 17.78 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.784 1.234 . . . . 0.0 113.971 -174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.22 -167.0 54.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.052 0.834 . . . . 0.0 112.566 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -77.96 122.6 25.73 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.464 0.706 . . . . 0.0 110.485 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -175.12 -176.72 43.64 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.462 1.03 . . . . 0.0 113.162 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 84.6 mt -128.59 136.62 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.918 1.287 . . . . 0.0 108.485 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -131.86 141.03 49.28 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.825 1.25 . . . . 0.0 110.506 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.93 144.13 43.27 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.072 0.939 . . . . 0.0 112.392 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -142.63 130.8 22.01 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.695 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -75.52 137.76 41.08 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.572 -0.705 . . . . 0.0 110.064 172.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.9 t -168.08 127.63 1.27 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.585 1.554 . . . . 0.0 109.933 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.2 p -70.56 -20.34 62.8 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.347 -0.846 . . . . 0.0 113.051 177.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -104.18 18.2 22.57 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.666 1.986 . . . . 0.0 112.361 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.84 -34.87 21.1 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.599 1.56 . . . . 0.0 113.986 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 -41.68 97.13 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.178 1.391 . . . . 0.0 112.677 174.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.07 -36.83 72.41 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.61 -0.681 . . . . 0.0 111.485 177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.16 -48.48 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.325 0.65 . . . . 0.0 110.065 175.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.17 -45.37 87.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.614 1.165 . . . . 0.0 111.927 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -63.31 -49.3 74.52 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.972 0.509 . . . . 0.0 112.309 176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -40.19 91.88 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.42 0.688 . . . . 0.0 111.415 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.24 -52.56 65.14 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.705 0.802 . . . . 0.0 112.013 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -68.11 -33.2 74.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.989 0.813 . . . . 0.0 112.371 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -63.35 -40.31 96.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.283 1.033 . . . . 0.0 111.896 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.8 mt -73.14 -27.06 61.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.314 1.045 . . . . 0.0 112.514 175.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.2 mtt -78.05 -38.39 44.6 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.94 0.896 . . . . 0.0 113.002 174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -88.74 -31.57 18.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.1 t 52.91 39.16 28.69 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.133 1.773 . . . . 0.0 113.688 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -154.94 153.95 31.85 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.373 1.869 . . . . 0.0 110.941 -173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.1 m 72.33 8.52 5.8 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.155 1.782 . . . . 0.0 115.022 174.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.6 mp -73.7 114.91 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 120.924 -1.11 . . . . 0.0 109.455 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -134.76 143.16 46.96 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.719 2.008 . . . . 0.0 110.595 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.1 p -73.5 133.17 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.887 0.875 . . . . 0.0 110.828 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.7 ptt? -155.93 135.47 12.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.891 1.676 . . . . 0.0 111.548 -171.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -83.9 136.38 34.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.095 1.358 . . . . 0.0 112.399 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -151.71 153.11 31.46 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.348 1.859 . . . . 0.0 109.995 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -70.7 164.05 36.84 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.46 2.773 . . . . 0.0 111.734 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 p -134.49 140.28 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.635 1.574 . . . . 0.0 110.342 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.0 mp -117.82 127.86 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 125.181 1.393 . . . . 0.0 108.351 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.5 mm -99.87 121.54 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.158 0.983 . . . . 0.0 109.812 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 61.4 m -142.85 145.85 33.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.109 1.763 . . . . 0.0 109.355 -173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.1 m -136.03 147.89 48.13 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.987 1.315 . . . . 0.0 111.087 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -85.32 -153.06 19.73 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.519 1.056 . . . . 0.0 112.84 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.3 t -156.66 166.2 34.08 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.839 1.256 . . . . 0.0 111.138 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.9 p -93.5 158.28 15.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.846 1.258 . . . . 0.0 113.125 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.95 -77.52 0.02 OUTLIER Glycine 0 N--CA 1.469 0.881 0 C-N-CA 124.596 1.094 . . . . 0.0 112.238 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t 67.24 15.68 10.03 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.615 1.566 . . . . 0.0 113.569 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.6 t -101.46 140.43 35.76 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 120.414 -1.429 . . . . 0.0 111.432 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.84 157.9 34.06 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.967 1.27 . . . . 0.0 113.699 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.8 p -172.12 156.61 4.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.074 1.749 . . . . 0.0 111.168 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 m -150.94 153.76 35.85 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.792 1.237 . . . . 0.0 111.208 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -77.36 56.57 3.7 Favored Glycine 0 N--CA 1.473 1.152 0 C-N-CA 125.173 1.368 . . . . 0.0 112.582 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.0 m -114.2 165.17 12.94 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.995 1.718 . . . . 0.0 112.689 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.7 p -76.85 -2.3 32.67 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 140.72 -123.97 2.48 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 125.646 1.593 . . . . 0.0 111.879 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 48.3 mt -54.77 148.91 12.04 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.72 1.608 . . . . 0.0 111.755 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -77.3 114.42 16.1 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.217 0.607 . . . . 0.0 110.708 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.2 121.56 22.32 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.607 0.763 . . . . 0.0 109.764 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.36 133.8 35.47 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.926 0.89 . . . . 0.0 109.951 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -71.49 -25.04 62.1 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -140.8 159.54 41.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.86 2.064 . . . . 0.0 111.726 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -82.81 124.77 76.77 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-O 118.578 -0.725 . . . . 0.0 110.686 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -83.12 -14.26 8.56 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.549 2.833 . . . . 0.0 114.356 -170.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.97 152.37 23.41 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.505 1.522 . . . . 0.0 111.526 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -91.29 -34.29 7.61 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 124.09 0.853 . . . . 0.0 113.81 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -87.92 80.79 7.68 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.234 1.814 . . . . 0.0 112.129 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 55.2 t -104.29 142.24 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.217 1.407 . . . . 0.0 111.242 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -130.36 165.08 23.28 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.761 2.825 . . . . 0.0 110.113 -175.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -130.18 136.74 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.432 1.093 . . . . 0.0 113.026 -168.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -97.59 -115.32 3.36 Favored Glycine 0 N--CA 1.467 0.728 0 C-N-CA 125.786 1.66 . . . . 0.0 112.531 -171.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -55.13 138.73 43.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.512 1.525 . . . . 0.0 112.055 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -90.96 126.85 36.19 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.419 1.088 . . . . 0.0 108.72 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -144.02 133.51 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.26 1.824 . . . . 0.0 108.393 -177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.117 1.767 . . . . 0.0 113.768 -170.856 . . . . . . . . 1 1 . 1 stop_ save_